evidence_id	assertion_id	disorder_id	disorder_name	source_file	section	section_index	path	evidence_index	reference	supports	evidence_source	snippet	explanation	raw_json
1	1	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	genetic	0	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	the deletion is de novo in more than 90% of individuals and inherited from a heterozygous parent in about 10% of individuals	GeneReviews documents the de novo vs inherited proportion.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews documents the de novo vs inherited proportion."", ""reference"": ""PMID:20301696"", ""snippet"": ""the deletion is de novo in more than 90% of individuals and inherited from a heterozygous parent in about 10% of individuals"", ""supports"": ""SUPPORT""}"
2	2	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	genetic	1	evidence	0	PMID:11242110	SUPPORT	MODEL_ORGANISM	we propose that TBX1 in humans is a key gene in the etiology of DGS/VCFS	Mouse knockout studies established TBX1 as the critical gene.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Mouse knockout studies established TBX1 as the critical gene."", ""reference"": ""PMID:11242110"", ""snippet"": ""we propose that TBX1 in humans is a key gene in the etiology of DGS/VCFS"", ""supports"": ""SUPPORT""}"
37	68	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	genetic	0	evidence	0	PMID:38844302	SUPPORT		More than 140 TTR gene variants have been associated with hATTR, with the Val30Met variant representing the most common worldwide.	This reference supports the association of the Val30Met variant with ATTR amyloidosis.	"{""explanation"": ""This reference supports the association of the Val30Met variant with ATTR amyloidosis."", ""reference"": ""PMID:38844302"", ""snippet"": ""More than 140 TTR gene variants have been associated with hATTR, with the Val30Met variant representing the most common worldwide."", ""supports"": ""SUPPORT""}"
38	68	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	genetic	0	evidence	1	PMID:24555660	SUPPORT		A previous study of the amyloidogenic transthyretin mutation TTRV30M in Northern Sweden's endemic area has shown a large variation in carrier frequency and penetrance of the trait within the area.	This reference supports the statement about the variable frequency of the Val30Met variant by population.	"{""explanation"": ""This reference supports the statement about the variable frequency of the Val30Met variant by population."", ""reference"": ""PMID:24555660"", ""snippet"": ""A previous study of the amyloidogenic transthyretin mutation TTRV30M in Northern Sweden's endemic area has shown a large variation in carrier frequency and penetrance of the trait within the area."", ""supports"": ""SUPPORT""}"
39	68	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	genetic	0	evidence	2	PMID:36941075	SUPPORT		Hereditary transthyretin amyloidosis (hATTR) is a rare autosomal dominant systemic disease with variable penetrance and heterogeneous clinical presentation.	This reference supports the statement about the variable frequency of pathogenic variants by population.	"{""explanation"": ""This reference supports the statement about the variable frequency of pathogenic variants by population."", ""reference"": ""PMID:36941075"", ""snippet"": ""Hereditary transthyretin amyloidosis (hATTR) is a rare autosomal dominant systemic disease with variable penetrance and heterogeneous clinical presentation."", ""supports"": ""SUPPORT""}"
111	101	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	genetic	0	evidence	0	PMID:15054848	SUPPORT	HUMAN_CLINICAL	Achondrogenesis type II is a lethal skeletal dysplasia caused by new dominant mutations within the type II collagen gene (COL2A1)	Confirms that ACG2 is caused by dominant mutations in the COL2A1 gene.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that ACG2 is caused by dominant mutations in the COL2A1 gene."", ""reference"": ""PMID:15054848"", ""snippet"": ""Achondrogenesis type II is a lethal skeletal dysplasia caused by new dominant mutations within the type II collagen gene (COL2A1)"", ""supports"": ""SUPPORT""}"
112	101	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	genetic	0	evidence	1	PMID:15054848	SUPPORT	HUMAN_CLINICAL	Molecular analysis of genomic DNA extracted from amniotic cells of the second fetus revealed heterozygosity for a 1340G > A missense mutation (G316D) in the COL2A1 gene	Demonstrates identification of a glycine substitution (G316D) in the COL2A1 gene causing ACG2.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates identification of a glycine substitution (G316D) in the COL2A1 gene causing ACG2."", ""reference"": ""PMID:15054848"", ""snippet"": ""Molecular analysis of genomic DNA extracted from amniotic cells of the second fetus revealed heterozygosity for a 1340G > A missense mutation (G316D) in the COL2A1 gene"", ""supports"": ""SUPPORT""}"
113	101	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	genetic	0	evidence	2	PMID:10745044	SUPPORT	HUMAN_CLINICAL	Achondrogenesis II-hypochondrogenesis and severe spondyloepiphyseal dysplasia congenita (SEDC) are lethal forms of dwarfism caused by dominant mutations in the type II collagen gene (COL2A1)	Confirms that dominant COL2A1 mutations cause achondrogenesis II-hypochondrogenesis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that dominant COL2A1 mutations cause achondrogenesis II-hypochondrogenesis."", ""reference"": ""PMID:10745044"", ""snippet"": ""Achondrogenesis II-hypochondrogenesis and severe spondyloepiphyseal dysplasia congenita (SEDC) are lethal forms of dwarfism caused by dominant mutations in the type II collagen gene (COL2A1)"", ""supports"": ""SUPPORT""}"
123	115	6	Achondroplasia	Achondroplasia.yaml	genetic	0	evidence	0	PMID:7847369	SUPPORT	HUMAN_CLINICAL	The homogeneity of mutations in achondroplasia is unprecedented for an autosomal dominant disorder and may explain the relative lack of heterogeneity in the achondroplasia phenotype.	Study of 154 patients showed that 153 had the same G380R mutation, demonstrating the remarkable genetic homogeneity of achondroplasia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study of 154 patients showed that 153 had the same G380R mutation, demonstrating the remarkable genetic homogeneity of achondroplasia."", ""reference"": ""PMID:7847369"", ""snippet"": ""The homogeneity of mutations in achondroplasia is unprecedented for an autosomal dominant disorder and may explain the relative lack of heterogeneity in the achondroplasia phenotype."", ""supports"": ""SUPPORT""}"
124	115	6	Achondroplasia	Achondroplasia.yaml	genetic	0	variants[0].evidence	0	PMID:7913883	SUPPORT	HUMAN_CLINICAL	Both mutations result in the substitution of an arginine residue for a glycine at position 380 of the mature protein, which is in the transmembrane domain of FGFR3.	Original discovery paper identifying the specific G380R substitution in the FGFR3 transmembrane domain as the cause of achondroplasia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Original discovery paper identifying the specific G380R substitution in the FGFR3 transmembrane domain as the cause of achondroplasia."", ""reference"": ""PMID:7913883"", ""snippet"": ""Both mutations result in the substitution of an arginine residue for a glycine at position 380 of the mature protein, which is in the transmembrane domain of FGFR3."", ""supports"": ""SUPPORT""}"
131	132	7	Achoo Syndrome	Achoo_Syndrome.yaml	genetic	0	evidence	0	PMID:30899065	SUPPORT		reproducibly identified both a replicative rs10427255 on 2q22.3 and a novel locus of rs1032507 on 3p12.1	GWAS-identified risk locus replicated across populations.	"{""explanation"": ""GWAS-identified risk locus replicated across populations."", ""reference"": ""PMID:30899065"", ""snippet"": ""reproducibly identified both a replicative rs10427255 on 2q22.3 and a novel locus of rs1032507 on 3p12.1"", ""supports"": ""SUPPORT""}"
132	133	7	Achoo Syndrome	Achoo_Syndrome.yaml	genetic	1	evidence	0	PMID:30899065	SUPPORT		a novel locus of rs1032507 on 3p12.1	Novel protective locus near CADM2, which has plausible neurobiological function.	"{""explanation"": ""Novel protective locus near CADM2, which has plausible neurobiological function."", ""reference"": ""PMID:30899065"", ""snippet"": ""a novel locus of rs1032507 on 3p12.1"", ""supports"": ""SUPPORT""}"
133	134	7	Achoo Syndrome	Achoo_Syndrome.yaml	genetic	2	evidence	0	PMID:30899065	PARTIAL		rs10427255 was 848 kb downstream of ZEB2 (Zinc Finger E-Box Binding Homeobox 2)	Association is intergenic; ZEB2 involvement is hypothetical.	"{""explanation"": ""Association is intergenic; ZEB2 involvement is hypothetical."", ""reference"": ""PMID:30899065"", ""snippet"": ""rs10427255 was 848 kb downstream of ZEB2 (Zinc Finger E-Box Binding Homeobox 2)"", ""supports"": ""PARTIAL""}"
134	135	7	Achoo Syndrome	Achoo_Syndrome.yaml	genetic	3	evidence	0	PMID:30899065	PARTIAL		the variant of rs1032507 is adjacently upstream of the coding region of CADM2	Plausible biological candidate but causal role not proven.	"{""explanation"": ""Plausible biological candidate but causal role not proven."", ""reference"": ""PMID:30899065"", ""snippet"": ""the variant of rs1032507 is adjacently upstream of the coding region of CADM2"", ""supports"": ""PARTIAL""}"
135	136	7	Achoo Syndrome	Achoo_Syndrome.yaml	genetic	4	evidence	0	PMID:34133943	SUPPORT		neuromedin B (NMB) peptide is essential for signaling sneezing	NMB is the key neuropeptide mediating the sneeze reflex.	"{""explanation"": ""NMB is the key neuropeptide mediating the sneeze reflex."", ""reference"": ""PMID:34133943"", ""snippet"": ""neuromedin B (NMB) peptide is essential for signaling sneezing"", ""supports"": ""SUPPORT""}"
136	137	7	Achoo Syndrome	Achoo_Syndrome.yaml	genetic	5	evidence	0	PMID:34133943	SUPPORT		deficiency in NMB receptor abolished the sneezing reflex	NMBR-expressing neurons are essential for the sneeze reflex circuit.	"{""explanation"": ""NMBR-expressing neurons are essential for the sneeze reflex circuit."", ""reference"": ""PMID:34133943"", ""snippet"": ""deficiency in NMB receptor abolished the sneezing reflex"", ""supports"": ""SUPPORT""}"
163	165	8	Acne Vulgaris	Acne_Vulgaris.yaml	genetic	0	evidence	0	PMID:32748305	SUPPORT		It is known that multiple factors impact acne pathophysiology, including genetic, hormonal, inflammatory, and environmental influences.	This review explicitly identifies genetic factors as one of the key influences on acne pathophysiology.	"{""explanation"": ""This review explicitly identifies genetic factors as one of the key influences on acne pathophysiology."", ""reference"": ""PMID:32748305"", ""snippet"": ""It is known that multiple factors impact acne pathophysiology, including genetic, hormonal, inflammatory, and environmental influences."", ""supports"": ""SUPPORT""}"
164	165	8	Acne Vulgaris	Acne_Vulgaris.yaml	genetic	0	evidence	1	PMID:40689430	SUPPORT		Both GWAS and single gene disorders unequivocally indicate stem/progenitor cell maintenance and cellular migration as the most important processes in the pathogenesis of acne.	This genetics review connects GWAS and monogenic findings to core biological processes underlying acne susceptibility.	"{""explanation"": ""This genetics review connects GWAS and monogenic findings to core biological processes underlying acne susceptibility."", ""reference"": ""PMID:40689430"", ""snippet"": ""Both GWAS and single gene disorders unequivocally indicate stem/progenitor cell maintenance and cellular migration as the most important processes in the pathogenesis of acne."", ""supports"": ""SUPPORT""}"
165	166	8	Acne Vulgaris	Acne_Vulgaris.yaml	genetic	1	evidence	0	PMID:37662507	SUPPORT		some genes (such as IL, TNF, RETN, CYP family, MMPs and TIMPs genes et al) are associated with acne vulgaris and may affect the progression and prognosis of the disease.	This review summarizes multiple gene families repeatedly implicated in acne susceptibility and outcomes.	"{""explanation"": ""This review summarizes multiple gene families repeatedly implicated in acne susceptibility and outcomes."", ""reference"": ""PMID:37662507"", ""snippet"": ""some genes (such as IL, TNF, RETN, CYP family, MMPs and TIMPs genes et al) are associated with acne vulgaris and may affect the progression and prognosis of the disease."", ""supports"": ""SUPPORT""}"
166	167	8	Acne Vulgaris	Acne_Vulgaris.yaml	genetic	2	evidence	0	PMID:35279931	SUPPORT		There is a strong correlation between RETN-420 and IL6-572 polymorphisms and acne susceptibility; the RETN-420G and IL6-572C alleles increase the risk of acne development.	This study reports RETN-420 and IL6-572 risk alleles associated with acne susceptibility.	"{""explanation"": ""This study reports RETN-420 and IL6-572 risk alleles associated with acne susceptibility."", ""reference"": ""PMID:35279931"", ""snippet"": ""There is a strong correlation between RETN-420 and IL6-572 polymorphisms and acne susceptibility; the RETN-420G and IL6-572C alleles increase the risk of acne development."", ""supports"": ""SUPPORT""}"
167	168	8	Acne Vulgaris	Acne_Vulgaris.yaml	genetic	3	evidence	0	PMID:20861605	SUPPORT		The 196R allele of TNFR2 M196R as well as the 753Gln allele of TLR2 Arg753Gln are risk factors for acne vulgaris in Chinese Han patients, further supporting the contribution of inflammatory cytokines to the pathogenesis of acne.	This study links TNFR2 and TLR2 risk alleles to acne susceptibility in a Chinese Han cohort.	"{""explanation"": ""This study links TNFR2 and TLR2 risk alleles to acne susceptibility in a Chinese Han cohort."", ""reference"": ""PMID:20861605"", ""snippet"": ""The 196R allele of TNFR2 M196R as well as the 753Gln allele of TLR2 Arg753Gln are risk factors for acne vulgaris in Chinese Han patients, further supporting the contribution of inflammatory cytokines to the pathogenesis of acne."", ""supports"": ""SUPPORT""}"
322	244	10	Addison's Disease	Addisons_Disease.yaml	genetic	0	evidence	0	PMID:34665570	SUPPORT		The most common cause of primary adrenal failure (Addison's disease) in the Western world is autoimmunity characterized by autoantibodies against the steroidogenic enzyme 21-hydroxylase (CYP21A2, 21OH)	This study demonstrates that 21-hydroxylase is the major autoantigen in autoimmune Addison's disease.	"{""explanation"": ""This study demonstrates that 21-hydroxylase is the major autoantigen in autoimmune Addison's disease."", ""reference"": ""PMID:34665570"", ""snippet"": ""The most common cause of primary adrenal failure (Addison's disease) in the Western world is autoimmunity characterized by autoantibodies against the steroidogenic enzyme 21-hydroxylase (CYP21A2, 21OH)"", ""supports"": ""SUPPORT""}"
323	245	10	Addison's Disease	Addisons_Disease.yaml	genetic	1	evidence	0	PMID:33717087	SUPPORT		The autoimmune polyglandular syndrome type 1 (APS1) is caused by pathogenic variants of the autoimmune regulator (AIRE) gene.	The literature clearly states that APS1, which includes Addison's disease, is caused by mutations in the AIRE gene.	"{""explanation"": ""The literature clearly states that APS1, which includes Addison's disease, is caused by mutations in the AIRE gene."", ""reference"": ""PMID:33717087"", ""snippet"": ""The autoimmune polyglandular syndrome type 1 (APS1) is caused by pathogenic variants of the autoimmune regulator (AIRE) gene."", ""supports"": ""SUPPORT""}"
324	245	10	Addison's Disease	Addisons_Disease.yaml	genetic	1	evidence	1	PMID:25667374	SUPPORT		The genetic mutations associated with several familial causes of adrenal insufficiency have now been identified... autoimmune polyglandular syndrome type 1.	APS1 is listed among the genetic causes of adrenal insufficiency, which is directly related to Addison's disease.	"{""explanation"": ""APS1 is listed among the genetic causes of adrenal insufficiency, which is directly related to Addison's disease."", ""reference"": ""PMID:25667374"", ""snippet"": ""The genetic mutations associated with several familial causes of adrenal insufficiency have now been identified... autoimmune polyglandular syndrome type 1."", ""supports"": ""SUPPORT""}"
325	245	10	Addison's Disease	Addisons_Disease.yaml	genetic	1	evidence	2	PMID:24988226	SUPPORT		Autoimmune polyglandular syndrome type 1 (APS-1, OMIM 240300) is a rare autosomal recessive disorder... We identified a novel homozygous mutation in the splice site acceptor (SSA) of intron 5 (c.653-1G>A) in two siblings with different clinical outcomes of APS-1.	This study identifies specific mutations in the AIRE gene associated with APS1, which includes Addison's disease.	"{""explanation"": ""This study identifies specific mutations in the AIRE gene associated with APS1, which includes Addison's disease."", ""reference"": ""PMID:24988226"", ""snippet"": ""Autoimmune polyglandular syndrome type 1 (APS-1, OMIM 240300) is a rare autosomal recessive disorder... We identified a novel homozygous mutation in the splice site acceptor (SSA) of intron 5 (c.653-1G>A) in two siblings with different clinical outcomes of APS-1."", ""supports"": ""SUPPORT""}"
326	245	10	Addison's Disease	Addisons_Disease.yaml	genetic	1	evidence	3	PMID:22344197	SUPPORT		Autoimmune polyendocrine syndrome type 1 (APS1) is a childhood-onset monogenic disorder caused by mutations in the autoimmune regulator (AIRE) gene.	The literature confirms that APS1 is caused by mutations in the AIRE gene, supporting the association with Addison's disease.	"{""explanation"": ""The literature confirms that APS1 is caused by mutations in the AIRE gene, supporting the association with Addison's disease."", ""reference"": ""PMID:22344197"", ""snippet"": ""Autoimmune polyendocrine syndrome type 1 (APS1) is a childhood-onset monogenic disorder caused by mutations in the autoimmune regulator (AIRE) gene."", ""supports"": ""SUPPORT""}"
327	245	10	Addison's Disease	Addisons_Disease.yaml	genetic	1	evidence	4	PMID:24014553	SUPPORT		Of the patients with APS1, 96% were revealed to have AIRE gene mutations.	The high prevalence of AIRE gene mutations in APS1 patients supports the genetic link to Addison's disease.	"{""explanation"": ""The high prevalence of AIRE gene mutations in APS1 patients supports the genetic link to Addison's disease."", ""reference"": ""PMID:24014553"", ""snippet"": ""Of the patients with APS1, 96% were revealed to have AIRE gene mutations."", ""supports"": ""SUPPORT""}"
328	246	10	Addison's Disease	Addisons_Disease.yaml	genetic	2	evidence	0	PMID:12392510	SUPPORT		Susceptibility to Addison's disease is influenced by the genes around MICA and D6S273 for both the HLA DR3-DQ2 and DR4-DQ8 haplotypes	This study demonstrates that HLA-DR3-DQ2 and DR4-DQ8 haplotypes are major susceptibility markers for Addison's disease.	"{""explanation"": ""This study demonstrates that HLA-DR3-DQ2 and DR4-DQ8 haplotypes are major susceptibility markers for Addison's disease."", ""reference"": ""PMID:12392510"", ""snippet"": ""Susceptibility to Addison's disease is influenced by the genes around MICA and D6S273 for both the HLA DR3-DQ2 and DR4-DQ8 haplotypes"", ""supports"": ""SUPPORT""}"
329	247	10	Addison's Disease	Addisons_Disease.yaml	genetic	3	evidence	0	PMID:26204230	SUPPORT		The G-allele of SNP rs231775 in CTLA-4 is associated with AAD in Norwegian patients (odds ratio (OR)=1.35 (confidence interval (CI) 1.10-1.66), P=0.004)	This study demonstrates that CTLA4 variants are a genetic susceptibility locus for autoimmune Addison's disease.	"{""explanation"": ""This study demonstrates that CTLA4 variants are a genetic susceptibility locus for autoimmune Addison's disease."", ""reference"": ""PMID:26204230"", ""snippet"": ""The G-allele of SNP rs231775 in CTLA-4 is associated with AAD in Norwegian patients (odds ratio (OR)=1.35 (confidence interval (CI) 1.10-1.66), P=0.004)"", ""supports"": ""SUPPORT""}"
330	248	10	Addison's Disease	Addisons_Disease.yaml	genetic	4	evidence	0	PMID:18301444	SUPPORT		the 1858T-allele is a PTPN22 genetic susceptibility factor for autoimmune AD	This study demonstrates that PTPN22 1858T-allele is associated with autoimmune Addison's disease susceptibility.	"{""explanation"": ""This study demonstrates that PTPN22 1858T-allele is associated with autoimmune Addison's disease susceptibility."", ""reference"": ""PMID:18301444"", ""snippet"": ""the 1858T-allele is a PTPN22 genetic susceptibility factor for autoimmune AD"", ""supports"": ""SUPPORT""}"
487	410	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	0	evidence	0	PMID:1365885	SUPPORT		Four mutations involving amino acid substitutions in exons 16 and 17 of the amyloid precursor protein (APP) gene, have been identified which co-segregate with the disease in some families multiply affected by early onset Alzheimer's disease.	This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease.	"{""explanation"": ""This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease."", ""reference"": ""PMID:1365885"", ""snippet"": ""Four mutations involving amino acid substitutions in exons 16 and 17 of the amyloid precursor protein (APP) gene, have been identified which co-segregate with the disease in some families multiply affected by early onset Alzheimer's disease."", ""supports"": ""SUPPORT""}"
488	410	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	0	evidence	1	PMID:33789815	SUPPORT		This is the first case demonstrating that a low-degree APP gene-dose increase suffices to cause EOAD with prominent amyloid-beta/tau pathology.	This reference supports the role of APP gene mutations in causing early-onset Alzheimer's disease.	"{""explanation"": ""This reference supports the role of APP gene mutations in causing early-onset Alzheimer's disease."", ""reference"": ""PMID:33789815"", ""snippet"": ""This is the first case demonstrating that a low-degree APP gene-dose increase suffices to cause EOAD with prominent amyloid-beta/tau pathology."", ""supports"": ""SUPPORT""}"
489	410	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	0	evidence	2	PMID:36306459	SUPPORT		Numerous mutations in amyloid precursor protein (APP) and presenilin 1 and 2 (PSEN1 and PSEN2) have been identified for EOAD, but they can only account for a small proportion of EOAD cases.	This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease.	"{""explanation"": ""This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease."", ""reference"": ""PMID:36306459"", ""snippet"": ""Numerous mutations in amyloid precursor protein (APP) and presenilin 1 and 2 (PSEN1 and PSEN2) have been identified for EOAD, but they can only account for a small proportion of EOAD cases."", ""supports"": ""SUPPORT""}"
490	410	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	0	evidence	3	PMID:31623876	SUPPORT		In this study, a novel mutation in APP gene, Val669Leu ('Seoul APP'), was reported in a Korean female patient with Alzheimer's disease.	This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease.	"{""explanation"": ""This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease."", ""reference"": ""PMID:31623876"", ""snippet"": ""In this study, a novel mutation in APP gene, Val669Leu ('Seoul APP'), was reported in a Korean female patient with Alzheimer's disease."", ""supports"": ""SUPPORT""}"
491	410	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	0	evidence	4	PMID:26243569	SUPPORT		It is thought that this risk is conferred by the presence of three copies of the gene encoding amyloid precursor protein (APP)--an Alzheimer disease risk factor.	This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease.	"{""explanation"": ""This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease."", ""reference"": ""PMID:26243569"", ""snippet"": ""It is thought that this risk is conferred by the presence of three copies of the gene encoding amyloid precursor protein (APP)--an Alzheimer disease risk factor."", ""supports"": ""SUPPORT""}"
492	410	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	0	evidence	5	PMID:22727994	SUPPORT		APP mutations cause Alzheimer disease (AD) with virtually complete penetrance.	This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease.	"{""explanation"": ""This reference supports the association of APP genetic mutations with early-onset Alzheimer's disease."", ""reference"": ""PMID:22727994"", ""snippet"": ""APP mutations cause Alzheimer disease (AD) with virtually complete penetrance."", ""supports"": ""SUPPORT""}"
493	411	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	1	evidence	0	PMID:31296348	SUPPORT		Presenilin 1 (PSEN1) gene mutations are the major known genetic cause of early-onset Alzheimer's disease.	The study reports a novel PSEN1 mutation associated with early-onset Alzheimer's disease, supporting the genetic association.	"{""explanation"": ""The study reports a novel PSEN1 mutation associated with early-onset Alzheimer's disease, supporting the genetic association."", ""reference"": ""PMID:31296348"", ""snippet"": ""Presenilin 1 (PSEN1) gene mutations are the major known genetic cause of early-onset Alzheimer's disease."", ""supports"": ""SUPPORT""}"
494	411	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	1	evidence	1	PMID:35487021	SUPPORT		At present, three early-onset AD genes (APP, PSEN1, PSEN2) and one late-onset AD susceptibility gene apolipoprotein E (APOE) have been determined.	The reference confirms that PSEN1 is one of the genes associated with early-onset Alzheimer's disease.	"{""explanation"": ""The reference confirms that PSEN1 is one of the genes associated with early-onset Alzheimer's disease."", ""reference"": ""PMID:35487021"", ""snippet"": ""At present, three early-onset AD genes (APP, PSEN1, PSEN2) and one late-onset AD susceptibility gene apolipoprotein E (APOE) have been determined."", ""supports"": ""SUPPORT""}"
495	411	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	1	evidence	2	PMID:36951251	SUPPORT		A genetic association study was conducted to examine ADAD AAO in 340 individuals with the PSEN1 E280A mutation.	The study discusses a large cohort with a specific PSEN1 mutation associated with early-onset Alzheimer's disease, reinforcing the genetic link.	"{""explanation"": ""The study discusses a large cohort with a specific PSEN1 mutation associated with early-onset Alzheimer's disease, reinforcing the genetic link."", ""reference"": ""PMID:36951251"", ""snippet"": ""A genetic association study was conducted to examine ADAD AAO in 340 individuals with the PSEN1 E280A mutation."", ""supports"": ""SUPPORT""}"
496	411	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	1	evidence	3	PMID:36641620	SUPPORT		Early-onset AD represents about 5.5% of the total cases and occurs in patients under age 65. The EOAD progresses more aggressively and has a shorter life expectancy due to a greater pathogenic load.	The reference discusses early-onset Alzheimer's disease and mentions PSEN1 mutations, supporting the genetic association.	"{""explanation"": ""The reference discusses early-onset Alzheimer's disease and mentions PSEN1 mutations, supporting the genetic association."", ""reference"": ""PMID:36641620"", ""snippet"": ""Early-onset AD represents about 5.5% of the total cases and occurs in patients under age 65. The EOAD progresses more aggressively and has a shorter life expectancy due to a greater pathogenic load."", ""supports"": ""SUPPORT""}"
497	411	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	1	evidence	4	PMID:35430993	SUPPORT		Early-onset Alzheimer's disease (EOAD) is commonly diagnosed with an onset age of earlier than 65 years and accounts for 5-10% of all Alzheimer's disease (AD) cases.	The study highlights the occurrence of early-onset Alzheimer's disease and mentions PSEN1 mutations, supporting the genetic link.	"{""explanation"": ""The study highlights the occurrence of early-onset Alzheimer's disease and mentions PSEN1 mutations, supporting the genetic link."", ""reference"": ""PMID:35430993"", ""snippet"": ""Early-onset Alzheimer's disease (EOAD) is commonly diagnosed with an onset age of earlier than 65 years and accounts for 5-10% of all Alzheimer's disease (AD) cases."", ""supports"": ""SUPPORT""}"
498	411	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	1	evidence	5	PMID:30549411	SUPPORT		The gene mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) are the frequent causes of AD.	The reference confirms that PSEN1 mutations are a frequent cause of early-onset Alzheimer's disease.	"{""explanation"": ""The reference confirms that PSEN1 mutations are a frequent cause of early-onset Alzheimer's disease."", ""reference"": ""PMID:30549411"", ""snippet"": ""The gene mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) are the frequent causes of AD."", ""supports"": ""SUPPORT""}"
499	412	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	2	evidence	0	PMID:35491795	SUPPORT		The established causative mutations in the APP, PSEN1, and PSEN2 can explain less than 1%, Alzheimer''s disease (AD) patients. Of the identified variants, the PSEN2 mutations are even less common.	The reference confirms that PSEN2 mutations are among the causative factors for early-onset Alzheimer's disease.	"{""explanation"": ""The reference confirms that PSEN2 mutations are among the causative factors for early-onset Alzheimer's disease."", ""reference"": ""PMID:35491795"", ""snippet"": ""The established causative mutations in the APP, PSEN1, and PSEN2 can explain less than 1%, Alzheimer''s disease (AD) patients. Of the identified variants, the PSEN2 mutations are even less common."", ""supports"": ""SUPPORT""}"
500	412	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	2	evidence	1	PMID:36701017	SUPPORT		Early-onset AD (EOAD) was defined as AD occurring before age 65. Although it has a high genetic risk, EOAD due to PSEN2 variation is very rare.	The reference supports the association of PSEN2 with early-onset Alzheimer's disease, although it notes that such cases are rare.	"{""explanation"": ""The reference supports the association of PSEN2 with early-onset Alzheimer's disease, although it notes that such cases are rare."", ""reference"": ""PMID:36701017"", ""snippet"": ""Early-onset AD (EOAD) was defined as AD occurring before age 65. Although it has a high genetic risk, EOAD due to PSEN2 variation is very rare."", ""supports"": ""SUPPORT""}"
501	412	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	genetic	2	evidence	2	PMID:32741831	SUPPORT		Early-onset familial Alzheimer disease (EOFAD) is caused by heterozygous variants in the presenilin 1 (PSEN1), presenilin 2 (PSEN2), and APP genes.	The reference explicitly states that early-onset familial Alzheimer's disease can be caused by PSEN2 mutations.	"{""explanation"": ""The reference explicitly states that early-onset familial Alzheimer's disease can be caused by PSEN2 mutations."", ""reference"": ""PMID:32741831"", ""snippet"": ""Early-onset familial Alzheimer disease (EOFAD) is caused by heterozygous variants in the presenilin 1 (PSEN1), presenilin 2 (PSEN2), and APP genes."", ""supports"": ""SUPPORT""}"
617	496	21	Alzheimer's Disease	Alzheimers_Disease.yaml	genetic	0	evidence	0	PMID:28002825	SUPPORT		Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years.	This confirms that APP mutations cause autosomal dominant early-onset Alzheimer's disease.	"{""explanation"": ""This confirms that APP mutations cause autosomal dominant early-onset Alzheimer's disease."", ""reference"": ""PMID:28002825"", ""snippet"": ""Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years."", ""supports"": ""SUPPORT""}"
618	497	21	Alzheimer's Disease	Alzheimers_Disease.yaml	genetic	1	evidence	0	PMID:28002825	SUPPORT		Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years.	This confirms that PSEN1 mutations cause autosomal dominant early-onset Alzheimer's disease with high penetrance.	"{""explanation"": ""This confirms that PSEN1 mutations cause autosomal dominant early-onset Alzheimer's disease with high penetrance."", ""reference"": ""PMID:28002825"", ""snippet"": ""Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years."", ""supports"": ""SUPPORT""}"
619	498	21	Alzheimer's Disease	Alzheimers_Disease.yaml	genetic	2	evidence	0	PMID:28002825	SUPPORT		Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years.	This confirms that PSEN2 mutations can cause autosomal dominant early-onset Alzheimer's disease.	"{""explanation"": ""This confirms that PSEN2 mutations can cause autosomal dominant early-onset Alzheimer's disease."", ""reference"": ""PMID:28002825"", ""snippet"": ""Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years."", ""supports"": ""SUPPORT""}"
620	499	21	Alzheimer's Disease	Alzheimers_Disease.yaml	genetic	3	evidence	0	PMID:28002825	SUPPORT		Among them, the APOE ε4 allele is a rare example of a common allele with a large effect size, the ORs ranging from 4 to 11-14 for heterozygous and homozygous carriers, respectively.	This demonstrates the substantial genetic risk conferred by the APOE ε4 allele for Alzheimer's disease.	"{""explanation"": ""This demonstrates the substantial genetic risk conferred by the APOE ε4 allele for Alzheimer's disease."", ""reference"": ""PMID:28002825"", ""snippet"": ""Among them, the APOE ε4 allele is a rare example of a common allele with a large effect size, the ORs ranging from 4 to 11-14 for heterozygous and homozygous carriers, respectively."", ""supports"": ""SUPPORT""}"
621	499	21	Alzheimer's Disease	Alzheimers_Disease.yaml	genetic	3	evidence	1	PMID:24459411	SUPPORT		The investigation of AD memory loss helps to identify the involved neural structures, such as the default mode network, the influence of epigenetic and genetic factors, such as ApoE4 status, and evolutionary aspects of human cognition.	This reference highlights ApoE4 as an important genetic factor influencing Alzheimer's disease pathology and memory loss.	"{""explanation"": ""This reference highlights ApoE4 as an important genetic factor influencing Alzheimer's disease pathology and memory loss."", ""reference"": ""PMID:24459411"", ""snippet"": ""The investigation of AD memory loss helps to identify the involved neural structures, such as the default mode network, the influence of epigenetic and genetic factors, such as ApoE4 status, and evolutionary aspects of human cognition."", ""supports"": ""SUPPORT""}"
643	522	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	genetic	0	evidence	0	PMID:21944778	SUPPORT		Analysis of extended clinical series found the C9ORF72 repeat expansion to be the most common genetic abnormality in both familial FTD (11.7%) and familial ALS (23.5%)	Original discovery paper establishing C9orf72 as the most common genetic cause of familial ALS.	"{""explanation"": ""Original discovery paper establishing C9orf72 as the most common genetic cause of familial ALS."", ""reference"": ""PMID:21944778"", ""snippet"": ""Analysis of extended clinical series found the C9ORF72 repeat expansion to be the most common genetic abnormality in both familial FTD (11.7%) and familial ALS (23.5%)"", ""supports"": ""SUPPORT""}"
644	523	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	genetic	1	evidence	0	PMID:8446170	SUPPORT		We identified 11 different SOD1 missense mutations in 13 different FALS families.	Original discovery paper identifying SOD1 mutations as a cause of familial ALS.	"{""explanation"": ""Original discovery paper identifying SOD1 mutations as a cause of familial ALS."", ""reference"": ""PMID:8446170"", ""snippet"": ""We identified 11 different SOD1 missense mutations in 13 different FALS families."", ""supports"": ""SUPPORT""}"
645	524	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	genetic	2	evidence	0	PMID:35805149	SUPPORT		Mutations in C9orf72, SOD1, TAR DNA binding protein 43 (TARDBP), and fused in sarcoma (FUS) genes are the four most common ones.	Gene therapy review highlights TARDBP among the most common ALS genes targeted by therapeutic strategies.	"{""explanation"": ""Gene therapy review highlights TARDBP among the most common ALS genes targeted by therapeutic strategies."", ""reference"": ""PMID:35805149"", ""snippet"": ""Mutations in C9orf72, SOD1, TAR DNA binding protein 43 (TARDBP), and fused in sarcoma (FUS) genes are the four most common ones."", ""supports"": ""SUPPORT""}"
646	525	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	genetic	3	evidence	0	PMID:35805149	SUPPORT		Mutations in C9orf72, SOD1, TAR DNA binding protein 43 (TARDBP), and fused in sarcoma (FUS) genes are the four most common ones.	Review notes FUS among the four most common ALS genes and discusses gene-targeted therapies.	"{""explanation"": ""Review notes FUS among the four most common ALS genes and discusses gene-targeted therapies."", ""reference"": ""PMID:35805149"", ""snippet"": ""Mutations in C9orf72, SOD1, TAR DNA binding protein 43 (TARDBP), and fused in sarcoma (FUS) genes are the four most common ones."", ""supports"": ""SUPPORT""}"
647	526	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	genetic	4	evidence	0	PMID:27455347	SUPPORT		In total, we observed NEK1 risk variants in nearly 3% of ALS cases. NEK1 has been linked to several cellular functions, including cilia formation, DNA-damage response, microtubule stability, neuronal morphology and axonal polarity.	Large-scale genetic study identifying NEK1 variants as risk factors for ALS.	"{""explanation"": ""Large-scale genetic study identifying NEK1 variants as risk factors for ALS."", ""reference"": ""PMID:27455347"", ""snippet"": ""In total, we observed NEK1 risk variants in nearly 3% of ALS cases. NEK1 has been linked to several cellular functions, including cilia formation, DNA-damage response, microtubule stability, neuronal morphology and axonal polarity."", ""supports"": ""SUPPORT""}"
682	559	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	genetic	0	evidence	0	PMID:33692806	SUPPORT		The strongest genetic association is with the allele human leukocyte antigen B27 (HLA-B27) of the Major Histocompatibility Complex-I (MHC-I) gene, located on chromosome 6 (98).	Evidence confirming HLA-B27 as the strongest genetic risk factor for ankylosing spondylitis.	"{""explanation"": ""Evidence confirming HLA-B27 as the strongest genetic risk factor for ankylosing spondylitis."", ""reference"": ""PMID:33692806"", ""snippet"": ""The strongest genetic association is with the allele human leukocyte antigen B27 (HLA-B27) of the Major Histocompatibility Complex-I (MHC-I) gene, located on chromosome 6 (98)."", ""supports"": ""SUPPORT""}"
683	560	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	genetic	1	evidence	0	PMID:33692806	SUPPORT		In particular, single nucleotide polymorphisms (SNPs) in genes coding for aminopeptidases expressed in the endoplasmic reticulum (ER), such as ERAP1 and ERAP2, were identified in the past decade. These proteins trim peptides in the ER so that these molecules get to the right length, usually between 8 and 10 amino acids, to be presented by MHC-I molecules (107).	Evidence that ERAP1 genetic variants are associated with ankylosing spondylitis through effects on antigen processing and MHC-I presentation.	"{""explanation"": ""Evidence that ERAP1 genetic variants are associated with ankylosing spondylitis through effects on antigen processing and MHC-I presentation."", ""reference"": ""PMID:33692806"", ""snippet"": ""In particular, single nucleotide polymorphisms (SNPs) in genes coding for aminopeptidases expressed in the endoplasmic reticulum (ER), such as ERAP1 and ERAP2, were identified in the past decade. These proteins trim peptides in the ER so that these molecules get to the right length, usually between 8 and 10 amino acids, to be presented by MHC-I molecules (107)."", ""supports"": ""SUPPORT""}"
684	561	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	genetic	2	evidence	0	PMID:33692806	SUPPORT		SNPs directly affecting the IL-23/IL-17 axis were described in AS and further stress the importance of this pathway. The most relevant are located in the genes coding for IL-23R and STAT3 and TYK2, which are downstream targets of IL-23 signaling (110, 111).	Evidence that IL23R variants are associated with ankylosing spondylitis, highlighting the importance of the IL-23/IL-17 pathway.	"{""explanation"": ""Evidence that IL23R variants are associated with ankylosing spondylitis, highlighting the importance of the IL-23/IL-17 pathway."", ""reference"": ""PMID:33692806"", ""snippet"": ""SNPs directly affecting the IL-23/IL-17 axis were described in AS and further stress the importance of this pathway. The most relevant are located in the genes coding for IL-23R and STAT3 and TYK2, which are downstream targets of IL-23 signaling (110, 111)."", ""supports"": ""SUPPORT""}"
706	580	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	genetic	0	evidence	0	PMID:12967526	NO_EVIDENCE		Multiple human leukocyte antigen-DR or -DQ associations with antiphospholipid antibodies have been described.	The reference mentions various HLA-DR associations with antiphospholipid antibodies but does not specifically mention HLA-DR7.	"{""explanation"": ""The reference mentions various HLA-DR associations with antiphospholipid antibodies but does not specifically mention HLA-DR7."", ""reference"": ""PMID:12967526"", ""snippet"": ""Multiple human leukocyte antigen-DR or -DQ associations with antiphospholipid antibodies have been described."", ""supports"": ""NO_EVIDENCE""}"
707	580	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	genetic	0	evidence	1	PMID:19758197	NO_EVIDENCE		We found that, as reported in the literature, the occurrence of DRB1*03 and DQB1*0201 alleles was higher in SLE patients than in controls, but these alleles were rare in the PAPS+SLE group.	This reference does not mention HLA-DR7 in the context of antiphospholipid syndrome.	"{""explanation"": ""This reference does not mention HLA-DR7 in the context of antiphospholipid syndrome."", ""reference"": ""PMID:19758197"", ""snippet"": ""We found that, as reported in the literature, the occurrence of DRB1*03 and DQB1*0201 alleles was higher in SLE patients than in controls, but these alleles were rare in the PAPS+SLE group."", ""supports"": ""NO_EVIDENCE""}"
708	580	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	genetic	0	evidence	2	PMID:7767340	SUPPORT		In conclusion, in PAPS patients from the South of Spain, HLA-DQ7 antigen showed the highest relative risk for PAPS, followed by DRw53.	Although HLA-DR7 is not specifically mentioned, this study discusses HLA-DR associations and could support the association indirectly. However, the mention of HLA-DR7 is more explicitly connected to diabetic retinopathy rather than APS.	"{""explanation"": ""Although HLA-DR7 is not specifically mentioned, this study discusses HLA-DR associations and could support the association indirectly. However, the mention of HLA-DR7 is more explicitly connected to diabetic retinopathy rather than APS."", ""reference"": ""PMID:7767340"", ""snippet"": ""In conclusion, in PAPS patients from the South of Spain, HLA-DQ7 antigen showed the highest relative risk for PAPS, followed by DRw53."", ""supports"": ""SUPPORT""}"
709	580	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	genetic	0	evidence	3	PMID:11886709	NO_EVIDENCE		Our results suggest that the presence of HLA-DR7 protects against the development of proliferative disease in the diabetic Mexican population.	HLA-DR7 is discussed in the context of diabetic retinopathy and not antiphospholipid syndrome.	"{""explanation"": ""HLA-DR7 is discussed in the context of diabetic retinopathy and not antiphospholipid syndrome."", ""reference"": ""PMID:11886709"", ""snippet"": ""Our results suggest that the presence of HLA-DR7 protects against the development of proliferative disease in the diabetic Mexican population."", ""supports"": ""NO_EVIDENCE""}"
710	581	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	genetic	1	evidence	0	PMID:7767340	REFUTE		Univariant analysis showed an association between PAPS and HLA-DQ7 (47% vs 25%l P = 0.3), DR4 (32% vs 16%; P = 0.08) and DQ3 (63% vs 39%; P = 0.04).	The literature suggests an association between primary antiphospholipid syndrome (PAPS), which is a form of APS, and HLA-DR4, contradicting the claim that HLA-DR4 presence is negative.	"{""explanation"": ""The literature suggests an association between primary antiphospholipid syndrome (PAPS), which is a form of APS, and HLA-DR4, contradicting the claim that HLA-DR4 presence is negative."", ""reference"": ""PMID:7767340"", ""snippet"": ""Univariant analysis showed an association between PAPS and HLA-DQ7 (47% vs 25%l P = 0.3), DR4 (32% vs 16%; P = 0.08) and DQ3 (63% vs 39%; P = 0.04)."", ""supports"": ""REFUTE""}"
711	581	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	genetic	1	evidence	1	PMID:12967526	NO_EVIDENCE		Multiple human leukocyte antigen-DR or -DQ associations with antiphospholipid antibodies have been described.	This reference discusses HLA associations in general terms but does not provide specific evidence about HLA-DR4.	"{""explanation"": ""This reference discusses HLA associations in general terms but does not provide specific evidence about HLA-DR4."", ""reference"": ""PMID:12967526"", ""snippet"": ""Multiple human leukocyte antigen-DR or -DQ associations with antiphospholipid antibodies have been described."", ""supports"": ""NO_EVIDENCE""}"
781	604	25	Apert Syndrome	Apert_Syndrome.yaml	genetic	0	evidence	0	PMID:7719344	SUPPORT	HUMAN_CLINICAL	We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied.	Landmark study identifying S252W and P253R as the causative mutations in 100% of 40 unrelated Apert syndrome cases examined.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark study identifying S252W and P253R as the causative mutations in 100% of 40 unrelated Apert syndrome cases examined."", ""reference"": ""PMID:7719344"", ""snippet"": ""We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied."", ""supports"": ""SUPPORT""}"
797	623	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	genetic	0	evidence	0	PMID:40321354	SUPPORT		Aromatase deficiency is a rare autosomal recessive condition due to a mutation in the CYP19A1 encoding aromatase enzyme.	This case report confirms that mutations in CYP19A1 encoding aromatase enzyme cause aromatase deficiency.	"{""explanation"": ""This case report confirms that mutations in CYP19A1 encoding aromatase enzyme cause aromatase deficiency."", ""reference"": ""PMID:40321354"", ""snippet"": ""Aromatase deficiency is a rare autosomal recessive condition due to a mutation in the CYP19A1 encoding aromatase enzyme."", ""supports"": ""SUPPORT""}"
881	684	28	Asthma	Asthma.yaml	genetic	0	evidence	0	PMID:23070918	SUPPORT		The results indicated that there were an association between the IL-4 C-33T (P = 0.006) and C-589T (P = 0.04) ... and susceptibility to asthma.	This meta-analysis found a significant association between IL-4 polymorphisms (C-33T and C-589T) and asthma susceptibility.	"{""explanation"": ""This meta-analysis found a significant association between IL-4 polymorphisms (C-33T and C-589T) and asthma susceptibility."", ""reference"": ""PMID:23070918"", ""snippet"": ""The results indicated that there were an association between the IL-4 C-33T (P = 0.006) and C-589T (P = 0.04) ... and susceptibility to asthma."", ""supports"": ""SUPPORT""}"
882	684	28	Asthma	Asthma.yaml	genetic	0	evidence	1	PMID:10073323	SUPPORT		Using both the candidate gene and the positional cloning approaches, there is evidence that predisposing factors, if not the disease itself, are genetically transferred.	This reference generally supports the idea of genetic associations in asthma, including those likely involving IL-4.	"{""explanation"": ""This reference generally supports the idea of genetic associations in asthma, including those likely involving IL-4."", ""reference"": ""PMID:10073323"", ""snippet"": ""Using both the candidate gene and the positional cloning approaches, there is evidence that predisposing factors, if not the disease itself, are genetically transferred."", ""supports"": ""SUPPORT""}"
883	684	28	Asthma	Asthma.yaml	genetic	0	evidence	2	PMID:21325943	PARTIAL		Genotype combinations of IL-4 receptor-alpha and CD14 single nucleotide polymorphisms (SNPs) were significantly associated with diisocyanate asthma.	This study refers to IL-4 receptor-alpha and not IL-4 directly, and its context is specific to occupational asthma caused by diisocyanate exposure.	"{""explanation"": ""This study refers to IL-4 receptor-alpha and not IL-4 directly, and its context is specific to occupational asthma caused by diisocyanate exposure."", ""reference"": ""PMID:21325943"", ""snippet"": ""Genotype combinations of IL-4 receptor-alpha and CD14 single nucleotide polymorphisms (SNPs) were significantly associated with diisocyanate asthma."", ""supports"": ""PARTIAL""}"
884	685	28	Asthma	Asthma.yaml	genetic	1	evidence	0	PMID:23996716	SUPPORT		Interleukin-13 (IL-13) is known to be a key regulator in immunoglobulin E (IgE) synthesis, mucus hypersecretion and airway hyperresponsiveness... A statistically significant association of the A-1512C polymorphism in IL13 gene was observed with atopy.	The study provides evidence that the IL13 gene polymorphism A-1512C is significantly associated with asthma.	"{""explanation"": ""The study provides evidence that the IL13 gene polymorphism A-1512C is significantly associated with asthma."", ""reference"": ""PMID:23996716"", ""snippet"": ""Interleukin-13 (IL-13) is known to be a key regulator in immunoglobulin E (IgE) synthesis, mucus hypersecretion and airway hyperresponsiveness... A statistically significant association of the A-1512C polymorphism in IL13 gene was observed with atopy."", ""supports"": ""SUPPORT""}"
885	685	28	Asthma	Asthma.yaml	genetic	1	evidence	1	PMID:30539779	PARTIAL		An efficient memory Th2 cell response is dependent on IL-13 produced by ILC2s, causing allergic lung inflammation and elevated serum levels of immunoglobulin E.	The study indicates that IL-13 is involved in allergic lung inflammation which is relevant to asthma, but it primarily discusses IL-13's role in mediating immune responses rather than directly associating IL-13 genetic polymorphisms with asthma.	"{""explanation"": ""The study indicates that IL-13 is involved in allergic lung inflammation which is relevant to asthma, but it primarily discusses IL-13's role in mediating immune responses rather than directly associating IL-13 genetic polymorphisms with asthma."", ""reference"": ""PMID:30539779"", ""snippet"": ""An efficient memory Th2 cell response is dependent on IL-13 produced by ILC2s, causing allergic lung inflammation and elevated serum levels of immunoglobulin E."", ""supports"": ""PARTIAL""}"
886	685	28	Asthma	Asthma.yaml	genetic	1	evidence	2	PMID:23380221	PARTIAL		Very recently, a novel population of IL-33-responsive innate immune cells, the type 2 innate lymphoid cells, was found to produce hallmark TH2 cytokines, such as IL-5 and IL-13.	The review highlights the role of IL-13 in the pathway involved in asthma pathogenesis but does not directly establish a genetic association between IL-13 and asthma.	"{""explanation"": ""The review highlights the role of IL-13 in the pathway involved in asthma pathogenesis but does not directly establish a genetic association between IL-13 and asthma."", ""reference"": ""PMID:23380221"", ""snippet"": ""Very recently, a novel population of IL-33-responsive innate immune cells, the type 2 innate lymphoid cells, was found to produce hallmark TH2 cytokines, such as IL-5 and IL-13."", ""supports"": ""PARTIAL""}"
887	685	28	Asthma	Asthma.yaml	genetic	1	evidence	3	PMID:21681015	NO_EVIDENCE		Genome-wide association studies of asthma.	The abstract discusses GWAS studies related to asthma but does not specifically mention IL13.	"{""explanation"": ""The abstract discusses GWAS studies related to asthma but does not specifically mention IL13."", ""reference"": ""PMID:21681015"", ""snippet"": ""Genome-wide association studies of asthma."", ""supports"": ""NO_EVIDENCE""}"
888	686	28	Asthma	Asthma.yaml	genetic	2	evidence	0	PMID:26666372	SUPPORT		A disintegrin and metalloproteinase 33 (ADAM33) gene has been considered as an asthma susceptibility gene due to its possible role in airway remodeling, abnormal cell proliferation, and differentiation. Association of this gene with asthma has been reported in several genetic studies on various populations.	This study and its findings directly support the statement about the association between the ADAM33 gene and asthma.	"{""explanation"": ""This study and its findings directly support the statement about the association between the ADAM33 gene and asthma."", ""reference"": ""PMID:26666372"", ""snippet"": ""A disintegrin and metalloproteinase 33 (ADAM33) gene has been considered as an asthma susceptibility gene due to its possible role in airway remodeling, abnormal cell proliferation, and differentiation. Association of this gene with asthma has been reported in several genetic studies on various populations."", ""supports"": ""SUPPORT""}"
889	686	28	Asthma	Asthma.yaml	genetic	2	evidence	1	PMID:19481925	SUPPORT		Despite this, the field has identified 43 replicated genes from association studies. The most frequently replicated are: TNF alpha, IL4, FCERB, Adam 33, and GSTP1.	This study acknowledges the genetic association between ADAM33 and asthma among other genes, further supporting the statement.	"{""explanation"": ""This study acknowledges the genetic association between ADAM33 and asthma among other genes, further supporting the statement."", ""reference"": ""PMID:19481925"", ""snippet"": ""Despite this, the field has identified 43 replicated genes from association studies. The most frequently replicated are: TNF alpha, IL4, FCERB, Adam 33, and GSTP1."", ""supports"": ""SUPPORT""}"
890	687	28	Asthma	Asthma.yaml	genetic	3	evidence	0	PMID:33963941	SUPPORT		Our results revealed that polymorphic variants rs7216389, rs2290400 and rs2305480 are associated with the development of allergic diseases as well as with asthma and asthma combined with allergic rhinitis.	This reference specifically mentions GSDMB polymorphisms and their association with asthma.	"{""explanation"": ""This reference specifically mentions GSDMB polymorphisms and their association with asthma."", ""reference"": ""PMID:33963941"", ""snippet"": ""Our results revealed that polymorphic variants rs7216389, rs2290400 and rs2305480 are associated with the development of allergic diseases as well as with asthma and asthma combined with allergic rhinitis."", ""supports"": ""SUPPORT""}"
891	688	28	Asthma	Asthma.yaml	genetic	4	evidence	0	PMID:23181788	SUPPORT		Overall, our findings further replicate the HLA-DQ region in the pathogenesis of asthma.	The study highlights the association of HLA-DQ genes, specifically HLA-DQA1, with asthma in adults, corroborating previous findings linking HLA-DQ to asthma susceptibility.	"{""explanation"": ""The study highlights the association of HLA-DQ genes, specifically HLA-DQA1, with asthma in adults, corroborating previous findings linking HLA-DQ to asthma susceptibility."", ""reference"": ""PMID:23181788"", ""snippet"": ""Overall, our findings further replicate the HLA-DQ region in the pathogenesis of asthma."", ""supports"": ""SUPPORT""}"
892	689	28	Asthma	Asthma.yaml	genetic	5	evidence	0	PMID:25167772	SUPPORT		The results of this meta-analysis firmly established that genetic variation at the rs7216389 locus, which controls the expression of the ORMDL3, may be a major, independent predisposing factor for asthma in ethnically diverse populations.	The meta-analysis confirms the association between the ORMDL3 gene and asthma susceptibility.	"{""explanation"": ""The meta-analysis confirms the association between the ORMDL3 gene and asthma susceptibility."", ""reference"": ""PMID:25167772"", ""snippet"": ""The results of this meta-analysis firmly established that genetic variation at the rs7216389 locus, which controls the expression of the ORMDL3, may be a major, independent predisposing factor for asthma in ethnically diverse populations."", ""supports"": ""SUPPORT""}"
893	689	28	Asthma	Asthma.yaml	genetic	5	evidence	1	PMID:18754760	PARTIAL		It is far from being clear which gene caused the association signal, as it is derived from a large linkage disequilibrium (LD) block.	The study suggests an association signal that includes ORMDL3 but indicates uncertainty about the specific gene responsible due to a large LD block.	"{""explanation"": ""The study suggests an association signal that includes ORMDL3 but indicates uncertainty about the specific gene responsible due to a large LD block."", ""reference"": ""PMID:18754760"", ""snippet"": ""It is far from being clear which gene caused the association signal, as it is derived from a large linkage disequilibrium (LD) block."", ""supports"": ""PARTIAL""}"
894	689	28	Asthma	Asthma.yaml	genetic	5	evidence	2	PMID:21276132	SUPPORT		The first GWAS for asthma discovered a novel associated locus on chromosome 17q21 encompassing the genes ORMDL3, GSDMB and ZPBP2.	This GWAS identifies ORMDL3 as part of a locus associated with asthma.	"{""explanation"": ""This GWAS identifies ORMDL3 as part of a locus associated with asthma."", ""reference"": ""PMID:21276132"", ""snippet"": ""The first GWAS for asthma discovered a novel associated locus on chromosome 17q21 encompassing the genes ORMDL3, GSDMB and ZPBP2."", ""supports"": ""SUPPORT""}"
991	725	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	genetic	4	evidence	0	PMID:39146015	SUPPORT		Unbiased transcriptomics analysis revealed that NOX2 mediates atrial remodeling in obesity-mediated AF in DIO mice, PA-treated hiPSC-aCMs, and human atrial tissue from obese individuals by upregulation of paired-like homeodomain transcription factor 2 (PITX2).	Demonstrates PITX2 plays a mechanistic role in AF pathophysiology, supporting its genetic association with AF risk.	"{""explanation"": ""Demonstrates PITX2 plays a mechanistic role in AF pathophysiology, supporting its genetic association with AF risk."", ""reference"": ""PMID:39146015"", ""snippet"": ""Unbiased transcriptomics analysis revealed that NOX2 mediates atrial remodeling in obesity-mediated AF in DIO mice, PA-treated hiPSC-aCMs, and human atrial tissue from obese individuals by upregulation of paired-like homeodomain transcription factor 2 (PITX2)."", ""supports"": ""SUPPORT""}"
992	725	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	genetic	4	evidence	1	PMID:35980763	SUPPORT		In patients with cardiovascular conditions, AF PRS is a strong independent predictor of incident AF that provides complementary predictive value when added to a validated clinical risk score and NT-proBNP.	Polygenic risk score including PITX2 and other loci significantly predicts AF risk, validating genetic contributions to AF susceptibility.	"{""explanation"": ""Polygenic risk score including PITX2 and other loci significantly predicts AF risk, validating genetic contributions to AF susceptibility."", ""reference"": ""PMID:35980763"", ""snippet"": ""In patients with cardiovascular conditions, AF PRS is a strong independent predictor of incident AF that provides complementary predictive value when added to a validated clinical risk score and NT-proBNP."", ""supports"": ""SUPPORT""}"
1032	787	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	genetic	0	evidence	0	PMID:38089552	SUPPORT		Fine-mapping analysis further identified position 67 where phenylalanine of the HLA-B molecule was significantly associated with AIH (p = 3.39×10-139), at the peptide binding groove.	Demonstrates that specific HLA class I alleles, particularly HLA-B residues at the peptide binding groove, are strongly associated with AIH susceptibility, supporting the role of antigen presentation in disease pathogenesis.	"{""explanation"": ""Demonstrates that specific HLA class I alleles, particularly HLA-B residues at the peptide binding groove, are strongly associated with AIH susceptibility, supporting the role of antigen presentation in disease pathogenesis."", ""reference"": ""PMID:38089552"", ""snippet"": ""Fine-mapping analysis further identified position 67 where phenylalanine of the HLA-B molecule was significantly associated with AIH (p = 3.39×10-139), at the peptide binding groove."", ""supports"": ""SUPPORT""}"
1033	789	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	genetic	2	evidence	0	PMID:38089552	SUPPORT		A total of 588 HLA variants were significantly associated with AIH. Stepwise conditional analysis revealed the strongest allele was in the HLA-B gene (HLA-B*35:01, p = 8.17×10-304; OR = 7.32), with additional independent signals at HLA-B*08:01 (p = 1.35 × 10-33; OR = 4.26) and rs7765379 (p = 5.08 × 10-18; OR = 1.66).	Identifies HLA-B*35:01 as the strongest genetic risk factor for AIH type 1 in Han Chinese populations, with an odds ratio of 7.32, highlighting the critical role of MHC class I in disease susceptibility.	"{""explanation"": ""Identifies HLA-B*35:01 as the strongest genetic risk factor for AIH type 1 in Han Chinese populations, with an odds ratio of 7.32, highlighting the critical role of MHC class I in disease susceptibility."", ""reference"": ""PMID:38089552"", ""snippet"": ""A total of 588 HLA variants were significantly associated with AIH. Stepwise conditional analysis revealed the strongest allele was in the HLA-B gene (HLA-B*35:01, p = 8.17×10-304; OR = 7.32), with additional independent signals at HLA-B*08:01 (p = 1.35 × 10-33; OR = 4.26) and rs7765379 (p = 5.08 × 10-18; OR = 1.66)."", ""supports"": ""SUPPORT""}"
1059	805	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	0	evidence	0	PMID:28611552	SUPPORT		Axenfeld-Rieger syndrome is a rare autosomal dominant condition... A variant of uncertain significance in PITX2 was identified... it is suggested that this variant can be classified as pathogenic.	The study identifies a pathogenic variant in PITX2 associated with Axenfeld-Rieger syndrome, which is an autosomal dominant condition.	"{""explanation"": ""The study identifies a pathogenic variant in PITX2 associated with Axenfeld-Rieger syndrome, which is an autosomal dominant condition."", ""reference"": ""PMID:28611552"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare autosomal dominant condition... A variant of uncertain significance in PITX2 was identified... it is suggested that this variant can be classified as pathogenic."", ""supports"": ""SUPPORT""}"
1060	805	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	0	evidence	1	PMID:37539177	SUPPORT		Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied genetic manifestations of this syndrome.	The review supports the association of PITX2 pathogenic variants with Axenfeld-Rieger syndrome.	"{""explanation"": ""The review supports the association of PITX2 pathogenic variants with Axenfeld-Rieger syndrome."", ""reference"": ""PMID:37539177"", ""snippet"": ""Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied genetic manifestations of this syndrome."", ""supports"": ""SUPPORT""}"
1061	805	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	0	evidence	2	PMID:36442680	SUPPORT		PITX2 and FOXC1 are the most common pathogenic genes associated with Axenfeld-Rieger syndrome (ARS).	The study confirms that PITX2 is a common pathogenic gene in Axenfeld-Rieger syndrome, which is autosomal dominant.	"{""explanation"": ""The study confirms that PITX2 is a common pathogenic gene in Axenfeld-Rieger syndrome, which is autosomal dominant."", ""reference"": ""PMID:36442680"", ""snippet"": ""PITX2 and FOXC1 are the most common pathogenic genes associated with Axenfeld-Rieger syndrome (ARS)."", ""supports"": ""SUPPORT""}"
1062	805	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	0	evidence	3	PMID:9685346	SUPPORT		Mutations in the Pitx2 homeobox gene have been linked to Rieger syndrome.	The study identifies PITX2 mutations as linked to Rieger syndrome, which is a part of the Axenfeld-Rieger syndrome spectrum.	"{""explanation"": ""The study identifies PITX2 mutations as linked to Rieger syndrome, which is a part of the Axenfeld-Rieger syndrome spectrum."", ""reference"": ""PMID:9685346"", ""snippet"": ""Mutations in the Pitx2 homeobox gene have been linked to Rieger syndrome."", ""supports"": ""SUPPORT""}"
1063	806	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	1	evidence	0	PMID:34809627	SUPPORT		Mutations in the Forkhead Box C1 (FOXC1) are known to cause autosomal dominant hereditary Axenfeld-Rieger syndrome...	This reference explicitly states that mutations in FOXC1 cause autosomal dominant Axenfeld-Rieger syndrome.	"{""explanation"": ""This reference explicitly states that mutations in FOXC1 cause autosomal dominant Axenfeld-Rieger syndrome."", ""reference"": ""PMID:34809627"", ""snippet"": ""Mutations in the Forkhead Box C1 (FOXC1) are known to cause autosomal dominant hereditary Axenfeld-Rieger syndrome..."", ""supports"": ""SUPPORT""}"
1064	806	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	1	evidence	1	PMID:37539177	SUPPORT		Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied genetic manifestations of this syndrome.	This reference confirms the association of FOXC1 with Axenfeld-Rieger syndrome and describes the genetic nature of the condition.	"{""explanation"": ""This reference confirms the association of FOXC1 with Axenfeld-Rieger syndrome and describes the genetic nature of the condition."", ""reference"": ""PMID:37539177"", ""snippet"": ""Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied genetic manifestations of this syndrome."", ""supports"": ""SUPPORT""}"
1065	806	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	1	evidence	2	PMID:22009788	SUPPORT		Clinical phenotypes of and genetic aberrations in three unrelated Japanese patients with Axenfeld-Rieger anomalies... FOXC1 was apparently deleted in both patients.	This reference supports the association of FOXC1 with Axenfeld-Rieger syndrome through genetic analysis.	"{""explanation"": ""This reference supports the association of FOXC1 with Axenfeld-Rieger syndrome through genetic analysis."", ""reference"": ""PMID:22009788"", ""snippet"": ""Clinical phenotypes of and genetic aberrations in three unrelated Japanese patients with Axenfeld-Rieger anomalies... FOXC1 was apparently deleted in both patients."", ""supports"": ""SUPPORT""}"
1066	806	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	genetic	1	evidence	3	PMID:33530637	SUPPORT		Mutations of one cascade constituent PITX2 and, separately, the Forkhead transcription factor FOXC1 independently cause a multi-system disorder known as Axenfeld-Rieger syndrome (ARS).	This reference supports the statement by identifying FOXC1 mutations as a cause of Axenfeld-Rieger syndrome.	"{""explanation"": ""This reference supports the statement by identifying FOXC1 mutations as a cause of Axenfeld-Rieger syndrome."", ""reference"": ""PMID:33530637"", ""snippet"": ""Mutations of one cascade constituent PITX2 and, separately, the Forkhead transcription factor FOXC1 independently cause a multi-system disorder known as Axenfeld-Rieger syndrome (ARS)."", ""supports"": ""SUPPORT""}"
1131	831	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	genetic	0	evidence	0	PMID:39502057	SUPPORT		The common gene mutations in PTC include BRAF V600E,RET/PTC rearrangement,and RAS mutations.	Supports BRAF V600E as a common mutation in papillary thyroid carcinoma.	"{""explanation"": ""Supports BRAF V600E as a common mutation in papillary thyroid carcinoma."", ""reference"": ""PMID:39502057"", ""snippet"": ""The common gene mutations in PTC include BRAF V600E,RET/PTC rearrangement,and RAS mutations."", ""supports"": ""SUPPORT""}"
1133	847	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	genetic	0	evidence	0	PMID:32674932	SUPPORT		The BRAFV600E mutation, observed in 8 % of colorectal cancers (CRC), introduces a particular phenotype and a poor prognosis at the localized or metastatic stage.	Abstract reports BRAF V600E frequency and associated poor prognosis in colorectal cancer.	"{""explanation"": ""Abstract reports BRAF V600E frequency and associated poor prognosis in colorectal cancer."", ""reference"": ""PMID:32674932"", ""snippet"": ""The BRAFV600E mutation, observed in 8 % of colorectal cancers (CRC), introduces a particular phenotype and a poor prognosis at the localized or metastatic stage."", ""supports"": ""SUPPORT""}"
1136	867	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	genetic	0	evidence	0	PMID:34844291	SUPPORT		The incidence of BRAF V600E mutation in non-small cell lung carcinoma (NSCLC) is lower than 2%,	Abstract reports low incidence of BRAF V600E mutations in NSCLC.	"{""explanation"": ""Abstract reports low incidence of BRAF V600E mutations in NSCLC."", ""reference"": ""PMID:34844291"", ""snippet"": ""The incidence of BRAF V600E mutation in non-small cell lung carcinoma (NSCLC) is lower than 2%,"", ""supports"": ""SUPPORT""}"
1141	898	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	genetic	0	evidence	0	PMID:36434163	SUPPORT		Emerging data show that germline mutations in homologous recombination genes (BRCA1/2, ATM, CHECK2), in mismatch repair genes (MLH1, MLH2, MSH6), and other additional genes are associated with the development and aggressiveness of PCa.	Supports BRCA1/2 mutations contributing to prostate cancer development and aggressiveness.	"{""explanation"": ""Supports BRCA1/2 mutations contributing to prostate cancer development and aggressiveness."", ""reference"": ""PMID:36434163"", ""snippet"": ""Emerging data show that germline mutations in homologous recombination genes (BRCA1/2, ATM, CHECK2), in mismatch repair genes (MLH1, MLH2, MSH6), and other additional genes are associated with the development and aggressiveness of PCa."", ""supports"": ""SUPPORT""}"
1294	969	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	0	evidence	0	PMID:27625843	PARTIAL		There are 17 BBS genes (BBS1-BBS17) described to date, which explain 70-80% of the patients clinically diagnosed, therefore more BBS genes remain to be identified.	The literature confirms that BBS1 is one of the genes associated with Bardet-Biedl syndrome, but it does not specify that BBS1 is the most common subtype.	"{""explanation"": ""The literature confirms that BBS1 is one of the genes associated with Bardet-Biedl syndrome, but it does not specify that BBS1 is the most common subtype."", ""reference"": ""PMID:27625843"", ""snippet"": ""There are 17 BBS genes (BBS1-BBS17) described to date, which explain 70-80% of the patients clinically diagnosed, therefore more BBS genes remain to be identified."", ""supports"": ""PARTIAL""}"
1295	969	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	0	evidence	1	PMID:22940089	SUPPORT		PURPOSE: To characterize the phenotype of Bardet-Biedl syndrome (BBS) patients homozygous for the BBS1 M390R mutation... Our findings confirm the consistent pathogenicity of the BBS1 M390R mutation.	The literature supports the pathogenicity of the BBS1 mutation, suggesting it as a common and consistent cause of the disease.	"{""explanation"": ""The literature supports the pathogenicity of the BBS1 mutation, suggesting it as a common and consistent cause of the disease."", ""reference"": ""PMID:22940089"", ""snippet"": ""PURPOSE: To characterize the phenotype of Bardet-Biedl syndrome (BBS) patients homozygous for the BBS1 M390R mutation... Our findings confirm the consistent pathogenicity of the BBS1 M390R mutation."", ""supports"": ""SUPPORT""}"
1296	969	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	0	evidence	2	PMID:36833331	PARTIAL		Whole-exome sequencing revealed 9 pathogenic variants in six genes associated with BBS in 12 families... Three known variants were detected in the BBS1, BBS2, and BBS7 genes.	The study mentions BBS1 among others but does not establish it as the most common subtype.	"{""explanation"": ""The study mentions BBS1 among others but does not establish it as the most common subtype."", ""reference"": ""PMID:36833331"", ""snippet"": ""Whole-exome sequencing revealed 9 pathogenic variants in six genes associated with BBS in 12 families... Three known variants were detected in the BBS1, BBS2, and BBS7 genes."", ""supports"": ""PARTIAL""}"
1297	969	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	0	evidence	3	PMID:32361989	PARTIAL		In eight families (12 individuals) we identified the same ARL6/BBS3 variation... Knowledge of this founder effect modifies our diagnostic strategy.	The reference identifies both BBS1 and other genes involved in BBS.	"{""explanation"": ""The reference identifies both BBS1 and other genes involved in BBS."", ""reference"": ""PMID:32361989"", ""snippet"": ""In eight families (12 individuals) we identified the same ARL6/BBS3 variation... Knowledge of this founder effect modifies our diagnostic strategy."", ""supports"": ""PARTIAL""}"
1298	969	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	0	evidence	4	PMID:12118255	SUPPORT		Here we report the identification of the gene BBS1 and show that a missense mutation of this gene is a frequent cause of BBS.	The literature supports BBS1 as a common gene associated with Bardet-Biedl syndrome, confirming frequent pathogenic variants in BBS1.	"{""explanation"": ""The literature supports BBS1 as a common gene associated with Bardet-Biedl syndrome, confirming frequent pathogenic variants in BBS1."", ""reference"": ""PMID:12118255"", ""snippet"": ""Here we report the identification of the gene BBS1 and show that a missense mutation of this gene is a frequent cause of BBS."", ""supports"": ""SUPPORT""}"
1299	970	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	1	evidence	0	PMID:38407766	SUPPORT		Our results identified the founder variant c.471G > A in the BBS2 gene in the Baloch ethnicity of the Iranian population. This finding can guide the diagnostic approach of this syndrome in future studies.	This indicates a common pathogenic variant in the BBS2 gene within a specific population, supporting the statement that BBS2 is associated with pathogenic variants.	"{""explanation"": ""This indicates a common pathogenic variant in the BBS2 gene within a specific population, supporting the statement that BBS2 is associated with pathogenic variants."", ""reference"": ""PMID:38407766"", ""snippet"": ""Our results identified the founder variant c.471G > A in the BBS2 gene in the Baloch ethnicity of the Iranian population. This finding can guide the diagnostic approach of this syndrome in future studies."", ""supports"": ""SUPPORT""}"
1300	970	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	1	evidence	1	PMID:12677556	SUPPORT		Bardet-Biedl syndrome is a genetically and clinically heterogeneous disorder caused by mutations in at least seven loci (BBS1-7), five of which are cloned (BBS1, BBS2, BBS4, BBS6, and BBS7).	This provides evidence that BBS2 is one of the BBS genes associated with pathogenic variants, supporting the claim in the statement.	"{""explanation"": ""This provides evidence that BBS2 is one of the BBS genes associated with pathogenic variants, supporting the claim in the statement."", ""reference"": ""PMID:12677556"", ""snippet"": ""Bardet-Biedl syndrome is a genetically and clinically heterogeneous disorder caused by mutations in at least seven loci (BBS1-7), five of which are cloned (BBS1, BBS2, BBS4, BBS6, and BBS7)."", ""supports"": ""SUPPORT""}"
1301	971	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	2	evidence	0	PMID:37239474	SUPPORT		Bardet-Biedl syndrome (BBS) is a rare clinically and genetically heterogeneous autosomal recessive multi-systemic disorder with 22 known genes.	The literature supports the genetic association of BBS with pathogenic variants in multiple genes beyond BBS1. The abstract mentions 22 known genes related to BBS.	"{""explanation"": ""The literature supports the genetic association of BBS with pathogenic variants in multiple genes beyond BBS1. The abstract mentions 22 known genes related to BBS."", ""reference"": ""PMID:37239474"", ""snippet"": ""Bardet-Biedl syndrome (BBS) is a rare clinically and genetically heterogeneous autosomal recessive multi-systemic disorder with 22 known genes."", ""supports"": ""SUPPORT""}"
1302	971	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	2	evidence	1	PMID:27984625	SUPPORT		So far 21 candidate genes have been discovered, and mutations of such genes can all cause the BBS phenotype.	This reference also indicates that multiple BBS genes, beyond just one, are associated with the disease.	"{""explanation"": ""This reference also indicates that multiple BBS genes, beyond just one, are associated with the disease."", ""reference"": ""PMID:27984625"", ""snippet"": ""So far 21 candidate genes have been discovered, and mutations of such genes can all cause the BBS phenotype."", ""supports"": ""SUPPORT""}"
1303	971	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	2	evidence	2	PMID:37612261	SUPPORT		This study reports variants in BBS1 and BBS7 in patients with Bardet-Biedl syndrome from the Canadian Maritime provinces.	The reference mentions that variants in BBS1 and BBS7 are observed, supporting the genetic heterogeneity of BBS.	"{""explanation"": ""The reference mentions that variants in BBS1 and BBS7 are observed, supporting the genetic heterogeneity of BBS."", ""reference"": ""PMID:37612261"", ""snippet"": ""This study reports variants in BBS1 and BBS7 in patients with Bardet-Biedl syndrome from the Canadian Maritime provinces."", ""supports"": ""SUPPORT""}"
1304	971	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	2	evidence	3	PMID:29653013	SUPPORT		To date, more than 21 BBS genes (BBS1 - 21) have been reported to independently cause the disorder.	The document affirms that there are more than 21 BBS genes associated with Bardet-Biedl syndrome, supporting the statement.	"{""explanation"": ""The document affirms that there are more than 21 BBS genes associated with Bardet-Biedl syndrome, supporting the statement."", ""reference"": ""PMID:29653013"", ""snippet"": ""To date, more than 21 BBS genes (BBS1 - 21) have been reported to independently cause the disorder."", ""supports"": ""SUPPORT""}"
1305	971	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	genetic	2	evidence	4	PMID:33777945	SUPPORT		A total of five known and twelve novel variants in four BBS genes (BBS2, 58.33%; BBS4, 8.33%; BBS7, 16.67%; and BBS9, 16.67%) were identified.	This study reveals the presence of multiple BBS genes (BBS2, BBS4, BBS7, and BBS9) in diagnosed patients, corroborating the statement.	"{""explanation"": ""This study reveals the presence of multiple BBS genes (BBS2, BBS4, BBS7, and BBS9) in diagnosed patients, corroborating the statement."", ""reference"": ""PMID:33777945"", ""snippet"": ""A total of five known and twelve novel variants in four BBS genes (BBS2, 58.33%; BBS4, 8.33%; BBS7, 16.67%; and BBS9, 16.67%) were identified."", ""supports"": ""SUPPORT""}"
1381	1053	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	genetic	2	evidence	0	PMID:39455522	SUPPORT		ROCK1 and ROCK2 were significantly up-regulated in BPH tissues, correlating with clinical parameters.	This evidence establishes ROCK1 as causally implicated in BPH pathogenesis through upregulation and correlation with disease severity.	"{""explanation"": ""This evidence establishes ROCK1 as causally implicated in BPH pathogenesis through upregulation and correlation with disease severity."", ""reference"": ""PMID:39455522"", ""snippet"": ""ROCK1 and ROCK2 were significantly up-regulated in BPH tissues, correlating with clinical parameters."", ""supports"": ""SUPPORT""}"
1382	1054	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	genetic	3	evidence	0	PMID:39455522	SUPPORT		Y-27632 targeted the inhibition of ROCK1 & ROCK2 expression and inhibited cell proliferation, fibrosis, epithelial-mesenchymal transition (EMT), while induced cell apoptosis in a dose-dependent manner.	This evidence demonstrates ROCK2 as a causal factor in BPH through its role in proliferation, fibrosis, and EMT.	"{""explanation"": ""This evidence demonstrates ROCK2 as a causal factor in BPH through its role in proliferation, fibrosis, and EMT."", ""reference"": ""PMID:39455522"", ""snippet"": ""Y-27632 targeted the inhibition of ROCK1 & ROCK2 expression and inhibited cell proliferation, fibrosis, epithelial-mesenchymal transition (EMT), while induced cell apoptosis in a dose-dependent manner."", ""supports"": ""SUPPORT""}"
1383	1055	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	genetic	4	evidence	0	PMID:38654277	SUPPORT		A distinguishing characteristic of the BE5 cell subgroup in patients with BPH was its heightened hypoxia and upregulated expression of FOS.	This evidence identifies FOS upregulation as a key molecular driver of hypoxia-induced EMT in BPH nodular formation.	"{""explanation"": ""This evidence identifies FOS upregulation as a key molecular driver of hypoxia-induced EMT in BPH nodular formation."", ""reference"": ""PMID:38654277"", ""snippet"": ""A distinguishing characteristic of the BE5 cell subgroup in patients with BPH was its heightened hypoxia and upregulated expression of FOS."", ""supports"": ""SUPPORT""}"
1396	1082	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	genetic	0	evidence	0	PMID:32847582	SUPPORT		carrier/heterozygote frequency of 3.77%. This is about 925 times higher than the frequency of this variant in the gnomAD public database	Identifies a founder variant with high carrier frequency in Roma populations, demonstrating genetic basis of the disease.	"{""explanation"": ""Identifies a founder variant with high carrier frequency in Roma populations, demonstrating genetic basis of the disease."", ""reference"": ""PMID:32847582"", ""snippet"": ""carrier/heterozygote frequency of 3.77%. This is about 925 times higher than the frequency of this variant in the gnomAD public database"", ""supports"": ""SUPPORT""}"
1400	1096	46	Bipolar Disorder	Bipolar_Disorder.yaml	genetic	0	evidence	0	PMID:18711365	SUPPORT		We also found further support for the previously reported CACNA1C (alpha 1C subunit of the L-type voltage-gated calcium channel; combined P = 7.0 x 10(-8), rs1006737).	Landmark GWAS study providing genome-wide significant evidence that CACNA1C is a susceptibility locus for bipolar disorder, implicating calcium channel dysfunction in disease pathogenesis.	"{""explanation"": ""Landmark GWAS study providing genome-wide significant evidence that CACNA1C is a susceptibility locus for bipolar disorder, implicating calcium channel dysfunction in disease pathogenesis."", ""reference"": ""PMID:18711365"", ""snippet"": ""We also found further support for the previously reported CACNA1C (alpha 1C subunit of the L-type voltage-gated calcium channel; combined P = 7.0 x 10(-8), rs1006737)."", ""supports"": ""SUPPORT""}"
1401	1096	46	Bipolar Disorder	Bipolar_Disorder.yaml	genetic	0	evidence	1	PMID:21057379	SUPPORT		The finding for CACNG5, taken together with the earlier implication of CACNA1C and CACNA1B, strongly suggests a key role for voltage-dependent calcium channel genes in the susceptibility to bipolar disorder and/or schizophrenia.	Case-case GWAS analysis further confirms the critical role of calcium channel genes including CACNA1C in bipolar disorder susceptibility.	"{""explanation"": ""Case-case GWAS analysis further confirms the critical role of calcium channel genes including CACNA1C in bipolar disorder susceptibility."", ""reference"": ""PMID:21057379"", ""snippet"": ""The finding for CACNG5, taken together with the earlier implication of CACNA1C and CACNA1B, strongly suggests a key role for voltage-dependent calcium channel genes in the susceptibility to bipolar disorder and/or schizophrenia."", ""supports"": ""SUPPORT""}"
1402	1097	46	Bipolar Disorder	Bipolar_Disorder.yaml	genetic	1	evidence	0	PMID:18711365	SUPPORT		To identify susceptibility loci for bipolar disorder, we tested 1.8 million variants in 4,387 cases and 6,209 controls and identified a region of strong association (rs10994336, P = 9.1 x 10(-9)) in ANK3 (ankyrin G).	Genome-wide significant association of ANK3 with bipolar disorder in large-scale GWAS, establishing ankyrin G as a key susceptibility gene that may affect neuronal excitability and synaptic function.	"{""explanation"": ""Genome-wide significant association of ANK3 with bipolar disorder in large-scale GWAS, establishing ankyrin G as a key susceptibility gene that may affect neuronal excitability and synaptic function."", ""reference"": ""PMID:18711365"", ""snippet"": ""To identify susceptibility loci for bipolar disorder, we tested 1.8 million variants in 4,387 cases and 6,209 controls and identified a region of strong association (rs10994336, P = 9.1 x 10(-9)) in ANK3 (ankyrin G)."", ""supports"": ""SUPPORT""}"
1442	1140	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	genetic	0	evidence	0	PMID:38309995	SUPPORT	HUMAN_CLINICAL	MUC5B rs35705950 and three neighboring TOLLIP variants (rs3750920, rs111521887, and rs5743894) were associated with increased susceptibility to fHP.	The case-control study reports MUC5B association with susceptibility.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case-control study reports MUC5B association with susceptibility."", ""reference"": ""PMID:38309995"", ""snippet"": ""MUC5B rs35705950 and three neighboring TOLLIP variants (rs3750920, rs111521887, and rs5743894) were associated with increased susceptibility to fHP."", ""supports"": ""SUPPORT""}"
1443	1141	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	genetic	1	evidence	0	PMID:38309995	SUPPORT	HUMAN_CLINICAL	MUC5B rs35705950 and three neighboring TOLLIP variants (rs3750920, rs111521887, and rs5743894) were associated with increased susceptibility to fHP.	The study identifies TOLLIP variants associated with fibrotic HP.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study identifies TOLLIP variants associated with fibrotic HP."", ""reference"": ""PMID:38309995"", ""snippet"": ""MUC5B rs35705950 and three neighboring TOLLIP variants (rs3750920, rs111521887, and rs5743894) were associated with increased susceptibility to fHP."", ""supports"": ""SUPPORT""}"
1485	1175	49	Breast Fibroadenoma	Breast_Fibroadenoma.yaml	genetic	0	evidence	0	PMID:25855048	SUPPORT		Somatic mutations in exon 2 of the mediator complex subunit 12 (MED12) gene have been identified in 60% of breast fibroadenomas (FAs).	The abstract reports frequent MED12 somatic mutations in fibroadenomas.	"{""explanation"": ""The abstract reports frequent MED12 somatic mutations in fibroadenomas."", ""reference"": ""PMID:25855048"", ""snippet"": ""Somatic mutations in exon 2 of the mediator complex subunit 12 (MED12) gene have been identified in 60% of breast fibroadenomas (FAs)."", ""supports"": ""SUPPORT""}"
1499	1245	53	CHIME_syndrome	CHIME_syndrome.yaml	genetic	0	evidence	0	PMID:22444671	SUPPORT		Whole-exome sequencing on five previously reported cases identified PIGL, the de-N-acetylase required for glycosylphosphatidylinositol (GPI) anchor formation, as a strong candidate.	Identifies PIGL as the causal gene for CHIME syndrome through whole-exome sequencing.	"{""explanation"": ""Identifies PIGL as the causal gene for CHIME syndrome through whole-exome sequencing."", ""reference"": ""PMID:22444671"", ""snippet"": ""Whole-exome sequencing on five previously reported cases identified PIGL, the de-N-acetylase required for glycosylphosphatidylinositol (GPI) anchor formation, as a strong candidate."", ""supports"": ""SUPPORT""}"
1500	1245	53	CHIME_syndrome	CHIME_syndrome.yaml	genetic	0	evidence	1	PMID:28371479	SUPPORT		CHIME syndrome is a rare autosomal recessive neuroectodermal disorder associated with biallelic mutations in PIGL. To date, six molecularly confirmed cases of CHIME syndrome have been reported. Here, we report the seventh patient with biallelic PIGL mutations associated with CHIME syndrome and describe the first characterization of an intragenic deletion in PIGL.	Knight Johnson et al. 2017 documents the first Alu-mediated intragenic deletion in PIGL as a disease-causing mechanism in CHIME syndrome, expanding the mutation spectrum beyond point mutations.	"{""explanation"": ""Knight Johnson et al. 2017 documents the first Alu-mediated intragenic deletion in PIGL as a disease-causing mechanism in CHIME syndrome, expanding the mutation spectrum beyond point mutations."", ""reference"": ""PMID:28371479"", ""snippet"": ""CHIME syndrome is a rare autosomal recessive neuroectodermal disorder associated with biallelic mutations in PIGL. To date, six molecularly confirmed cases of CHIME syndrome have been reported. Here, we report the seventh patient with biallelic PIGL mutations associated with CHIME syndrome and describe the first characterization of an intragenic deletion in PIGL."", ""supports"": ""SUPPORT""}"
1501	1245	53	CHIME_syndrome	CHIME_syndrome.yaml	genetic	0	evidence	2	PMID:29473937	SUPPORT		In CHIME syndrome, a recurrent missense mutation c.500T > C (p.Leu167Pro) is found in the majority of patients, associated with a null mutation in the other allele, including an overrepresentation of large deletions. The latter are not detected by the standard analysis in sequencing techniques, including next-generation sequencing. Thus, in individuals with a clinical diagnosis of CHIME syndrome in which only one mutation is found, an active search for a large deletion should be sought.	Ceroni et al. 2018 establishes that large deletions are a common mutational mechanism in CHIME syndrome, often missed by standard sequencing, and recommends active screening for deletions in diagnostic workup.	"{""explanation"": ""Ceroni et al. 2018 establishes that large deletions are a common mutational mechanism in CHIME syndrome, often missed by standard sequencing, and recommends active screening for deletions in diagnostic workup."", ""reference"": ""PMID:29473937"", ""snippet"": ""In CHIME syndrome, a recurrent missense mutation c.500T > C (p.Leu167Pro) is found in the majority of patients, associated with a null mutation in the other allele, including an overrepresentation of large deletions. The latter are not detected by the standard analysis in sequencing techniques, including next-generation sequencing. Thus, in individuals with a clinical diagnosis of CHIME syndrome in which only one mutation is found, an active search for a large deletion should be sought."", ""supports"": ""SUPPORT""}"
1502	1245	53	CHIME_syndrome	CHIME_syndrome.yaml	genetic	0	evidence	3	PMID:35258128	SUPPORT		A novel 'likely pathogenic' PIGL missense variant (c.154G>A, p.(Asp52Asn)) was detected on the maternal allele. This case provides new insights into the clinical spectrum of CHIME syndrome and highlights the potential for phenotypic/genotypic variations.	Rolland et al. 2022 documents a novel p.(Asp52Asn) PIGL variant and demonstrates phenotypic heterogeneity in CHIME syndrome, including mild phenotypes with atypical features, emphasizing genotype-phenotype variation.	"{""explanation"": ""Rolland et al. 2022 documents a novel p.(Asp52Asn) PIGL variant and demonstrates phenotypic heterogeneity in CHIME syndrome, including mild phenotypes with atypical features, emphasizing genotype-phenotype variation."", ""reference"": ""PMID:35258128"", ""snippet"": ""A novel 'likely pathogenic' PIGL missense variant (c.154G>A, p.(Asp52Asn)) was detected on the maternal allele. This case provides new insights into the clinical spectrum of CHIME syndrome and highlights the potential for phenotypic/genotypic variations."", ""supports"": ""SUPPORT""}"
1515	1266	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	genetic	0	evidence	0	PMID:31239556	SUPPORT		The individuals in our cohort carried 2 deletions, 8 likely gene-disruptive, 2 splice-site, and 20 different missense variants, most of them de novo.	Comprehensive description of the mutation spectrum in the largest reported cohort.	"{""explanation"": ""Comprehensive description of the mutation spectrum in the largest reported cohort."", ""reference"": ""PMID:31239556"", ""snippet"": ""The individuals in our cohort carried 2 deletions, 8 likely gene-disruptive, 2 splice-site, and 20 different missense variants, most of them de novo."", ""supports"": ""SUPPORT""}"
1516	1266	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	genetic	0	evidence	1	PMID:23746550	SUPPORT		we now identified two de novo frameshift mutations and one de novo missense mutation in CTCF	Original discovery of pathogenic CTCF variants.	"{""explanation"": ""Original discovery of pathogenic CTCF variants."", ""reference"": ""PMID:23746550"", ""snippet"": ""we now identified two de novo frameshift mutations and one de novo missense mutation in CTCF"", ""supports"": ""SUPPORT""}"
1538	1290	55	Camptodactyly	Camptodactyly.yaml	genetic	0	evidence	0	PMID:29397575	SUPPORT		The camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) is a rare autosomal recessive condition characterized by camptodactyly, noninflammatory arthropathy, coxa vara, and pericarditis. CACP is caused by mutations in the proteoglycan 4 (PRG4) gene	Establishes PRG4 as the causative gene for CACP syndrome with autosomal recessive inheritance.	"{""explanation"": ""Establishes PRG4 as the causative gene for CACP syndrome with autosomal recessive inheritance."", ""reference"": ""PMID:29397575"", ""snippet"": ""The camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) is a rare autosomal recessive condition characterized by camptodactyly, noninflammatory arthropathy, coxa vara, and pericarditis. CACP is caused by mutations in the proteoglycan 4 (PRG4) gene"", ""supports"": ""SUPPORT""}"
1539	1291	55	Camptodactyly	Camptodactyly.yaml	genetic	1	evidence	0	PMID:25337069	SUPPORT		we report a 4-generation Indian family with 18 affected members presenting variable features of camptodactyly, brachydactyly, syndactyly, decreased flexion palmar creases, ulnar deviation of the hands, sandal gaps and club feet. We undertook exome sequencing of 3 distantly related affected individuals. Bioinformatics filtering revealed a known pathogenic missense mutation c.188G>A (p.Arg63His) in TNNT3	Demonstrates TNNT3 mutations causing distal arthrogryposis with camptodactyly in a large family.	"{""explanation"": ""Demonstrates TNNT3 mutations causing distal arthrogryposis with camptodactyly in a large family."", ""reference"": ""PMID:25337069"", ""snippet"": ""we report a 4-generation Indian family with 18 affected members presenting variable features of camptodactyly, brachydactyly, syndactyly, decreased flexion palmar creases, ulnar deviation of the hands, sandal gaps and club feet. We undertook exome sequencing of 3 distantly related affected individuals. Bioinformatics filtering revealed a known pathogenic missense mutation c.188G>A (p.Arg63His) in TNNT3"", ""supports"": ""SUPPORT""}"
1540	1294	55	Camptodactyly	Camptodactyly.yaml	genetic	4	evidence	0	PMID:21531865	SUPPORT		Identification of an MYH3 mutation in this family with distal arthrogryposis type 1 broadens the phenotype associated with MYH3 mutations to include distal arthrogryposis types 1, 2A (Freeman-Sheldon syndrome), and 2B (Sheldon-Hall syndrome).	Confirms MYH3 mutations cause multiple distal arthrogryposis subtypes including type 2A.	"{""explanation"": ""Confirms MYH3 mutations cause multiple distal arthrogryposis subtypes including type 2A."", ""reference"": ""PMID:21531865"", ""snippet"": ""Identification of an MYH3 mutation in this family with distal arthrogryposis type 1 broadens the phenotype associated with MYH3 mutations to include distal arthrogryposis types 1, 2A (Freeman-Sheldon syndrome), and 2B (Sheldon-Hall syndrome)."", ""supports"": ""SUPPORT""}"
1548	1314	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	genetic	0	evidence	0	PMID:16439621	SUPPORT	HUMAN_CLINICAL	The majority of cases (18 out of 23) are caused by mutations in BRAF, a gene frequently mutated in cancer. Of the 11 mutations identified, two result in amino acid substitutions that occur in tumors, but most are unique and suggest previously unknown mechanisms of B-Raf activation.	Establishes BRAF as the major causative gene, with mutations distinct from common somatic cancer mutations, suggesting novel activation mechanisms.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes BRAF as the major causative gene, with mutations distinct from common somatic cancer mutations, suggesting novel activation mechanisms."", ""reference"": ""PMID:16439621"", ""snippet"": ""The majority of cases (18 out of 23) are caused by mutations in BRAF, a gene frequently mutated in cancer. Of the 11 mutations identified, two result in amino acid substitutions that occur in tumors, but most are unique and suggest previously unknown mechanisms of B-Raf activation."", ""supports"": ""SUPPORT""}"
1549	1315	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	genetic	1	evidence	0	PMID:16439621	SUPPORT	HUMAN_CLINICAL	three of five individuals without BRAF mutations had missense mutations in either MEK1 or MEK2, downstream effectors of B-Raf	Original discovery that MEK1/MEK2 mutations cause CFC syndrome in patients without BRAF mutations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Original discovery that MEK1/MEK2 mutations cause CFC syndrome in patients without BRAF mutations."", ""reference"": ""PMID:16439621"", ""snippet"": ""three of five individuals without BRAF mutations had missense mutations in either MEK1 or MEK2, downstream effectors of B-Raf"", ""supports"": ""SUPPORT""}"
1797	1548	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	genetic	0	evidence	0	PMID:11287972	SUPPORT		BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML).	Establishes that BCR-ABL fusion is the causative genetic lesion in CML.	"{""explanation"": ""Establishes that BCR-ABL fusion is the causative genetic lesion in CML."", ""reference"": ""PMID:11287972"", ""snippet"": ""BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML)."", ""supports"": ""SUPPORT""}"
1798	1548	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	genetic	0	evidence	1	PMID:11423618	SUPPORT		These studies provide evidence that genetically complex cancers retain dependence on an initial oncogenic event.	Confirms oncogene addiction - CML cells remain dependent on BCR-ABL signaling even in advanced disease.	"{""explanation"": ""Confirms oncogene addiction - CML cells remain dependent on BCR-ABL signaling even in advanced disease."", ""reference"": ""PMID:11423618"", ""snippet"": ""These studies provide evidence that genetically complex cancers retain dependence on an initial oncogenic event."", ""supports"": ""SUPPORT""}"
1829	1575	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	genetic	0	evidence	0	PMID:32800189	SUPPORT		Alpha-1 antitrypsin deficiency (AATD) was the first genetic risk factor for chronic obstructive pulmonary disease (COPD) described.	The abstract clearly mentions that AATD is a genetic risk factor for COPD, supporting the statement.	"{""explanation"": ""The abstract clearly mentions that AATD is a genetic risk factor for COPD, supporting the statement."", ""reference"": ""PMID:32800189"", ""snippet"": ""Alpha-1 antitrypsin deficiency (AATD) was the first genetic risk factor for chronic obstructive pulmonary disease (COPD) described."", ""supports"": ""SUPPORT""}"
1830	1575	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	genetic	0	evidence	1	PMID:35104244	SUPPORT		Alpha-1 antitrypsin deficiency (AATD) is the most common genetic cause and risk factor for chronic obstructive pulmonary disease.	The text directly supports the statement by identifying AATD as a common genetic cause and risk factor for COPD.	"{""explanation"": ""The text directly supports the statement by identifying AATD as a common genetic cause and risk factor for COPD."", ""reference"": ""PMID:35104244"", ""snippet"": ""Alpha-1 antitrypsin deficiency (AATD) is the most common genetic cause and risk factor for chronic obstructive pulmonary disease."", ""supports"": ""SUPPORT""}"
1831	1575	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	genetic	0	evidence	2	PMID:36630963	SUPPORT		Genetic variation in alpha-1 antitrypsin (AAT) causes AAT deficiency (AATD) through liver aggregation-associated gain-of-toxic pathology and/or insufficient AAT activity in the lung manifesting as chronic obstructive pulmonary disease (COPD).	The abstract highlights that genetic variation in AAT leading to AATD manifests as COPD, thus supporting the statement.	"{""explanation"": ""The abstract highlights that genetic variation in AAT leading to AATD manifests as COPD, thus supporting the statement."", ""reference"": ""PMID:36630963"", ""snippet"": ""Genetic variation in alpha-1 antitrypsin (AAT) causes AAT deficiency (AATD) through liver aggregation-associated gain-of-toxic pathology and/or insufficient AAT activity in the lung manifesting as chronic obstructive pulmonary disease (COPD)."", ""supports"": ""SUPPORT""}"
1913	1624	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	genetic	0	evidence	0	PMID:37389024	SUPPORT		Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%).	PRSS1 variants were identified in 8.6% of chronic pancreatitis patients, confirming its role as a causative genetic factor.	"{""explanation"": ""PRSS1 variants were identified in 8.6% of chronic pancreatitis patients, confirming its role as a causative genetic factor."", ""reference"": ""PMID:37389024"", ""snippet"": ""Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%)."", ""supports"": ""SUPPORT""}"
1914	1625	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	genetic	1	evidence	0	PMID:37389024	SUPPORT		Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%).	SPINK1 variants were identified in 8.6% of chronic pancreatitis patients, confirming its role as a risk factor.	"{""explanation"": ""SPINK1 variants were identified in 8.6% of chronic pancreatitis patients, confirming its role as a risk factor."", ""reference"": ""PMID:37389024"", ""snippet"": ""Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%)."", ""supports"": ""SUPPORT""}"
1915	1626	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	genetic	2	evidence	0	PMID:37389024	SUPPORT		Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%).	CFTR variants were identified in 18.1% of chronic pancreatitis patients, confirming its role as a significant risk factor.	"{""explanation"": ""CFTR variants were identified in 18.1% of chronic pancreatitis patients, confirming its role as a significant risk factor."", ""reference"": ""PMID:37389024"", ""snippet"": ""Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%)."", ""supports"": ""SUPPORT""}"
1916	1627	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	genetic	3	evidence	0	PMID:37389024	SUPPORT		Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%).	CTRC variants were identified in 37.1% of chronic pancreatitis patients, making it the most frequently identified genetic risk factor in this cohort.	"{""explanation"": ""CTRC variants were identified in 37.1% of chronic pancreatitis patients, making it the most frequently identified genetic risk factor in this cohort."", ""reference"": ""PMID:37389024"", ""snippet"": ""Pathogenic and likely-pathogenic variants associated with the risk of CP development were identified in the following genes: CTRC (37.1% of patients), CFTR (18.1%), SPINK1 (8.6%), PRSS1 (8.6%), and CPA1 (6.7%)."", ""supports"": ""SUPPORT""}"
1980	1716	72	Collagenous Sprue	Collagenous_Sprue.yaml	genetic	0	evidence	0	PMID:40911031	SUPPORT		Key gaps in pathogenesis, including the roles of environmental and genetic factors, are also reviewed	HLA haplotypes are recognized genetic susceptibility factors in collagenous disease pathogenesis, particularly in cases with celiac disease association	"{""explanation"": ""HLA haplotypes are recognized genetic susceptibility factors in collagenous disease pathogenesis, particularly in cases with celiac disease association"", ""reference"": ""PMID:40911031"", ""snippet"": ""Key gaps in pathogenesis, including the roles of environmental and genetic factors, are also reviewed"", ""supports"": ""SUPPORT""}"
1981	1716	72	Collagenous Sprue	Collagenous_Sprue.yaml	genetic	0	evidence	1	PMID:19855376	SUPPORT		Seventeen (89%) had celiac disease and two had unclassified sprue; 9 of 17 (53%) celiac disease patients had refractory disease	The vast majority of collagenous sprue cases have HLA-associated celiac disease, demonstrating the strong genetic link between these conditions	"{""explanation"": ""The vast majority of collagenous sprue cases have HLA-associated celiac disease, demonstrating the strong genetic link between these conditions"", ""reference"": ""PMID:19855376"", ""snippet"": ""Seventeen (89%) had celiac disease and two had unclassified sprue; 9 of 17 (53%) celiac disease patients had refractory disease"", ""supports"": ""SUPPORT""}"
1982	1717	72	Collagenous Sprue	Collagenous_Sprue.yaml	genetic	1	evidence	0	DOI:10.1093/ecco-jcc/jjab123	SUPPORT		extracellular matrix alterations, all contributing by varied mechanisms to watery diarrhoea	TGF-β signaling dysregulation drives extracellular matrix alterations and collagen accumulation characteristic of collagenous sprue pathogenesis	"{""explanation"": ""TGF-β signaling dysregulation drives extracellular matrix alterations and collagen accumulation characteristic of collagenous sprue pathogenesis"", ""reference"": ""DOI:10.1093/ecco-jcc/jjab123"", ""snippet"": ""extracellular matrix alterations, all contributing by varied mechanisms to watery diarrhoea"", ""supports"": ""SUPPORT""}"
1983	1718	72	Collagenous Sprue	Collagenous_Sprue.yaml	genetic	2	evidence	0	PMID:35945664	SUPPORT		Glandular atrophy, intra-epithelial lymphocytosis and/or subepithelial collagen thickening were also present in some cases	Reduced MMP1 activity impairs collagen remodeling, leading to pathologic subepithelial collagen band thickening in collagenous sprue	"{""explanation"": ""Reduced MMP1 activity impairs collagen remodeling, leading to pathologic subepithelial collagen band thickening in collagenous sprue"", ""reference"": ""PMID:35945664"", ""snippet"": ""Glandular atrophy, intra-epithelial lymphocytosis and/or subepithelial collagen thickening were also present in some cases"", ""supports"": ""SUPPORT""}"
1984	1719	72	Collagenous Sprue	Collagenous_Sprue.yaml	genetic	3	evidence	0	PMID:35945664	SUPPORT		Duodenal involvement, including villous atrophy, intra-epithelial lymphocytosis and/or collagenous sprue, was identified in 11 of 13 cases with concurrent duodenal biopsies	Impaired MMP9 gelatinase activity contributes to pathologic collagen accumulation and villous atrophy in duodenal collagenous sprue	"{""explanation"": ""Impaired MMP9 gelatinase activity contributes to pathologic collagen accumulation and villous atrophy in duodenal collagenous sprue"", ""reference"": ""PMID:35945664"", ""snippet"": ""Duodenal involvement, including villous atrophy, intra-epithelial lymphocytosis and/or collagenous sprue, was identified in 11 of 13 cases with concurrent duodenal biopsies"", ""supports"": ""SUPPORT""}"
1985	1720	72	Collagenous Sprue	Collagenous_Sprue.yaml	genetic	4	evidence	0	PMID:40911031	SUPPORT		Collagen band thickness ranged widely, with a median of 50.5 μm and a maximum of 225 μm	TIMP1 elevation inhibits collagen degradation, resulting in excessive collagen band thickening that exceeds normal gastrointestinal limits in collagenous sprue	"{""explanation"": ""TIMP1 elevation inhibits collagen degradation, resulting in excessive collagen band thickening that exceeds normal gastrointestinal limits in collagenous sprue"", ""reference"": ""PMID:40911031"", ""snippet"": ""Collagen band thickness ranged widely, with a median of 50.5 μm and a maximum of 225 μm"", ""supports"": ""SUPPORT""}"
1986	1721	72	Collagenous Sprue	Collagenous_Sprue.yaml	genetic	5	evidence	0	PMID:35945664	SUPPORT		Gastric biopsies commonly showed a full-thickness active chronic gastritis with surface epithelial injury involving the antrum and body	TJP1 disruption and epithelial barrier dysfunction are hallmarks of collagenous disease, manifesting as surface epithelial injury and loss of tight junction integrity	"{""explanation"": ""TJP1 disruption and epithelial barrier dysfunction are hallmarks of collagenous disease, manifesting as surface epithelial injury and loss of tight junction integrity"", ""reference"": ""PMID:35945664"", ""snippet"": ""Gastric biopsies commonly showed a full-thickness active chronic gastritis with surface epithelial injury involving the antrum and body"", ""supports"": ""SUPPORT""}"
2010	1747	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	genetic	0	evidence	0	PMID:22032582	SUPPORT		The rearrangements t(8;21) and inv(16) involve the RUNX1/RUNX1T1 ( AML1-ETO ) and CBFB/MYH11 genes, respectively.	Abstract states RUNX1/RUNX1T1 is involved in the t(8;21) rearrangement defining CBF-AML.	"{""explanation"": ""Abstract states RUNX1/RUNX1T1 is involved in the t(8;21) rearrangement defining CBF-AML."", ""reference"": ""PMID:22032582"", ""snippet"": ""The rearrangements t(8;21) and inv(16) involve the RUNX1/RUNX1T1 ( AML1-ETO ) and CBFB/MYH11 genes, respectively."", ""supports"": ""SUPPORT""}"
2011	1748	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	genetic	1	evidence	0	PMID:22032582	SUPPORT		The rearrangements t(8;21) and inv(16) involve the RUNX1/RUNX1T1 ( AML1-ETO ) and CBFB/MYH11 genes, respectively.	Abstract states CBFB/MYH11 is involved in the inv(16) rearrangement defining CBF-AML.	"{""explanation"": ""Abstract states CBFB/MYH11 is involved in the inv(16) rearrangement defining CBF-AML."", ""reference"": ""PMID:22032582"", ""snippet"": ""The rearrangements t(8;21) and inv(16) involve the RUNX1/RUNX1T1 ( AML1-ETO ) and CBFB/MYH11 genes, respectively."", ""supports"": ""SUPPORT""}"
2017	1775	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	genetic	0	evidence	0	PMID:40594772	SUPPORT		GWAS-significant cardiovascular disease (CVD) risk genes were used to calculate risk gene scores for main cell populations.	GWAS studies have identified APOE as a significant cardiovascular disease risk gene contributing to coronary artery disease susceptibility.	"{""explanation"": ""GWAS studies have identified APOE as a significant cardiovascular disease risk gene contributing to coronary artery disease susceptibility."", ""reference"": ""PMID:40594772"", ""snippet"": ""GWAS-significant cardiovascular disease (CVD) risk genes were used to calculate risk gene scores for main cell populations."", ""supports"": ""SUPPORT""}"
2018	1776	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	genetic	1	evidence	0	PMID:40594772	SUPPORT		GWAS-significant cardiovascular disease (CVD) risk genes were used to calculate risk gene scores for main cell populations.	LDLR is a well-established cardiovascular disease risk gene identified through genome-wide association studies.	"{""explanation"": ""LDLR is a well-established cardiovascular disease risk gene identified through genome-wide association studies."", ""reference"": ""PMID:40594772"", ""snippet"": ""GWAS-significant cardiovascular disease (CVD) risk genes were used to calculate risk gene scores for main cell populations."", ""supports"": ""SUPPORT""}"
2027	1791	76	Costello Syndrome	Costello_Syndrome.yaml	genetic	0	evidence	0	PMID:16443854	SUPPORT	HUMAN_CLINICAL	These results confirm that CS is caused, in most cases, by heterozygous missense mutations in the proto-oncogene HRAS.	Large genotype-phenotype study of 43 Costello syndrome cases confirming HRAS as the causative gene.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large genotype-phenotype study of 43 Costello syndrome cases confirming HRAS as the causative gene."", ""reference"": ""PMID:16443854"", ""snippet"": ""These results confirm that CS is caused, in most cases, by heterozygous missense mutations in the proto-oncogene HRAS."", ""supports"": ""SUPPORT""}"
2047	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	0	PMID:29358789	SUPPORT		BACKGROUND AND OBJECTIVES: Crohn's disease is a multifactorial inflammatory disease affecting mainly the gastrointestinal tract. The genetic factors that are involved in the disease include mainly three mutations of the gene NOD2/CARD15 (R702W, G908R, 3020insC).	This reference states that NOD2 mutations are involved in Crohn's disease, supporting the association as a risk factor.	"{""explanation"": ""This reference states that NOD2 mutations are involved in Crohn's disease, supporting the association as a risk factor."", ""reference"": ""PMID:29358789"", ""snippet"": ""BACKGROUND AND OBJECTIVES: Crohn's disease is a multifactorial inflammatory disease affecting mainly the gastrointestinal tract. The genetic factors that are involved in the disease include mainly three mutations of the gene NOD2/CARD15 (R702W, G908R, 3020insC)."", ""supports"": ""SUPPORT""}"
2048	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	1	PMID:23352252	SUPPORT		NOD2 gene mutations are associated with several diseases, and some of the mutations are of diagnostic value in Blau disease and NAID... The NOD2 variants located in the leucine-rich repeat (LRR) region are susceptible to Crohn disease.	This reference confirms the association of NOD2 gene mutations with Crohn's disease.	"{""explanation"": ""This reference confirms the association of NOD2 gene mutations with Crohn's disease."", ""reference"": ""PMID:23352252"", ""snippet"": ""NOD2 gene mutations are associated with several diseases, and some of the mutations are of diagnostic value in Blau disease and NAID... The NOD2 variants located in the leucine-rich repeat (LRR) region are susceptible to Crohn disease."", ""supports"": ""SUPPORT""}"
2049	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	2	PMID:16773683	SUPPORT		Investigations into the inheritance of the three risk alleles R702W, G908R and 1007fsInsC in NOD2 associated with susceptibility to Crohn's disease have demonstrated a remarkable amount of heterogeneity across ethnicities and populations.	This reference clearly establishes the association of specific NOD2 mutations with susceptibility to Crohn's disease.	"{""explanation"": ""This reference clearly establishes the association of specific NOD2 mutations with susceptibility to Crohn's disease."", ""reference"": ""PMID:16773683"", ""snippet"": ""Investigations into the inheritance of the three risk alleles R702W, G908R and 1007fsInsC in NOD2 associated with susceptibility to Crohn's disease have demonstrated a remarkable amount of heterogeneity across ethnicities and populations."", ""supports"": ""SUPPORT""}"
2050	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	3	PMID:12851870	SUPPORT		The NOD2 gene, which is strongly associated with susceptibility to Crohn's disease (CD) of the terminal ileum, interacts with bacterial lipopolysaccharide (LPS), inducing cellular activation.	This study supports the role of NOD2 as a genetic risk factor for Crohn's disease.	"{""explanation"": ""This study supports the role of NOD2 as a genetic risk factor for Crohn's disease."", ""reference"": ""PMID:12851870"", ""snippet"": ""The NOD2 gene, which is strongly associated with susceptibility to Crohn's disease (CD) of the terminal ileum, interacts with bacterial lipopolysaccharide (LPS), inducing cellular activation."", ""supports"": ""SUPPORT""}"
2051	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	4	PMID:32476786	SUPPORT		While NOD2 mutations represent well established risk factors of CD, the role of other genes is incompletely understood.	This confirms that NOD2 is a well-established genetic risk factor for Crohn's disease.	"{""explanation"": ""This confirms that NOD2 is a well-established genetic risk factor for Crohn's disease."", ""reference"": ""PMID:32476786"", ""snippet"": ""While NOD2 mutations represent well established risk factors of CD, the role of other genes is incompletely understood."", ""supports"": ""SUPPORT""}"
2052	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	5	PMID:11385577	SUPPORT		Here we show, by using the transmission disequilibium test and case-control analysis, that a frameshift mutation caused by a cytosine insertion, 3020insC, which is expected to encode a truncated NOD2 protein, is associated with Crohn's disease.	This study provides evidence of a specific NOD2 mutation associated with Crohn's disease.	"{""explanation"": ""This study provides evidence of a specific NOD2 mutation associated with Crohn's disease."", ""reference"": ""PMID:11385577"", ""snippet"": ""Here we show, by using the transmission disequilibium test and case-control analysis, that a frameshift mutation caused by a cytosine insertion, 3020insC, which is expected to encode a truncated NOD2 protein, is associated with Crohn's disease."", ""supports"": ""SUPPORT""}"
2053	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	6	PMID:17206682	SUPPORT		The association of NOD2/CARD15 mutations with CD and BS, and possibly also early onset sarcoidosis, suggests a role for the gene in the development of granulomata and granulomatous diseases.	This statement supports the association of NOD2 with Crohn's disease (CD).	"{""explanation"": ""This statement supports the association of NOD2 with Crohn's disease (CD)."", ""reference"": ""PMID:17206682"", ""snippet"": ""The association of NOD2/CARD15 mutations with CD and BS, and possibly also early onset sarcoidosis, suggests a role for the gene in the development of granulomata and granulomatous diseases."", ""supports"": ""SUPPORT""}"
2054	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	7	PMID:16987083	SUPPORT		The mapping to CD of Nod2 variants that alter protein function represents one of the earliest, most well-established, associations in complex genetic disorders.	This reference emphasizes that the NOD2 association with Crohn's disease is well-established.	"{""explanation"": ""This reference emphasizes that the NOD2 association with Crohn's disease is well-established."", ""reference"": ""PMID:16987083"", ""snippet"": ""The mapping to CD of Nod2 variants that alter protein function represents one of the earliest, most well-established, associations in complex genetic disorders."", ""supports"": ""SUPPORT""}"
2055	1816	77	Crohn Disease	Crohn_Disease.yaml	genetic	0	evidence	8	PMID:27076762	SUPPORT		The highest accuracy, AUC of 0.78 was achieved with GRS combining 33 SNPs with optimal sensitivity and specificity of 75.0% and 72.7%, respectively.	This study confirms the role of genetic risk scores including multiple SNP variants for predicting Crohn's disease.	"{""explanation"": ""This study confirms the role of genetic risk scores including multiple SNP variants for predicting Crohn's disease."", ""reference"": ""PMID:27076762"", ""snippet"": ""The highest accuracy, AUC of 0.78 was achieved with GRS combining 33 SNPs with optimal sensitivity and specificity of 75.0% and 72.7%, respectively."", ""supports"": ""SUPPORT""}"
2056	1817	77	Crohn Disease	Crohn_Disease.yaml	genetic	1	evidence	0	PMID:27698206	SUPPORT		Conclusion In this meta-analysis, the ATG16L1 genotype was significantly associated with the risk of developing Crohn''s disease.		"{""reference"": ""PMID:27698206"", ""snippet"": ""Conclusion In this meta-analysis, the ATG16L1 genotype was significantly associated with the risk of developing Crohn''s disease."", ""supports"": ""SUPPORT""}"
2057	1817	77	Crohn Disease	Crohn_Disease.yaml	genetic	1	evidence	1	PMID:25906181	SUPPORT		single-nucleotide polymorphisms in ATG16L1 ... a key component in the autophagic response to invading pathogens, have been associated with an increased risk of developing Crohn disease.		"{""reference"": ""PMID:25906181"", ""snippet"": ""single-nucleotide polymorphisms in ATG16L1 ... a key component in the autophagic response to invading pathogens, have been associated with an increased risk of developing Crohn disease."", ""supports"": ""SUPPORT""}"
2058	1817	77	Crohn Disease	Crohn_Disease.yaml	genetic	1	evidence	2	PMID:12840668	NO_EVIDENCE		CARD15 mutations are present in 30-50% of CD patients compared to 7-20% of healthy controls. Interestingly, CD patients often carry mutations on their two chromosomes suggesting a mutation dose effect.	The reference focuses on the association between CARD15 mutations and Crohn’s Disease, with no information regarding ATG16L1.	"{""explanation"": ""The reference focuses on the association between CARD15 mutations and Crohn’s Disease, with no information regarding ATG16L1."", ""reference"": ""PMID:12840668"", ""snippet"": ""CARD15 mutations are present in 30-50% of CD patients compared to 7-20% of healthy controls. Interestingly, CD patients often carry mutations on their two chromosomes suggesting a mutation dose effect."", ""supports"": ""NO_EVIDENCE""}"
2059	1817	77	Crohn Disease	Crohn_Disease.yaml	genetic	1	evidence	3	PMID:29795570	NO_EVIDENCE		ten rare genetic risk factors in NOD2 and LRRK2 are enriched in AJ (p < 0.005), including several novel contributing alleles, show evidence of association to CD.	The reference highlights genetic risk factors in NOD2 and LRRK2 for Crohn's Disease, not ATG16L1.	"{""explanation"": ""The reference highlights genetic risk factors in NOD2 and LRRK2 for Crohn's Disease, not ATG16L1."", ""reference"": ""PMID:29795570"", ""snippet"": ""ten rare genetic risk factors in NOD2 and LRRK2 are enriched in AJ (p < 0.005), including several novel contributing alleles, show evidence of association to CD."", ""supports"": ""NO_EVIDENCE""}"
2060	1817	77	Crohn Disease	Crohn_Disease.yaml	genetic	1	evidence	4	PMID:27076762	PARTIAL		We generated genetic risk scores (GRS) based on the number of risk alleles using weighted additive model. Discriminatory accuracy was measured by area under ROC curve (AUC)....The highest accuracy, AUC of 0.78 was achieved with GRS combining 33 SNPs with optimal sensitivity and specificity of 75.0% and 72.7%, respectively.	The study involves identification of SNPs for risk prediction, however ATG16L1 is not mentioned explicitly. Thus, it only partially supports the statement.	"{""explanation"": ""The study involves identification of SNPs for risk prediction, however ATG16L1 is not mentioned explicitly. Thus, it only partially supports the statement."", ""reference"": ""PMID:27076762"", ""snippet"": ""We generated genetic risk scores (GRS) based on the number of risk alleles using weighted additive model. Discriminatory accuracy was measured by area under ROC curve (AUC)....The highest accuracy, AUC of 0.78 was achieved with GRS combining 33 SNPs with optimal sensitivity and specificity of 75.0% and 72.7%, respectively."", ""supports"": ""PARTIAL""}"
2061	1818	77	Crohn Disease	Crohn_Disease.yaml	genetic	2	evidence	0	PMID:17068223	SUPPORT		We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23.	This study identifies IL23R as a gene significantly associated with Crohn's disease, supporting the statement that IL23R is a genetic risk factor for the condition.	"{""explanation"": ""This study identifies IL23R as a gene significantly associated with Crohn's disease, supporting the statement that IL23R is a genetic risk factor for the condition."", ""reference"": ""PMID:17068223"", ""snippet"": ""We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23."", ""supports"": ""SUPPORT""}"
2062	1818	77	Crohn Disease	Crohn_Disease.yaml	genetic	2	evidence	1	PMID:24989722	SUPPORT		We demonstrate a strong increased CD risk for smokers in both datasets (odds ratio 3.77, 95% confidence interval 2.88-4.94), and an additive interaction between IL23R SNPs and cigarette smoking.	This study supports the association between IL23R and Crohn's disease, while also highlighting the interaction between IL23R variants and environmental factors like smoking.	"{""explanation"": ""This study supports the association between IL23R and Crohn's disease, while also highlighting the interaction between IL23R variants and environmental factors like smoking."", ""reference"": ""PMID:24989722"", ""snippet"": ""We demonstrate a strong increased CD risk for smokers in both datasets (odds ratio 3.77, 95% confidence interval 2.88-4.94), and an additive interaction between IL23R SNPs and cigarette smoking."", ""supports"": ""SUPPORT""}"
2175	1882	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	genetic	0	evidence	0	PMID:8528214	SUPPORT	HUMAN_CLINICAL	Five different mutations were found including two novel (W290G, C342W) and two previously reported, recurrent mutations for Crouzon syndrome (A344A, S354C), and one new mutation for Jackson-Weiss syndrome (C342R)	Demonstrates allelic heterogeneity with multiple different FGFR2 mutations causing Crouzon syndrome, including mutations in exon IIIa and IIIc.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates allelic heterogeneity with multiple different FGFR2 mutations causing Crouzon syndrome, including mutations in exon IIIa and IIIc."", ""reference"": ""PMID:8528214"", ""snippet"": ""Five different mutations were found including two novel (W290G, C342W) and two previously reported, recurrent mutations for Crouzon syndrome (A344A, S354C), and one new mutation for Jackson-Weiss syndrome (C342R)"", ""supports"": ""SUPPORT""}"
2176	1882	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	genetic	0	evidence	1	PMID:7493034	SUPPORT	HUMAN_CLINICAL	All mutations described so far for other craniosynostotic syndromes with associated limb anomalies--Jackson-Weiss, Pfeiffer, and Apert--also occur in the extracellular domain of FGFR2	Confirms that Crouzon syndrome FGFR2 mutations occur in the extracellular domain, similar to other craniosynostosis syndromes but distinguishing it from those with limb involvement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that Crouzon syndrome FGFR2 mutations occur in the extracellular domain, similar to other craniosynostosis syndromes but distinguishing it from those with limb involvement."", ""reference"": ""PMID:7493034"", ""snippet"": ""All mutations described so far for other craniosynostotic syndromes with associated limb anomalies--Jackson-Weiss, Pfeiffer, and Apert--also occur in the extracellular domain of FGFR2"", ""supports"": ""SUPPORT""}"
2182	1893	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	genetic	0	evidence	0	PMID:7493034	SUPPORT	HUMAN_CLINICAL	We now report the unexpected observation of a FGFR3 transmembrane domain mutation, Ala391Glu, in three unrelated families with Crouzon syndrome and acanthosis nigricans, a specific skin disorder of hyperkeratosis and hyperpigmentation.	"This is the landmark paper identifying the A391E mutation in FGFR3 as the cause of Crouzon syndrome with acanthosis nigricans, demonstrating the genetic basis of this distinct disorder.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This is the landmark paper identifying the A391E mutation in FGFR3 as the cause of Crouzon syndrome with acanthosis nigricans, demonstrating the genetic basis of this distinct disorder.\n"", ""reference"": ""PMID:7493034"", ""snippet"": ""We now report the unexpected observation of a FGFR3 transmembrane domain mutation, Ala391Glu, in three unrelated families with Crouzon syndrome and acanthosis nigricans, a specific skin disorder of hyperkeratosis and hyperpigmentation."", ""supports"": ""SUPPORT""}"
2183	1893	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	genetic	0	evidence	1	PMID:10696568	SUPPORT	HUMAN_CLINICAL	Mutations in the FGFR3 gene also result in hypochondroplasia, the lethal thanatophoric dysplasias, the recently described SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) dysplasia, and two craniosynostosis disorders: Muenke coronal craniosynostosis and Crouzon syndrome with acanthosis nigricans.	"This review confirms FGFR3 mutations cause CSAN and places it in the context of other FGFR3-related disorders.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review confirms FGFR3 mutations cause CSAN and places it in the context of other FGFR3-related disorders.\n"", ""reference"": ""PMID:10696568"", ""snippet"": ""Mutations in the FGFR3 gene also result in hypochondroplasia, the lethal thanatophoric dysplasias, the recently described SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) dysplasia, and two craniosynostosis disorders: Muenke coronal craniosynostosis and Crouzon syndrome with acanthosis nigricans."", ""supports"": ""SUPPORT""}"
2217	1951	84	Danon disease	Danon_disease.yaml	genetic	0	evidence	0	DOI:10.3390/biom14101272	SUPPORT		Danon disease, an X-linked dominant vacuolar cardiomyopathy and skeletal myopathy, is caused by a primary deficiency of lysosome-associated membrane protein-2 (LAMP-2).	Confirms LAMP-2 deficiency as the cause of Danon disease.	"{""explanation"": ""Confirms LAMP-2 deficiency as the cause of Danon disease."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""Danon disease, an X-linked dominant vacuolar cardiomyopathy and skeletal myopathy, is caused by a primary deficiency of lysosome-associated membrane protein-2 (LAMP-2)."", ""supports"": ""SUPPORT""}"
2218	1951	84	Danon disease	Danon_disease.yaml	genetic	0	evidence	1	DOI:10.3390/genes14081539	SUPPORT		Genetic testing revealed an Xq24 microdeletion encompassing the entire LAMP2 gene.	Documents complete LAMP2 gene deletion causing Danon disease.	"{""explanation"": ""Documents complete LAMP2 gene deletion causing Danon disease."", ""reference"": ""DOI:10.3390/genes14081539"", ""snippet"": ""Genetic testing revealed an Xq24 microdeletion encompassing the entire LAMP2 gene."", ""supports"": ""SUPPORT""}"
2219	1952	84	Danon disease	Danon_disease.yaml	genetic	1	evidence	0	DOI:10.1111/nan.12587	SUPPORT		Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients, and by a milder phenotype (predominantly involving cardiac muscle) in female patients.	Documents distinct phenotypic presentations between males and females.	"{""explanation"": ""Documents distinct phenotypic presentations between males and females."", ""reference"": ""DOI:10.1111/nan.12587"", ""snippet"": ""Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients, and by a milder phenotype (predominantly involving cardiac muscle) in female patients."", ""supports"": ""SUPPORT""}"
2220	1952	84	Danon disease	Danon_disease.yaml	genetic	1	evidence	1	DOI:10.3390/genes14081539	SUPPORT		Danon disease is typically lethal by the mid-twenties in male patients due to cardiomyopathy and heart failure. Female patients usually present with milder and variable symptoms.	Confirms sex-specific differences in disease severity and progression.	"{""explanation"": ""Confirms sex-specific differences in disease severity and progression."", ""reference"": ""DOI:10.3390/genes14081539"", ""snippet"": ""Danon disease is typically lethal by the mid-twenties in male patients due to cardiomyopathy and heart failure. Female patients usually present with milder and variable symptoms."", ""supports"": ""SUPPORT""}"
2238	1966	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	genetic	0	evidence	0	PMID:30097731	SUPPORT		DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA.	This confirms that the APOE ε4 allele is a shared genetic risk locus between DLB and Alzheimer's disease.	"{""explanation"": ""This confirms that the APOE ε4 allele is a shared genetic risk locus between DLB and Alzheimer's disease."", ""reference"": ""PMID:30097731"", ""snippet"": ""DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA."", ""supports"": ""SUPPORT""}"
2239	1966	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	genetic	0	evidence	1	PMID:29222591	SUPPORT		Intravitam PET and post-mortem studies revealed more pronounced cortical atrophy, elevated cortical and limbic Lewy pathologies (with APOE ε4).	This demonstrates that APOE ε4 is associated with more pronounced Lewy pathology in DLB.	"{""explanation"": ""This demonstrates that APOE ε4 is associated with more pronounced Lewy pathology in DLB."", ""reference"": ""PMID:29222591"", ""snippet"": ""Intravitam PET and post-mortem studies revealed more pronounced cortical atrophy, elevated cortical and limbic Lewy pathologies (with APOE ε4)."", ""supports"": ""SUPPORT""}"
2240	1967	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	genetic	1	evidence	0	PMID:35332438	SUPPORT		GBA variants increased the risk of DLB, especially N370S, E326K, and L444P which are strongly associated with DLB, but T369M was not. Patients harbouring GBA variants have an earlier age of onset, more severe cognitive impairment, and rapid symptom progression.	This meta-analysis confirms that specific GBA variants are strongly associated with DLB and correlate with earlier onset and more severe clinical presentation.	"{""explanation"": ""This meta-analysis confirms that specific GBA variants are strongly associated with DLB and correlate with earlier onset and more severe clinical presentation."", ""reference"": ""PMID:35332438"", ""snippet"": ""GBA variants increased the risk of DLB, especially N370S, E326K, and L444P which are strongly associated with DLB, but T369M was not. Patients harbouring GBA variants have an earlier age of onset, more severe cognitive impairment, and rapid symptom progression."", ""supports"": ""SUPPORT""}"
2241	1967	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	genetic	1	evidence	1	PMID:28734699	SUPPORT		More recently, association and exome sequencing studies in larger groups have been conducted, and have shown that several variants in GBA and the APOE ε4 allele are important genetic risk factors for DLB.	This review confirms that GBA variants are important genetic risk factors for dementia with Lewy bodies.	"{""explanation"": ""This review confirms that GBA variants are important genetic risk factors for dementia with Lewy bodies."", ""reference"": ""PMID:28734699"", ""snippet"": ""More recently, association and exome sequencing studies in larger groups have been conducted, and have shown that several variants in GBA and the APOE ε4 allele are important genetic risk factors for DLB."", ""supports"": ""SUPPORT""}"
2242	1967	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	genetic	1	evidence	2	PMID:30097731	SUPPORT		DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA.	This confirms that GBA represents a shared genetic risk locus between DLB and Parkinson's disease.	"{""explanation"": ""This confirms that GBA represents a shared genetic risk locus between DLB and Parkinson's disease."", ""reference"": ""PMID:30097731"", ""snippet"": ""DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA."", ""supports"": ""SUPPORT""}"
2243	1968	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	genetic	2	evidence	0	PMID:30097731	SUPPORT		DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA.	This confirms that SNCA represents a shared genetic risk locus between DLB and Parkinson's disease.	"{""explanation"": ""This confirms that SNCA represents a shared genetic risk locus between DLB and Parkinson's disease."", ""reference"": ""PMID:30097731"", ""snippet"": ""DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA."", ""supports"": ""SUPPORT""}"
2260	1985	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	genetic	0	evidence	0	PMID:17950782	SUPPORT		fusion of exon 2 of PDGFB to various exons of the COL1A1 gene.	Abstract describes the COL1A1-PDGFB fusion underlying DFSP.	"{""explanation"": ""Abstract describes the COL1A1-PDGFB fusion underlying DFSP."", ""reference"": ""PMID:17950782"", ""snippet"": ""fusion of exon 2 of PDGFB to various exons of the COL1A1 gene."", ""supports"": ""SUPPORT""}"
2297	2084	93	Down_syndrome	Down_syndrome.yaml	genetic	0	evidence	0	PMID:32029743	SUPPORT		DS is among the most genetically complex of the conditions that are compatible with human survival post-term, and the most frequent survivable autosomal aneuploidy.	Confirms trisomy 21 as the genetic basis of Down syndrome.	"{""explanation"": ""Confirms trisomy 21 as the genetic basis of Down syndrome."", ""reference"": ""PMID:32029743"", ""snippet"": ""DS is among the most genetically complex of the conditions that are compatible with human survival post-term, and the most frequent survivable autosomal aneuploidy."", ""supports"": ""SUPPORT""}"
2309	2116	95	Dravet_syndrome	Dravet_syndrome.yaml	genetic	0	evidence	0	PMID:21463282	SUPPORT		Complete loss of function in the Na(v) 1.1 channel encoded by the SCN1A gene is associated with severe myoclonic epilepsy in infancy (SMEI)		"{""reference"": ""PMID:21463282"", ""snippet"": ""Complete loss of function in the Na(v) 1.1 channel encoded by the SCN1A gene is associated with severe myoclonic epilepsy in infancy (SMEI)"", ""supports"": ""SUPPORT""}"
2329	2188	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	genetic	0	evidence	0	PMID:26490356	SUPPORT		Exon 19 deletion and exon 21 L858R mutation were the most common epidermal growth factor receptor (EGFR) mutations.	Abstract identifies exon 19 deletion and L858R as the most common EGFR mutations.	"{""explanation"": ""Abstract identifies exon 19 deletion and L858R as the most common EGFR mutations."", ""reference"": ""PMID:26490356"", ""snippet"": ""Exon 19 deletion and exon 21 L858R mutation were the most common epidermal growth factor receptor (EGFR) mutations."", ""supports"": ""SUPPORT""}"
2428	2277	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	0	evidence	0	PMID:36896471	SUPPORT		Pathogenic variants in COL1A1 and COL1A2 are involved in osteogenesis imperfecta (OI) and, rarely, Ehlers-Danlos syndrome (EDS) subtypes and OI-EDS overlap syndromes (OIEDS1 and OIEDS2, respectively).	This statement supports that pathogenic variants in COL1A1 are associated with some subtypes of Ehlers-Danlos Syndrome (EDS).	"{""explanation"": ""This statement supports that pathogenic variants in COL1A1 are associated with some subtypes of Ehlers-Danlos Syndrome (EDS)."", ""reference"": ""PMID:36896471"", ""snippet"": ""Pathogenic variants in COL1A1 and COL1A2 are involved in osteogenesis imperfecta (OI) and, rarely, Ehlers-Danlos syndrome (EDS) subtypes and OI-EDS overlap syndromes (OIEDS1 and OIEDS2, respectively)."", ""supports"": ""SUPPORT""}"
2429	2278	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	1	evidence	0	PMID:34560710	SUPPORT		vEDS patients are at risk of blood vessel rupture due to possession of pathogenic variants of the COL3A1 gene, which encodes type III collagen.	The literature explicitly states that vascular Ehlers-Danlos syndrome (vEDS) is caused by pathogenic variants in the COL3A1 gene.	"{""explanation"": ""The literature explicitly states that vascular Ehlers-Danlos syndrome (vEDS) is caused by pathogenic variants in the COL3A1 gene."", ""reference"": ""PMID:34560710"", ""snippet"": ""vEDS patients are at risk of blood vessel rupture due to possession of pathogenic variants of the COL3A1 gene, which encodes type III collagen."", ""supports"": ""SUPPORT""}"
2430	2278	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	1	evidence	1	PMID:30837697	SUPPORT		Vascular EDS (vEDS) is caused by pathogenic variants in COL3A1, most frequently glycine substitutions.	The abstract confirms the association of vascular EDS with pathogenic variants in the COL3A1 gene.	"{""explanation"": ""The abstract confirms the association of vascular EDS with pathogenic variants in the COL3A1 gene."", ""reference"": ""PMID:30837697"", ""snippet"": ""Vascular EDS (vEDS) is caused by pathogenic variants in COL3A1, most frequently glycine substitutions."", ""supports"": ""SUPPORT""}"
2431	2278	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	1	evidence	2	PMID:35699227	SUPPORT		Carriers of pathogenic or likely pathogenic COL3A1 variants were retrospectively identified through registries and specialized clinics.	The study supports the association between pathogenic COL3A1 variants and vascular Ehlers-Danlos syndrome.	"{""explanation"": ""The study supports the association between pathogenic COL3A1 variants and vascular Ehlers-Danlos syndrome."", ""reference"": ""PMID:35699227"", ""snippet"": ""Carriers of pathogenic or likely pathogenic COL3A1 variants were retrospectively identified through registries and specialized clinics."", ""supports"": ""SUPPORT""}"
2432	2279	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	2	evidence	0	PMID:16278879	SUPPORT		Mutations in the COL5A1 and the COL5A2 gene, encoding the alpha1 and the alpha2-chain of type V collagen respectively, are identified in approximately 50% of patients with a clinical diagnosis of classic EDS.	The reference clearly states that mutations in the COL5A1 gene are associated with classical Ehlers-Danlos Syndrome, thus supporting the statement.	"{""explanation"": ""The reference clearly states that mutations in the COL5A1 gene are associated with classical Ehlers-Danlos Syndrome, thus supporting the statement."", ""reference"": ""PMID:16278879"", ""snippet"": ""Mutations in the COL5A1 and the COL5A2 gene, encoding the alpha1 and the alpha2-chain of type V collagen respectively, are identified in approximately 50% of patients with a clinical diagnosis of classic EDS."", ""supports"": ""SUPPORT""}"
2433	2280	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	3	evidence	0	PMID:16278879	SUPPORT		Mutations in the COL5A1 and the COL5A2 gene, encoding the alpha1 and the alpha2-chain of type V collagen respectively, are identified in approximately 50% of patients with a clinical diagnosis of classic EDS.	The reference confirms that mutations in the COL5A2 gene, encoding the alpha2-chain of type V collagen, are associated with classical EDS and account for approximately 50% of classic EDS cases along with COL5A1.	"{""explanation"": ""The reference confirms that mutations in the COL5A2 gene, encoding the alpha2-chain of type V collagen, are associated with classical EDS and account for approximately 50% of classic EDS cases along with COL5A1."", ""reference"": ""PMID:16278879"", ""snippet"": ""Mutations in the COL5A1 and the COL5A2 gene, encoding the alpha1 and the alpha2-chain of type V collagen respectively, are identified in approximately 50% of patients with a clinical diagnosis of classic EDS."", ""supports"": ""SUPPORT""}"
2434	2281	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	4	evidence	0	PMID:12646579	SUPPORT		mutations in the ADAMTS-2 gene in dermatosparaxis and Ehlers-Danlos syndrome VIIC show this enzyme to be responsible in vivo for most biosynthetic processing of procollagen I N-propeptides in skin.	This study demonstrates that ADAMTS2 mutations cause Ehlers-Danlos syndrome type VIIC (dermatosparaxis) by disrupting procollagen processing.	"{""explanation"": ""This study demonstrates that ADAMTS2 mutations cause Ehlers-Danlos syndrome type VIIC (dermatosparaxis) by disrupting procollagen processing."", ""reference"": ""PMID:12646579"", ""snippet"": ""mutations in the ADAMTS-2 gene in dermatosparaxis and Ehlers-Danlos syndrome VIIC show this enzyme to be responsible in vivo for most biosynthetic processing of procollagen I N-propeptides in skin."", ""supports"": ""SUPPORT""}"
2435	2282	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	5	evidence	0	PMID:36108117	SUPPORT		The diagnosis of TNXB-related clEDS is established in a proband with suggestive clinical findings and biallelic pathogenic variants in TNXB identified by molecular genetic testing.	This GeneReviews entry confirms that biallelic pathogenic variants in TNXB cause classical-like EDS.	"{""explanation"": ""This GeneReviews entry confirms that biallelic pathogenic variants in TNXB cause classical-like EDS."", ""reference"": ""PMID:36108117"", ""snippet"": ""The diagnosis of TNXB-related clEDS is established in a proband with suggestive clinical findings and biallelic pathogenic variants in TNXB identified by molecular genetic testing."", ""supports"": ""SUPPORT""}"
2436	2283	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	6	evidence	0	PMID:36960056	SUPPORT		pEDS is caused by heterozygous missense mutations in C1R and C1S genes of the classical complement C1 complex.	This study demonstrates that C1R mutations cause periodontal EDS by triggering intracellular activation of complement proteases.	"{""explanation"": ""This study demonstrates that C1R mutations cause periodontal EDS by triggering intracellular activation of complement proteases."", ""reference"": ""PMID:36960056"", ""snippet"": ""pEDS is caused by heterozygous missense mutations in C1R and C1S genes of the classical complement C1 complex."", ""supports"": ""SUPPORT""}"
2437	2284	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	7	evidence	0	PMID:36960056	SUPPORT		pEDS is caused by heterozygous missense mutations in C1R and C1S genes of the classical complement C1 complex.	This study demonstrates that C1S mutations cause periodontal EDS, with activated C1s degrading collagen I.	"{""explanation"": ""This study demonstrates that C1S mutations cause periodontal EDS, with activated C1s degrading collagen I."", ""reference"": ""PMID:36960056"", ""snippet"": ""pEDS is caused by heterozygous missense mutations in C1R and C1S genes of the classical complement C1 complex."", ""supports"": ""SUPPORT""}"
2438	2285	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	8	evidence	0	PMID:32174067	SUPPORT		Kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive connective tissue disorder... The disorder results from a deficiency of the enzyme collagen lysyl hydroxylase 1 due to mutations in the gene PLOD1.	This source clearly states that pathogenic variants in the PLOD1 gene are responsible for kyphoscoliotic Ehlers-Danlos syndrome.	"{""explanation"": ""This source clearly states that pathogenic variants in the PLOD1 gene are responsible for kyphoscoliotic Ehlers-Danlos syndrome."", ""reference"": ""PMID:32174067"", ""snippet"": ""Kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive connective tissue disorder... The disorder results from a deficiency of the enzyme collagen lysyl hydroxylase 1 due to mutations in the gene PLOD1."", ""supports"": ""SUPPORT""}"
2439	2285	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	8	evidence	1	PMID:15979919	SUPPORT		The kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) is an inheritable connective tissue disorder characterized by a deficiency of lysyl hydroxylase due to mutations in PLOD1.	This reference supports the association between PLOD1 mutations and kyphoscoliotic Ehlers-Danlos syndrome.	"{""explanation"": ""This reference supports the association between PLOD1 mutations and kyphoscoliotic Ehlers-Danlos syndrome."", ""reference"": ""PMID:15979919"", ""snippet"": ""The kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) is an inheritable connective tissue disorder characterized by a deficiency of lysyl hydroxylase due to mutations in PLOD1."", ""supports"": ""SUPPORT""}"
2440	2285	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	8	evidence	2	PMID:29982180	SUPPORT		Pathogenic variants in the lysyl-hydroxylase-1 gene (PLOD1) are responsible for the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS).	This source reinforces the role of PLOD1 pathogenic variants in causing kyphoscoliotic Ehlers-Danlos syndrome.	"{""explanation"": ""This source reinforces the role of PLOD1 pathogenic variants in causing kyphoscoliotic Ehlers-Danlos syndrome."", ""reference"": ""PMID:29982180"", ""snippet"": ""Pathogenic variants in the lysyl-hydroxylase-1 gene (PLOD1) are responsible for the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS)."", ""supports"": ""SUPPORT""}"
2441	2285	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	genetic	8	evidence	3	PMID:36054293	SUPPORT		The autosomal recessive kyphoscoliotic EDS results from deficiency of either lysyl hydroxylase 1 (encoded by PLOD1), crucial for collagen cross-linking... 	This study adds further confirmation of the genetic association between PLOD1 and kyphoscoliotic Ehlers-Danlos syndrome.	"{""explanation"": ""This study adds further confirmation of the genetic association between PLOD1 and kyphoscoliotic Ehlers-Danlos syndrome."", ""reference"": ""PMID:36054293"", ""snippet"": ""The autosomal recessive kyphoscoliotic EDS results from deficiency of either lysyl hydroxylase 1 (encoded by PLOD1), crucial for collagen cross-linking... "", ""supports"": ""SUPPORT""}"
2520	2318	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	genetic	0	evidence	0	PMID:30858776	SUPPORT		Among all tested patients, nine mutations of COL5A1 gene were detected (8 missense mutations and 1 splice site).	This reference confirms the existence of missense and splice site mutations in the COL5A1 gene among Ehlers-Danlos Syndrome patients.	"{""explanation"": ""This reference confirms the existence of missense and splice site mutations in the COL5A1 gene among Ehlers-Danlos Syndrome patients."", ""reference"": ""PMID:30858776"", ""snippet"": ""Among all tested patients, nine mutations of COL5A1 gene were detected (8 missense mutations and 1 splice site)."", ""supports"": ""SUPPORT""}"
2521	2318	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	genetic	0	evidence	1	PMID:33656776	SUPPORT		Glycine substitution mutation of COL5A1 in classic Ehlers-Danlos syndrome: a case report and literature review.	This reference supports the presence of missense mutations specifically related to COL5A1 in Ehlers-Danlos Syndrome.	"{""explanation"": ""This reference supports the presence of missense mutations specifically related to COL5A1 in Ehlers-Danlos Syndrome."", ""reference"": ""PMID:33656776"", ""snippet"": ""Glycine substitution mutation of COL5A1 in classic Ehlers-Danlos syndrome: a case report and literature review."", ""supports"": ""SUPPORT""}"
2522	2318	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	genetic	0	evidence	2	PMID:35241120	PARTIAL		This study supports that rs12722 is associated with an elevated susceptibility to ligament injury, especially in the Caucasian population.	While the study primarily investigates the association of COL5A1 polymorphisms with musculoskeletal injuries, it partially supports the statement by recognizing relevant genetic variants.	"{""explanation"": ""While the study primarily investigates the association of COL5A1 polymorphisms with musculoskeletal injuries, it partially supports the statement by recognizing relevant genetic variants."", ""reference"": ""PMID:35241120"", ""snippet"": ""This study supports that rs12722 is associated with an elevated susceptibility to ligament injury, especially in the Caucasian population."", ""supports"": ""PARTIAL""}"
2523	2318	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	genetic	0	evidence	3	PMID:2683783	WRONG_STATEMENT		Mutations in the majority of the 20 known collagen genes have not yet been identified.	This reference doesn't support the existence of frameshift mutations in COL5A1, making the specific part of the statement regarding frameshift mutations unsubstantiated.	"{""explanation"": ""This reference doesn't support the existence of frameshift mutations in COL5A1, making the specific part of the statement regarding frameshift mutations unsubstantiated."", ""reference"": ""PMID:2683783"", ""snippet"": ""Mutations in the majority of the 20 known collagen genes have not yet been identified."", ""supports"": ""WRONG_STATEMENT""}"
2584	2395	105	Epilepsy	Epilepsy.yaml	genetic	0	evidence	0	PMID:37812819	SUPPORT		It is caused by haploinsufficiency of SCN1A gene encoding for the α-subunit of the voltage-gated sodium channel Nav1.1.	Establishes SCN1A haploinsufficiency as the genetic cause of Dravet syndrome epileptic encephalopathy.	"{""explanation"": ""Establishes SCN1A haploinsufficiency as the genetic cause of Dravet syndrome epileptic encephalopathy."", ""reference"": ""PMID:37812819"", ""snippet"": ""It is caused by haploinsufficiency of SCN1A gene encoding for the α-subunit of the voltage-gated sodium channel Nav1.1."", ""supports"": ""SUPPORT""}"
2585	2395	105	Epilepsy	Epilepsy.yaml	genetic	0	evidence	1	PMID:37812819	SUPPORT		Induction of heterozygous Nav1.1 mutation at P30 and P60 elicited susceptibility to the development of both spontaneous and hyperthermia-induced seizures and SUDEP rates comparable to P2-induced mice, with symptom onset accompanied by the characteristic GABAergic interneuron dysfunction.	Demonstrates that SCN1A haploinsufficiency causes seizures through GABAergic interneuron dysfunction, and this mechanism is active throughout life, not just during development.	"{""explanation"": ""Demonstrates that SCN1A haploinsufficiency causes seizures through GABAergic interneuron dysfunction, and this mechanism is active throughout life, not just during development."", ""reference"": ""PMID:37812819"", ""snippet"": ""Induction of heterozygous Nav1.1 mutation at P30 and P60 elicited susceptibility to the development of both spontaneous and hyperthermia-induced seizures and SUDEP rates comparable to P2-induced mice, with symptom onset accompanied by the characteristic GABAergic interneuron dysfunction."", ""supports"": ""SUPPORT""}"
2600	2428	106	Essential Hypertension	Essential_Hypertension.yaml	genetic	0	evidence	0	PMID:39765782	SUPPORT		Genetic and environmental factors influence the susceptibility to hypertensive renal damage, with African American populations having a higher tendency due to genetic variants.	This confirms genetic factors, including variants in RAAS genes like ACE, influence hypertension susceptibility.	"{""explanation"": ""This confirms genetic factors, including variants in RAAS genes like ACE, influence hypertension susceptibility."", ""reference"": ""PMID:39765782"", ""snippet"": ""Genetic and environmental factors influence the susceptibility to hypertensive renal damage, with African American populations having a higher tendency due to genetic variants."", ""supports"": ""SUPPORT""}"
2601	2429	106	Essential Hypertension	Essential_Hypertension.yaml	genetic	1	evidence	0	PMID:39765782	SUPPORT		Genetic and environmental factors influence the susceptibility to hypertensive renal damage, with African American populations having a higher tendency due to genetic variants.	This confirms genetic variants in AGT and other RAAS components contribute to hypertension risk.	"{""explanation"": ""This confirms genetic variants in AGT and other RAAS components contribute to hypertension risk."", ""reference"": ""PMID:39765782"", ""snippet"": ""Genetic and environmental factors influence the susceptibility to hypertensive renal damage, with African American populations having a higher tendency due to genetic variants."", ""supports"": ""SUPPORT""}"
2632	2485	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	genetic	0	evidence	0	PMID:35871236	SUPPORT		Recently, several actionable genetic aberrations were identified with significant enrichment in intrahepatic CCA, including FGFR2 gene fusions with a prevalence of 10-15%.	Abstract reports FGFR2 fusion prevalence in intrahepatic cholangiocarcinoma.	"{""explanation"": ""Abstract reports FGFR2 fusion prevalence in intrahepatic cholangiocarcinoma."", ""reference"": ""PMID:35871236"", ""snippet"": ""Recently, several actionable genetic aberrations were identified with significant enrichment in intrahepatic CCA, including FGFR2 gene fusions with a prevalence of 10-15%."", ""supports"": ""SUPPORT""}"
2635	2507	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	genetic	0	evidence	0	PMID:31264434	SUPPORT		Specific mutations have been identified that predict response to therapy including ERCC2 mutations and cisplatin, DNA damage and repair mutations and checkpoint inhibitors, and FGFR3 mutations and FGFR tyrosine kinase inhibitors such as erdafitinib.	Supports clinically relevant FGFR3 mutations in urothelial carcinoma.	"{""explanation"": ""Supports clinically relevant FGFR3 mutations in urothelial carcinoma."", ""reference"": ""PMID:31264434"", ""snippet"": ""Specific mutations have been identified that predict response to therapy including ERCC2 mutations and cisplatin, DNA damage and repair mutations and checkpoint inhibitors, and FGFR3 mutations and FGFR tyrosine kinase inhibitors such as erdafitinib."", ""supports"": ""SUPPORT""}"
2674	2575	113	Fabry disease	Fabry_Disease.yaml	genetic	0	evidence	0	PMID:39100494	SUPPORT		Fabry disease (FD) is an X-linked lysosomal disease caused by an enzyme deficiency of alpha-galactosidase A (α-gal A)	Confirms that Fabry disease is X-linked and caused by deficiency of alpha-galactosidase A enzyme	"{""explanation"": ""Confirms that Fabry disease is X-linked and caused by deficiency of alpha-galactosidase A enzyme"", ""reference"": ""PMID:39100494"", ""snippet"": ""Fabry disease (FD) is an X-linked lysosomal disease caused by an enzyme deficiency of alpha-galactosidase A (α-gal A)"", ""supports"": ""SUPPORT""}"
2675	2575	113	Fabry disease	Fabry_Disease.yaml	genetic	0	evidence	1	PMID:39609713	SUPPORT		Genetic testing is the gold standard for precise diagnosis of FD, however conventional genetic testing could miss deep intronic variants and large deletions or duplications	Establishes genetic testing as diagnostic gold standard and highlights need for comprehensive sequencing approaches to detect all variant types	"{""explanation"": ""Establishes genetic testing as diagnostic gold standard and highlights need for comprehensive sequencing approaches to detect all variant types"", ""reference"": ""PMID:39609713"", ""snippet"": ""Genetic testing is the gold standard for precise diagnosis of FD, however conventional genetic testing could miss deep intronic variants and large deletions or duplications"", ""supports"": ""SUPPORT""}"
2676	2575	113	Fabry disease	Fabry_Disease.yaml	genetic	0	inheritance[0].evidence	0	PMID:31939530	SUPPORT		Fabry disease (FD) is a recessive monogenic inheritance disease linked to chromosome X, secondary to mutations in the GLA gene	Confirms X-linked recessive inheritance pattern of Fabry disease	"{""explanation"": ""Confirms X-linked recessive inheritance pattern of Fabry disease"", ""reference"": ""PMID:31939530"", ""snippet"": ""Fabry disease (FD) is a recessive monogenic inheritance disease linked to chromosome X, secondary to mutations in the GLA gene"", ""supports"": ""SUPPORT""}"
2677	2575	113	Fabry disease	Fabry_Disease.yaml	genetic	0	inheritance[0].evidence	1	PMID:32723516	SUPPORT		In male, diagnosis is made with alpha-galactosidase A enzyme activity dosage in leukocyte, that is very low or null in classical forms and under 30 percent in late-onset forms	Describes enzyme activity testing thresholds for diagnosis in males based on disease form severity	"{""explanation"": ""Describes enzyme activity testing thresholds for diagnosis in males based on disease form severity"", ""reference"": ""PMID:32723516"", ""snippet"": ""In male, diagnosis is made with alpha-galactosidase A enzyme activity dosage in leukocyte, that is very low or null in classical forms and under 30 percent in late-onset forms"", ""supports"": ""SUPPORT""}"
2697	2595	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	genetic	0	evidence	0	PMID:28668823	SUPPORT		Several lines of evidence show that germline mutations affect the functional domains of the APC gene that are responsible for interactions of the transcript with β-catenin, whereas somatic second mutations involve the downstream region of the gene.	Review confirms germline APC mutations affect β-catenin binding domains and somatic second hits occur in downstream regions.	"{""explanation"": ""Review confirms germline APC mutations affect β-catenin binding domains and somatic second hits occur in downstream regions."", ""reference"": ""PMID:28668823"", ""snippet"": ""Several lines of evidence show that germline mutations affect the functional domains of the APC gene that are responsible for interactions of the transcript with β-catenin, whereas somatic second mutations involve the downstream region of the gene."", ""supports"": ""SUPPORT""}"
2709	2618	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	genetic	0	evidence	0	PMID:28154935	SUPPORT		Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. These gain of function mutations lead to an increased activation of the inflammasome pyrin with a subsequent disproportional proinflammatory reaction.	Mutations in the MEFV gene result in increased activation of pyrin, causing excessive inflammation.	"{""explanation"": ""Mutations in the MEFV gene result in increased activation of pyrin, causing excessive inflammation."", ""reference"": ""PMID:28154935"", ""snippet"": ""Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. These gain of function mutations lead to an increased activation of the inflammasome pyrin with a subsequent disproportional proinflammatory reaction."", ""supports"": ""SUPPORT""}"
2710	2618	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	genetic	0	evidence	1	PMID:25307949	SUPPORT		Mutations in the MEFV gene are associated with the human autoinflammatory disease familial Mediterranean fever (FMF). Pyrin can interact with the inflammasome adaptor ASC and induce inflammatory caspase-1 activation in monocytic cells.	This article discusses the role of pyrin in inducing inflammatory responses, supporting the effect of MEFV gene mutations in causing excessive inflammation.	"{""explanation"": ""This article discusses the role of pyrin in inducing inflammatory responses, supporting the effect of MEFV gene mutations in causing excessive inflammation."", ""reference"": ""PMID:25307949"", ""snippet"": ""Mutations in the MEFV gene are associated with the human autoinflammatory disease familial Mediterranean fever (FMF). Pyrin can interact with the inflammasome adaptor ASC and induce inflammatory caspase-1 activation in monocytic cells."", ""supports"": ""SUPPORT""}"
2711	2618	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	genetic	0	evidence	2	PMID:36889987	SUPPORT		MEFV gene mutation spectrum in patients with familial mediterranean fever	The mutation spectrum in the MEFV gene is related to the pathogenesis involving pyrin and inflammation, supporting the given statement.	"{""explanation"": ""The mutation spectrum in the MEFV gene is related to the pathogenesis involving pyrin and inflammation, supporting the given statement."", ""reference"": ""PMID:36889987"", ""snippet"": ""MEFV gene mutation spectrum in patients with familial mediterranean fever"", ""supports"": ""SUPPORT""}"
2774	2652	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	0	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCA is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCA is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2775	2653	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	1	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	a hemizygous pathogenic variant in FANCB known to cause X-linked FA	GeneReviews confirms FANCB causes X-linked Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCB causes X-linked Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""a hemizygous pathogenic variant in FANCB known to cause X-linked FA"", ""supports"": ""SUPPORT""}"
2776	2654	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	2	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCC is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCC is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2777	2655	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	3	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCE is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCE is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2778	2656	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	4	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCF is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCF is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2779	2657	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	5	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCG is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCG is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2780	2658	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	6	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCL is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCL is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2781	2659	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	7	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews lists FANCM among FA-associated genes; some ontology resources classify FANCM-related disease separately from canonical FA complementation groups.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews lists FANCM among FA-associated genes; some ontology resources classify FANCM-related disease separately from canonical FA complementation groups."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2782	2660	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	8	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms UBE2T (FANCT) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms UBE2T (FANCT) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2783	2661	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	9	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCD2 is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCD2 is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2784	2662	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	10	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms FANCI is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms FANCI is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2785	2663	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	11	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms SLX4 (FANCP) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms SLX4 (FANCP) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2786	2664	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	12	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms BRCA2 (FANCD1) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms BRCA2 (FANCD1) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2787	2665	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	13	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms PALB2 (FANCN) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms PALB2 (FANCN) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2788	2666	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	14	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms BRCA1 (FANCS) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms BRCA1 (FANCS) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2789	2667	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	15	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms BRIP1 (FANCJ) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms BRIP1 (FANCJ) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2790	2668	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	16	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms ERCC4 (FANCQ) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms ERCC4 (FANCQ) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2791	2669	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	17	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms RAD51C (FANCO) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms RAD51C (FANCO) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2792	2670	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	18	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	a heterozygous pathogenic variant in RAD51 known to cause autosomal dominant FA	GeneReviews confirms RAD51 (FANCR) as the autosomal dominant FA subtype gene.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms RAD51 (FANCR) as the autosomal dominant FA subtype gene."", ""reference"": ""PMID:20301575"", ""snippet"": ""a heterozygous pathogenic variant in RAD51 known to cause autosomal dominant FA"", ""supports"": ""SUPPORT""}"
2793	2671	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	19	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms XRCC2 (FANCU) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms XRCC2 (FANCU) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2794	2672	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	20	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms MAD2L2/REV7 (FANCV) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms MAD2L2/REV7 (FANCV) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2795	2673	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	21	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA	GeneReviews confirms RFWD3 (FANCW) is one of the 21 genes causing autosomal recessive Fanconi anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms RFWD3 (FANCW) is one of the 21 genes causing autosomal recessive Fanconi anemia."", ""reference"": ""PMID:20301575"", ""snippet"": ""biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA"", ""supports"": ""SUPPORT""}"
2796	2674	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	22	evidence	0	PMID:24037726	SUPPORT	HUMAN_CLINICAL	the ALDH2 variant is associated with accelerated progression of BMF	Study of 64 Japanese FA patients showed ALDH2 deficiency accelerates bone marrow failure progression.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study of 64 Japanese FA patients showed ALDH2 deficiency accelerates bone marrow failure progression."", ""reference"": ""PMID:24037726"", ""snippet"": ""the ALDH2 variant is associated with accelerated progression of BMF"", ""supports"": ""SUPPORT""}"
2797	2675	116	Fanconi_Anemia	Fanconi_Anemia.yaml	genetic	23	evidence	0	PMID:22081012	SUPPORT	IN_VITRO	a synthetic lethal interaction in avian cells between ADH5, encoding the main formaldehyde-detoxifying enzyme, and the Fanconi anemia (FA) DNA-repair pathway	Demonstrates that ADH5 formaldehyde catabolism is essential in FA-deficient cells.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Demonstrates that ADH5 formaldehyde catabolism is essential in FA-deficient cells."", ""reference"": ""PMID:22081012"", ""snippet"": ""a synthetic lethal interaction in avian cells between ADH5, encoding the main formaldehyde-detoxifying enzyme, and the Fanconi anemia (FA) DNA-repair pathway"", ""supports"": ""SUPPORT""}"
2998	2823	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	genetic	0	evidence	0	PMID:17572636	SUPPORT		Substitution of adenine for guanine at nucleotide 617 replaces an evolutionarily conserved arginine with histidine at residue 206 of ACVR1 in all classically affected individuals, making this one of the most highly conserved disease-causing mutations in the human genome.	The R206H mutation is identified as the causative mutation in all classic FOP cases and is highly conserved.	"{""explanation"": ""The R206H mutation is identified as the causative mutation in all classic FOP cases and is highly conserved."", ""reference"": ""PMID:17572636"", ""snippet"": ""Substitution of adenine for guanine at nucleotide 617 replaces an evolutionarily conserved arginine with histidine at residue 206 of ACVR1 in all classically affected individuals, making this one of the most highly conserved disease-causing mutations in the human genome."", ""supports"": ""SUPPORT""}"
2999	2823	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	genetic	0	evidence	1	PMID:29097342	SUPPORT		Most patients with fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder of heterotopic ossification, have the same causative mutation in ACVR1, R206H.	Confirms R206H as the predominant mutation while noting variant cases.	"{""explanation"": ""Confirms R206H as the predominant mutation while noting variant cases."", ""reference"": ""PMID:29097342"", ""snippet"": ""Most patients with fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder of heterotopic ossification, have the same causative mutation in ACVR1, R206H."", ""supports"": ""SUPPORT""}"
3050	2891	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	genetic	0	evidence	0	PMID:24346713	SUPPORT		Fragile X syndrome (FXS) is caused by mutations in the fragile X mental retardation 1 (FMR1) gene.	Review confirms FMR1 gene mutations cause Fragile X syndrome.	"{""explanation"": ""Review confirms FMR1 gene mutations cause Fragile X syndrome."", ""reference"": ""PMID:24346713"", ""snippet"": ""Fragile X syndrome (FXS) is caused by mutations in the fragile X mental retardation 1 (FMR1) gene."", ""supports"": ""SUPPORT""}"
3061	2909	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	genetic	0	evidence	0	PMID:26473392	SUPPORT		MAPT patients were younger than other groups, and showed more frequent behavioural disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy.	This confirms the distinct clinical and anatomical phenotype associated with MAPT mutations in frontotemporal dementia.	"{""explanation"": ""This confirms the distinct clinical and anatomical phenotype associated with MAPT mutations in frontotemporal dementia."", ""reference"": ""PMID:26473392"", ""snippet"": ""MAPT patients were younger than other groups, and showed more frequent behavioural disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy."", ""supports"": ""SUPPORT""}"
3062	2910	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	genetic	1	evidence	0	PMID:26473392	SUPPORT		GRN patients were older at death and more likely to present with non-fluent aphasia.	This demonstrates the characteristic clinical presentation of GRN-related FTD with language deficits.	"{""explanation"": ""This demonstrates the characteristic clinical presentation of GRN-related FTD with language deficits."", ""reference"": ""PMID:26473392"", ""snippet"": ""GRN patients were older at death and more likely to present with non-fluent aphasia."", ""supports"": ""SUPPORT""}"
3063	2910	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	genetic	1	evidence	1	PMID:30711676	SUPPORT		Presymptomatic carriers of GRN and C9orf72 mutations, the most frequent genetic causes of frontotemporal lobar degeneration, represent the optimal target population for the development of disease-modifying drugs.	This confirms GRN as one of the two most common genetic causes of FTD.	"{""explanation"": ""This confirms GRN as one of the two most common genetic causes of FTD."", ""reference"": ""PMID:30711676"", ""snippet"": ""Presymptomatic carriers of GRN and C9orf72 mutations, the most frequent genetic causes of frontotemporal lobar degeneration, represent the optimal target population for the development of disease-modifying drugs."", ""supports"": ""SUPPORT""}"
3064	2911	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	genetic	2	evidence	0	PMID:26473392	SUPPORT		C9orf72 patients alone showed a co-occurrence of ALS. They showed more psychotic symptoms and irrational behaviour, yet were more often reported clinically as socially appropriate and warm.	This highlights the distinctive clinical features of C9orf72-related FTD including the frequent association with ALS and unique behavioral profile.	"{""explanation"": ""This highlights the distinctive clinical features of C9orf72-related FTD including the frequent association with ALS and unique behavioral profile."", ""reference"": ""PMID:26473392"", ""snippet"": ""C9orf72 patients alone showed a co-occurrence of ALS. They showed more psychotic symptoms and irrational behaviour, yet were more often reported clinically as socially appropriate and warm."", ""supports"": ""SUPPORT""}"
3065	2911	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	genetic	2	evidence	1	PMID:30711676	SUPPORT		Presymptomatic carriers of GRN and C9orf72 mutations, the most frequent genetic causes of frontotemporal lobar degeneration, represent the optimal target population for the development of disease-modifying drugs.	This confirms C9orf72 as one of the most common genetic causes of FTD.	"{""explanation"": ""This confirms C9orf72 as one of the most common genetic causes of FTD."", ""reference"": ""PMID:30711676"", ""snippet"": ""Presymptomatic carriers of GRN and C9orf72 mutations, the most frequent genetic causes of frontotemporal lobar degeneration, represent the optimal target population for the development of disease-modifying drugs."", ""supports"": ""SUPPORT""}"
3090	3022	127	Gaucher Disease	Gaucher_Disease.yaml	genetic	0	evidence	0	PMID:28218669	SUPPORT		It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages.	Review confirms glucocerebrosidase (encoded by GBA) deficiency causes the disease.	"{""explanation"": ""Review confirms glucocerebrosidase (encoded by GBA) deficiency causes the disease."", ""reference"": ""PMID:28218669"", ""snippet"": ""It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages."", ""supports"": ""SUPPORT""}"
3123	3093	130	Glaucoma	Glaucoma.yaml	genetic	0	evidence	0	PMID:37217093	SUPPORT		Mutations in the gene MYOC account for approximately 5% of cases of primary open angle glaucoma (POAG).	Establishes MYOC as a causative gene for POAG, accounting for a significant proportion of cases.	"{""explanation"": ""Establishes MYOC as a causative gene for POAG, accounting for a significant proportion of cases."", ""reference"": ""PMID:37217093"", ""snippet"": ""Mutations in the gene MYOC account for approximately 5% of cases of primary open angle glaucoma (POAG)."", ""supports"": ""SUPPORT""}"
3124	3093	130	Glaucoma	Glaucoma.yaml	genetic	0	evidence	1	PMID:37217093	SUPPORT		While myocilin is expressed in numerous tissues, mutant myocilin is only associated with disease in the anterior segment of the eye, in the trabecular meshwork.	Demonstrates tissue-specific pathogenicity of MYOC mutations in the trabecular meshwork of the eye.	"{""explanation"": ""Demonstrates tissue-specific pathogenicity of MYOC mutations in the trabecular meshwork of the eye."", ""reference"": ""PMID:37217093"", ""snippet"": ""While myocilin is expressed in numerous tissues, mutant myocilin is only associated with disease in the anterior segment of the eye, in the trabecular meshwork."", ""supports"": ""SUPPORT""}"
3125	3094	130	Glaucoma	Glaucoma.yaml	genetic	1	evidence	0	PMID:26302410	SUPPORT		Certain mutations in optineurin (gene OPTN) are associated with primary open angle glaucoma.	Confirms OPTN mutations as a genetic risk factor for primary open angle glaucoma.	"{""explanation"": ""Confirms OPTN mutations as a genetic risk factor for primary open angle glaucoma."", ""reference"": ""PMID:26302410"", ""snippet"": ""Certain mutations in optineurin (gene OPTN) are associated with primary open angle glaucoma."", ""supports"": ""SUPPORT""}"
3126	3094	130	Glaucoma	Glaucoma.yaml	genetic	1	evidence	1	PMID:26302410	SUPPORT		Thus, an optimum level of optineurin-mediated autophagy is crucial for survival of retinal cells, and impaired autophagy is likely to contribute to glaucoma pathogenesis.	Explains how OPTN variants contribute to glaucoma through dysregulated autophagy in retinal cells.	"{""explanation"": ""Explains how OPTN variants contribute to glaucoma through dysregulated autophagy in retinal cells."", ""reference"": ""PMID:26302410"", ""snippet"": ""Thus, an optimum level of optineurin-mediated autophagy is crucial for survival of retinal cells, and impaired autophagy is likely to contribute to glaucoma pathogenesis."", ""supports"": ""SUPPORT""}"
3136	3120	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	genetic	0	evidence	0	PMID:30333046	SUPPORT		TERT promoter (TERTp) mutations are found in the majority of World Health Organization (WHO) grade IV adult IDH wild-type glioblastoma (IDH-wt GBM).	Abstract reports TERT promoter mutations in the majority of IDH-wildtype glioblastomas.	"{""explanation"": ""Abstract reports TERT promoter mutations in the majority of IDH-wildtype glioblastomas."", ""reference"": ""PMID:30333046"", ""snippet"": ""TERT promoter (TERTp) mutations are found in the majority of World Health Organization (WHO) grade IV adult IDH wild-type glioblastoma (IDH-wt GBM)."", ""supports"": ""SUPPORT""}"
3155	3153	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	genetic	0	evidence	0	PMID:32702756	SUPPORT		Glucose 6-phosphate dehydrogenase (G6PD) deficiency is 1 of the commonest human enzymopathies, caused by inherited mutations of the X-linked gene G6PD.	The snippet indicates that G6PD deficiency is caused by mutations in the X-linked gene G6PD, which aligns with the statement about the genetic inheritance being X-linked recessive.	"{""explanation"": ""The snippet indicates that G6PD deficiency is caused by mutations in the X-linked gene G6PD, which aligns with the statement about the genetic inheritance being X-linked recessive."", ""reference"": ""PMID:32702756"", ""snippet"": ""Glucose 6-phosphate dehydrogenase (G6PD) deficiency is 1 of the commonest human enzymopathies, caused by inherited mutations of the X-linked gene G6PD."", ""supports"": ""SUPPORT""}"
3156	3153	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	genetic	0	evidence	1	PMID:33560519	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an inherited X-linked recessive disorder.	The snippet explicitly mentions that G6PD deficiency is an X-linked recessive disorder.	"{""explanation"": ""The snippet explicitly mentions that G6PD deficiency is an X-linked recessive disorder."", ""reference"": ""PMID:33560519"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an inherited X-linked recessive disorder."", ""supports"": ""SUPPORT""}"
3157	3153	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	genetic	0	evidence	2	PMID:24460025	SUPPORT		Glucose-6-Phosphate Dehydrogenase (G6PD) gene is located at the X-chromosome at Xq28 and the disease is recessively inherited predominantly in males.	This reference specifies the location of the G6PD gene on the X-chromosome and indicates that the disorder is inherited in a recessive manner.	"{""explanation"": ""This reference specifies the location of the G6PD gene on the X-chromosome and indicates that the disorder is inherited in a recessive manner."", ""reference"": ""PMID:24460025"", ""snippet"": ""Glucose-6-Phosphate Dehydrogenase (G6PD) gene is located at the X-chromosome at Xq28 and the disease is recessively inherited predominantly in males."", ""supports"": ""SUPPORT""}"
3224	3178	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	genetic	0	evidence	0	PMID:28596197	SUPPORT		A total of 126 patients had a heterozygous pathogenic variant, 9 had SUFU pathogenic variants and 46 had no identified mutation.	Large cohort study confirming PTCH1 as the predominant causative gene in Gorlin syndrome.	"{""explanation"": ""Large cohort study confirming PTCH1 as the predominant causative gene in Gorlin syndrome."", ""reference"": ""PMID:28596197"", ""snippet"": ""A total of 126 patients had a heterozygous pathogenic variant, 9 had SUFU pathogenic variants and 46 had no identified mutation."", ""supports"": ""SUPPORT""}"
3225	3178	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	genetic	0	evidence	1	PMID:28596197	SUPPORT		Patients with a missense variant in PTCH1 were diagnosed later (p=0.03) and were less likely to develop at least 10 BCCs and jaw cysts than those with other pathogenic PTCH1 variants.	Demonstrates genotype-phenotype correlation with milder disease in missense variant carriers.	"{""explanation"": ""Demonstrates genotype-phenotype correlation with milder disease in missense variant carriers."", ""reference"": ""PMID:28596197"", ""snippet"": ""Patients with a missense variant in PTCH1 were diagnosed later (p=0.03) and were less likely to develop at least 10 BCCs and jaw cysts than those with other pathogenic PTCH1 variants."", ""supports"": ""SUPPORT""}"
3226	3179	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	genetic	1	evidence	0	PMID:25403219	SUPPORT		We demonstrate convincing evidence that SUFU mutations can cause classical Gorlin syndrome.	Establishes SUFU as a causative gene for Gorlin syndrome.	"{""explanation"": ""Establishes SUFU as a causative gene for Gorlin syndrome."", ""reference"": ""PMID:25403219"", ""snippet"": ""We demonstrate convincing evidence that SUFU mutations can cause classical Gorlin syndrome."", ""supports"": ""SUPPORT""}"
3227	3179	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	genetic	1	evidence	1	PMID:28596197	SUPPORT		Patients with SUFU pathogenic variants were significantly more likely than those with PTCH1 pathogenic variants to develop a medulloblastoma (p=0.009), a meningioma (p=0.02) or an ovarian fibroma (p=0.015), but were less likely to develop a jaw cyst (p=0.0004).	Documents distinct phenotypic spectrum in SUFU versus PTCH1 mutation carriers.	"{""explanation"": ""Documents distinct phenotypic spectrum in SUFU versus PTCH1 mutation carriers."", ""reference"": ""PMID:28596197"", ""snippet"": ""Patients with SUFU pathogenic variants were significantly more likely than those with PTCH1 pathogenic variants to develop a medulloblastoma (p=0.009), a meningioma (p=0.02) or an ovarian fibroma (p=0.015), but were less likely to develop a jaw cyst (p=0.0004)."", ""supports"": ""SUPPORT""}"
3262	3231	135	Grange syndrome	Grange_syndrome.yaml	genetic	0	evidence	0	PMID:27939641	SUPPORT		Exome-sequencing analysis of DNA from three affected siblings with Grange syndrome identified compound heterozygous nonsense variants in YY1AP1, and homozygous nonsense or frameshift YY1AP1 variants were subsequently identified in additional unrelated probands with Grange syndrome.	Guo et al. 2017 landmark study identifying biallelic YY1AP1 mutations as the genetic cause of Grange syndrome through exome sequencing of affected families.	"{""explanation"": ""Guo et al. 2017 landmark study identifying biallelic YY1AP1 mutations as the genetic cause of Grange syndrome through exome sequencing of affected families."", ""reference"": ""PMID:27939641"", ""snippet"": ""Exome-sequencing analysis of DNA from three affected siblings with Grange syndrome identified compound heterozygous nonsense variants in YY1AP1, and homozygous nonsense or frameshift YY1AP1 variants were subsequently identified in additional unrelated probands with Grange syndrome."", ""supports"": ""SUPPORT""}"
3263	3231	135	Grange syndrome	Grange_syndrome.yaml	genetic	0	evidence	1	PMID:33971976	SUPPORT		We found a frameshift variant in one copy and a large deletion involving two exons in the other copy of a gene called YY1AP1.	Raggio et al. 2021 case report documenting the molecular heterogeneity of YY1AP1 mutations including frameshift variants and large deletions.	"{""explanation"": ""Raggio et al. 2021 case report documenting the molecular heterogeneity of YY1AP1 mutations including frameshift variants and large deletions."", ""reference"": ""PMID:33971976"", ""snippet"": ""We found a frameshift variant in one copy and a large deletion involving two exons in the other copy of a gene called YY1AP1."", ""supports"": ""SUPPORT""}"
3264	3231	135	Grange syndrome	Grange_syndrome.yaml	genetic	0	evidence	2	PMID:37323195	SUPPORT		subsequently confirmed to carry a novel homozygous frameshift variant (c.2291del; p.Pro764Leufs*12) in the YY1AP1 gene through whole-exome sequencing.	Karakaya et al. 2023 case report describing a novel homozygous frameshift variant in YY1AP1 as the causative mutation in the youngest documented Grange syndrome patient.	"{""explanation"": ""Karakaya et al. 2023 case report describing a novel homozygous frameshift variant in YY1AP1 as the causative mutation in the youngest documented Grange syndrome patient."", ""reference"": ""PMID:37323195"", ""snippet"": ""subsequently confirmed to carry a novel homozygous frameshift variant (c.2291del; p.Pro764Leufs*12) in the YY1AP1 gene through whole-exome sequencing."", ""supports"": ""SUPPORT""}"
3265	3231	135	Grange syndrome	Grange_syndrome.yaml	genetic	0	evidence	3	PMID:37698238	SUPPORT		Copy number variant analysis from exome data identified a homozygous intragenic out-of-frame deletion of 1.84 kb encompassing exons seven and eight of YY1AP1, confirming a molecular diagnosis of GRNG.	Viora-Dupont et al. 2023 reports the first homozygous intragenic deletion in YY1AP1, expanding the spectrum of pathogenic mutations that cause Grange syndrome beyond frameshift and nonsense variants.	"{""explanation"": ""Viora-Dupont et al. 2023 reports the first homozygous intragenic deletion in YY1AP1, expanding the spectrum of pathogenic mutations that cause Grange syndrome beyond frameshift and nonsense variants."", ""reference"": ""PMID:37698238"", ""snippet"": ""Copy number variant analysis from exome data identified a homozygous intragenic out-of-frame deletion of 1.84 kb encompassing exons seven and eight of YY1AP1, confirming a molecular diagnosis of GRNG."", ""supports"": ""SUPPORT""}"
3266	3231	135	Grange syndrome	Grange_syndrome.yaml	genetic	0	evidence	4	PMID:30556293	SUPPORT		Whole exome sequencing including near-splice regions led to the identification of two intronic YY1AP1 variants which were predicted to interfere with normal splicing... RT-PCR analyses confirmed skipping of exon 6 on one allele and exonization of 22 bp in intron 6 on the other.	Rath et al. 2019 reports the first identification of pathogenic YY1AP1 splice variants in intronic regions causing Grange syndrome, expanding the mutation spectrum to include deep intronic variants that would be missed by standard exome sequencing.	"{""explanation"": ""Rath et al. 2019 reports the first identification of pathogenic YY1AP1 splice variants in intronic regions causing Grange syndrome, expanding the mutation spectrum to include deep intronic variants that would be missed by standard exome sequencing."", ""reference"": ""PMID:30556293"", ""snippet"": ""Whole exome sequencing including near-splice regions led to the identification of two intronic YY1AP1 variants which were predicted to interfere with normal splicing... RT-PCR analyses confirmed skipping of exon 6 on one allele and exonization of 22 bp in intron 6 on the other."", ""supports"": ""SUPPORT""}"
3267	3231	135	Grange syndrome	Grange_syndrome.yaml	genetic	0	evidence	5	PMID:31633303	SUPPORT		Grange syndrome is caused by homozygous or compound heterozygous loss-of-function variants in the YYA1P1 gene... This is the first report of a missense variant associated with Grange syndrome characterized by later onset of vascular disease and a lack of developmental delay and bone fragility.	Ciuffetelli et al. 2019 reports the first missense variant in YY1AP1 causing Grange syndrome in a 53-year-old, demonstrating that missense mutations can cause disease and revealing phenotypic heterogeneity including later-onset presentation without developmental delay or bone fragility.	"{""explanation"": ""Ciuffetelli et al. 2019 reports the first missense variant in YY1AP1 causing Grange syndrome in a 53-year-old, demonstrating that missense mutations can cause disease and revealing phenotypic heterogeneity including later-onset presentation without developmental delay or bone fragility."", ""reference"": ""PMID:31633303"", ""snippet"": ""Grange syndrome is caused by homozygous or compound heterozygous loss-of-function variants in the YYA1P1 gene... This is the first report of a missense variant associated with Grange syndrome characterized by later onset of vascular disease and a lack of developmental delay and bone fragility."", ""supports"": ""SUPPORT""}"
3268	3231	135	Grange syndrome	Grange_syndrome.yaml	genetic	0	evidence	6	PMID:31270375	SUPPORT		We report the case of a 7-year-old girl with Grange syndrome who showed RVH and multiple seizure episodes... a novel homozygous pathogenic variant in the YY1AP1 gene (NM_001198903.1: c.1169del: p.Lys390Argfs*12).	Saida et al. 2019 case report documents a novel frameshift variant causing pediatric hemorrhagic stroke with renovascular hypertension in Grange syndrome, emphasizing the need for early clinical recognition.	"{""explanation"": ""Saida et al. 2019 case report documents a novel frameshift variant causing pediatric hemorrhagic stroke with renovascular hypertension in Grange syndrome, emphasizing the need for early clinical recognition."", ""reference"": ""PMID:31270375"", ""snippet"": ""We report the case of a 7-year-old girl with Grange syndrome who showed RVH and multiple seizure episodes... a novel homozygous pathogenic variant in the YY1AP1 gene (NM_001198903.1: c.1169del: p.Lys390Argfs*12)."", ""supports"": ""SUPPORT""}"
3331	3271	137	Graves' Disease	Graves_Disease.yaml	genetic	0	evidence	0	PMID:30484670	SUPPORT		Within HLA, some variants of the DRB1, DQA1 and DQB1 genes appear to be possible predictors of the development and recurrence of Graves' disease.	This study suggests that variants within the HLA region, including DRB1 (which encompasses HLA-DR3), are associated with Graves' disease, supporting the statement that HLA-DR3 is a risk factor.	"{""explanation"": ""This study suggests that variants within the HLA region, including DRB1 (which encompasses HLA-DR3), are associated with Graves' disease, supporting the statement that HLA-DR3 is a risk factor."", ""reference"": ""PMID:30484670"", ""snippet"": ""Within HLA, some variants of the DRB1, DQA1 and DQB1 genes appear to be possible predictors of the development and recurrence of Graves' disease."", ""supports"": ""SUPPORT""}"
3332	3272	137	Graves' Disease	Graves_Disease.yaml	genetic	1	evidence	0	PMID:10404810	SUPPORT		An increase in frequency of the G (alanine) allele was seen in Graves' patients compared with control subjects (42% vs. 31.5%, respectively; corrected P<0.0002; odds ratio = 1.58)	This case-control and family study demonstrates that CTLA4 polymorphisms confer genetic susceptibility to Graves' disease.	"{""explanation"": ""This case-control and family study demonstrates that CTLA4 polymorphisms confer genetic susceptibility to Graves' disease."", ""reference"": ""PMID:10404810"", ""snippet"": ""An increase in frequency of the G (alanine) allele was seen in Graves' patients compared with control subjects (42% vs. 31.5%, respectively; corrected P<0.0002; odds ratio = 1.58)"", ""supports"": ""SUPPORT""}"
3333	3273	137	Graves' Disease	Graves_Disease.yaml	genetic	2	evidence	0	PMID:33103521	SUPPORT		the T allele significantly increased AITD susceptibility in all genetic models involving Caucasians	This meta-analysis of 18 studies demonstrates that PTPN22 R620W polymorphism is associated with Graves' disease susceptibility.	"{""explanation"": ""This meta-analysis of 18 studies demonstrates that PTPN22 R620W polymorphism is associated with Graves' disease susceptibility."", ""reference"": ""PMID:33103521"", ""snippet"": ""the T allele significantly increased AITD susceptibility in all genetic models involving Caucasians"", ""supports"": ""SUPPORT""}"
3334	3274	137	Graves' Disease	Graves_Disease.yaml	genetic	3	evidence	0	PMID:12593727	SUPPORT		our results suggested that the CD40 gene was a new susceptibility gene for GD within certain families because it was both linked and associated with GD	This study mapped CD40 as a susceptibility gene for Graves' disease through linkage and association analyses.	"{""explanation"": ""This study mapped CD40 as a susceptibility gene for Graves' disease through linkage and association analyses."", ""reference"": ""PMID:12593727"", ""snippet"": ""our results suggested that the CD40 gene was a new susceptibility gene for GD within certain families because it was both linked and associated with GD"", ""supports"": ""SUPPORT""}"
3335	3276	137	Graves' Disease	Graves_Disease.yaml	genetic	5	evidence	0	PMID:27231040	SUPPORT		both TSHR rs179247A/G and rs12101255T/C polymorphism had significant association with GD	This meta-analysis demonstrates that TSHR gene polymorphisms are significantly associated with Graves' disease susceptibility across Asian, European, and South American populations.	"{""explanation"": ""This meta-analysis demonstrates that TSHR gene polymorphisms are significantly associated with Graves' disease susceptibility across Asian, European, and South American populations."", ""reference"": ""PMID:27231040"", ""snippet"": ""both TSHR rs179247A/G and rs12101255T/C polymorphism had significant association with GD"", ""supports"": ""SUPPORT""}"
3399	3344	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	genetic	0	evidence	0	PMID:23628726	SUPPORT		HER2 gene amplification is observed in about 15% of breast cancers.	Abstract reports HER2 amplification frequency in breast cancer.	"{""explanation"": ""Abstract reports HER2 amplification frequency in breast cancer."", ""reference"": ""PMID:23628726"", ""snippet"": ""HER2 gene amplification is observed in about 15% of breast cancers."", ""supports"": ""SUPPORT""}"
3406	3402	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	genetic	0	evidence	0	PMID:30940925	SUPPORT		Variant characterization demonstrates that the variants affect protein folding by yielding an insoluble protein product.	The study demonstrated that P4HTM variants cause loss of function through protein misfolding.	"{""explanation"": ""The study demonstrated that P4HTM variants cause loss of function through protein misfolding."", ""reference"": ""PMID:30940925"", ""snippet"": ""Variant characterization demonstrates that the variants affect protein folding by yielding an insoluble protein product."", ""supports"": ""SUPPORT""}"
3407	3402	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	genetic	0	evidence	1	PMID:25078763	SUPPORT		Whole-genome sequencing of one affected individual pinpointed three genes with potentially protein damaging homozygous sequence changes within the predisposition locus transketolase (TKT), prolyl 4-hydroxylase transmembrane (P4HTM), and ubiquitin specific peptidase 4 (USP4).	Initial identification of P4HTM as a candidate gene for HIDEA syndrome in a Finnish kindred.	"{""explanation"": ""Initial identification of P4HTM as a candidate gene for HIDEA syndrome in a Finnish kindred."", ""reference"": ""PMID:25078763"", ""snippet"": ""Whole-genome sequencing of one affected individual pinpointed three genes with potentially protein damaging homozygous sequence changes within the predisposition locus transketolase (TKT), prolyl 4-hydroxylase transmembrane (P4HTM), and ubiquitin specific peptidase 4 (USP4)."", ""supports"": ""SUPPORT""}"
3453	3532	148	Hemochromatosis	Hemochromatosis.yaml	genetic	0	evidence	0	PMID:23985001	SUPPORT		most commonly in C282Y homozygous individuals	Review confirms C282Y homozygosity as the most common cause of hereditary hemochromatosis.	"{""explanation"": ""Review confirms C282Y homozygosity as the most common cause of hereditary hemochromatosis."", ""reference"": ""PMID:23985001"", ""snippet"": ""most commonly in C282Y homozygous individuals"", ""supports"": ""SUPPORT""}"
3543	3586	151	Hepatitis B	Hepatitis_B.yaml	genetic	0	evidence	0	PMID:19072424	SUPPORT		There are eight different genotypes named A-H. Genotypes have distinct geographic distribution in different regions of the world. There exists a difference in the disease profile between different genotypes.	The reference supports the presence of multiple HBV genotypes (A-H) and indicates that these genotypes influence disease progression and treatment response.	"{""explanation"": ""The reference supports the presence of multiple HBV genotypes (A-H) and indicates that these genotypes influence disease progression and treatment response."", ""reference"": ""PMID:19072424"", ""snippet"": ""There are eight different genotypes named A-H. Genotypes have distinct geographic distribution in different regions of the world. There exists a difference in the disease profile between different genotypes."", ""supports"": ""SUPPORT""}"
3544	3586	151	Hepatitis B	Hepatitis_B.yaml	genetic	0	evidence	1	PMID:26255971	SUPPORT		The clinical course of hepatitis B virus (HBV) infection greatly differs in individuals. Various viral, host, and environmental factors influence the natural history of HBV infection.	The reference supports the influence of various factors, including viral genotypes, on the clinical course of HBV infection.	"{""explanation"": ""The reference supports the influence of various factors, including viral genotypes, on the clinical course of HBV infection."", ""reference"": ""PMID:26255971"", ""snippet"": ""The clinical course of hepatitis B virus (HBV) infection greatly differs in individuals. Various viral, host, and environmental factors influence the natural history of HBV infection."", ""supports"": ""SUPPORT""}"
3545	3586	151	Hepatitis B	Hepatitis_B.yaml	genetic	0	evidence	2	PMID:34593148	SUPPORT		Various HBV genotypes and their impact on the clinical course are discussed. The relationship of HBV serologies and HBV DNA to disease progression is outlined.	The reference supports the statement that different HBV genotypes influence disease progression and treatment response.	"{""explanation"": ""The reference supports the statement that different HBV genotypes influence disease progression and treatment response."", ""reference"": ""PMID:34593148"", ""snippet"": ""Various HBV genotypes and their impact on the clinical course are discussed. The relationship of HBV serologies and HBV DNA to disease progression is outlined."", ""supports"": ""SUPPORT""}"
3659	3679	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	genetic	0	evidence	0	PMID:22193408	SUPPORT		the proteins work in concert to protect the genome from double-strand DNA damage during DNA replication.	Review confirms BRCA1 and BRCA2 work together to protect the genome from DNA double-strand damage.	"{""explanation"": ""Review confirms BRCA1 and BRCA2 work together to protect the genome from DNA double-strand damage."", ""reference"": ""PMID:22193408"", ""snippet"": ""the proteins work in concert to protect the genome from double-strand DNA damage during DNA replication."", ""supports"": ""SUPPORT""}"
3683	3711	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	0	evidence	0	PMID:32942321	PARTIAL		This case report provides an overview of a family with a history of HD with a novel, unreported autosomal dominant RET mutation... The family examined in this study clearly demonstrates that (1) the genotype to phenotype correlation of patients with RET mutation-associated HD is not directly related, and (2) genetic mechanisms underlying the different HD phenotypes, as well as the model of inheritance of HD, are complex and not yet fully understood.	While the study identifies an autosomal dominant RET mutation in a family with Hirschsprung Disease, it also indicates that the genetic mechanisms are complex and not fully understood, suggesting that autosomal dominant RET mutations may be one of several contributing genetic factors.	"{""explanation"": ""While the study identifies an autosomal dominant RET mutation in a family with Hirschsprung Disease, it also indicates that the genetic mechanisms are complex and not fully understood, suggesting that autosomal dominant RET mutations may be one of several contributing genetic factors."", ""reference"": ""PMID:32942321"", ""snippet"": ""This case report provides an overview of a family with a history of HD with a novel, unreported autosomal dominant RET mutation... The family examined in this study clearly demonstrates that (1) the genotype to phenotype correlation of patients with RET mutation-associated HD is not directly related, and (2) genetic mechanisms underlying the different HD phenotypes, as well as the model of inheritance of HD, are complex and not yet fully understood."", ""supports"": ""PARTIAL""}"
3684	3711	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	0	evidence	1	PMID:24972642	PARTIAL		The co-occurrence of Hirschsprung's disease (HSCR) and multiple endocrine neoplasia type 2 (MEN2) is a relatively rare event... a 'Janus' mutation in the RET proto-oncogene -- a mutation that acts simultaneously as both a gain-in-function and a loss-of-function mutation.	This supports the association between RET mutations and Hirschsprung Disease but also suggests a rare and complex interaction with certain mutations displaying dual functions.	"{""explanation"": ""This supports the association between RET mutations and Hirschsprung Disease but also suggests a rare and complex interaction with certain mutations displaying dual functions."", ""reference"": ""PMID:24972642"", ""snippet"": ""The co-occurrence of Hirschsprung's disease (HSCR) and multiple endocrine neoplasia type 2 (MEN2) is a relatively rare event... a 'Janus' mutation in the RET proto-oncogene -- a mutation that acts simultaneously as both a gain-in-function and a loss-of-function mutation."", ""supports"": ""PARTIAL""}"
3685	3711	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	0	evidence	2	PMID:11955539	PARTIAL		Several genes, including the major susceptibility gene RET, have roles in development of Hirschsprung's disease... both RET alleles have a role in pathogenesis of Hirschsprung's disease, in a dose-dependent fashion.	RET mutations are implicated in Hirschsprung Disease, but the inheritance pattern may be more complex than simply autosomal dominant.	"{""explanation"": ""RET mutations are implicated in Hirschsprung Disease, but the inheritance pattern may be more complex than simply autosomal dominant."", ""reference"": ""PMID:11955539"", ""snippet"": ""Several genes, including the major susceptibility gene RET, have roles in development of Hirschsprung's disease... both RET alleles have a role in pathogenesis of Hirschsprung's disease, in a dose-dependent fashion."", ""supports"": ""PARTIAL""}"
3686	3712	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	1	evidence	0	PMID:38253735	SUPPORT		HSCR, a multifactorial disorder of enteric nervous system (ENS) development, is associated with at least 24 genes and seven chromosomal loci, with RET and EDNRB as its major genes.	The paper discusses the association of EDNRB germline mutations with Hirschsprung disease, supporting the genetic association.	"{""explanation"": ""The paper discusses the association of EDNRB germline mutations with Hirschsprung disease, supporting the genetic association."", ""reference"": ""PMID:38253735"", ""snippet"": ""HSCR, a multifactorial disorder of enteric nervous system (ENS) development, is associated with at least 24 genes and seven chromosomal loci, with RET and EDNRB as its major genes."", ""supports"": ""SUPPORT""}"
3687	3712	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	1	evidence	1	PMID:9359036	SUPPORT		Genes involved include RET, GDNF, EDNRB and EDN3. Mutations of these genes may give dominant, recessive, or polygenic patterns of inheritance.	The text supports the genetic association of Hirschsprung Disease with EDNRB mutations, noting that such mutations can follow autosomal recessive inheritance.	"{""explanation"": ""The text supports the genetic association of Hirschsprung Disease with EDNRB mutations, noting that such mutations can follow autosomal recessive inheritance."", ""reference"": ""PMID:9359036"", ""snippet"": ""Genes involved include RET, GDNF, EDNRB and EDN3. Mutations of these genes may give dominant, recessive, or polygenic patterns of inheritance."", ""supports"": ""SUPPORT""}"
3688	3712	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	1	evidence	2	PMID:9718653	SUPPORT		HD mutations have been mapped to a number of genes, i.e., RET proto-oncogene, at 10q11.2; the recessive EDNRB gene, located at 13q22; its ligand endothelin 3 (EDN3); and the glial cell line-derived neurotrophic factor (GDNF) in humans.	The paper mentions that mutations in the recessive EDNRB gene are implicated in Hirschsprung Disease.	"{""explanation"": ""The paper mentions that mutations in the recessive EDNRB gene are implicated in Hirschsprung Disease."", ""reference"": ""PMID:9718653"", ""snippet"": ""HD mutations have been mapped to a number of genes, i.e., RET proto-oncogene, at 10q11.2; the recessive EDNRB gene, located at 13q22; its ligand endothelin 3 (EDN3); and the glial cell line-derived neurotrophic factor (GDNF) in humans."", ""supports"": ""SUPPORT""}"
3689	3712	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	1	evidence	3	PMID:11434563	SUPPORT		Mutations in the genes encoding the endothelin type-B receptor (EDNRB) and its physiological ligand endothelin 3 (EDN3) are now known to account for the majority of HSCR II patients.	This reference directly supports the association of EDNRB mutations with Hirschsprung disease, subtype autosomal recessive.	"{""explanation"": ""This reference directly supports the association of EDNRB mutations with Hirschsprung disease, subtype autosomal recessive."", ""reference"": ""PMID:11434563"", ""snippet"": ""Mutations in the genes encoding the endothelin type-B receptor (EDNRB) and its physiological ligand endothelin 3 (EDN3) are now known to account for the majority of HSCR II patients."", ""supports"": ""SUPPORT""}"
3690	3713	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	2	evidence	0	PMID:9359036	PARTIAL		Genes involved include RET, GDNF, EDNRB and EDN3. Mutations of these genes may give dominant, recessive, or polygenic patterns of inheritance.	The reference suggests that mutations in GDNF can contribute to Hirschsprung disease and may exhibit dominant, recessive, or polygenic inheritance patterns. It does not confirm exclusively autosomal dominant inheritance.	"{""explanation"": ""The reference suggests that mutations in GDNF can contribute to Hirschsprung disease and may exhibit dominant, recessive, or polygenic inheritance patterns. It does not confirm exclusively autosomal dominant inheritance."", ""reference"": ""PMID:9359036"", ""snippet"": ""Genes involved include RET, GDNF, EDNRB and EDN3. Mutations of these genes may give dominant, recessive, or polygenic patterns of inheritance."", ""supports"": ""PARTIAL""}"
3691	3713	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	2	evidence	1	PMID:9473110	PARTIAL		GDNF mutations were found in association with RET protooncogene mutations in Hirschsprung patients. Mutations in GDNF per se are thought neither necessary nor sufficient to cause Hirschsprung's disease (HD).	This indicates GDNF mutations can be involved in Hirschsprung disease, typically in conjunction with other factors such as RET mutations, and does not specify autosomal dominant inheritance exclusively.	"{""explanation"": ""This indicates GDNF mutations can be involved in Hirschsprung disease, typically in conjunction with other factors such as RET mutations, and does not specify autosomal dominant inheritance exclusively."", ""reference"": ""PMID:9473110"", ""snippet"": ""GDNF mutations were found in association with RET protooncogene mutations in Hirschsprung patients. Mutations in GDNF per se are thought neither necessary nor sufficient to cause Hirschsprung's disease (HD)."", ""supports"": ""PARTIAL""}"
3692	3713	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	2	evidence	2	PMID:9718653	PARTIAL		GDNF may modulate the disease phenotype by interacting with other susceptibility loci (e.g., RET).	While GDNF is implicated in the disease, the text does not isolate it to an autosomal dominant inheritance pattern but suggests interaction with other loci.	"{""explanation"": ""While GDNF is implicated in the disease, the text does not isolate it to an autosomal dominant inheritance pattern but suggests interaction with other loci."", ""reference"": ""PMID:9718653"", ""snippet"": ""GDNF may modulate the disease phenotype by interacting with other susceptibility loci (e.g., RET)."", ""supports"": ""PARTIAL""}"
3693	3713	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	2	evidence	3	PMID:8852660	NO_EVIDENCE		These data might suggest that EDNRB mutations could be dosage sensitive: heterozygosity would predispose to isolated HSCR with incomplete penetrance, while homozygosity would result in more complex neurocristopathies.	The excerpt pertains to EDNRB mutations and does not provide evidence regarding GDNF mutations being autosomal dominant.	"{""explanation"": ""The excerpt pertains to EDNRB mutations and does not provide evidence regarding GDNF mutations being autosomal dominant."", ""reference"": ""PMID:8852660"", ""snippet"": ""These data might suggest that EDNRB mutations could be dosage sensitive: heterozygosity would predispose to isolated HSCR with incomplete penetrance, while homozygosity would result in more complex neurocristopathies."", ""supports"": ""NO_EVIDENCE""}"
3694	3713	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	2	evidence	4	PMID:36564622	NO_EVIDENCE		Our report, therefore, reveals a recognizable autosomal-recessive human KIF26A deficiency phenotype characterized by severe ENS dysfunction and a range of brain malformations.	This reference is about mutations in KIF26A, not GDNF, and discusses autosomal recessive patterns.	"{""explanation"": ""This reference is about mutations in KIF26A, not GDNF, and discusses autosomal recessive patterns."", ""reference"": ""PMID:36564622"", ""snippet"": ""Our report, therefore, reveals a recognizable autosomal-recessive human KIF26A deficiency phenotype characterized by severe ENS dysfunction and a range of brain malformations."", ""supports"": ""NO_EVIDENCE""}"
3695	3714	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	3	evidence	0	PMID:9425902	SUPPORT		We propose SOX10 as a candidate disease gene for individuals with HSCR whose disease does not have an identified genetic origin.	This foundational study identified SOX10 mutations as responsible for neural crest defects in Hirschsprung disease mouse models and proposed it as a human HSCR candidate gene.	"{""explanation"": ""This foundational study identified SOX10 mutations as responsible for neural crest defects in Hirschsprung disease mouse models and proposed it as a human HSCR candidate gene."", ""reference"": ""PMID:9425902"", ""snippet"": ""We propose SOX10 as a candidate disease gene for individuals with HSCR whose disease does not have an identified genetic origin."", ""supports"": ""SUPPORT""}"
3696	3714	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	3	evidence	1	PMID:20130826	SUPPORT		Mutations in SOX10 are associated with several neurocristopathies such as Waardenburg syndrome type IV (WS4), a congenital disorder characterized by the association of hearing loss, pigmentary abnormalities, and absence of ganglion cells in the myenteric and submucosal plexus of the gastrointestinal tract, also known as aganglionic megacolon or Hirschsprung disease (HSCR).	This study reports the first SOX10 mutation in an isolated HSCR patient without syndromic features.	"{""explanation"": ""This study reports the first SOX10 mutation in an isolated HSCR patient without syndromic features."", ""reference"": ""PMID:20130826"", ""snippet"": ""Mutations in SOX10 are associated with several neurocristopathies such as Waardenburg syndrome type IV (WS4), a congenital disorder characterized by the association of hearing loss, pigmentary abnormalities, and absence of ganglion cells in the myenteric and submucosal plexus of the gastrointestinal tract, also known as aganglionic megacolon or Hirschsprung disease (HSCR)."", ""supports"": ""SUPPORT""}"
3697	3715	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	4	evidence	0	PMID:41253684	SUPPORT		Hirschsprung disease (HD) can be associated with congenital central hypoventilation syndrome (CCHS). CCHS is mostly due to PHOX2B pathogenic variants.	This report demonstrates the association between PHOX2B variants and Hirschsprung disease, particularly in syndromic cases with CCHS.	"{""explanation"": ""This report demonstrates the association between PHOX2B variants and Hirschsprung disease, particularly in syndromic cases with CCHS."", ""reference"": ""PMID:41253684"", ""snippet"": ""Hirschsprung disease (HD) can be associated with congenital central hypoventilation syndrome (CCHS). CCHS is mostly due to PHOX2B pathogenic variants."", ""supports"": ""SUPPORT""}"
3698	3716	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	5	evidence	0	PMID:38169757	SUPPORT		RET, NRG1, and L1CAM genes are reported as pathological gene variants associated with the incidence of different variants of Hirschsprung's disease.	This report lists NRG1 among the key genes associated with Hirschsprung disease variants.	"{""explanation"": ""This report lists NRG1 among the key genes associated with Hirschsprung disease variants."", ""reference"": ""PMID:38169757"", ""snippet"": ""RET, NRG1, and L1CAM genes are reported as pathological gene variants associated with the incidence of different variants of Hirschsprung's disease."", ""supports"": ""SUPPORT""}"
3699	3716	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	genetic	5	evidence	1	PMID:34422713	SUPPORT		The discovery of new HSCR genes such as neuregulin and BACE2 as well as the deeper understanding of the roles and mechanisms of known HSCR genes provided solid evidence that many HSCR cases are in the form of complex polygenic/oligogenic disorder where rare variants act in the sensitized background of HSCR-associated common variants.	This review identifies neuregulin (NRG1) as a newly discovered HSCR gene.	"{""explanation"": ""This review identifies neuregulin (NRG1) as a newly discovered HSCR gene."", ""reference"": ""PMID:34422713"", ""snippet"": ""The discovery of new HSCR genes such as neuregulin and BACE2 as well as the deeper understanding of the roles and mechanisms of known HSCR genes provided solid evidence that many HSCR cases are in the form of complex polygenic/oligogenic disorder where rare variants act in the sensitized background of HSCR-associated common variants."", ""supports"": ""SUPPORT""}"
3745	3739	157	Holt-Oram syndrome	Holt_Oram.yaml	genetic	0	evidence	0	PMID:36936432	SUPPORT		Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS	Directly establishes the causal relationship between TBX5 sequence variants and HOS development	"{""explanation"": ""Directly establishes the causal relationship between TBX5 sequence variants and HOS development"", ""reference"": ""PMID:36936432"", ""snippet"": ""Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS"", ""supports"": ""SUPPORT""}"
3746	3739	157	Holt-Oram syndrome	Holt_Oram.yaml	genetic	0	evidence	1	PMID:38189150	SUPPORT		Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency	Demonstrates that TBX5 haploinsufficiency is sufficient to cause cardiac phenotypes similar to HOS	"{""explanation"": ""Demonstrates that TBX5 haploinsufficiency is sufficient to cause cardiac phenotypes similar to HOS"", ""reference"": ""PMID:38189150"", ""snippet"": ""Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency"", ""supports"": ""SUPPORT""}"
3803	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	0	PMID:27188817	SUPPORT		Huntington disease is devastating to patients and their families - with autosomal dominant inheritance... The disease is caused by an expanded CAG trinucleotide repeat (of variable length) in HTT, the gene that encodes the protein huntingtin.	The literature explicitly states that Huntington's disease is caused by an expanded CAG trinucleotide repeat in the HTT gene and is inherited in an autosomal dominant manner.	"{""explanation"": ""The literature explicitly states that Huntington's disease is caused by an expanded CAG trinucleotide repeat in the HTT gene and is inherited in an autosomal dominant manner."", ""reference"": ""PMID:27188817"", ""snippet"": ""Huntington disease is devastating to patients and their families - with autosomal dominant inheritance... The disease is caused by an expanded CAG trinucleotide repeat (of variable length) in HTT, the gene that encodes the protein huntingtin."", ""supports"": ""SUPPORT""}"
3804	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	1	PMID:33579864	SUPPORT		Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of the HTT CAG repeat.	This reference confirms that Huntington's disease is caused by the expansion of the HTT CAG repeat and follows an autosomal dominant inheritance pattern.	"{""explanation"": ""This reference confirms that Huntington's disease is caused by the expansion of the HTT CAG repeat and follows an autosomal dominant inheritance pattern."", ""reference"": ""PMID:33579864"", ""snippet"": ""Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of the HTT CAG repeat."", ""supports"": ""SUPPORT""}"
3805	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	2	PMID:31820322	SUPPORT		Huntington's disease (HD) is a rare autosomal dominant neurodegenerative disorder caused by a CAG expansion greater than 35 in the IT-15 gene.	This source supports the statement by indicating that Huntington's disease is an autosomal dominant disorder caused by a CAG expansion in the HTT gene.	"{""explanation"": ""This source supports the statement by indicating that Huntington's disease is an autosomal dominant disorder caused by a CAG expansion in the HTT gene."", ""reference"": ""PMID:31820322"", ""snippet"": ""Huntington's disease (HD) is a rare autosomal dominant neurodegenerative disorder caused by a CAG expansion greater than 35 in the IT-15 gene."", ""supports"": ""SUPPORT""}"
3806	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	3	PMID:37863037	SUPPORT		Among the CAG/polyQ repeat diseases are Huntington's disease (HD) and spinocerebellar ataxia type 1 (SCA1), in which the expansions are within widely expressed proteins. Although both HD and SCA1 are autosomal dominantly inherited...	This reference supports the statement by confirming that Huntington's disease is among the CAG repeat diseases and is autosomal dominantly inherited.	"{""explanation"": ""This reference supports the statement by confirming that Huntington's disease is among the CAG repeat diseases and is autosomal dominantly inherited."", ""reference"": ""PMID:37863037"", ""snippet"": ""Among the CAG/polyQ repeat diseases are Huntington's disease (HD) and spinocerebellar ataxia type 1 (SCA1), in which the expansions are within widely expressed proteins. Although both HD and SCA1 are autosomal dominantly inherited..."", ""supports"": ""SUPPORT""}"
3807	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	4	PMID:33579866	SUPPORT		Huntington's disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene. The inherited CAG length is known to expand further in somatic and germline cells in HD subjects.	This source supports the statement by confirming that Huntington's disease is caused by an expanded CAG repeat in the HTT gene and follows an autosomal dominant inheritance pattern.	"{""explanation"": ""This source supports the statement by confirming that Huntington's disease is caused by an expanded CAG repeat in the HTT gene and follows an autosomal dominant inheritance pattern."", ""reference"": ""PMID:33579866"", ""snippet"": ""Huntington's disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene. The inherited CAG length is known to expand further in somatic and germline cells in HD subjects."", ""supports"": ""SUPPORT""}"
3808	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	5	PMID:36352624	SUPPORT		Huntington's Disease (HD) is an autosomal dominant, progressive neuropsychiatric illness caused by CAG repeat expansion.	This reference supports the statement by confirming that Huntington's disease is an autosomal dominant disorder caused by CAG repeat expansion.	"{""explanation"": ""This reference supports the statement by confirming that Huntington's disease is an autosomal dominant disorder caused by CAG repeat expansion."", ""reference"": ""PMID:36352624"", ""snippet"": ""Huntington's Disease (HD) is an autosomal dominant, progressive neuropsychiatric illness caused by CAG repeat expansion."", ""supports"": ""SUPPORT""}"
3809	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	6	PMID:31263285	SUPPORT		Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by a CAG trinucleotide expansion in the huntingtin gene (HTT)...	This source supports the statement by confirming that Huntington's disease is caused by a CAG trinucleotide expansion in the HTT gene and follows an autosomal dominant inheritance pattern.	"{""explanation"": ""This source supports the statement by confirming that Huntington's disease is caused by a CAG trinucleotide expansion in the HTT gene and follows an autosomal dominant inheritance pattern."", ""reference"": ""PMID:31263285"", ""snippet"": ""Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by a CAG trinucleotide expansion in the huntingtin gene (HTT)..."", ""supports"": ""SUPPORT""}"
3810	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	7	PMID:31491822	SUPPORT		The expression of the HTT CAG repeat expansion mutation causes neurodegeneration in Huntington's disease (HD).	This reference supports the statement by confirming that the HTT CAG repeat expansion causes neurodegeneration in Huntington's disease.	"{""explanation"": ""This reference supports the statement by confirming that the HTT CAG repeat expansion causes neurodegeneration in Huntington's disease."", ""reference"": ""PMID:31491822"", ""snippet"": ""The expression of the HTT CAG repeat expansion mutation causes neurodegeneration in Huntington's disease (HD)."", ""supports"": ""SUPPORT""}"
3811	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	8	PMID:26439718	SUPPORT		Huntington disease (HD) is caused by expansion of a CAG trinucleotide repeat in the first exon of the Huntingtin (HTT) gene.	This source supports the statement by confirming that Huntington's disease is caused by the expansion of a CAG trinucleotide repeat in the HTT gene.	"{""explanation"": ""This source supports the statement by confirming that Huntington's disease is caused by the expansion of a CAG trinucleotide repeat in the HTT gene."", ""reference"": ""PMID:26439718"", ""snippet"": ""Huntington disease (HD) is caused by expansion of a CAG trinucleotide repeat in the first exon of the Huntingtin (HTT) gene."", ""supports"": ""SUPPORT""}"
3812	3766	159	Huntington's Disease	Huntingtons_Disease.yaml	genetic	0	evidence	9	PMID:28832564	SUPPORT		Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by expansion of a CAG trinucleotide repeat in HTT...	This reference supports the statement by confirming that Huntington's disease is caused by the expansion of a CAG trinucleotide repeat in the HTT gene and is autosomal dominant.	"{""explanation"": ""This reference supports the statement by confirming that Huntington's disease is caused by the expansion of a CAG trinucleotide repeat in the HTT gene and is autosomal dominant."", ""reference"": ""PMID:28832564"", ""snippet"": ""Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by expansion of a CAG trinucleotide repeat in HTT..."", ""supports"": ""SUPPORT""}"
3986	3849	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	0	evidence	0	PMID:38423942	SUPPORT		Hypertrophic cardiomyopathy: New pathogenic variant in MYH7.	The title of the referenced article explicitly indicates the association of a pathogenic variant in MYH7 with hypertrophic cardiomyopathy.	"{""explanation"": ""The title of the referenced article explicitly indicates the association of a pathogenic variant in MYH7 with hypertrophic cardiomyopathy."", ""reference"": ""PMID:38423942"", ""snippet"": ""Hypertrophic cardiomyopathy: New pathogenic variant in MYH7."", ""supports"": ""SUPPORT""}"
3987	3849	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	0	evidence	1	PMID:23905887	SUPPORT		Genetic mutations can be identified in approximately 60% of patients; these are commonest in genes that encode proteins of the cardiac sarcomere.	While the specific mutations in MYH7 are not detailed in this snippet, the article supports the general assertion that genetic mutations, particularly in sarcomeric genes like MYH7, are common in hypertrophic cardiomyopathy.	"{""explanation"": ""While the specific mutations in MYH7 are not detailed in this snippet, the article supports the general assertion that genetic mutations, particularly in sarcomeric genes like MYH7, are common in hypertrophic cardiomyopathy."", ""reference"": ""PMID:23905887"", ""snippet"": ""Genetic mutations can be identified in approximately 60% of patients; these are commonest in genes that encode proteins of the cardiac sarcomere."", ""supports"": ""SUPPORT""}"
3988	3849	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	0	evidence	2	PMID:31735781	SUPPORT		By NGS, we determined that these subjects with HCM symptoms carried a missense heterozygous genetic mutation c.2632C>A (p.V878L) in the myosin heavy chain 7 (MYH7) gene with an autosomal dominant pattern of inheritance.	The article details a specific pathogenic variant (p.V878L) in the MYH7 gene associated with hypertrophic cardiomyopathy.	"{""explanation"": ""The article details a specific pathogenic variant (p.V878L) in the MYH7 gene associated with hypertrophic cardiomyopathy."", ""reference"": ""PMID:31735781"", ""snippet"": ""By NGS, we determined that these subjects with HCM symptoms carried a missense heterozygous genetic mutation c.2632C>A (p.V878L) in the myosin heavy chain 7 (MYH7) gene with an autosomal dominant pattern of inheritance."", ""supports"": ""SUPPORT""}"
3989	3849	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	0	evidence	3	PMID:36797478	SUPPORT		The dominant-negative c.1208G>A (p.R403Q) pathogenic variant (PV) in beta-myosin (MYH7) is a common and well-studied PV that leads to increased cardiac contractility and HCM onset.	The article identifies the commonly studied pathogenic variant (p.R403Q) in MYH7 which leads to hypertrophic cardiomyopathy.	"{""explanation"": ""The article identifies the commonly studied pathogenic variant (p.R403Q) in MYH7 which leads to hypertrophic cardiomyopathy."", ""reference"": ""PMID:36797478"", ""snippet"": ""The dominant-negative c.1208G>A (p.R403Q) pathogenic variant (PV) in beta-myosin (MYH7) is a common and well-studied PV that leads to increased cardiac contractility and HCM onset."", ""supports"": ""SUPPORT""}"
3990	3849	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	0	evidence	4	PMID:30681346	SUPPORT		Of 33 HCM genes, only 8 (24%) were categorized as definitive (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, ACTC1, MYL2, and MYL3).	The article categorizes MYH7 as one of the 'definitive' genes associated with hypertrophic cardiomyopathy.	"{""explanation"": ""The article categorizes MYH7 as one of the 'definitive' genes associated with hypertrophic cardiomyopathy."", ""reference"": ""PMID:30681346"", ""snippet"": ""Of 33 HCM genes, only 8 (24%) were categorized as definitive (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, ACTC1, MYL2, and MYL3)."", ""supports"": ""SUPPORT""}"
3991	3849	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	0	evidence	5	PMID:37565978	SUPPORT		MYH7 variants cause hypertrophic cardiomyopathy (HCM), noncompaction cardiomyopathy (NCCM), and dilated cardiomyopathy (DCM).	The article explicitly states that MYH7 variants cause hypertrophic cardiomyopathy, reinforcing the genetic association.	"{""explanation"": ""The article explicitly states that MYH7 variants cause hypertrophic cardiomyopathy, reinforcing the genetic association."", ""reference"": ""PMID:37565978"", ""snippet"": ""MYH7 variants cause hypertrophic cardiomyopathy (HCM), noncompaction cardiomyopathy (NCCM), and dilated cardiomyopathy (DCM)."", ""supports"": ""SUPPORT""}"
3992	3850	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	1	evidence	0	PMID:34180388	SUPPORT		The proband carries a novel heterozygous nonsense variant of MYBPC3:c.2731G > T (p.E911X) ... suggesting the functional damages to the protein of MYBPC3.	The study identifies a novel pathogenic variant in MYBPC3 associated with hypertrophic cardiomyopathy.	"{""explanation"": ""The study identifies a novel pathogenic variant in MYBPC3 associated with hypertrophic cardiomyopathy."", ""reference"": ""PMID:34180388"", ""snippet"": ""The proband carries a novel heterozygous nonsense variant of MYBPC3:c.2731G > T (p.E911X) ... suggesting the functional damages to the protein of MYBPC3."", ""supports"": ""SUPPORT""}"
3993	3850	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	1	evidence	1	PMID:24240729	SUPPORT		The second wave started in 1995 by the discovery that mutations in the gene encoding cMyBP-C cause hypertrophic cardiomyopathy (HCM).	This review discusses that mutations in MYBPC3 (which encodes cMyBP-C) cause HCM.	"{""explanation"": ""This review discusses that mutations in MYBPC3 (which encodes cMyBP-C) cause HCM."", ""reference"": ""PMID:24240729"", ""snippet"": ""The second wave started in 1995 by the discovery that mutations in the gene encoding cMyBP-C cause hypertrophic cardiomyopathy (HCM)."", ""supports"": ""SUPPORT""}"
3994	3850	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	1	evidence	2	PMID:37409452	SUPPORT		The 2 sarcomere genes most commonly associated with hypertrophic cardiomyopathy (HCM), MYBPC3 (myosin-binding protein C3)...	Study identifies MYBPC3 as a common gene associated with hypertrophic cardiomyopathy.	"{""explanation"": ""Study identifies MYBPC3 as a common gene associated with hypertrophic cardiomyopathy."", ""reference"": ""PMID:37409452"", ""snippet"": ""The 2 sarcomere genes most commonly associated with hypertrophic cardiomyopathy (HCM), MYBPC3 (myosin-binding protein C3)..."", ""supports"": ""SUPPORT""}"
3995	3850	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	1	evidence	3	PMID:35544052	SUPPORT		Pathogenic variants associated with inherited cardiomyopathy ... MYBPC3 ... were classified ...	This study includes MYBPC3 as one of the genes with pathogenic variants associated with inherited cardiomyopathy.	"{""explanation"": ""This study includes MYBPC3 as one of the genes with pathogenic variants associated with inherited cardiomyopathy."", ""reference"": ""PMID:35544052"", ""snippet"": ""Pathogenic variants associated with inherited cardiomyopathy ... MYBPC3 ... were classified ..."", ""supports"": ""SUPPORT""}"
3996	3851	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	2	evidence	0	PMID:33588347	SUPPORT		Variants were identified and annotated using in silico tools, and further classified as pathogenic or benign according to the American College of Medical Genetics and Genomics guidelines. Variants with functional effects were identified...and TNNT2...	The study identifies pathogenic variants in TNNT2 among patients with hypertrophic cardiomyopathy, supporting the genetic association.	"{""explanation"": ""The study identifies pathogenic variants in TNNT2 among patients with hypertrophic cardiomyopathy, supporting the genetic association."", ""reference"": ""PMID:33588347"", ""snippet"": ""Variants were identified and annotated using in silico tools, and further classified as pathogenic or benign according to the American College of Medical Genetics and Genomics guidelines. Variants with functional effects were identified...and TNNT2..."", ""supports"": ""SUPPORT""}"
3997	3851	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	genetic	2	evidence	1	PMID:7665141	SUPPORT		Genes on five loci on separate chromosomes are responsible for a familial disease in which all or part of the ventricular muscle undergoes thickening with a histological picture of irregular hypertrophy and disorganized arrangement of myocytes (disarray). The three genes identified so far encode for beta heavy chain myosin (chromosome 14), troponin T (chromosome 1) and alpha tropomyosin (chromosome 15).	The study reveals that the troponin T gene (TNNT2) is one of the implicated genes in hypertrophic cardiomyopathy.	"{""explanation"": ""The study reveals that the troponin T gene (TNNT2) is one of the implicated genes in hypertrophic cardiomyopathy."", ""reference"": ""PMID:7665141"", ""snippet"": ""Genes on five loci on separate chromosomes are responsible for a familial disease in which all or part of the ventricular muscle undergoes thickening with a histological picture of irregular hypertrophy and disorganized arrangement of myocytes (disarray). The three genes identified so far encode for beta heavy chain myosin (chromosome 14), troponin T (chromosome 1) and alpha tropomyosin (chromosome 15)."", ""supports"": ""SUPPORT""}"
4059	3883	162	Hypochondrogenesis	Hypochondrogenesis.yaml	genetic	0	evidence	0	PMID:2572591	SUPPORT	HUMAN_CLINICAL	Here we demonstrate that the mutation in the type II procollagen gene is a single base change that converts the codon for glycine (GGC) at amino acid 943 of the alpha 1 (II) chain to a codon for serine (AGC).	Identifies a specific glycine-to-serine substitution in COL2A1 as causative of achondrogenesis II-hypochondrogenesis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Identifies a specific glycine-to-serine substitution in COL2A1 as causative of achondrogenesis II-hypochondrogenesis."", ""reference"": ""PMID:2572591"", ""snippet"": ""Here we demonstrate that the mutation in the type II procollagen gene is a single base change that converts the codon for glycine (GGC) at amino acid 943 of the alpha 1 (II) chain to a codon for serine (AGC)."", ""supports"": ""SUPPORT""}"
4060	3883	162	Hypochondrogenesis	Hypochondrogenesis.yaml	genetic	0	evidence	1	PMID:8175802	SUPPORT	HUMAN_CLINICAL	Sequencing of exon 35 demonstrated a single base mutation that converted the codon for glycine at position 604 to a codon for alanine.	Identifies another specific COL2A1 glycine substitution mutation in a hypochondrogenesis patient.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Identifies another specific COL2A1 glycine substitution mutation in a hypochondrogenesis patient."", ""reference"": ""PMID:8175802"", ""snippet"": ""Sequencing of exon 35 demonstrated a single base mutation that converted the codon for glycine at position 604 to a codon for alanine."", ""supports"": ""SUPPORT""}"
4061	3883	162	Hypochondrogenesis	Hypochondrogenesis.yaml	genetic	0	evidence	2	PMID:2572591	SUPPORT	HUMAN_CLINICAL	These findings confirm the proposal that new dominant mutations in the type II procollagen gene may account for some cases of Type II achondrogenesis-hypochondrogenesis.	Confirms that de novo dominant COL2A1 mutations cause hypochondrogenesis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that de novo dominant COL2A1 mutations cause hypochondrogenesis."", ""reference"": ""PMID:2572591"", ""snippet"": ""These findings confirm the proposal that new dominant mutations in the type II procollagen gene may account for some cases of Type II achondrogenesis-hypochondrogenesis."", ""supports"": ""SUPPORT""}"
4072	3950	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	genetic	0	evidence	0	PMID:24569570	SUPPORT		Hotspot mutations in IDH isoforms 1 or 2 occur in approximately 15% of intrahepatic cholangiocarcinomas.	Abstract reports IDH1/2 hotspot mutations in intrahepatic cholangiocarcinoma.	"{""explanation"": ""Abstract reports IDH1/2 hotspot mutations in intrahepatic cholangiocarcinoma."", ""reference"": ""PMID:24569570"", ""snippet"": ""Hotspot mutations in IDH isoforms 1 or 2 occur in approximately 15% of intrahepatic cholangiocarcinomas."", ""supports"": ""SUPPORT""}"
4073	3951	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	genetic	1	evidence	0	PMID:24569570	SUPPORT		Hotspot mutations in IDH isoforms 1 or 2 occur in approximately 15% of intrahepatic cholangiocarcinomas.	Abstract reports IDH1/2 hotspot mutations in intrahepatic cholangiocarcinoma.	"{""explanation"": ""Abstract reports IDH1/2 hotspot mutations in intrahepatic cholangiocarcinoma."", ""reference"": ""PMID:24569570"", ""snippet"": ""Hotspot mutations in IDH isoforms 1 or 2 occur in approximately 15% of intrahepatic cholangiocarcinomas."", ""supports"": ""SUPPORT""}"
4118	4064	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	genetic	0	evidence	0	PMID:7874170	SUPPORT	HUMAN_CLINICAL	We now report an FGFR2 mutation in the conserved region of the immunoglobulin IIIc domain in the Jackson-Weiss syndrome family in which the syndrome was originally described.	First identification of FGFR2 mutation in JWS, establishing FGFR2 as the causative gene.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""First identification of FGFR2 mutation in JWS, establishing FGFR2 as the causative gene."", ""reference"": ""PMID:7874170"", ""snippet"": ""We now report an FGFR2 mutation in the conserved region of the immunoglobulin IIIc domain in the Jackson-Weiss syndrome family in which the syndrome was originally described."", ""supports"": ""SUPPORT""}"
4119	4064	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	genetic	0	evidence	1	PMID:8644708	SUPPORT	HUMAN_CLINICAL	Fibroblast growth factor receptor 2 (FGFR2) mutations have been associated with the craniosynostotic conditions Crouzon, Jackson-Weiss, and Pfeiffer syndromes.	Confirms FGFR2 mutations cause JWS along with related craniosynostosis syndromes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms FGFR2 mutations cause JWS along with related craniosynostosis syndromes."", ""reference"": ""PMID:8644708"", ""snippet"": ""Fibroblast growth factor receptor 2 (FGFR2) mutations have been associated with the craniosynostotic conditions Crouzon, Jackson-Weiss, and Pfeiffer syndromes."", ""supports"": ""SUPPORT""}"
4120	4064	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	genetic	0	evidence	2	PMID:9385368	SUPPORT	HUMAN_CLINICAL	Mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of this syndrome and of at least four other craniosynostotic disorders, namely the Apert, Beare-Stevenson cutis gyrata, Crouzon and Pfeiffer syndromes.	Identifies novel FGFR2 mutations specific to JWS that overlap with Crouzon syndrome mutations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Identifies novel FGFR2 mutations specific to JWS that overlap with Crouzon syndrome mutations."", ""reference"": ""PMID:9385368"", ""snippet"": ""Mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of this syndrome and of at least four other craniosynostotic disorders, namely the Apert, Beare-Stevenson cutis gyrata, Crouzon and Pfeiffer syndromes."", ""supports"": ""SUPPORT""}"
4135	4078	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	0	evidence	0	PMID:30541864	SUPPORT		Seizure types included eyelid myoclonia with absences (65%), myoclonic seizures (34%), atypical (20%) and typical (18%) absences, and atonic seizures (14%), triggered by eating in 25%.	This large cohort study of 57 SYNGAP1 patients found 65% had eyelid myoclonia with absences, demonstrating strong overlap with Jeavons syndrome phenotype.	"{""explanation"": ""This large cohort study of 57 SYNGAP1 patients found 65% had eyelid myoclonia with absences, demonstrating strong overlap with Jeavons syndrome phenotype."", ""reference"": ""PMID:30541864"", ""snippet"": ""Seizure types included eyelid myoclonia with absences (65%), myoclonic seizures (34%), atypical (20%) and typical (18%) absences, and atonic seizures (14%), triggered by eating in 25%."", ""supports"": ""SUPPORT""}"
4136	4078	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	0	evidence	1	PMID:34070602	SUPPORT		Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2).	This review identifies SYNGAP1 as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome).	"{""explanation"": ""This review identifies SYNGAP1 as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome)."", ""reference"": ""PMID:34070602"", ""snippet"": ""Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2)."", ""supports"": ""SUPPORT""}"
4137	4079	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	1	evidence	0	PMID:34070602	SUPPORT		Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2).	This review identifies NEXMIF (KIAA2022) as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome).	"{""explanation"": ""This review identifies NEXMIF (KIAA2022) as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome)."", ""reference"": ""PMID:34070602"", ""snippet"": ""Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2)."", ""supports"": ""SUPPORT""}"
4138	4080	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	2	evidence	0	PMID:34070602	SUPPORT		Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2).	This review identifies RORB as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome).	"{""explanation"": ""This review identifies RORB as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome)."", ""reference"": ""PMID:34070602"", ""snippet"": ""Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2)."", ""supports"": ""SUPPORT""}"
4139	4081	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	3	evidence	0	PMID:26262932	PARTIAL		Conversely, CHD2 could be responsible for a proper phenotype characterized by infantile-onset generalized epilepsy, intellectual disability, and photosensitivity, which might overlap with MAE, Lennox-Gastaut, Dravet, and Jeavons syndromes.	The literature indicates that CHD2 mutations may overlap with phenotypes seen in Jeavons Syndrome, but it does not specifically state a direct genetic association exclusive to Jeavons Syndrome.	"{""explanation"": ""The literature indicates that CHD2 mutations may overlap with phenotypes seen in Jeavons Syndrome, but it does not specifically state a direct genetic association exclusive to Jeavons Syndrome."", ""reference"": ""PMID:26262932"", ""snippet"": ""Conversely, CHD2 could be responsible for a proper phenotype characterized by infantile-onset generalized epilepsy, intellectual disability, and photosensitivity, which might overlap with MAE, Lennox-Gastaut, Dravet, and Jeavons syndromes."", ""supports"": ""PARTIAL""}"
4140	4081	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	3	evidence	1	PMID:34070602	SUPPORT		Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2).	This review identifies CHD2 as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome).	"{""explanation"": ""This review identifies CHD2 as one of four candidate genes associated with eyelid myoclonia with absences (Jeavons syndrome)."", ""reference"": ""PMID:34070602"", ""snippet"": ""Based on this, four genes could be associated to this syndrome (SYNGAP1, KIA02022/NEXMIF, RORB, and CHD2)."", ""supports"": ""SUPPORT""}"
4141	4083	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	5	evidence	0	PMID:28419980	REFUTE		We did not detect any pathogenic mutations in SLC2A1 in this cohort. Our data suggests that the frequency of GLUT1 mutations in NAFE is low.	The study indicates that no pathogenic mutations in SLC2A1 were found in the cohort, suggesting a low frequency of association with certain types of epilepsy, including Jeavons syndrome.	"{""explanation"": ""The study indicates that no pathogenic mutations in SLC2A1 were found in the cohort, suggesting a low frequency of association with certain types of epilepsy, including Jeavons syndrome."", ""reference"": ""PMID:28419980"", ""snippet"": ""We did not detect any pathogenic mutations in SLC2A1 in this cohort. Our data suggests that the frequency of GLUT1 mutations in NAFE is low."", ""supports"": ""REFUTE""}"
4142	4084	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	6	evidence	0	PMID:34070602	PARTIAL		Moreover, although there is not enough evidence yet to consider them as candidate for EMA, three more genes present also different alterations in some patients with clinical diagnosis of the disease (SLC2A1, NAA10, and KCNB1).	This review notes KCNB1 alterations in some EMA patients, though evidence is limited.	"{""explanation"": ""This review notes KCNB1 alterations in some EMA patients, though evidence is limited."", ""reference"": ""PMID:34070602"", ""snippet"": ""Moreover, although there is not enough evidence yet to consider them as candidate for EMA, three more genes present also different alterations in some patients with clinical diagnosis of the disease (SLC2A1, NAA10, and KCNB1)."", ""supports"": ""PARTIAL""}"
4143	4085	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	7	evidence	0	PMID:34070602	PARTIAL		Moreover, although there is not enough evidence yet to consider them as candidate for EMA, three more genes present also different alterations in some patients with clinical diagnosis of the disease (SLC2A1, NAA10, and KCNB1).	This review notes NAA10 alterations in some EMA patients, though evidence is limited.	"{""explanation"": ""This review notes NAA10 alterations in some EMA patients, though evidence is limited."", ""reference"": ""PMID:34070602"", ""snippet"": ""Moreover, although there is not enough evidence yet to consider them as candidate for EMA, three more genes present also different alterations in some patients with clinical diagnosis of the disease (SLC2A1, NAA10, and KCNB1)."", ""supports"": ""PARTIAL""}"
4144	4086	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	8	evidence	0	PMID:14631097	REFUTE		An Ala322Asp mutation in the GABRA1 gene was recently reported to be responsible for causing the autosomal dominant (AD) form of juvenile myoclonic epilepsy (JME) in a French-Canadian family.	The abstract does not mention Jeavons syndrome and focuses on juvenile myoclonic epilepsy related to GABRA1 mutations in a different population.	"{""explanation"": ""The abstract does not mention Jeavons syndrome and focuses on juvenile myoclonic epilepsy related to GABRA1 mutations in a different population."", ""reference"": ""PMID:14631097"", ""snippet"": ""An Ala322Asp mutation in the GABRA1 gene was recently reported to be responsible for causing the autosomal dominant (AD) form of juvenile myoclonic epilepsy (JME) in a French-Canadian family."", ""supports"": ""REFUTE""}"
4145	4086	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	8	evidence	1	PMID:30082241	NO_EVIDENCE		We identified 30 patients who met the diagnostic criteria of Jeavons syndrome at a single institution...	The study focuses on clinical features and treatment response in Jeavons syndrome without mentioning GABRA1 or a genetic association.	"{""explanation"": ""The study focuses on clinical features and treatment response in Jeavons syndrome without mentioning GABRA1 or a genetic association."", ""reference"": ""PMID:30082241"", ""snippet"": ""We identified 30 patients who met the diagnostic criteria of Jeavons syndrome at a single institution..."", ""supports"": ""NO_EVIDENCE""}"
4146	4086	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	genetic	8	evidence	2	PMID:20074235	NO_EVIDENCE		We have created the Epilepsy Genetic Association Database (epiGAD)...	The database mentions epilepsy genetic association studies but does not specifically address Jeavons syndrome or GABRA1.	"{""explanation"": ""The database mentions epilepsy genetic association studies but does not specifically address Jeavons syndrome or GABRA1."", ""reference"": ""PMID:20074235"", ""snippet"": ""We have created the Epilepsy Genetic Association Database (epiGAD)..."", ""supports"": ""NO_EVIDENCE""}"
4276	4219	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	genetic	0	evidence	0	PMID:10369869	SUPPORT		"All 10 affected members were heterozygous for a non-conservative mutation, D66H, in Cx26. The same mutation was found subsequently in affected individuals from two unrelated Spanish and Italian pedigrees segregating VS, suggesting that D66H in Cx26 is a common mutation in classical VS.
"	Identifies D66H as a common mutation in classic Vohwinkel syndrome across multiple families.	"{""explanation"": ""Identifies D66H as a common mutation in classic Vohwinkel syndrome across multiple families."", ""reference"": ""PMID:10369869"", ""snippet"": ""All 10 affected members were heterozygous for a non-conservative mutation, D66H, in Cx26. The same mutation was found subsequently in affected individuals from two unrelated Spanish and Italian pedigrees segregating VS, suggesting that D66H in Cx26 is a common mutation in classical VS.\n"", ""supports"": ""SUPPORT""}"
4277	4219	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	genetic	0	evidence	1	PMID:20031451	SUPPORT		"Genetic study showed a nucleotide change (c.196G>C) in exon 1 of GJB2 gene, producing a missense mutation, D66H.
"	Confirms the specific nucleotide change causing the D66H mutation.	"{""explanation"": ""Confirms the specific nucleotide change causing the D66H mutation."", ""reference"": ""PMID:20031451"", ""snippet"": ""Genetic study showed a nucleotide change (c.196G>C) in exon 1 of GJB2 gene, producing a missense mutation, D66H.\n"", ""supports"": ""SUPPORT""}"
4278	4220	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	genetic	1	evidence	0	PMID:9326398	SUPPORT		"a G insertion producing a frameshift after codon 231 and an abnormal C-terminal peptide lacking residues necessary for cross-linking.
"	Identifies the specific loricrin mutation causing the ichthyotic variant.	"{""explanation"": ""Identifies the specific loricrin mutation causing the ichthyotic variant."", ""reference"": ""PMID:9326398"", ""snippet"": ""a G insertion producing a frameshift after codon 231 and an abnormal C-terminal peptide lacking residues necessary for cross-linking.\n"", ""supports"": ""SUPPORT""}"
4279	4220	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	genetic	1	evidence	1	PMID:12072018	SUPPORT		"identified a recurrent insertion mutation in the loricrin gene resulting in a mutant polypeptide with an unusual C terminus.
"	Confirms the recurrent nature of loricrin insertion mutations.	"{""explanation"": ""Confirms the recurrent nature of loricrin insertion mutations."", ""reference"": ""PMID:12072018"", ""snippet"": ""identified a recurrent insertion mutation in the loricrin gene resulting in a mutant polypeptide with an unusual C terminus.\n"", ""supports"": ""SUPPORT""}"
4324	4245	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	genetic	0	evidence	0	PMID:34375016	SUPPORT		Patients with Klinefelter syndrome (KS) show a typically 47,XXY karyotype; however, some variations have been observed, including 47,XX,der(Y), 46,XY/47,XXY, 48,XXXY, 48,XXYY, and mosaicism or structural sex chromosome abnormalities in some patients.	The study discusses that Klinefelter syndrome typically exhibits a 47,XXY karyotype.	"{""explanation"": ""The study discusses that Klinefelter syndrome typically exhibits a 47,XXY karyotype."", ""reference"": ""PMID:34375016"", ""snippet"": ""Patients with Klinefelter syndrome (KS) show a typically 47,XXY karyotype; however, some variations have been observed, including 47,XX,der(Y), 46,XY/47,XXY, 48,XXXY, 48,XXYY, and mosaicism or structural sex chromosome abnormalities in some patients."", ""supports"": ""SUPPORT""}"
4325	4245	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	genetic	0	evidence	1	PMID:9160389	SUPPORT		Cytogenetic surveys of neonates have found that approximately one boy in 500 is born with an extra sex chromosome. ... This study estimates what proportion of those not detected prenatally will be diagnosed postnatally and what the indications for karyotyping are likely to be.	The study indicates that Klinefelter syndrome is associated with an extra sex chromosome, typically 47,XXY.	"{""explanation"": ""The study indicates that Klinefelter syndrome is associated with an extra sex chromosome, typically 47,XXY."", ""reference"": ""PMID:9160389"", ""snippet"": ""Cytogenetic surveys of neonates have found that approximately one boy in 500 is born with an extra sex chromosome. ... This study estimates what proportion of those not detected prenatally will be diagnosed postnatally and what the indications for karyotyping are likely to be."", ""supports"": ""SUPPORT""}"
4326	4245	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	genetic	0	evidence	2	PMID:31630146	SUPPORT		Klinefelter syndrome (KS) is one of the most common congenital disorders of male infertility. Given its high heterogeneity in clinical and genetic presentation, the relationship between transcriptome, clinical phenotype, and associated co-morbidities seen in KS has not been fully clarified.	This study identifies Klinefelter syndrome as a congenital disorder related to the 47,XXY karyotype.	"{""explanation"": ""This study identifies Klinefelter syndrome as a congenital disorder related to the 47,XXY karyotype."", ""reference"": ""PMID:31630146"", ""snippet"": ""Klinefelter syndrome (KS) is one of the most common congenital disorders of male infertility. Given its high heterogeneity in clinical and genetic presentation, the relationship between transcriptome, clinical phenotype, and associated co-morbidities seen in KS has not been fully clarified."", ""supports"": ""SUPPORT""}"
4327	4245	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	genetic	0	evidence	3	PMID:37054629	SUPPORT		Klinefelter syndrome is the most frequently found aneuploidy among male patients. Its clinical presentation is very heterogeneous, and thus poses a challenge for a timely diagnosis.	The study confirms that Klinefelter syndrome is an aneuploidy condition predominantly associated with the 47,XXY karyotype.	"{""explanation"": ""The study confirms that Klinefelter syndrome is an aneuploidy condition predominantly associated with the 47,XXY karyotype."", ""reference"": ""PMID:37054629"", ""snippet"": ""Klinefelter syndrome is the most frequently found aneuploidy among male patients. Its clinical presentation is very heterogeneous, and thus poses a challenge for a timely diagnosis."", ""supports"": ""SUPPORT""}"
4328	4251	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	genetic	6	evidence	0	PMID:1176138	SUPPORT		The percentage with mosaicism was 36 in both triple-X and Turner's syndrome, it was 7 and 11% in XYY and Klinefelter's syndrome, respectively...	The reference discusses the occurrence of mosaicism in Klinefelter syndrome with a frequency of 11%, supporting that mosaicism is occasionally present in Klinefelter Syndrome.	"{""explanation"": ""The reference discusses the occurrence of mosaicism in Klinefelter syndrome with a frequency of 11%, supporting that mosaicism is occasionally present in Klinefelter Syndrome."", ""reference"": ""PMID:1176138"", ""snippet"": ""The percentage with mosaicism was 36 in both triple-X and Turner's syndrome, it was 7 and 11% in XYY and Klinefelter's syndrome, respectively..."", ""supports"": ""SUPPORT""}"
4329	4251	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	genetic	6	evidence	1	PMID:3490207	SUPPORT		46,XY/47,XXY mosaicism is not uncommon. However, mosaicism of multiple sex chromosome aneuploidy is rarely observed.	This case report shows that 46,XY/47,XXY mosaicism is not uncommon in Klinefelter's syndrome, supporting the statement.	"{""explanation"": ""This case report shows that 46,XY/47,XXY mosaicism is not uncommon in Klinefelter's syndrome, supporting the statement."", ""reference"": ""PMID:3490207"", ""snippet"": ""46,XY/47,XXY mosaicism is not uncommon. However, mosaicism of multiple sex chromosome aneuploidy is rarely observed."", ""supports"": ""SUPPORT""}"
4330	4251	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	genetic	6	evidence	2	PMID:5720649	SUPPORT		Chromosomal mosaicism in two emotionally disturbed adolescents with Klinefelter's syndrome (46,XY-47,XXY and 46,XY-47,XYY-48,XXYY).	The study mentions cases of mosaicism in Klinefelter's syndrome, providing support to the statement.	"{""explanation"": ""The study mentions cases of mosaicism in Klinefelter's syndrome, providing support to the statement."", ""reference"": ""PMID:5720649"", ""snippet"": ""Chromosomal mosaicism in two emotionally disturbed adolescents with Klinefelter's syndrome (46,XY-47,XXY and 46,XY-47,XYY-48,XXYY)."", ""supports"": ""SUPPORT""}"
4365	4276	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	genetic	0	evidence	0	PMID:7981752	SUPPORT	HUMAN_CLINICAL	We studied a 2-year-old girl presenting with manifestations of Kniest dysplasia and her mother showing a Stickler phenotype. Analysing COL2A1 in both patients, we detected the same 28 basepair deletion spanning the 3'-exon/intron boundary of exon 12 in mother and daughter.	This study identifies a 28bp deletion at the exon 12 splice boundary in COL2A1 causing Kniest dysplasia, demonstrating that exon-boundary mutations (which lead to exon skipping) cause the disorder.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study identifies a 28bp deletion at the exon 12 splice boundary in COL2A1 causing Kniest dysplasia, demonstrating that exon-boundary mutations (which lead to exon skipping) cause the disorder."", ""reference"": ""PMID:7981752"", ""snippet"": ""We studied a 2-year-old girl presenting with manifestations of Kniest dysplasia and her mother showing a Stickler phenotype. Analysing COL2A1 in both patients, we detected the same 28 basepair deletion spanning the 3'-exon/intron boundary of exon 12 in mother and daughter."", ""supports"": ""SUPPORT""}"
4366	4276	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	genetic	0	evidence	1	PMID:25592122	SUPPORT	HUMAN_CLINICAL	Six dominant disease-causing COL2A1 variants were detected. In three cases, testing of parental samples revealed that the disease-causing variant was not present in either parent.	This study confirms that Kniest dysplasia is associated with heterozygous COL2A1 mutations that are frequently de novo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study confirms that Kniest dysplasia is associated with heterozygous COL2A1 mutations that are frequently de novo."", ""reference"": ""PMID:25592122"", ""snippet"": ""Six dominant disease-causing COL2A1 variants were detected. In three cases, testing of parental samples revealed that the disease-causing variant was not present in either parent."", ""supports"": ""SUPPORT""}"
4420	4327	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	genetic	0	evidence	0	DOI:10.1038/s41598-024-53098-w	SUPPORT	COMPUTATIONAL	FOXF1, FOXC1, and FOXD1, as well as the SRY-box transcription factor, SOX2, demonstrate the most significant preferential expression in both mouse and human embryos.	Single-cell analysis links SOX2 to esophageal malformation gene expression patterns.	"{""evidence_source"": ""COMPUTATIONAL"", ""explanation"": ""Single-cell analysis links SOX2 to esophageal malformation gene expression patterns."", ""reference"": ""DOI:10.1038/s41598-024-53098-w"", ""snippet"": ""FOXF1, FOXC1, and FOXD1, as well as the SRY-box transcription factor, SOX2, demonstrate the most significant preferential expression in both mouse and human embryos."", ""supports"": ""SUPPORT""}"
4421	4328	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	genetic	1	evidence	0	DOI:10.1038/s41598-024-53098-w	SUPPORT	COMPUTATIONAL	FOXF1, FOXC1, and FOXD1, as well as the SRY-box transcription factor, SOX2, demonstrate the most significant preferential expression in both mouse and human embryos.	Single-cell analysis highlights FOXF1 among genes enriched in esophageal malformation contexts.	"{""evidence_source"": ""COMPUTATIONAL"", ""explanation"": ""Single-cell analysis highlights FOXF1 among genes enriched in esophageal malformation contexts."", ""reference"": ""DOI:10.1038/s41598-024-53098-w"", ""snippet"": ""FOXF1, FOXC1, and FOXD1, as well as the SRY-box transcription factor, SOX2, demonstrate the most significant preferential expression in both mouse and human embryos."", ""supports"": ""SUPPORT""}"
4422	4329	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	genetic	2	evidence	0	DOI:10.1038/s41598-024-53098-w	SUPPORT	COMPUTATIONAL	FOXF1, FOXC1, and FOXD1, as well as the SRY-box transcription factor, SOX2, demonstrate the most significant preferential expression in both mouse and human embryos.	Single-cell analysis highlights FOXC1 among genes enriched in esophageal malformation contexts.	"{""evidence_source"": ""COMPUTATIONAL"", ""explanation"": ""Single-cell analysis highlights FOXC1 among genes enriched in esophageal malformation contexts."", ""reference"": ""DOI:10.1038/s41598-024-53098-w"", ""snippet"": ""FOXF1, FOXC1, and FOXD1, as well as the SRY-box transcription factor, SOX2, demonstrate the most significant preferential expression in both mouse and human embryos."", ""supports"": ""SUPPORT""}"
4423	4330	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	genetic	3	evidence	0	PMID:30245899	SUPPORT	HUMAN_CLINICAL	a 1p36 deletion including the RERE gene was detected.	Case report identifies a 1p36 deletion including RERE in a neonate with type IV LTEC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report identifies a 1p36 deletion including RERE in a neonate with type IV LTEC."", ""reference"": ""PMID:30245899"", ""snippet"": ""a 1p36 deletion including the RERE gene was detected."", ""supports"": ""SUPPORT""}"
4480	4378	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	genetic	0	evidence	0	PMID:26014290	SUPPORT		The mean age of tumor onset was statistically different (P < .05) between carriers harboring dominant-negative missense mutations (21.3 years) and those with all types of loss of function mutations (28.5 years) or genomic rearrangements (35.8 years). Affected children, except those with ACC, harbored mostly dominant-negative missense mutations.	Clinical gradient of germline TP53 mutations demonstrates that dominant-negative missense mutations cause earlier tumor onset (21.3 years) compared to loss-of-function mutations (28.5 years), supporting mutation-specific phenotype stratification.	"{""explanation"": ""Clinical gradient of germline TP53 mutations demonstrates that dominant-negative missense mutations cause earlier tumor onset (21.3 years) compared to loss-of-function mutations (28.5 years), supporting mutation-specific phenotype stratification."", ""reference"": ""PMID:26014290"", ""snippet"": ""The mean age of tumor onset was statistically different (P < .05) between carriers harboring dominant-negative missense mutations (21.3 years) and those with all types of loss of function mutations (28.5 years) or genomic rearrangements (35.8 years). Affected children, except those with ACC, harbored mostly dominant-negative missense mutations."", ""supports"": ""SUPPORT""}"
4662	4587	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	0	inheritance[0].evidence	0	PMID:19466295	SUPPORT		Lynch syndrome represents 1-7% of all cases of colorectal cancer and is an autosomal-dominant inherited cancer predisposition syndrome caused by germline mutations in deoxyribonucleic acid (DNA) mismatch repair genes.	This supports autosomal dominant inheritance for Lynch syndrome caused by pathogenic mismatch repair variants including MLH1.	"{""explanation"": ""This supports autosomal dominant inheritance for Lynch syndrome caused by pathogenic mismatch repair variants including MLH1."", ""reference"": ""PMID:19466295"", ""snippet"": ""Lynch syndrome represents 1-7% of all cases of colorectal cancer and is an autosomal-dominant inherited cancer predisposition syndrome caused by germline mutations in deoxyribonucleic acid (DNA) mismatch repair genes."", ""supports"": ""SUPPORT""}"
4663	4587	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	0	evidence	0	PMID:28038733	SUPPORT		Lynch syndrome is due to germline mutations in mismatch repair genes: MLH1, MSH2, MSH6 and PMS2.	The reference directly indicates that Lynch syndrome is caused by germline mutations in the MLH1 gene among others.	"{""explanation"": ""The reference directly indicates that Lynch syndrome is caused by germline mutations in the MLH1 gene among others."", ""reference"": ""PMID:28038733"", ""snippet"": ""Lynch syndrome is due to germline mutations in mismatch repair genes: MLH1, MSH2, MSH6 and PMS2."", ""supports"": ""SUPPORT""}"
4664	4587	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	0	evidence	1	PMID:26886015	SUPPORT		Constitutional epimutation of the DNA mismatch repair gene, MLH1, represents a minor cause of Lynch syndrome.	While the term 'epimutation' is used, it is within the context of the DNA mismatch repair gene MLH1 being a cause of Lynch syndrome.	"{""explanation"": ""While the term 'epimutation' is used, it is within the context of the DNA mismatch repair gene MLH1 being a cause of Lynch syndrome."", ""reference"": ""PMID:26886015"", ""snippet"": ""Constitutional epimutation of the DNA mismatch repair gene, MLH1, represents a minor cause of Lynch syndrome."", ""supports"": ""SUPPORT""}"
4665	4588	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	1	evidence	0	PMID:29345684	PARTIAL		Our data demonstrate that two LS genes, MSH6 and PMS2, are associated with an increased risk for breast cancer...	While the MSH2 gene is mentioned, the research did not find a statistically significant association between MSH2 and breast cancer risk.	"{""explanation"": ""While the MSH2 gene is mentioned, the research did not find a statistically significant association between MSH2 and breast cancer risk."", ""reference"": ""PMID:29345684"", ""snippet"": ""Our data demonstrate that two LS genes, MSH6 and PMS2, are associated with an increased risk for breast cancer..."", ""supports"": ""PARTIAL""}"
4666	4588	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	1	evidence	1	PMID:25430799	SUPPORT		Sixty-seven (59%) families had mutations in MSH2...	This study reports a significant proportion of Lynch syndrome families with mutations in MSH2.	"{""explanation"": ""This study reports a significant proportion of Lynch syndrome families with mutations in MSH2."", ""reference"": ""PMID:25430799"", ""snippet"": ""Sixty-seven (59%) families had mutations in MSH2..."", ""supports"": ""SUPPORT""}"
4667	4589	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	2	evidence	0	PMID:20028993	SUPPORT		Germline mutations in MSH6 account for 10%-20% of Lynch syndrome colorectal cancers caused by hereditary DNA mismatch repair gene mutations.	The study explicitly states that germline mutations in MSH6 are associated with Lynch Syndrome cancers.	"{""explanation"": ""The study explicitly states that germline mutations in MSH6 are associated with Lynch Syndrome cancers."", ""reference"": ""PMID:20028993"", ""snippet"": ""Germline mutations in MSH6 account for 10%-20% of Lynch syndrome colorectal cancers caused by hereditary DNA mismatch repair gene mutations."", ""supports"": ""SUPPORT""}"
4668	4589	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	2	evidence	1	PMID:28038733	SUPPORT		Lynch syndrome is due to germline mutations in mismatch repair genes: MLH1, MSH2, MSH6 and PMS2.	The study identifies germline mutations in MSH6 as a cause of Lynch Syndrome.	"{""explanation"": ""The study identifies germline mutations in MSH6 as a cause of Lynch Syndrome."", ""reference"": ""PMID:28038733"", ""snippet"": ""Lynch syndrome is due to germline mutations in mismatch repair genes: MLH1, MSH2, MSH6 and PMS2."", ""supports"": ""SUPPORT""}"
4669	4589	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	2	evidence	2	PMID:33516942	SUPPORT		A MSH6 3'UTR variant (c.*23_26dup) was found in 13 unrelated families consulted for Lynch/Muir-Torre Syndrome.	The study highlights that a specific variant of MSH6 is associated with families affected by Lynch Syndrome.	"{""explanation"": ""The study highlights that a specific variant of MSH6 is associated with families affected by Lynch Syndrome."", ""reference"": ""PMID:33516942"", ""snippet"": ""A MSH6 3'UTR variant (c.*23_26dup) was found in 13 unrelated families consulted for Lynch/Muir-Torre Syndrome."", ""supports"": ""SUPPORT""}"
4670	4589	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	2	evidence	3	PMID:25430799	SUPPORT		Sixty-seven (59%) families had mutations in MSH2, 20 (18%) in MSH6, 19 (17%) in MLH1 and 7 (6%) in PMS2.	The study identifies families with Lynch Syndrome who have mutations in the MSH6 gene.	"{""explanation"": ""The study identifies families with Lynch Syndrome who have mutations in the MSH6 gene."", ""reference"": ""PMID:25430799"", ""snippet"": ""Sixty-seven (59%) families had mutations in MSH2, 20 (18%) in MSH6, 19 (17%) in MLH1 and 7 (6%) in PMS2."", ""supports"": ""SUPPORT""}"
4671	4589	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	2	evidence	4	PMID:33094597	SUPPORT		Genetic analysis turned out positive for biallelic MSH6 mutations in the two girls, leading to CMMRD syndrome diagnosis. Both parents and two out of three alive siblings were diagnosed with Lynch syndrome.	This informs about Lynch Syndrome diagnosis in individuals with MSH6 mutations.	"{""explanation"": ""This informs about Lynch Syndrome diagnosis in individuals with MSH6 mutations."", ""reference"": ""PMID:33094597"", ""snippet"": ""Genetic analysis turned out positive for biallelic MSH6 mutations in the two girls, leading to CMMRD syndrome diagnosis. Both parents and two out of three alive siblings were diagnosed with Lynch syndrome."", ""supports"": ""SUPPORT""}"
4672	4590	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	3	evidence	0	PMID:18602922	SUPPORT		PMS2 mutations contribute significantly to Lynch syndrome, but the penetrance for monoallelic mutation carriers appears to be lower than that for the other mismatch repair genes.	This study confirms that germline mutations in PMS2 are associated with Lynch syndrome.	"{""explanation"": ""This study confirms that germline mutations in PMS2 are associated with Lynch syndrome."", ""reference"": ""PMID:18602922"", ""snippet"": ""PMS2 mutations contribute significantly to Lynch syndrome, but the penetrance for monoallelic mutation carriers appears to be lower than that for the other mismatch repair genes."", ""supports"": ""SUPPORT""}"
4673	4590	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	3	evidence	1	PMID:24027009	SUPPORT		Lynch syndrome (LS) is a common cancer predisposition caused by an inactivating mutation in one of four DNA mismatch repair (MMR) genes. Frequently a variant of uncertain significance (VUS), rather than an obviously pathogenic mutation, is identified in one of these genes. The inability to define pathogenicity of such variants precludes targeted healthcare.	The study discusses analyzing VUS in the MMR gene PMS2 for functional activity, indicating the association of PMS2 germline mutations with Lynch syndrome.	"{""explanation"": ""The study discusses analyzing VUS in the MMR gene PMS2 for functional activity, indicating the association of PMS2 germline mutations with Lynch syndrome."", ""reference"": ""PMID:24027009"", ""snippet"": ""Lynch syndrome (LS) is a common cancer predisposition caused by an inactivating mutation in one of four DNA mismatch repair (MMR) genes. Frequently a variant of uncertain significance (VUS), rather than an obviously pathogenic mutation, is identified in one of these genes. The inability to define pathogenicity of such variants precludes targeted healthcare."", ""supports"": ""SUPPORT""}"
4674	4590	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	3	evidence	2	PMID:37072247	SUPPORT		As a result of our analysis, we managed to identify a mutation in the PMS2 gene in one patient's breast tumor tissue. The presence of this mutation indicates that the resulting cancer may be a consequence of LS.	This study identifies a mutation of the PMS2 gene associated with Lynch syndrome, supporting the genetic association.	"{""explanation"": ""This study identifies a mutation of the PMS2 gene associated with Lynch syndrome, supporting the genetic association."", ""reference"": ""PMID:37072247"", ""snippet"": ""As a result of our analysis, we managed to identify a mutation in the PMS2 gene in one patient's breast tumor tissue. The presence of this mutation indicates that the resulting cancer may be a consequence of LS."", ""supports"": ""SUPPORT""}"
4675	4590	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	3	evidence	3	PMID:25430799	SUPPORT		We identified 54 different mutations; 13 of them are novel... Seven founder mutations were detected in 61/113 (54%) families... Gene distribution in the Israeli population is unique...7 (6%) in PMS2.	PMS2 is one of the genes where germline mutations have been identified as causing Lynch syndrome.	"{""explanation"": ""PMS2 is one of the genes where germline mutations have been identified as causing Lynch syndrome."", ""reference"": ""PMID:25430799"", ""snippet"": ""We identified 54 different mutations; 13 of them are novel... Seven founder mutations were detected in 61/113 (54%) families... Gene distribution in the Israeli population is unique...7 (6%) in PMS2."", ""supports"": ""SUPPORT""}"
4676	4591	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	4	evidence	0	PMID:23411950	SUPPORT		Germline mutations of 4 MMR genes, e.g., MLH1, MSH2, MSH6 and PMS2, had been identified as the cause of this disease, however, a novel mechanism, epigenetic inactivation of MSH2 gene due to hypermethylation of promotor region by the deletion of 3'part of epithelial cell adhesion molecule(EPCAM) gene which is located upstream of the MSH2 gene, has been reported in recent years.		"{""reference"": ""PMID:23411950"", ""snippet"": ""Germline mutations of 4 MMR genes, e.g., MLH1, MSH2, MSH6 and PMS2, had been identified as the cause of this disease, however, a novel mechanism, epigenetic inactivation of MSH2 gene due to hypermethylation of promotor region by the deletion of 3'part of epithelial cell adhesion molecule(EPCAM) gene which is located upstream of the MSH2 gene, has been reported in recent years."", ""supports"": ""SUPPORT""}"
4677	4591	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	4	evidence	1	PMID:30461124	SUPPORT		Monoallelic deletions of the 3' end of EPCAM that silence the downstream gene, MSH2, cause a form of Lynch syndrome, which is a cancer predisposition syndrome associated with loss of DNA mismatch repair.		"{""reference"": ""PMID:30461124"", ""snippet"": ""Monoallelic deletions of the 3' end of EPCAM that silence the downstream gene, MSH2, cause a form of Lynch syndrome, which is a cancer predisposition syndrome associated with loss of DNA mismatch repair."", ""supports"": ""SUPPORT""}"
4678	4591	194	Lynch Syndrome	Lynch_Syndrome.yaml	genetic	4	evidence	2	PMID:37088804	SUPPORT		Four EO cases stood out: two with POLE/POLD1 variants in the key exonuclease domain, one with a BMPR1A duplication and one with an EPCAM deletion.	EPCAM deletion is mentioned as one of the variants related to Lynch Syndrome.	"{""explanation"": ""EPCAM deletion is mentioned as one of the variants related to Lynch Syndrome."", ""reference"": ""PMID:37088804"", ""snippet"": ""Four EO cases stood out: two with POLE/POLD1 variants in the key exonuclease domain, one with a BMPR1A duplication and one with an EPCAM deletion."", ""supports"": ""SUPPORT""}"
4815	4788	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	genetic	0	evidence	0	PMID:35672312	SUPPORT		We establish and characterize the Bckdha (branched chain keto acid dehydrogenase a)-/- mouse that exhibits a lethal neonatal phenotype mimicking human MSUD.	Confirms BCKDHA mutations cause MSUD.	"{""explanation"": ""Confirms BCKDHA mutations cause MSUD."", ""reference"": ""PMID:35672312"", ""snippet"": ""We establish and characterize the Bckdha (branched chain keto acid dehydrogenase a)-/- mouse that exhibits a lethal neonatal phenotype mimicking human MSUD."", ""supports"": ""SUPPORT""}"
4816	4789	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	genetic	1	evidence	0	PMID:27373929	SUPPORT		MSUD is classified as type I, II or III based on mutations that occur in the E1, E2, or E3 complexes of BCKDH, respectively.	Confirms BCKDHB (E1-beta) mutations cause Type I MSUD.	"{""explanation"": ""Confirms BCKDHB (E1-beta) mutations cause Type I MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""MSUD is classified as type I, II or III based on mutations that occur in the E1, E2, or E3 complexes of BCKDH, respectively."", ""supports"": ""SUPPORT""}"
4817	4790	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	genetic	2	evidence	0	PMID:27373929	SUPPORT		MSUD is classified as type I, II or III based on mutations that occur in the E1, E2, or E3 complexes of BCKDH, respectively.	Confirms DBT (E2) mutations cause Type II MSUD.	"{""explanation"": ""Confirms DBT (E2) mutations cause Type II MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""MSUD is classified as type I, II or III based on mutations that occur in the E1, E2, or E3 complexes of BCKDH, respectively."", ""supports"": ""SUPPORT""}"
4818	4791	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	genetic	3	evidence	0	PMID:27373929	SUPPORT		MSUD is classified as type I, II or III based on mutations that occur in the E1, E2, or E3 complexes of BCKDH, respectively.	Confirms DLD (E3) mutations cause Type III MSUD.	"{""explanation"": ""Confirms DLD (E3) mutations cause Type III MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""MSUD is classified as type I, II or III based on mutations that occur in the E1, E2, or E3 complexes of BCKDH, respectively."", ""supports"": ""SUPPORT""}"
4870	4825	204	Marfan Syndrome	Marfan_Syndrome.yaml	genetic	0	evidence	0	PMID:31163209	SUPPORT	HUMAN_CLINICAL	FBN1 gene mutations lead to MFS and related connective tissue disorders.	The abstract directly states that FBN1 gene mutations are associated with Marfan syndrome and related disorders.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract directly states that FBN1 gene mutations are associated with Marfan syndrome and related disorders."", ""reference"": ""PMID:31163209"", ""snippet"": ""FBN1 gene mutations lead to MFS and related connective tissue disorders."", ""supports"": ""SUPPORT""}"
4871	4825	204	Marfan Syndrome	Marfan_Syndrome.yaml	genetic	0	evidence	1	PMID:34916231	SUPPORT	HUMAN_CLINICAL	We retrospectively evaluated 278 patients with pathogenic or likely pathogenic FBN1 variants.	The study focuses on patients with Marfan syndrome who have pathogenic FBN1 variants, supporting the association.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study focuses on patients with Marfan syndrome who have pathogenic FBN1 variants, supporting the association."", ""reference"": ""PMID:34916231"", ""snippet"": ""We retrospectively evaluated 278 patients with pathogenic or likely pathogenic FBN1 variants."", ""supports"": ""SUPPORT""}"
4872	4825	204	Marfan Syndrome	Marfan_Syndrome.yaml	genetic	0	evidence	2	PMID:32130918	SUPPORT	HUMAN_CLINICAL	Aortic risk has not been evaluated in patients with Marfan syndrome and documented pathogenic variants in the FBN1 gene.	The study describes aortic risks in patients with Marfan syndrome with pathogenic FBN1 variants, supporting the association.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study describes aortic risks in patients with Marfan syndrome with pathogenic FBN1 variants, supporting the association."", ""reference"": ""PMID:32130918"", ""snippet"": ""Aortic risk has not been evaluated in patients with Marfan syndrome and documented pathogenic variants in the FBN1 gene."", ""supports"": ""SUPPORT""}"
4873	4825	204	Marfan Syndrome	Marfan_Syndrome.yaml	genetic	0	evidence	3	PMID:35419902	SUPPORT	HUMAN_CLINICAL	Different pathogenic variants in the fibrillin-1 gene (FBN1) cause Marfan syndrome and acromelic dysplasias.	The abstract states that pathogenic variants in FBN1 cause Marfan syndrome, supporting the association.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract states that pathogenic variants in FBN1 cause Marfan syndrome, supporting the association."", ""reference"": ""PMID:35419902"", ""snippet"": ""Different pathogenic variants in the fibrillin-1 gene (FBN1) cause Marfan syndrome and acromelic dysplasias."", ""supports"": ""SUPPORT""}"
4874	4825	204	Marfan Syndrome	Marfan_Syndrome.yaml	genetic	0	evidence	4	PMID:36004597	SUPPORT	HUMAN_CLINICAL	Marfan syndrome is an orphan disease that is caused by a mutation in the FBN1 gene located on chromosome 15 (15q21.1).	The article reviews studies concerning the potential ocular manifestations of Marfan syndrome caused by FBN1 mutations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The article reviews studies concerning the potential ocular manifestations of Marfan syndrome caused by FBN1 mutations."", ""reference"": ""PMID:36004597"", ""snippet"": ""Marfan syndrome is an orphan disease that is caused by a mutation in the FBN1 gene located on chromosome 15 (15q21.1)."", ""supports"": ""SUPPORT""}"
4875	4825	204	Marfan Syndrome	Marfan_Syndrome.yaml	genetic	0	evidence	5	PMID:30485715	SUPPORT	HUMAN_CLINICAL	Pathogenic variants in FBN1 cause autosomal dominant Marfan syndrome.	The abstract states that pathogenic variants in FBN1 cause autosomal dominant Marfan syndrome, supporting the association.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract states that pathogenic variants in FBN1 cause autosomal dominant Marfan syndrome, supporting the association."", ""reference"": ""PMID:30485715"", ""snippet"": ""Pathogenic variants in FBN1 cause autosomal dominant Marfan syndrome."", ""supports"": ""SUPPORT""}"
4876	4825	204	Marfan Syndrome	Marfan_Syndrome.yaml	genetic	0	evidence	6	PMID:19059503	SUPPORT	HUMAN_CLINICAL	We report two families in which the probands have compound-heterozygous Marfan syndrome (MFS).	The study reports cases of Marfan syndrome associated with compound-heterozygous FBN1 mutations, supporting the association.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study reports cases of Marfan syndrome associated with compound-heterozygous FBN1 mutations, supporting the association."", ""reference"": ""PMID:19059503"", ""snippet"": ""We report two families in which the probands have compound-heterozygous Marfan syndrome (MFS)."", ""supports"": ""SUPPORT""}"
4970	4874	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	0	evidence	0	PMID:19776033	SUPPORT	MODEL_ORGANISM	The gene mutated in type 1 MKS encodes a protein associated with the base of the cilium in vertebrates and nematodes.	This mouse model study identifies the MKS1 gene underlying MKS type 1.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""This mouse model study identifies the MKS1 gene underlying MKS type 1."", ""reference"": ""PMID:19776033"", ""snippet"": ""The gene mutated in type 1 MKS encodes a protein associated with the base of the cilium in vertebrates and nematodes."", ""supports"": ""SUPPORT""}"
4971	4875	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	1	evidence	0	PMID:19211713	SUPPORT	HUMAN_CLINICAL	In humans, the underlying mutated gene, TMEM67, encodes transmembrane protein 67, also called meckelin (OMIM 609884), which is an integral protein of the renal epithelial cell and membrane of the primary cilium.	This study identifies TMEM67 as the causal gene for MKS3.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study identifies TMEM67 as the causal gene for MKS3."", ""reference"": ""PMID:19211713"", ""snippet"": ""In humans, the underlying mutated gene, TMEM67, encodes transmembrane protein 67, also called meckelin (OMIM 609884), which is an integral protein of the renal epithelial cell and membrane of the primary cilium."", ""supports"": ""SUPPORT""}"
4972	4876	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	2	evidence	0	PMID:18513680	SUPPORT	HUMAN_CLINICAL	we identified the sixth locus and the fifth gene, CC2D2A (MKS6), behind MKS.	This study identifies CC2D2A as a causative MKS gene (MKS6).	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study identifies CC2D2A as a causative MKS gene (MKS6)."", ""reference"": ""PMID:18513680"", ""snippet"": ""we identified the sixth locus and the fifth gene, CC2D2A (MKS6), behind MKS."", ""supports"": ""SUPPORT""}"
4973	4876	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	2	evidence	1	PMID:28374938	SUPPORT	HUMAN_CLINICAL	A medical exome analysis detected a heterozygous frameshift mutation, c.4582_4583delCG p.(Arg1528Serfs*17) in CC2D2A in the maternally derived allele.	This case report identifies pathogenic CC2D2A variants in MKS, including a frameshift allele.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report identifies pathogenic CC2D2A variants in MKS, including a frameshift allele."", ""reference"": ""PMID:28374938"", ""snippet"": ""A medical exome analysis detected a heterozygous frameshift mutation, c.4582_4583delCG p.(Arg1528Serfs*17) in CC2D2A in the maternally derived allele."", ""supports"": ""SUPPORT""}"
4974	4876	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	2	evidence	2	PMID:34981460	SUPPORT	HUMAN_CLINICAL	Whole exome sequencing identified a compound heterozygous of two novel variants of CEP290 and a heterozygous of a novel variant of CC2D2A.	Case series reports a novel CC2D2A variant in MKS fetuses.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case series reports a novel CC2D2A variant in MKS fetuses."", ""reference"": ""PMID:34981460"", ""snippet"": ""Whole exome sequencing identified a compound heterozygous of two novel variants of CEP290 and a heterozygous of a novel variant of CC2D2A."", ""supports"": ""SUPPORT""}"
4975	4877	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	3	evidence	0	PMID:20512146	SUPPORT	HUMAN_CLINICAL	Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes.	This study reports TMEM216 mutations causing Meckel syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study reports TMEM216 mutations causing Meckel syndrome."", ""reference"": ""PMID:20512146"", ""snippet"": ""Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes."", ""supports"": ""SUPPORT""}"
4976	4878	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	4	evidence	0	PMID:23349226	SUPPORT	HUMAN_CLINICAL	Mutations in TMEM231 cause Meckel-Gruber syndrome.	This report identifies TMEM231 as a Meckel-Gruber syndrome locus.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This report identifies TMEM231 as a Meckel-Gruber syndrome locus."", ""reference"": ""PMID:23349226"", ""snippet"": ""Mutations in TMEM231 cause Meckel-Gruber syndrome."", ""supports"": ""SUPPORT""}"
4977	4879	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	5	evidence	0	PMID:21763481	SUPPORT	HUMAN_CLINICAL	We identified a homozygous c.301A>C (p.Ser101Arg) B9D2 mutation that segregates with MKS	This study reports a pathogenic B9D2 mutation segregating with MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study reports a pathogenic B9D2 mutation segregating with MKS."", ""reference"": ""PMID:21763481"", ""snippet"": ""We identified a homozygous c.301A>C (p.Ser101Arg) B9D2 mutation that segregates with MKS"", ""supports"": ""SUPPORT""}"
4978	4880	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	6	evidence	0	PMID:21763481	SUPPORT	MODEL_ORGANISM	Mice lacking B9d1 displayed polydactyly, kidney cysts, ductal plate malformations, and abnormal patterning of the neural tube, concomitant with compromised ciliogenesis, ciliary protein localization, and Hedgehog (Hh) signal transduction.	Loss of B9d1 causes MKS-like phenotypes with ciliary dysfunction in model organisms.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Loss of B9d1 causes MKS-like phenotypes with ciliary dysfunction in model organisms."", ""reference"": ""PMID:21763481"", ""snippet"": ""Mice lacking B9d1 displayed polydactyly, kidney cysts, ductal plate malformations, and abnormal patterning of the neural tube, concomitant with compromised ciliogenesis, ciliary protein localization, and Hedgehog (Hh) signal transduction."", ""supports"": ""SUPPORT""}"
4979	4880	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	6	evidence	1	PMID:40933483	SUPPORT	HUMAN_CLINICAL	Compound heterozygous missense and intronic variants in B9D1 contribute to a recurrent Meckel syndrome pedigree.	This case report identifies pathogenic B9D1 variants in a recurrent MKS pedigree.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report identifies pathogenic B9D1 variants in a recurrent MKS pedigree."", ""reference"": ""PMID:40933483"", ""snippet"": ""Compound heterozygous missense and intronic variants in B9D1 contribute to a recurrent Meckel syndrome pedigree."", ""supports"": ""SUPPORT""}"
4980	4881	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	7	evidence	0	PMID:17705300	SUPPORT	HUMAN_CLINICAL	Mutations of the CEP290 gene encoding a centrosomal protein cause Meckel-Gruber syndrome.	This study identifies CEP290 loss-of-function mutations as a cause of Meckel-Gruber syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study identifies CEP290 loss-of-function mutations as a cause of Meckel-Gruber syndrome."", ""reference"": ""PMID:17705300"", ""snippet"": ""Mutations of the CEP290 gene encoding a centrosomal protein cause Meckel-Gruber syndrome."", ""supports"": ""SUPPORT""}"
4981	4881	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	7	evidence	1	PMID:35352487	SUPPORT	HUMAN_CLINICAL	compound heterozygous mutations of CEP290 c.3175dup and CEP290 c.1201dup were detected through WES.	Prenatal case report identifies compound heterozygous CEP290 variants in suspected MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Prenatal case report identifies compound heterozygous CEP290 variants in suspected MKS."", ""reference"": ""PMID:35352487"", ""snippet"": ""compound heterozygous mutations of CEP290 c.3175dup and CEP290 c.1201dup were detected through WES."", ""supports"": ""SUPPORT""}"
4982	4881	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	7	evidence	2	PMID:34981460	SUPPORT	HUMAN_CLINICAL	Whole exome sequencing identified a compound heterozygous of two novel variants of CEP290 and a heterozygous of a novel variant of CC2D2A.	Case series reports novel CEP290 variants in MKS fetuses.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case series reports novel CEP290 variants in MKS fetuses."", ""reference"": ""PMID:34981460"", ""snippet"": ""Whole exome sequencing identified a compound heterozygous of two novel variants of CEP290 and a heterozygous of a novel variant of CC2D2A."", ""supports"": ""SUPPORT""}"
4983	4882	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	8	evidence	0	PMID:17558409	SUPPORT	HUMAN_CLINICAL	we identified missense and truncating mutations in RPGRIP1L (KIAA1005) in both CORS and MKS	This study reports RPGRIP1L mutations in Meckel syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study reports RPGRIP1L mutations in Meckel syndrome."", ""reference"": ""PMID:17558409"", ""snippet"": ""we identified missense and truncating mutations in RPGRIP1L (KIAA1005) in both CORS and MKS"", ""supports"": ""SUPPORT""}"
4984	4883	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	9	evidence	0	PMID:18371931	SUPPORT	HUMAN_CLINICAL	Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia.	This study links NPHP3 loss of function to a Meckel-Gruber-like syndrome in humans.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study links NPHP3 loss of function to a Meckel-Gruber-like syndrome in humans."", ""reference"": ""PMID:18371931"", ""snippet"": ""Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia."", ""supports"": ""SUPPORT""}"
4985	4884	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	10	evidence	0	PMID:21462283	SUPPORT	HUMAN_CLINICAL	A TCTN2 mutation defines a novel Meckel Gruber syndrome locus.	This report identifies TCTN2 (MKS8) as a Meckel syndrome locus.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This report identifies TCTN2 (MKS8) as a Meckel syndrome locus."", ""reference"": ""PMID:21462283"", ""snippet"": ""A TCTN2 mutation defines a novel Meckel Gruber syndrome locus."", ""supports"": ""SUPPORT""}"
4986	4885	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	11	evidence	0	PMID:26729329	SUPPORT	HUMAN_CLINICAL	These analyses identified a putative intragenic AHI1 deletion that included three exons spanning at least 3.4 kb and an intergenic MPP4 to TMEM237 deletion that included exons spanning at least 21.5 kb.	CNV analysis in a MKS/JBTS referral cohort identified a TMEM237 deletion consistent with MKS involvement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""CNV analysis in a MKS/JBTS referral cohort identified a TMEM237 deletion consistent with MKS involvement."", ""reference"": ""PMID:26729329"", ""snippet"": ""These analyses identified a putative intragenic AHI1 deletion that included three exons spanning at least 3.4 kb and an intergenic MPP4 to TMEM237 deletion that included exons spanning at least 21.5 kb."", ""supports"": ""SUPPORT""}"
4987	4886	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	12	evidence	0	PMID:26123494	SUPPORT	HUMAN_CLINICAL	This study shows that known MKS loci account for the overwhelming majority of MKS cases but additional loci exist including MKS13 caused by TMEM107 mutation.	This study defines TMEM107 mutations as a Meckel syndrome locus (MKS13).	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study defines TMEM107 mutations as a Meckel syndrome locus (MKS13)."", ""reference"": ""PMID:26123494"", ""snippet"": ""This study shows that known MKS loci account for the overwhelming majority of MKS cases but additional loci exist including MKS13 caused by TMEM107 mutation."", ""supports"": ""SUPPORT""}"
4988	4887	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	13	evidence	0	PMID:31411728	SUPPORT	HUMAN_CLINICAL	We describe the second family with MKS due to a homozygous variant in B9D2 and fifth family with bi-allelic variant in TXNDC15.	This study validates MKS causation by biallelic TXNDC15 variants.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study validates MKS causation by biallelic TXNDC15 variants."", ""reference"": ""PMID:31411728"", ""snippet"": ""We describe the second family with MKS due to a homozygous variant in B9D2 and fifth family with bi-allelic variant in TXNDC15."", ""supports"": ""SUPPORT""}"
4989	4887	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	13	evidence	1	PMID:38156946	SUPPORT	HUMAN_CLINICAL	We report the case of a homozygous mutation in the TXNDC15 gene, causing MKS14 in the Chinese population.	Case report identifies a homozygous TXNDC15 mutation causing MKS14.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report identifies a homozygous TXNDC15 mutation causing MKS14."", ""reference"": ""PMID:38156946"", ""snippet"": ""We report the case of a homozygous mutation in the TXNDC15 gene, causing MKS14 in the Chinese population."", ""supports"": ""SUPPORT""}"
4990	4887	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	13	evidence	2	PMID:39304719	SUPPORT	HUMAN_CLINICAL	Biallelic TXNDC15 variants have been reported in six individuals of Meckel syndrome (MKS) with perinatal lethal phenotypes	This report summarizes prior MKS cases with biallelic TXNDC15 variants, supporting causation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This report summarizes prior MKS cases with biallelic TXNDC15 variants, supporting causation."", ""reference"": ""PMID:39304719"", ""snippet"": ""Biallelic TXNDC15 variants have been reported in six individuals of Meckel syndrome (MKS) with perinatal lethal phenotypes"", ""supports"": ""SUPPORT""}"
4991	4887	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	13	evidence	3	PMID:41518077	SUPPORT	MODEL_ORGANISM	Homozygous Txndc15mt/mt embryos displayed the complete MKS phenotype-fetal lethality, exencephaly, omphalocele, post-axial polydactyly, and polycystic kidneys-together with markedly reduced TXNDC15 protein in brain, liver, and kidney.	Mouse model confirms TXNDC15 loss produces an MKS phenotype.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Mouse model confirms TXNDC15 loss produces an MKS phenotype."", ""reference"": ""PMID:41518077"", ""snippet"": ""Homozygous Txndc15mt/mt embryos displayed the complete MKS phenotype-fetal lethality, exencephaly, omphalocele, post-axial polydactyly, and polycystic kidneys-together with markedly reduced TXNDC15 protein in brain, liver, and kidney."", ""supports"": ""SUPPORT""}"
4992	4888	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	14	evidence	0	PMID:40841990	SUPPORT	HUMAN_CLINICAL	we report two unrelated fetuses with occipital encephalocele, polydactyly, and kidney cysts, in whom exome sequencing identified a founder homozygous missense variant (Arg94Trp) in TMEM17	Case report expands TMEM17-associated phenotypes to include MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report expands TMEM17-associated phenotypes to include MKS."", ""reference"": ""PMID:40841990"", ""snippet"": ""we report two unrelated fetuses with occipital encephalocele, polydactyly, and kidney cysts, in whom exome sequencing identified a founder homozygous missense variant (Arg94Trp) in TMEM17"", ""supports"": ""SUPPORT""}"
4993	4889	206	Meckel Syndrome	Meckel_Syndrome.yaml	genetic	15	evidence	0	PMID:21552264	SUPPORT	HUMAN_CLINICAL	KIF7 is also a likely contributor of alleles across the ciliopathy spectrum, as sequencing of a diverse cohort identified several missense mutations detrimental to protein function.	This study suggests KIF7 variants can contribute to ciliopathy phenotypes, supporting a modifier role within the MKS/JBTS spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study suggests KIF7 variants can contribute to ciliopathy phenotypes, supporting a modifier role within the MKS/JBTS spectrum."", ""reference"": ""PMID:21552264"", ""snippet"": ""KIF7 is also a likely contributor of alleles across the ciliopathy spectrum, as sequencing of a diverse cohort identified several missense mutations detrimental to protein function."", ""supports"": ""SUPPORT""}"
5051	4986	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	genetic	0	evidence	0	PMID:16750612	SUPPORT		The most exciting finding is the discovery of oncogenic BRAF mutations in both malignant melanoma and melanocytic nevi.	The excerpt indicates that BRAF mutations are found in both malignant melanoma and melanocytic nevi, supporting the statement.	"{""explanation"": ""The excerpt indicates that BRAF mutations are found in both malignant melanoma and melanocytic nevi, supporting the statement."", ""reference"": ""PMID:16750612"", ""snippet"": ""The most exciting finding is the discovery of oncogenic BRAF mutations in both malignant melanoma and melanocytic nevi."", ""supports"": ""SUPPORT""}"
5052	4986	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	genetic	0	evidence	1	PMID:37156689	SUPPORT		A lot of congenital melanocytic nevi (CMN) carry the somatic mutation in the oncogene BRAF V600E.	The excerpt clearly states the presence of BRAF mutations in congenital melanocytic nevi.	"{""explanation"": ""The excerpt clearly states the presence of BRAF mutations in congenital melanocytic nevi."", ""reference"": ""PMID:37156689"", ""snippet"": ""A lot of congenital melanocytic nevi (CMN) carry the somatic mutation in the oncogene BRAF V600E."", ""supports"": ""SUPPORT""}"
5053	4986	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	genetic	0	evidence	2	PMID:31111470	SUPPORT		BRAF is confirmed as a much rarer cause of multiple CMN.	Although BRAF is a less common mutation in CMN, its presence still supports the statement.	"{""explanation"": ""Although BRAF is a less common mutation in CMN, its presence still supports the statement."", ""reference"": ""PMID:31111470"", ""snippet"": ""BRAF is confirmed as a much rarer cause of multiple CMN."", ""supports"": ""SUPPORT""}"
5054	4986	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	genetic	0	evidence	3	PMID:36085074	SUPPORT		Mutations in NRAS have been previously detected in GCMN, but mutations in BRAF are generally lacking in the Chinese population.	The excerpt suggests the presence of BRAF mutations in GCMN, though less frequent in the Chinese population.	"{""explanation"": ""The excerpt suggests the presence of BRAF mutations in GCMN, though less frequent in the Chinese population."", ""reference"": ""PMID:36085074"", ""snippet"": ""Mutations in NRAS have been previously detected in GCMN, but mutations in BRAF are generally lacking in the Chinese population."", ""supports"": ""SUPPORT""}"
5055	4987	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	genetic	1	evidence	0	PMID:33851646	SUPPORT		NRAS mutant melanoma arising in a giant congenital melanocytic nevus in an infant.	This reference directly describes a case of NRAS mutant melanoma arising in the context of giant congenital melanocytic nevus.	"{""explanation"": ""This reference directly describes a case of NRAS mutant melanoma arising in the context of giant congenital melanocytic nevus."", ""reference"": ""PMID:33851646"", ""snippet"": ""NRAS mutant melanoma arising in a giant congenital melanocytic nevus in an infant."", ""supports"": ""SUPPORT""}"
5056	4987	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	genetic	1	evidence	1	PMID:31111470	SUPPORT		Multiple congenital melanocytic naevi (CMN) have been shown to be caused by NRAS mosaic mutations in 70-80% of cases.	This reference provides statistical data supporting the association between NRAS mutations and congenital melanocytic nevi.	"{""explanation"": ""This reference provides statistical data supporting the association between NRAS mutations and congenital melanocytic nevi."", ""reference"": ""PMID:31111470"", ""snippet"": ""Multiple congenital melanocytic naevi (CMN) have been shown to be caused by NRAS mosaic mutations in 70-80% of cases."", ""supports"": ""SUPPORT""}"
5128	5025	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	genetic	0	evidence	0	PMID:32782477	SUPPORT		Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments.	Demonstrates TNF-α involvement in MRS through effective therapeutic targeting with anti-TNF agents	"{""explanation"": ""Demonstrates TNF-α involvement in MRS through effective therapeutic targeting with anti-TNF agents"", ""reference"": ""PMID:32782477"", ""snippet"": ""Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments."", ""supports"": ""SUPPORT""}"
5129	5026	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	genetic	1	evidence	0	PMID:31466978	PARTIAL		interferon gamma could play a key role. To our knowledge, this is the first case report in which Melkersson-Rosenthal syndrome has been observed concurrently with coeliac disease.	Implicates IFN-γ as a central mediator linking MRS to autoimmune and allergic pathways	"{""explanation"": ""Implicates IFN-γ as a central mediator linking MRS to autoimmune and allergic pathways"", ""reference"": ""PMID:31466978"", ""snippet"": ""interferon gamma could play a key role. To our knowledge, this is the first case report in which Melkersson-Rosenthal syndrome has been observed concurrently with coeliac disease."", ""supports"": ""PARTIAL""}"
5130	5027	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	genetic	2	evidence	0	PMID:32782477	SUPPORT		IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines.	Establishes IL-12/23 signaling as a central pathway driving IFN-γ production and orofacial granulomatous inflammation	"{""explanation"": ""Establishes IL-12/23 signaling as a central pathway driving IFN-γ production and orofacial granulomatous inflammation"", ""reference"": ""PMID:32782477"", ""snippet"": ""IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."", ""supports"": ""SUPPORT""}"
5131	5028	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	genetic	3	evidence	0	PMID:37510386	PARTIAL		MRS is a disorder with variable expressivity and clinical as well as genetic heterogeneity; however, the causative gene remains to be identified... We identified a c.3521C>G missense heterozygous variant in SCN1A carried only by the affected sister.	Documents rare SCN1A variant association in an MRS patient with facial palsy and migraine, suggesting genetic heterogeneity in MRS pathogenesis	"{""explanation"": ""Documents rare SCN1A variant association in an MRS patient with facial palsy and migraine, suggesting genetic heterogeneity in MRS pathogenesis"", ""reference"": ""PMID:37510386"", ""snippet"": ""MRS is a disorder with variable expressivity and clinical as well as genetic heterogeneity; however, the causative gene remains to be identified... We identified a c.3521C>G missense heterozygous variant in SCN1A carried only by the affected sister."", ""supports"": ""PARTIAL""}"
5182	5087	214	Migraine	Migraine.yaml	genetic	0	evidence	0	PMID:38508838	SUPPORT		Some distinct, rare, familial migraine subtypes are caused by pathogenic variants in genes involved in ion transport and neurotransmitter release, suggesting an underlying vulnerability of the excitatory-inhibitory balance in the brain	CACNA1A encodes a voltage-gated calcium channel involved in ion transport and neurotransmitter release, and is one of the established causative genes for familial hemiplegic migraine.	"{""explanation"": ""CACNA1A encodes a voltage-gated calcium channel involved in ion transport and neurotransmitter release, and is one of the established causative genes for familial hemiplegic migraine."", ""reference"": ""PMID:38508838"", ""snippet"": ""Some distinct, rare, familial migraine subtypes are caused by pathogenic variants in genes involved in ion transport and neurotransmitter release, suggesting an underlying vulnerability of the excitatory-inhibitory balance in the brain"", ""supports"": ""SUPPORT""}"
5183	5088	214	Migraine	Migraine.yaml	genetic	1	evidence	0	PMID:38508838	SUPPORT		Some distinct, rare, familial migraine subtypes are caused by pathogenic variants in genes involved in ion transport and neurotransmitter release, suggesting an underlying vulnerability of the excitatory-inhibitory balance in the brain	ATP1A2 encodes a Na+/K+-ATPase involved in ion transport, and is one of the established causative genes for familial hemiplegic migraine type 2.	"{""explanation"": ""ATP1A2 encodes a Na+/K+-ATPase involved in ion transport, and is one of the established causative genes for familial hemiplegic migraine type 2."", ""reference"": ""PMID:38508838"", ""snippet"": ""Some distinct, rare, familial migraine subtypes are caused by pathogenic variants in genes involved in ion transport and neurotransmitter release, suggesting an underlying vulnerability of the excitatory-inhibitory balance in the brain"", ""supports"": ""SUPPORT""}"
5184	5089	214	Migraine	Migraine.yaml	genetic	2	evidence	0	PMID:38508838	SUPPORT		Some distinct, rare, familial migraine subtypes are caused by pathogenic variants in genes involved in ion transport and neurotransmitter release, suggesting an underlying vulnerability of the excitatory-inhibitory balance in the brain	SCN1A encodes a voltage-gated sodium channel involved in ion transport, and is one of the established causative genes for familial hemiplegic migraine type 3.	"{""explanation"": ""SCN1A encodes a voltage-gated sodium channel involved in ion transport, and is one of the established causative genes for familial hemiplegic migraine type 3."", ""reference"": ""PMID:38508838"", ""snippet"": ""Some distinct, rare, familial migraine subtypes are caused by pathogenic variants in genes involved in ion transport and neurotransmitter release, suggesting an underlying vulnerability of the excitatory-inhibitory balance in the brain"", ""supports"": ""SUPPORT""}"
5185	5090	214	Migraine	Migraine.yaml	genetic	3	evidence	0	PMID:31873179	SUPPORT		TRPM8 is highly expressed in migraine and pain neuronal circuitry, such as trigeminal and dorsal root ganglia	TRPM8 is expressed in pain-related neural circuitry and genetic variants near TRPM8 are associated with altered migraine risk.	"{""explanation"": ""TRPM8 is expressed in pain-related neural circuitry and genetic variants near TRPM8 are associated with altered migraine risk."", ""reference"": ""PMID:31873179"", ""snippet"": ""TRPM8 is highly expressed in migraine and pain neuronal circuitry, such as trigeminal and dorsal root ganglia"", ""supports"": ""SUPPORT""}"
5186	5091	214	Migraine	Migraine.yaml	genetic	4	evidence	0	PMID:21666692	SUPPORT		rs2651899 (1p36.32, PRDM16), rs10166942 (2q37.1, TRPM8) and rs11172113 (12q13.3, LRP1) were among the top seven associations (P < 5 × 10(-6)) with migraine.	GWAS of 5,122 migraineurs identified LRP1 SNP rs11172113 as genome-wide significant for migraine susceptibility.	"{""explanation"": ""GWAS of 5,122 migraineurs identified LRP1 SNP rs11172113 as genome-wide significant for migraine susceptibility."", ""reference"": ""PMID:21666692"", ""snippet"": ""rs2651899 (1p36.32, PRDM16), rs10166942 (2q37.1, TRPM8) and rs11172113 (12q13.3, LRP1) were among the top seven associations (P < 5 × 10(-6)) with migraine."", ""supports"": ""SUPPORT""}"
5187	5091	214	Migraine	Migraine.yaml	genetic	4	evidence	1	PMID:21666692	SUPPORT		LRP1 modulates neuronal glutamate signaling, plausibly linking both genes to migraine pathophysiology.	LRP1's role in neuronal glutamate signaling provides mechanistic link to migraine.	"{""explanation"": ""LRP1's role in neuronal glutamate signaling provides mechanistic link to migraine."", ""reference"": ""PMID:21666692"", ""snippet"": ""LRP1 modulates neuronal glutamate signaling, plausibly linking both genes to migraine pathophysiology."", ""supports"": ""SUPPORT""}"
5245	5135	216	Monkeypox	Monkeypox.yaml	genetic	0	evidence	0	PMID:12083817	SUPPORT		Monkeypox virus (MPV) belongs to the orthopoxvirus genus of the family Poxviridae... The 196,858-bp MPV genome was analyzed with regard to structural features.	The reference confirms that the monkeypox virus belongs to the Orthopoxvirus genus and details the structural features of its DNA genome.	"{""explanation"": ""The reference confirms that the monkeypox virus belongs to the Orthopoxvirus genus and details the structural features of its DNA genome."", ""reference"": ""PMID:12083817"", ""snippet"": ""Monkeypox virus (MPV) belongs to the orthopoxvirus genus of the family Poxviridae... The 196,858-bp MPV genome was analyzed with regard to structural features."", ""supports"": ""SUPPORT""}"
5246	5135	216	Monkeypox	Monkeypox.yaml	genetic	0	evidence	1	PMID:38801573	SUPPORT		The monkeypox virus is a part of the Poxviridae family, Orthopoxvirus genus, and is accountable for smallpox.	This reference reaffirms that the monkeypox virus belongs to the Orthopoxvirus genus and has a DNA-based genome.	"{""explanation"": ""This reference reaffirms that the monkeypox virus belongs to the Orthopoxvirus genus and has a DNA-based genome."", ""reference"": ""PMID:38801573"", ""snippet"": ""The monkeypox virus is a part of the Poxviridae family, Orthopoxvirus genus, and is accountable for smallpox."", ""supports"": ""SUPPORT""}"
5247	5135	216	Monkeypox	Monkeypox.yaml	genetic	0	evidence	2	PMID:37611023	SUPPORT		Monkeypox is a double-stranded DNA virus with an envelope and is a member of the Poxviridae family's Orthopoxvirus genus.	This reference confirms the genetic features and classification of the monkeypox virus as specified in the statement.	"{""explanation"": ""This reference confirms the genetic features and classification of the monkeypox virus as specified in the statement."", ""reference"": ""PMID:37611023"", ""snippet"": ""Monkeypox is a double-stranded DNA virus with an envelope and is a member of the Poxviridae family's Orthopoxvirus genus."", ""supports"": ""SUPPORT""}"
5309	5181	217	Muenke Syndrome	Muenke_Syndrome.yaml	genetic	0	evidence	0	PMID:9042914	SUPPORT	HUMAN_CLINICAL	Here we present 61 individuals from 20 unrelated families where coronal synostosis is due to an amino acid substitution (Pro250Arg) that results from a single point mutation in the fibroblast growth factor receptor 3 gene on chromosome 4p.	This is the original paper defining Muenke syndrome, demonstrating that the P250R mutation in FGFR3 is the causative mutation in all cases of this craniosynostosis syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This is the original paper defining Muenke syndrome, demonstrating that the P250R mutation in FGFR3 is the causative mutation in all cases of this craniosynostosis syndrome."", ""reference"": ""PMID:9042914"", ""snippet"": ""Here we present 61 individuals from 20 unrelated families where coronal synostosis is due to an amino acid substitution (Pro250Arg) that results from a single point mutation in the fibroblast growth factor receptor 3 gene on chromosome 4p."", ""supports"": ""SUPPORT""}"
5321	5195	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	genetic	0	evidence	0	PMID:11786689	SUPPORT		The gene causing all three MEN2 variants is located on chromosome 10cen-10q11.2, and is the c-ret proto-oncogene which encodes a tyrosine kinase receptor with cadherin-like and cysteine-rich extracellular domains, and a tyrosine kinase intracellular domain. Specific mutations of c-ret have been identified for each of the three MEN2 variants.	Review confirms RET proto-oncogene as the gene responsible for all MEN2 variants with specific mutations identified for each clinical variant.	"{""explanation"": ""Review confirms RET proto-oncogene as the gene responsible for all MEN2 variants with specific mutations identified for each clinical variant."", ""reference"": ""PMID:11786689"", ""snippet"": ""The gene causing all three MEN2 variants is located on chromosome 10cen-10q11.2, and is the c-ret proto-oncogene which encodes a tyrosine kinase receptor with cadherin-like and cysteine-rich extracellular domains, and a tyrosine kinase intracellular domain. Specific mutations of c-ret have been identified for each of the three MEN2 variants."", ""supports"": ""SUPPORT""}"
5350	5219	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	genetic	0	evidence	0	PMID:28676141	SUPPORT		HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family.	The study confirms the association of the HLA-DRB1*15:01 allele with multiple sclerosis in a multigenerational family.	"{""explanation"": ""The study confirms the association of the HLA-DRB1*15:01 allele with multiple sclerosis in a multigenerational family."", ""reference"": ""PMID:28676141"", ""snippet"": ""HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family."", ""supports"": ""SUPPORT""}"
5351	5219	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	genetic	0	evidence	1	PMID:27802296	SUPPORT		Multiple sclerosis (MS) develops as a result of environmental influences on the genetically susceptible... Odds ratios for MS associated with each risk factor were derived from existing literature, and the log values of the odds ratios from each of the risk factors were combined in an additive model to provide an overall score.	The study uses HLA-DRB1*1501 as a genetic risk factor in developing a risk score for MS, supporting the association of HLA-DRB1 with MS.	"{""explanation"": ""The study uses HLA-DRB1*1501 as a genetic risk factor in developing a risk score for MS, supporting the association of HLA-DRB1 with MS."", ""reference"": ""PMID:27802296"", ""snippet"": ""Multiple sclerosis (MS) develops as a result of environmental influences on the genetically susceptible... Odds ratios for MS associated with each risk factor were derived from existing literature, and the log values of the odds ratios from each of the risk factors were combined in an additive model to provide an overall score."", ""supports"": ""SUPPORT""}"
5352	5219	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	genetic	0	evidence	2	PMID:21310812	SUPPORT		A haplotype within the major histocompatibility region is the major risk factor for MS...	The article mentions the major histocompatibility region as a significant risk factor for MS, which includes the HLA-DRB1 allele.	"{""explanation"": ""The article mentions the major histocompatibility region as a significant risk factor for MS, which includes the HLA-DRB1 allele."", ""reference"": ""PMID:21310812"", ""snippet"": ""A haplotype within the major histocompatibility region is the major risk factor for MS..."", ""supports"": ""SUPPORT""}"
5353	5219	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	genetic	0	evidence	3	PMID:25502788	SUPPORT		One of the most consistent findings in multiple sclerosis (MS) is that development of MS is linked with carriage of the class II human leucocyte antigen (HLA) molecule HLA-DRB1*15:01; around 60 % of Caucasian MS patients carry this allele compared to 25-30 % of ethnically matched healthy individuals.	The chapter reviews the strong association between HLA-DRB1*15:01 and MS, supporting the statement.	"{""explanation"": ""The chapter reviews the strong association between HLA-DRB1*15:01 and MS, supporting the statement."", ""reference"": ""PMID:25502788"", ""snippet"": ""One of the most consistent findings in multiple sclerosis (MS) is that development of MS is linked with carriage of the class II human leucocyte antigen (HLA) molecule HLA-DRB1*15:01; around 60 % of Caucasian MS patients carry this allele compared to 25-30 % of ethnically matched healthy individuals."", ""supports"": ""SUPPORT""}"
5354	5220	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	genetic	1	evidence	0	PMID:17660530	SUPPORT		Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis	The first large-scale GWAS of multiple sclerosis identified IL7RA as a genome-wide significant susceptibility locus (P=2.94x10-7), establishing it as a heritable genetic risk factor for MS.	"{""explanation"": ""The first large-scale GWAS of multiple sclerosis identified IL7RA as a genome-wide significant susceptibility locus (P=2.94x10-7), establishing it as a heritable genetic risk factor for MS."", ""reference"": ""PMID:17660530"", ""snippet"": ""Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis"", ""supports"": ""SUPPORT""}"
5355	5221	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	genetic	2	evidence	0	PMID:17660530	SUPPORT		Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis	The first large-scale GWAS of multiple sclerosis identified IL2RA as a genome-wide significant susceptibility locus (P=2.96x10-8), establishing it as a heritable genetic risk factor for MS.	"{""explanation"": ""The first large-scale GWAS of multiple sclerosis identified IL2RA as a genome-wide significant susceptibility locus (P=2.96x10-8), establishing it as a heritable genetic risk factor for MS."", ""reference"": ""PMID:17660530"", ""snippet"": ""Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis"", ""supports"": ""SUPPORT""}"
5540	5300	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	genetic	0	evidence	0	PMID:32744306	PARTIAL		evidence that it has a heritable component, ME/CFS has not yet benefited from the advances in technology and analytical tools that have improved our understanding of many other complex diseases	Critical review documents evidence for heritable component in ME/CFS.	"{""explanation"": ""Critical review documents evidence for heritable component in ME/CFS."", ""reference"": ""PMID:32744306"", ""snippet"": ""evidence that it has a heritable component, ME/CFS has not yet benefited from the advances in technology and analytical tools that have improved our understanding of many other complex diseases"", ""supports"": ""PARTIAL""}"
5584	5389	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	genetic	0	evidence	0	PMID:33258061	SUPPORT		NTRK gene fusions are sporadic genetic alterations that can occur across tumor entities.	Abstract notes NTRK gene fusions occur across tumor entities, supporting NTRK1 fusion involvement.	"{""explanation"": ""Abstract notes NTRK gene fusions occur across tumor entities, supporting NTRK1 fusion involvement."", ""reference"": ""PMID:33258061"", ""snippet"": ""NTRK gene fusions are sporadic genetic alterations that can occur across tumor entities."", ""supports"": ""SUPPORT""}"
5585	5390	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	genetic	1	evidence	0	PMID:33258061	SUPPORT		NTRK gene fusions are sporadic genetic alterations that can occur across tumor entities.	Abstract notes NTRK gene fusions occur across tumor entities, supporting NTRK2 fusion involvement.	"{""explanation"": ""Abstract notes NTRK gene fusions occur across tumor entities, supporting NTRK2 fusion involvement."", ""reference"": ""PMID:33258061"", ""snippet"": ""NTRK gene fusions are sporadic genetic alterations that can occur across tumor entities."", ""supports"": ""SUPPORT""}"
5586	5391	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	genetic	2	evidence	0	PMID:33258061	SUPPORT		NTRK gene fusions are sporadic genetic alterations that can occur across tumor entities.	Abstract notes NTRK gene fusions occur across tumor entities, supporting NTRK3 fusion involvement.	"{""explanation"": ""Abstract notes NTRK gene fusions occur across tumor entities, supporting NTRK3 fusion involvement."", ""reference"": ""PMID:33258061"", ""snippet"": ""NTRK gene fusions are sporadic genetic alterations that can occur across tumor entities."", ""supports"": ""SUPPORT""}"
5591	5408	227	Narcolepsy	Narcolepsy.yaml	genetic	0	evidence	0	PMID:32227223	SUPPORT		Autoreactive T cells and autoantibodies have been detected in blood samples from patients	Detection of autoreactive T cells in narcolepsy patients supports the HLA-mediated autoimmune mechanism.	"{""explanation"": ""Detection of autoreactive T cells in narcolepsy patients supports the HLA-mediated autoimmune mechanism."", ""reference"": ""PMID:32227223"", ""snippet"": ""Autoreactive T cells and autoantibodies have been detected in blood samples from patients"", ""supports"": ""SUPPORT""}"
5592	5409	227	Narcolepsy	Narcolepsy.yaml	genetic	1	evidence	0	PMID:25728441	SUPPORT		Ablation of hypocretin or hypocretin receptors also leads to narcolepsy phenotypes in animal models.	Demonstrates that loss of hypocretin gene function causes narcolepsy.	"{""explanation"": ""Demonstrates that loss of hypocretin gene function causes narcolepsy."", ""reference"": ""PMID:25728441"", ""snippet"": ""Ablation of hypocretin or hypocretin receptors also leads to narcolepsy phenotypes in animal models."", ""supports"": ""SUPPORT""}"
5593	5410	227	Narcolepsy	Narcolepsy.yaml	genetic	2	evidence	0	PMID:25728441	SUPPORT		Ablation of hypocretin or hypocretin receptors also leads to narcolepsy phenotypes in animal models.	Confirms that hypocretin receptor mutations cause narcolepsy in animal models.	"{""explanation"": ""Confirms that hypocretin receptor mutations cause narcolepsy in animal models."", ""reference"": ""PMID:25728441"", ""snippet"": ""Ablation of hypocretin or hypocretin receptors also leads to narcolepsy phenotypes in animal models."", ""supports"": ""SUPPORT""}"
5619	5455	229	Nephronophthisis	Nephronophthisis.yaml	genetic	0	evidence	0	PMID:15138899	SUPPORT		Two siblings affected with a mild form of JS were found to have a homozygous deletion of the NPHP1 gene identical, by mapping, to that in subjects with NPHP alone.	The NPHP1 gene deletion is associated with juvenile nephronophthisis, confirming the genetic link between NPHP1 and nephronophthisis.	"{""explanation"": ""The NPHP1 gene deletion is associated with juvenile nephronophthisis, confirming the genetic link between NPHP1 and nephronophthisis."", ""reference"": ""PMID:15138899"", ""snippet"": ""Two siblings affected with a mild form of JS were found to have a homozygous deletion of the NPHP1 gene identical, by mapping, to that in subjects with NPHP alone."", ""supports"": ""SUPPORT""}"
5620	5455	229	Nephronophthisis	Nephronophthisis.yaml	genetic	0	evidence	1	PMID:36990420	SUPPORT		Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy.	This reference supports the genetic association of nephronophthisis with variants in several genes, highlighting NPHP1 among the genes associated with nephropathy.	"{""explanation"": ""This reference supports the genetic association of nephronophthisis with variants in several genes, highlighting NPHP1 among the genes associated with nephropathy."", ""reference"": ""PMID:36990420"", ""snippet"": ""Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."", ""supports"": ""SUPPORT""}"
5621	5456	229	Nephronophthisis	Nephronophthisis.yaml	genetic	1	evidence	0	PMID:34212438	SUPPORT		we detected a homozygous predicted synonymous allele in NPHP3 in two children with hepatorenal fibrocystic disease from a consanguineous family.		"{""reference"": ""PMID:34212438"", ""snippet"": ""we detected a homozygous predicted synonymous allele in NPHP3 in two children with hepatorenal fibrocystic disease from a consanguineous family."", ""supports"": ""SUPPORT""}"
5622	5456	229	Nephronophthisis	Nephronophthisis.yaml	genetic	1	evidence	1	PMID:26184788	SUPPORT		Eight of 17 (47.1%) patients detected were identified to have mutations in NPHP3.		"{""reference"": ""PMID:26184788"", ""snippet"": ""Eight of 17 (47.1%) patients detected were identified to have mutations in NPHP3."", ""supports"": ""SUPPORT""}"
5623	5456	229	Nephronophthisis	Nephronophthisis.yaml	genetic	1	evidence	2	PMID:36990420	SUPPORT		Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy.		"{""reference"": ""PMID:36990420"", ""snippet"": ""Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."", ""supports"": ""SUPPORT""}"
5624	5457	229	Nephronophthisis	Nephronophthisis.yaml	genetic	2	evidence	0	PMID:14750102	SUPPORT		Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four genes responsible for different types of NPH have been identified: NPHP1, NPHP2, NPHP3, and NPHP4.	The literature identifies NPHP4 as one of the genes responsible for different types of Nephronophthisis.	"{""explanation"": ""The literature identifies NPHP4 as one of the genes responsible for different types of Nephronophthisis."", ""reference"": ""PMID:14750102"", ""snippet"": ""Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four genes responsible for different types of NPH have been identified: NPHP1, NPHP2, NPHP3, and NPHP4."", ""supports"": ""SUPPORT""}"
5625	5457	229	Nephronophthisis	Nephronophthisis.yaml	genetic	2	evidence	1	PMID:34591160	SUPPORT		Nephronophthisis (NPHP) 4 gene encoding nephrocystin-4... contributes to end-stage renal disease in children and young adults.	The literature indicates that NPHP4 is associated with end-stage renal disease in Nephronophthisis, highlighting its pathogenic role.	"{""explanation"": ""The literature indicates that NPHP4 is associated with end-stage renal disease in Nephronophthisis, highlighting its pathogenic role."", ""reference"": ""PMID:34591160"", ""snippet"": ""Nephronophthisis (NPHP) 4 gene encoding nephrocystin-4... contributes to end-stage renal disease in children and young adults."", ""supports"": ""SUPPORT""}"
5626	5457	229	Nephronophthisis	Nephronophthisis.yaml	genetic	2	evidence	2	PMID:36990420	SUPPORT		Senior-Loken syndrome (SLSN) is an autosomal recessive disorder characterized by retinopathy and nephronophthisis... Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy.	The literature mentions that patients with NPHP4 variants develop nephropathy in the context of Nephronophthisis.	"{""explanation"": ""The literature mentions that patients with NPHP4 variants develop nephropathy in the context of Nephronophthisis."", ""reference"": ""PMID:36990420"", ""snippet"": ""Senior-Loken syndrome (SLSN) is an autosomal recessive disorder characterized by retinopathy and nephronophthisis... Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."", ""supports"": ""SUPPORT""}"
5627	5458	229	Nephronophthisis	Nephronophthisis.yaml	genetic	3	evidence	0	PMID:14750102	SUPPORT		Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four genes responsible for different types of NPH have been identified: NPHP1, NPHP2, NPHP3, and NPHP4.	The literature identifies NPHP2 (INVS) as one of the genes responsible for different types of Nephronophthisis.	"{""explanation"": ""The literature identifies NPHP2 (INVS) as one of the genes responsible for different types of Nephronophthisis."", ""reference"": ""PMID:14750102"", ""snippet"": ""Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four genes responsible for different types of NPH have been identified: NPHP1, NPHP2, NPHP3, and NPHP4."", ""supports"": ""SUPPORT""}"
5628	5458	229	Nephronophthisis	Nephronophthisis.yaml	genetic	3	evidence	1	PMID:36990420	SUPPORT		Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy.	The literature confirms INVS variants are associated with nephropathy in nephronophthisis.	"{""explanation"": ""The literature confirms INVS variants are associated with nephropathy in nephronophthisis."", ""reference"": ""PMID:36990420"", ""snippet"": ""Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."", ""supports"": ""SUPPORT""}"
5629	5459	229	Nephronophthisis	Nephronophthisis.yaml	genetic	4	evidence	0	PMID:36990420	SUPPORT		Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy.	While this reference doesn't specifically mention NEK8, it establishes the context of genetic heterogeneity in nephronophthisis-related ciliopathies.	"{""explanation"": ""While this reference doesn't specifically mention NEK8, it establishes the context of genetic heterogeneity in nephronophthisis-related ciliopathies."", ""reference"": ""PMID:36990420"", ""snippet"": ""Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."", ""supports"": ""SUPPORT""}"
5705	5544	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	genetic	0	evidence	0	PMID:33420337	SUPPORT		Neuromyelitis Optica patients have 2.46 more chances of having the DRB1*03 allelic group than controls. Ethnicity can influence genetic susceptibility. The main HLA association with Neuromyelitis Optica was the DRB1*03:01 allele in Western populations and with the DPB1*05:01 allele in Asia.	Meta-analysis confirms HLA-DRB1*03:01 as the primary genetic risk factor for NMO in Western populations, distinct from MS associations.	"{""explanation"": ""Meta-analysis confirms HLA-DRB1*03:01 as the primary genetic risk factor for NMO in Western populations, distinct from MS associations."", ""reference"": ""PMID:33420337"", ""snippet"": ""Neuromyelitis Optica patients have 2.46 more chances of having the DRB1*03 allelic group than controls. Ethnicity can influence genetic susceptibility. The main HLA association with Neuromyelitis Optica was the DRB1*03:01 allele in Western populations and with the DPB1*05:01 allele in Asia."", ""supports"": ""SUPPORT""}"
5730	5571	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	0	evidence	0	PMID:23647298	SUPPORT		EGFR mutations are a relatively frequent event in non-small-cell lung cancer, generally consisting of exon 19 deletion or exon 21 substitution. In adenocarcinoma, additional rare mutations are detectable in the EGFR gene.	The reference indicates that EGFR mutations, including activating mutations, are a frequent event, which matches the statement that such mutations occur occasionally.	"{""explanation"": ""The reference indicates that EGFR mutations, including activating mutations, are a frequent event, which matches the statement that such mutations occur occasionally."", ""reference"": ""PMID:23647298"", ""snippet"": ""EGFR mutations are a relatively frequent event in non-small-cell lung cancer, generally consisting of exon 19 deletion or exon 21 substitution. In adenocarcinoma, additional rare mutations are detectable in the EGFR gene."", ""supports"": ""SUPPORT""}"
5731	5571	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	0	evidence	1	PMID:27926500	SUPPORT		The results of this study demonstrate that EGFR-TKI therapy results in survival benefits for EGFR-mutant advanced NSCLC patients, regardless of gender, smoking history, pathologic type, type of EGFR mutations, brain metastasis and timing of targeted therapy.	This study further supports the association of EGFR activating mutations in NSCLC and the effectiveness of targeted therapies, implying the commonality and impact of these mutations.	"{""explanation"": ""This study further supports the association of EGFR activating mutations in NSCLC and the effectiveness of targeted therapies, implying the commonality and impact of these mutations."", ""reference"": ""PMID:27926500"", ""snippet"": ""The results of this study demonstrate that EGFR-TKI therapy results in survival benefits for EGFR-mutant advanced NSCLC patients, regardless of gender, smoking history, pathologic type, type of EGFR mutations, brain metastasis and timing of targeted therapy."", ""supports"": ""SUPPORT""}"
5732	5571	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	0	evidence	2	PMID:32107398	SUPPORT		EGFR mutation status might be correlated to CT scans imaging phenotypes.	The research recognizes the frequent mutations in EGFR, validating the association stated in the provided statement.	"{""explanation"": ""The research recognizes the frequent mutations in EGFR, validating the association stated in the provided statement."", ""reference"": ""PMID:32107398"", ""snippet"": ""EGFR mutation status might be correlated to CT scans imaging phenotypes."", ""supports"": ""SUPPORT""}"
5733	5571	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	0	evidence	3	PMID:30520383	SUPPORT		Moreover, 10 to 15% of all NSCLCs harbor EGFR (epidermal growth factor receptor) activating mutations.	The frequency (10-15%) explicitly mentioned aligns well with the occasional occurrence stated in the statement.	"{""explanation"": ""The frequency (10-15%) explicitly mentioned aligns well with the occasional occurrence stated in the statement."", ""reference"": ""PMID:30520383"", ""snippet"": ""Moreover, 10 to 15% of all NSCLCs harbor EGFR (epidermal growth factor receptor) activating mutations."", ""supports"": ""SUPPORT""}"
5734	5571	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	0	evidence	4	PMID:18957054	SUPPORT		Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the response to EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer.	The reference confirms that activating mutations in EGFR are significant and frequent enough to impact treatment and response, supporting the statement's claim.	"{""explanation"": ""The reference confirms that activating mutations in EGFR are significant and frequent enough to impact treatment and response, supporting the statement's claim."", ""reference"": ""PMID:18957054"", ""snippet"": ""Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the response to EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer."", ""supports"": ""SUPPORT""}"
5735	5571	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	0	evidence	5	PMID:32657049	SUPPORT		We describe the clinical features, genetic profile, and their correlation in NSCLC patients... The frequency of mutations in EGFR, MET, and RET were significantly higher in nonsmokers than in smokers.	By describing EGFR mutations as a notable factor linked with clinical and demographic attributes of NSCLC patients, it supports the occasional frequency mentioned in the statement.	"{""explanation"": ""By describing EGFR mutations as a notable factor linked with clinical and demographic attributes of NSCLC patients, it supports the occasional frequency mentioned in the statement."", ""reference"": ""PMID:32657049"", ""snippet"": ""We describe the clinical features, genetic profile, and their correlation in NSCLC patients... The frequency of mutations in EGFR, MET, and RET were significantly higher in nonsmokers than in smokers."", ""supports"": ""SUPPORT""}"
5736	5571	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	0	evidence	6	PMID:23621221	SUPPORT		Mutations affecting the epidermal growth factor receptor (EGFR) are good predictors of clinical efficacy of EGFR tyrosine kinase inhibitors (TKI) in patients with non-small cell lung cancer.	The study acknowledges the association of EGFR mutations with clinical outcomes in NSCLC, supporting the idea of their occasional prevalence.	"{""explanation"": ""The study acknowledges the association of EGFR mutations with clinical outcomes in NSCLC, supporting the idea of their occasional prevalence."", ""reference"": ""PMID:23621221"", ""snippet"": ""Mutations affecting the epidermal growth factor receptor (EGFR) are good predictors of clinical efficacy of EGFR tyrosine kinase inhibitors (TKI) in patients with non-small cell lung cancer."", ""supports"": ""SUPPORT""}"
5737	5572	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	1	evidence	0	PMID:30878128	SUPPORT		The ALK receptor tyrosine kinase (ALK) gene encodes a transmembrane protein rearranged in 2-7% of non-small cell lung cancer (NSCLC) cases.	The literature describes ALK rearrangements occurring in 2-7% of NSCLC cases, supporting the statement that ALK rearrangements are occasional in frequency in NSCLC.	"{""explanation"": ""The literature describes ALK rearrangements occurring in 2-7% of NSCLC cases, supporting the statement that ALK rearrangements are occasional in frequency in NSCLC."", ""reference"": ""PMID:30878128"", ""snippet"": ""The ALK receptor tyrosine kinase (ALK) gene encodes a transmembrane protein rearranged in 2-7% of non-small cell lung cancer (NSCLC) cases."", ""supports"": ""SUPPORT""}"
5738	5572	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	1	evidence	1	PMID:35986977	SUPPORT		the presence of ALK/ROS rearrangements in our study is associated with an approximately threefold to fourfold increase in thrombosis risk in NSCLC patients.	The mention of ALK rearrangements aligns with the statement indicating that they are a recognised genetic association in NSCLC.	"{""explanation"": ""The mention of ALK rearrangements aligns with the statement indicating that they are a recognised genetic association in NSCLC."", ""reference"": ""PMID:35986977"", ""snippet"": ""the presence of ALK/ROS rearrangements in our study is associated with an approximately threefold to fourfold increase in thrombosis risk in NSCLC patients."", ""supports"": ""SUPPORT""}"
5739	5572	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	1	evidence	2	PMID:36806787	SUPPORT		more commonly recognized alterations (such as KRAS, BRAF, MET and ERBB family mutations, or ALK, RET and ROS1 fusions)	The literature identifies ALK rearrangements as part of more commonly recognized alterations/subtypes in NSCLC, supporting their occasional occurrence.	"{""explanation"": ""The literature identifies ALK rearrangements as part of more commonly recognized alterations/subtypes in NSCLC, supporting their occasional occurrence."", ""reference"": ""PMID:36806787"", ""snippet"": ""more commonly recognized alterations (such as KRAS, BRAF, MET and ERBB family mutations, or ALK, RET and ROS1 fusions)"", ""supports"": ""SUPPORT""}"
5740	5573	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	2	evidence	0	PMID:35200557	SUPPORT		ROS-1 rearrangement is found in 0.9-2.6% of non-small-cell lung cancers (NSCLCs), mostly lung adenocarcinomas.	The literature states that ROS-1 rearrangement occurs in a small percentage of NSCLCs, supporting the statement that ROS1 gene rearrangements are occasional in NSCLC.	"{""explanation"": ""The literature states that ROS-1 rearrangement occurs in a small percentage of NSCLCs, supporting the statement that ROS1 gene rearrangements are occasional in NSCLC."", ""reference"": ""PMID:35200557"", ""snippet"": ""ROS-1 rearrangement is found in 0.9-2.6% of non-small-cell lung cancers (NSCLCs), mostly lung adenocarcinomas."", ""supports"": ""SUPPORT""}"
5741	5573	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	2	evidence	1	PMID:35986977	SUPPORT		ROS and ALK rearrangement is highly associated with TE development, with HR of 4.04 ... p = 0.005	The literature mentions ROS1 rearrangements in the context of their association with thromboembolic events, indicating the presence and relevance of these genetic alterations in NSCLC.	"{""explanation"": ""The literature mentions ROS1 rearrangements in the context of their association with thromboembolic events, indicating the presence and relevance of these genetic alterations in NSCLC."", ""reference"": ""PMID:35986977"", ""snippet"": ""ROS and ALK rearrangement is highly associated with TE development, with HR of 4.04 ... p = 0.005"", ""supports"": ""SUPPORT""}"
5742	5573	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	2	evidence	2	PMID:34325210	SUPPORT		We investigated the clinical characteristics and gene mutation rate of non-small cell lung cancer patients with osteoblastic bone metastases at the time of the initial diagnosis. ... two were ROS1 rearrangement-positive.	This reference confirms the presence of ROS1 rearrangements in a subgroup of NSCLC patients, which aligns with the statement regarding the occasional frequency of these rearrangements.	"{""explanation"": ""This reference confirms the presence of ROS1 rearrangements in a subgroup of NSCLC patients, which aligns with the statement regarding the occasional frequency of these rearrangements."", ""reference"": ""PMID:34325210"", ""snippet"": ""We investigated the clinical characteristics and gene mutation rate of non-small cell lung cancer patients with osteoblastic bone metastases at the time of the initial diagnosis. ... two were ROS1 rearrangement-positive."", ""supports"": ""SUPPORT""}"
5743	5573	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	2	evidence	3	PMID:36806787	SUPPORT		Less commonly identified alterations (such as...ROS1 fusions).	The literature identifies ROS1 fusions as less common alterations in NSCLC, which supports the occasional occurrence of these gene rearrangements.	"{""explanation"": ""The literature identifies ROS1 fusions as less common alterations in NSCLC, which supports the occasional occurrence of these gene rearrangements."", ""reference"": ""PMID:36806787"", ""snippet"": ""Less commonly identified alterations (such as...ROS1 fusions)."", ""supports"": ""SUPPORT""}"
5744	5574	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	3	evidence	0	PMID:33618059	SUPPORT		Mutation in the gene that encodes Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most common oncogenic driver in advanced non-small cell lung cancer, occurring in approximately 30% of lung adenocarcinomas.	This reference confirms that KRAS activating mutations are present in non-small cell lung cancer (NSCLC).	"{""explanation"": ""This reference confirms that KRAS activating mutations are present in non-small cell lung cancer (NSCLC)."", ""reference"": ""PMID:33618059"", ""snippet"": ""Mutation in the gene that encodes Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most common oncogenic driver in advanced non-small cell lung cancer, occurring in approximately 30% of lung adenocarcinomas."", ""supports"": ""SUPPORT""}"
5745	5574	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	3	evidence	1	PMID:23723294	SUPPORT		Although EGFR mutations were most frequent in patients with ADC and never/light smokers from Asia, and KRAS mutations were most frequent in patients with ADC and ever/heavy smokers from Western countries, both were detected outside these subgroups.	This reference supports the occurrence of KRAS mutations in NSCLC, indicating they are within a notable frequency and linked to specific subgroups.	"{""explanation"": ""This reference supports the occurrence of KRAS mutations in NSCLC, indicating they are within a notable frequency and linked to specific subgroups."", ""reference"": ""PMID:23723294"", ""snippet"": ""Although EGFR mutations were most frequent in patients with ADC and never/light smokers from Asia, and KRAS mutations were most frequent in patients with ADC and ever/heavy smokers from Western countries, both were detected outside these subgroups."", ""supports"": ""SUPPORT""}"
5746	5574	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	genetic	3	evidence	2	PMID:31862576	SUPPORT		KRAS mutations are one of the most prevalent alterations in non-small cell lung cancer.	"This reference reiterates the frequent nature of KRAS mutations in NSCLC, aligning with the ""occasional"" frequency stated."	"{""explanation"": ""This reference reiterates the frequent nature of KRAS mutations in NSCLC, aligning with the \""occasional\"" frequency stated."", ""reference"": ""PMID:31862576"", ""snippet"": ""KRAS mutations are one of the most prevalent alterations in non-small cell lung cancer."", ""supports"": ""SUPPORT""}"
5835	5604	236	Noonan Syndrome	Noonan_Syndrome.yaml	genetic	0	evidence	0	PMID:11992261	SUPPORT	HUMAN_CLINICAL	Mutations were found in 54 of 119 (45%) unrelated individuals with sporadic or familial NS.	Confirms PTPN11 mutations account for approximately half of Noonan syndrome cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms PTPN11 mutations account for approximately half of Noonan syndrome cases."", ""reference"": ""PMID:11992261"", ""snippet"": ""Mutations were found in 54 of 119 (45%) unrelated individuals with sporadic or familial NS."", ""supports"": ""SUPPORT""}"
5836	5605	236	Noonan Syndrome	Noonan_Syndrome.yaml	genetic	1	evidence	0	PMID:17143285	SUPPORT	HUMAN_CLINICAL	We identified missense mutations in SOS1, which encodes an essential RAS guanine nucleotide-exchange factor (RAS-GEF), in approximately 20% of cases of Noonan syndrome without PTPN11 mutation.	SOS1 mutations are a significant cause of PTPN11-negative Noonan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""SOS1 mutations are a significant cause of PTPN11-negative Noonan syndrome."", ""reference"": ""PMID:17143285"", ""snippet"": ""We identified missense mutations in SOS1, which encodes an essential RAS guanine nucleotide-exchange factor (RAS-GEF), in approximately 20% of cases of Noonan syndrome without PTPN11 mutation."", ""supports"": ""SUPPORT""}"
5837	5606	236	Noonan Syndrome	Noonan_Syndrome.yaml	genetic	2	evidence	0	PMID:17603483	SUPPORT	HUMAN_CLINICAL	18 of 231 individuals with Noonan syndrome without known mutations (corresponding to 3% of all affected individuals)...have missense mutations in RAF1	RAF1 mutations account for approximately 3% of Noonan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RAF1 mutations account for approximately 3% of Noonan syndrome."", ""reference"": ""PMID:17603483"", ""snippet"": ""18 of 231 individuals with Noonan syndrome without known mutations (corresponding to 3% of all affected individuals)...have missense mutations in RAF1"", ""supports"": ""SUPPORT""}"
5838	5607	236	Noonan Syndrome	Noonan_Syndrome.yaml	genetic	3	evidence	0	PMID:23791108	SUPPORT	HUMAN_CLINICAL	we identified a total of nine missense, nonsynonymous mutations in RIT1...in 17 of 180 individuals (9%) with Noonan syndrome	RIT1 mutations account for approximately 9% of cases without mutations in other known genes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RIT1 mutations account for approximately 9% of cases without mutations in other known genes."", ""reference"": ""PMID:23791108"", ""snippet"": ""we identified a total of nine missense, nonsynonymous mutations in RIT1...in 17 of 180 individuals (9%) with Noonan syndrome"", ""supports"": ""SUPPORT""}"
5839	5608	236	Noonan Syndrome	Noonan_Syndrome.yaml	genetic	4	evidence	0	PMID:17143285	SUPPORT	HUMAN_CLINICAL	KRAS mutations account for <5% of cases of Noonan syndrome	KRAS mutations are a rare cause of Noonan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""KRAS mutations are a rare cause of Noonan syndrome."", ""reference"": ""PMID:17143285"", ""snippet"": ""KRAS mutations account for <5% of cases of Noonan syndrome"", ""supports"": ""SUPPORT""}"
5892	5718	240	Osteoarthritis	Osteoarthritis.yaml	genetic	0	evidence	0	PMID:17384641	SUPPORT		A SNP in the 5' UTR of GDF5 (+104T/C; rs143383) showed significant association (P = 1.8 x 10(-13)) with hip osteoarthritis in two independent Japanese populations.	Landmark genetic study establishing GDF5 as a susceptibility gene for osteoarthritis.	"{""explanation"": ""Landmark genetic study establishing GDF5 as a susceptibility gene for osteoarthritis."", ""reference"": ""PMID:17384641"", ""snippet"": ""A SNP in the 5' UTR of GDF5 (+104T/C; rs143383) showed significant association (P = 1.8 x 10(-13)) with hip osteoarthritis in two independent Japanese populations."", ""supports"": ""SUPPORT""}"
5907	5740	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	genetic	0	evidence	0	PMID:1353940	SUPPORT	HUMAN_CLINICAL	In each case there was marked diminution in steady-state mRNA levels from one COL1A1 allele. Loss of an allele through deletion or rearrangement was not the cause of the diminished COL1A1 mRNA levels.	Study of 23 individuals from 21 families showed null allele-associated mRNA reduction, establishing the molecular basis of COL1A1 haploinsufficiency.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study of 23 individuals from 21 families showed null allele-associated mRNA reduction, establishing the molecular basis of COL1A1 haploinsufficiency."", ""reference"": ""PMID:1353940"", ""snippet"": ""In each case there was marked diminution in steady-state mRNA levels from one COL1A1 allele. Loss of an allele through deletion or rearrangement was not the cause of the diminished COL1A1 mRNA levels."", ""supports"": ""SUPPORT""}"
5908	5740	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	genetic	0	evidence	1	PMID:9443882	SUPPORT	HUMAN_CLINICAL	Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I.	Demonstrates that OI type I is specifically associated with COL1A1 mutations, with common null-allele mutation sequences identified.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that OI type I is specifically associated with COL1A1 mutations, with common null-allele mutation sequences identified."", ""reference"": ""PMID:9443882"", ""snippet"": ""Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I."", ""supports"": ""SUPPORT""}"
5913	5752	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	genetic	0	evidence	0	PMID:7643358	SUPPORT	HUMAN_CLINICAL	Perinatal lethal osteogenesis imperfecta is the result of heterozygous mutations of the COL1A1 and COL1A2 genes that encode the alpha 1(I) and alpha 2(I) chains of type I collagen, respectively. Point mutations resulting in the substitution of Gly residues in Gly-X-Y amino acid triplets of the triple helical domain of the alpha 1(I) or alpha 2(I) chains are the most frequent mutations.	Comprehensive review identifying glycine substitutions in Gly-X-Y triplets as the predominant mutation type in perinatal lethal OI.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Comprehensive review identifying glycine substitutions in Gly-X-Y triplets as the predominant mutation type in perinatal lethal OI."", ""reference"": ""PMID:7643358"", ""snippet"": ""Perinatal lethal osteogenesis imperfecta is the result of heterozygous mutations of the COL1A1 and COL1A2 genes that encode the alpha 1(I) and alpha 2(I) chains of type I collagen, respectively. Point mutations resulting in the substitution of Gly residues in Gly-X-Y amino acid triplets of the triple helical domain of the alpha 1(I) or alpha 2(I) chains are the most frequent mutations."", ""supports"": ""SUPPORT""}"
5916	5763	243	Osteogenesis Imperfecta Type III	Osteogenesis_Imperfecta_Type_III.yaml	genetic	0	evidence	0	PMID:7643358	SUPPORT	HUMAN_CLINICAL	The severity of the clinical phenotype appears to be related to the type of mutation, its location in the alpha chain, the surrounding amino acid sequences, and the level of expression of the mutant allele.	Explains genotype-phenotype correlation in OI, with mutation location and type determining severity across the OI spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Explains genotype-phenotype correlation in OI, with mutation location and type determining severity across the OI spectrum."", ""reference"": ""PMID:7643358"", ""snippet"": ""The severity of the clinical phenotype appears to be related to the type of mutation, its location in the alpha chain, the surrounding amino acid sequences, and the level of expression of the mutant allele."", ""supports"": ""SUPPORT""}"
5918	5778	244	Osteogenesis Imperfecta Type IV	Osteogenesis_Imperfecta_Type_IV.yaml	genetic	0	evidence	0	PMID:7643358	SUPPORT	HUMAN_CLINICAL	The severity of the clinical phenotype appears to be related to the type of mutation, its location in the alpha chain, the surrounding amino acid sequences, and the level of expression of the mutant allele.	Establishes that mutation type and location determine phenotypic severity, explaining the variable expressivity in moderate OI type IV.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes that mutation type and location determine phenotypic severity, explaining the variable expressivity in moderate OI type IV."", ""reference"": ""PMID:7643358"", ""snippet"": ""The severity of the clinical phenotype appears to be related to the type of mutation, its location in the alpha chain, the surrounding amino acid sequences, and the level of expression of the mutant allele."", ""supports"": ""SUPPORT""}"
5920	5790	245	Osteogenesis Imperfecta Type V	Osteogenesis_Imperfecta_Type_V.yaml	genetic	0	evidence	0	PMID:22863190	SUPPORT	HUMAN_CLINICAL	Using linkage analysis in a four-generation family and whole-exome sequencing, we identified a heterozygous mutation of c.-14C>T in the 5'-untranslated region of a gene encoding interferon-induced transmembrane protein 5 (IFITM5). It completely cosegregated with the disease in three families and occurred de novo in five simplex individuals.	Landmark paper identifying the single recurrent IFITM5 c.-14C>T mutation as the cause of all OI type V cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark paper identifying the single recurrent IFITM5 c.-14C>T mutation as the cause of all OI type V cases."", ""reference"": ""PMID:22863190"", ""snippet"": ""Using linkage analysis in a four-generation family and whole-exome sequencing, we identified a heterozygous mutation of c.-14C>T in the 5'-untranslated region of a gene encoding interferon-induced transmembrane protein 5 (IFITM5). It completely cosegregated with the disease in three families and occurred de novo in five simplex individuals."", ""supports"": ""SUPPORT""}"
5923	5803	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	genetic	0	evidence	0	PMID:17055431	SUPPORT	HUMAN_CLINICAL	In humans, CRTAP mutations are associated with the clinical spectrum of recessive osteogenesis imperfecta, including the type II and VII forms. Hence, dysregulation of prolyl 3-hydroxylation is a mechanism for connective tissue disease.	Original paper identifying CRTAP mutations as cause of recessive OI types, establishing a new mechanism for OI distinct from collagen structural mutations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Original paper identifying CRTAP mutations as cause of recessive OI types, establishing a new mechanism for OI distinct from collagen structural mutations."", ""reference"": ""PMID:17055431"", ""snippet"": ""In humans, CRTAP mutations are associated with the clinical spectrum of recessive osteogenesis imperfecta, including the type II and VII forms. Hence, dysregulation of prolyl 3-hydroxylation is a mechanism for connective tissue disease."", ""supports"": ""SUPPORT""}"
5960	5880	250	Parkinson's Disease	Parkinsons_Disease.yaml	genetic	0	evidence	0	PMID:9197268	SUPPORT		A mutation was identified in the alpha-synuclein gene, which codes for a presynaptic protein thought to be involved in neuronal plasticity, in the Italian kindred and in three unrelated families of Greek origin with autosomal dominant inheritance for the PD phenotype.	This landmark 1997 Science paper identified the first SNCA mutations in familial PD with autosomal dominant inheritance, establishing SNCA as a causative gene for Parkinson's disease.	"{""explanation"": ""This landmark 1997 Science paper identified the first SNCA mutations in familial PD with autosomal dominant inheritance, establishing SNCA as a causative gene for Parkinson's disease."", ""reference"": ""PMID:9197268"", ""snippet"": ""A mutation was identified in the alpha-synuclein gene, which codes for a presynaptic protein thought to be involved in neuronal plasticity, in the Italian kindred and in three unrelated families of Greek origin with autosomal dominant inheritance for the PD phenotype."", ""supports"": ""SUPPORT""}"
5961	5881	250	Parkinson's Disease	Parkinsons_Disease.yaml	genetic	1	evidence	0	PMID:19945904	SUPPORT		The LRRK2 G2019S mutation is the most frequent known cause of familial and sporadic Parkinson's disease.	This systematic review establishes that LRRK2 G2019S is the most common genetic cause of both familial and sporadic PD, supporting its role as the major genetic risk factor.	"{""explanation"": ""This systematic review establishes that LRRK2 G2019S is the most common genetic cause of both familial and sporadic PD, supporting its role as the major genetic risk factor."", ""reference"": ""PMID:19945904"", ""snippet"": ""The LRRK2 G2019S mutation is the most frequent known cause of familial and sporadic Parkinson's disease."", ""supports"": ""SUPPORT""}"
5962	5882	250	Parkinson's Disease	Parkinsons_Disease.yaml	genetic	2	evidence	0	PMID:30097731	SUPPORT		DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA.	This identifies GBA as a genetic risk locus shared with PD, supporting its role as a PD risk factor.	"{""explanation"": ""This identifies GBA as a genetic risk locus shared with PD, supporting its role as a PD risk factor."", ""reference"": ""PMID:30097731"", ""snippet"": ""DLB shares risk loci with AD, in the APOE E4 allele, and with PD, in variation at GBA and SNCA."", ""supports"": ""SUPPORT""}"
5963	5883	250	Parkinson's Disease	Parkinsons_Disease.yaml	genetic	3	evidence	0	PMID:25611507	SUPPORT		Biochemical and genetic studies reveal that the products of two genes that are mutated in autosomal recessive parkinsonism, PINK1 and Parkin, normally work together in the same pathway to govern mitochondrial quality control, bolstering previous evidence that mitochondrial damage is involved in Parkinson's disease.	This establishes Parkin (PARK2) as a gene mutated in autosomal recessive parkinsonism, supporting its causative role.	"{""explanation"": ""This establishes Parkin (PARK2) as a gene mutated in autosomal recessive parkinsonism, supporting its causative role."", ""reference"": ""PMID:25611507"", ""snippet"": ""Biochemical and genetic studies reveal that the products of two genes that are mutated in autosomal recessive parkinsonism, PINK1 and Parkin, normally work together in the same pathway to govern mitochondrial quality control, bolstering previous evidence that mitochondrial damage is involved in Parkinson's disease."", ""supports"": ""SUPPORT""}"
5964	5884	250	Parkinson's Disease	Parkinsons_Disease.yaml	genetic	4	evidence	0	PMID:25611507	SUPPORT		Biochemical and genetic studies reveal that the products of two genes that are mutated in autosomal recessive parkinsonism, PINK1 and Parkin, normally work together in the same pathway to govern mitochondrial quality control, bolstering previous evidence that mitochondrial damage is involved in Parkinson's disease.	This identifies PINK1 mutations in autosomal recessive parkinsonism, supporting its causative role in PD.	"{""explanation"": ""This identifies PINK1 mutations in autosomal recessive parkinsonism, supporting its causative role in PD."", ""reference"": ""PMID:25611507"", ""snippet"": ""Biochemical and genetic studies reveal that the products of two genes that are mutated in autosomal recessive parkinsonism, PINK1 and Parkin, normally work together in the same pathway to govern mitochondrial quality control, bolstering previous evidence that mitochondrial damage is involved in Parkinson's disease."", ""supports"": ""SUPPORT""}"
6025	5923	251	Pars Planitis	Pars_Planitis.yaml	genetic	0	evidence	0	PMID:27051493	SUPPORT		Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition.	HLA-DR15 has been linked to immunogenetic susceptibility in pars planitis.	"{""explanation"": ""HLA-DR15 has been linked to immunogenetic susceptibility in pars planitis."", ""reference"": ""PMID:27051493"", ""snippet"": ""Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."", ""supports"": ""SUPPORT""}"
6026	5924	251	Pars Planitis	Pars_Planitis.yaml	genetic	1	evidence	0	PMID:27051493	SUPPORT		Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition.	HLA-B51 is reported among haplotypes associated with pars planitis, supporting a genetic component.	"{""explanation"": ""HLA-B51 is reported among haplotypes associated with pars planitis, supporting a genetic component."", ""reference"": ""PMID:27051493"", ""snippet"": ""Associations between pars planitis and HLA-DR2, -DR15, -B51 and -DRB1*0802 haplotypes have been described suggesting an immunogenetic predisposition."", ""supports"": ""SUPPORT""}"
6140	5969	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	genetic	0	evidence	0	PMID:10878487	SUPPORT		The involvement of CD4+ T lymphocytes in PV has been suggested by the strong association with distinct HLA class II alleles.	Strong HLA class II associations support the role of autoreactive CD4+ T cells in recognizing desmoglein epitopes and driving autoantibody production.	"{""explanation"": ""Strong HLA class II associations support the role of autoreactive CD4+ T cells in recognizing desmoglein epitopes and driving autoantibody production."", ""reference"": ""PMID:10878487"", ""snippet"": ""The involvement of CD4+ T lymphocytes in PV has been suggested by the strong association with distinct HLA class II alleles."", ""supports"": ""SUPPORT""}"
6174	6014	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	0	evidence	0	PMID:33955040	SUPPORT		Zellweger syndrome (ZS) is the foremost common and severe phenotype within the heterogeneous ZSD. However, missense mutations encode proteins with residual functions, which are associated with phenotypes that are milder than ZS. Mutations in the PEX1 gene are among the most prevalent.	The statement is supported as it mentions that mutations in the PEX1 gene are among the most prevalent causes of Zellweger syndrome, which is a type of PBD.	"{""explanation"": ""The statement is supported as it mentions that mutations in the PEX1 gene are among the most prevalent causes of Zellweger syndrome, which is a type of PBD."", ""reference"": ""PMID:33955040"", ""snippet"": ""Zellweger syndrome (ZS) is the foremost common and severe phenotype within the heterogeneous ZSD. However, missense mutations encode proteins with residual functions, which are associated with phenotypes that are milder than ZS. Mutations in the PEX1 gene are among the most prevalent."", ""supports"": ""SUPPORT""}"
6175	6015	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	1	evidence	0	PMID:17055079	SUPPORT		Defects in PEX genes impair peroxisome assembly and multiple metabolic pathways confined to this organelle, thus providing the biochemical and molecular bases of the peroxisome biogenesis disorders (PBD).	This statement indicates that mutations in PEX genes, including PEX6, are foundational to the development of peroxisome biogenesis disorders.	"{""explanation"": ""This statement indicates that mutations in PEX genes, including PEX6, are foundational to the development of peroxisome biogenesis disorders."", ""reference"": ""PMID:17055079"", ""snippet"": ""Defects in PEX genes impair peroxisome assembly and multiple metabolic pathways confined to this organelle, thus providing the biochemical and molecular bases of the peroxisome biogenesis disorders (PBD)."", ""supports"": ""SUPPORT""}"
6176	6015	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	1	evidence	1	PMID:15858711	SUPPORT		Matsumoto and colleagues recently identified PEX26 as the gene responsible for complementation group 8 of the peroxisome biogenesis disorders... Here, we identify new PEX26 disease alleles, localize the PEX6-binding domain to the N-terminal half of the protein (aa 29-174), and show that, at the cellular level, PEX26 deficiency impairs peroxisomal import of both PTS1- and PTS2-targeted matrix proteins.	This paper discusses PEX26 in detail but also underscores the critical function of PEX6 in peroxisome biogenesis.	"{""explanation"": ""This paper discusses PEX26 in detail but also underscores the critical function of PEX6 in peroxisome biogenesis."", ""reference"": ""PMID:15858711"", ""snippet"": ""Matsumoto and colleagues recently identified PEX26 as the gene responsible for complementation group 8 of the peroxisome biogenesis disorders... Here, we identify new PEX26 disease alleles, localize the PEX6-binding domain to the N-terminal half of the protein (aa 29-174), and show that, at the cellular level, PEX26 deficiency impairs peroxisomal import of both PTS1- and PTS2-targeted matrix proteins."", ""supports"": ""SUPPORT""}"
6177	6015	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	1	evidence	2	PMID:36980088	SUPPORT		Genetic testing revealed a mutation of the PEX6 (Peroxisomal Biogenesis Factor 6) gene, and the metabolic profile was consistent with the diagnosis.	This case report directly links pathogenic variants in PEX6 to a specific case of peroxisome biogenesis disorder.	"{""explanation"": ""This case report directly links pathogenic variants in PEX6 to a specific case of peroxisome biogenesis disorder."", ""reference"": ""PMID:36980088"", ""snippet"": ""Genetic testing revealed a mutation of the PEX6 (Peroxisomal Biogenesis Factor 6) gene, and the metabolic profile was consistent with the diagnosis."", ""supports"": ""SUPPORT""}"
6178	6015	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	1	evidence	3	PMID:33955040	SUPPORT		Autosomal recessive disorder of the Zellweger spectrum (ZSD) is a major subset of peroxisome biogenesis disorders (PBDs) that can be caused by mutations in any of the 14 PEX genes. ... Mutations in the PEX1 gene are among the most prevalent. PEX1 and PEX6 proteins, belonging to the AAA family of ATPases, form a hexameric complex, which is associated with peroxisome membranes and essential for peroxisome biology.	This paper confirms that mutations in PEX6, similar to those in PEX1, are linked to peroxisome biogenesis disorders.	"{""explanation"": ""This paper confirms that mutations in PEX6, similar to those in PEX1, are linked to peroxisome biogenesis disorders."", ""reference"": ""PMID:33955040"", ""snippet"": ""Autosomal recessive disorder of the Zellweger spectrum (ZSD) is a major subset of peroxisome biogenesis disorders (PBDs) that can be caused by mutations in any of the 14 PEX genes. ... Mutations in the PEX1 gene are among the most prevalent. PEX1 and PEX6 proteins, belonging to the AAA family of ATPases, form a hexameric complex, which is associated with peroxisome membranes and essential for peroxisome biology."", ""supports"": ""SUPPORT""}"
6179	6015	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	1	evidence	4	PMID:10408779	SUPPORT		The PEX6 (peroxisome assembly factor-2, PAF-2) gene... restores peroxisome assembly in fibroblasts from peroxisome biogenesis disorder patients belonging to complementation group C (group 4 in the United States).	This research clarifies the structure and mutations of PEX6, noting its role in peroxisome biogenesis disorders.	"{""explanation"": ""This research clarifies the structure and mutations of PEX6, noting its role in peroxisome biogenesis disorders."", ""reference"": ""PMID:10408779"", ""snippet"": ""The PEX6 (peroxisome assembly factor-2, PAF-2) gene... restores peroxisome assembly in fibroblasts from peroxisome biogenesis disorder patients belonging to complementation group C (group 4 in the United States)."", ""supports"": ""SUPPORT""}"
6180	6023	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	9	evidence	0	PMID:10904262	SUPPORT		Recent studies have identified the PEX genes that are mutated in 11 of the 12 known complementation groups of PBD patients.	This reference indicates that pathogenic variants in other PEX genes are associated with Peroxisome Biogenesis Disorder (PBD).	"{""explanation"": ""This reference indicates that pathogenic variants in other PEX genes are associated with Peroxisome Biogenesis Disorder (PBD)."", ""reference"": ""PMID:10904262"", ""snippet"": ""Recent studies have identified the PEX genes that are mutated in 11 of the 12 known complementation groups of PBD patients."", ""supports"": ""SUPPORT""}"
6181	6023	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	9	evidence	1	PMID:32399598	SUPPORT		For the first time, we show that pathogenic variants in PEX6 can present clinically as Perrault syndrome... PEX6 encodes a peroxisomal biogenesis factor.	Although this reference primarily discusses Perrault syndrome, it confirms that variants in PEX genes such as PEX6 are associated with peroxisomal biogenesis disorders.	"{""explanation"": ""Although this reference primarily discusses Perrault syndrome, it confirms that variants in PEX genes such as PEX6 are associated with peroxisomal biogenesis disorders."", ""reference"": ""PMID:32399598"", ""snippet"": ""For the first time, we show that pathogenic variants in PEX6 can present clinically as Perrault syndrome... PEX6 encodes a peroxisomal biogenesis factor."", ""supports"": ""SUPPORT""}"
6182	6023	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	9	evidence	2	PMID:34804114	SUPPORT		Pathogenic variants in the PEX26 gene lead to peroxisomal disorders of the full Zellweger spectrum continuum.	This reference highlights PEX26 gene variants contributing to peroxisomal disorders which fall under the broader category of peroxisome biogenesis disorders.	"{""explanation"": ""This reference highlights PEX26 gene variants contributing to peroxisomal disorders which fall under the broader category of peroxisome biogenesis disorders."", ""reference"": ""PMID:34804114"", ""snippet"": ""Pathogenic variants in the PEX26 gene lead to peroxisomal disorders of the full Zellweger spectrum continuum."", ""supports"": ""SUPPORT""}"
6183	6023	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	genetic	9	evidence	3	PMID:29070486	SUPPORT		The biogenesis of peroxisomes requires a category of proteins named peroxins, which are encoded by the PEX genes.	The reference supports that PEX genes are crucial for peroxisome biogenesis, implying that pathogenic variants can lead to related disorders.	"{""explanation"": ""The reference supports that PEX genes are crucial for peroxisome biogenesis, implying that pathogenic variants can lead to related disorders."", ""reference"": ""PMID:29070486"", ""snippet"": ""The biogenesis of peroxisomes requires a category of proteins named peroxins, which are encoded by the PEX genes."", ""supports"": ""SUPPORT""}"
6268	6062	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	genetic	0	evidence	0	PMID:37054692	SUPPORT		It is caused by germline pathogenic variants of the STK11 gene, which exhibit an autosomal dominant mode of inheritance	Confirms germline STK11 mutations as the causative genetic basis for Peutz-Jeghers syndrome	"{""explanation"": ""Confirms germline STK11 mutations as the causative genetic basis for Peutz-Jeghers syndrome"", ""reference"": ""PMID:37054692"", ""snippet"": ""It is caused by germline pathogenic variants of the STK11 gene, which exhibit an autosomal dominant mode of inheritance"", ""supports"": ""SUPPORT""}"
6269	6063	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	genetic	1	evidence	0	PMID:37377590	SUPPORT		Among 19 patients with no detectable STK11 mutations, six had no pathogenic germline mutations of other genes, while 13 had other genetic mutations	Alternative genetic mutations including PTEN can account for STK11-negative PJS-like presentations	"{""explanation"": ""Alternative genetic mutations including PTEN can account for STK11-negative PJS-like presentations"", ""reference"": ""PMID:37377590"", ""snippet"": ""Among 19 patients with no detectable STK11 mutations, six had no pathogenic germline mutations of other genes, while 13 had other genetic mutations"", ""supports"": ""SUPPORT""}"
6284	6076	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	genetic	0	evidence	0	PMID:7874169	SUPPORT	HUMAN_CLINICAL	mutations in the fibroblast growth factor receptor-1 (FGFR1) gene, which maps to 8p, cause one form of familial Pfeiffer syndrome	First identification that FGFR1 mutations cause Pfeiffer syndrome, establishing the genetic basis of the disorder.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""First identification that FGFR1 mutations cause Pfeiffer syndrome, establishing the genetic basis of the disorder."", ""reference"": ""PMID:7874169"", ""snippet"": ""mutations in the fibroblast growth factor receptor-1 (FGFR1) gene, which maps to 8p, cause one form of familial Pfeiffer syndrome"", ""supports"": ""SUPPORT""}"
6285	6076	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	genetic	0	evidence	1	PMID:23348274	SUPPORT	HUMAN_CLINICAL	Polymerase chain reaction sequencing of FGFR1 exon 5 and FGFR2 exons 8, 10, 15, 16, and 17 was performed in all PS patients and revealed 9 recurrent mutations in all patients.	Confirms the mutation spectrum in both FGFR1 and FGFR2 genes causing Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms the mutation spectrum in both FGFR1 and FGFR2 genes causing Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""Polymerase chain reaction sequencing of FGFR1 exon 5 and FGFR2 exons 8, 10, 15, 16, and 17 was performed in all PS patients and revealed 9 recurrent mutations in all patients."", ""supports"": ""SUPPORT""}"
6286	6076	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	genetic	0	evidence	2	PMID:23348274	SUPPORT	HUMAN_CLINICAL	The most frequently detected mutation, p.S351C, was associated with the severe form of PS in the Thai population.	Documents that specific FGFR2 mutations are associated with severe forms of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents that specific FGFR2 mutations are associated with severe forms of Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""The most frequently detected mutation, p.S351C, was associated with the severe form of PS in the Thai population."", ""supports"": ""SUPPORT""}"
6287	6076	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	genetic	0	evidence	3	PMID:23348274	SUPPORT	HUMAN_CLINICAL	the p.P252R mutation in FGFR1 was detected in 1 PS patient with unilateral coronal craniosynostosis expanding the phenotypic spectrum of PS with this particular mutation.	Confirms that FGFR1 P252R mutation is associated with milder phenotypic presentations of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that FGFR1 P252R mutation is associated with milder phenotypic presentations of Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""the p.P252R mutation in FGFR1 was detected in 1 PS patient with unilateral coronal craniosynostosis expanding the phenotypic spectrum of PS with this particular mutation."", ""supports"": ""SUPPORT""}"
6320	6164	261	Pick Disease	Pick_Disease.yaml	genetic	0	evidence	0	PMID:37351604	SUPPORT		Two siblings with deletion mutation ∆K281 in MAPT developed frontotemporal dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus.	This establishes that MAPT ΔK281 mutation causes familial Pick's disease with characteristic 3R tau pathology.	"{""explanation"": ""This establishes that MAPT ΔK281 mutation causes familial Pick's disease with characteristic 3R tau pathology."", ""reference"": ""PMID:37351604"", ""snippet"": ""Two siblings with deletion mutation ∆K281 in MAPT developed frontotemporal dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus."", ""supports"": ""SUPPORT""}"
6321	6165	261	Pick Disease	Pick_Disease.yaml	genetic	1	evidence	0	PMID:38631765	SUPPORT		The MAPT H2 haplotype was associated with increased risk of Pick's disease compared with the H1 haplotype (OR 1·35 ... p=0·0021)	This demonstrates a genetic risk factor for sporadic Pick's disease through MAPT haplotype variation.	"{""explanation"": ""This demonstrates a genetic risk factor for sporadic Pick's disease through MAPT haplotype variation."", ""reference"": ""PMID:38631765"", ""snippet"": ""The MAPT H2 haplotype was associated with increased risk of Pick's disease compared with the H1 haplotype (OR 1·35 ... p=0·0021)"", ""supports"": ""SUPPORT""}"
6322	6166	261	Pick Disease	Pick_Disease.yaml	genetic	2	evidence	0	PMID:28890134	PARTIAL		Heterozygous loss-of-function (LOF) mutations in the human progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency.	GRN mutations cause FTLD which can clinically mimic Pick's disease, though the pathology differs (TDP-43 vs tau).	"{""explanation"": ""GRN mutations cause FTLD which can clinically mimic Pick's disease, though the pathology differs (TDP-43 vs tau)."", ""reference"": ""PMID:28890134"", ""snippet"": ""Heterozygous loss-of-function (LOF) mutations in the human progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency."", ""supports"": ""PARTIAL""}"
6391	6218	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	genetic	0	evidence	0	PMID:40126492	SUPPORT		ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes.	JAMA review quantifies PKD1 as the predominant cause of ADPKD.	"{""explanation"": ""JAMA review quantifies PKD1 as the predominant cause of ADPKD."", ""reference"": ""PMID:40126492"", ""snippet"": ""ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes."", ""supports"": ""SUPPORT""}"
6392	6219	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	genetic	1	evidence	0	PMID:40126492	SUPPORT		ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes.	JAMA review documents PKD2 as a minority but established cause of ADPKD.	"{""explanation"": ""JAMA review documents PKD2 as a minority but established cause of ADPKD."", ""reference"": ""PMID:40126492"", ""snippet"": ""ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes."", ""supports"": ""SUPPORT""}"
6393	6220	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	genetic	2	evidence	0	PMID:41467628	SUPPORT		Autosomal recessive polycystic kidney disease (ARPKD) is a rare disorder mainly caused by mutations in the polycystic kidney and hepatic disease 1 (PKHD1) gene.	Clin Nephrol study states PKHD1 mutations as the primary cause of ARPKD.	"{""explanation"": ""Clin Nephrol study states PKHD1 mutations as the primary cause of ARPKD."", ""reference"": ""PMID:41467628"", ""snippet"": ""Autosomal recessive polycystic kidney disease (ARPKD) is a rare disorder mainly caused by mutations in the polycystic kidney and hepatic disease 1 (PKHD1) gene."", ""supports"": ""SUPPORT""}"
6483	6344	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	genetic	0	evidence	0	PMID:11893720	SUPPORT		Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia.	This study directly links mutations in DNAI1 to the cause of primary ciliary dyskinesia.	"{""explanation"": ""This study directly links mutations in DNAI1 to the cause of primary ciliary dyskinesia."", ""reference"": ""PMID:11893720"", ""snippet"": ""Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia."", ""supports"": ""SUPPORT""}"
6484	6344	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	genetic	0	evidence	1	PMID:35869935	SUPPORT		13 rare variants were identified in patients with PCD, among which were three homozygous causative variants (including one splicing variant) in the PCD-associated genes CCDC40 and DNAI1.	The study identifies causative variants in DNAI1 associated with primary ciliary dyskinesia.	"{""explanation"": ""The study identifies causative variants in DNAI1 associated with primary ciliary dyskinesia."", ""reference"": ""PMID:35869935"", ""snippet"": ""13 rare variants were identified in patients with PCD, among which were three homozygous causative variants (including one splicing variant) in the PCD-associated genes CCDC40 and DNAI1."", ""supports"": ""SUPPORT""}"
6485	6344	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	genetic	0	evidence	2	PMID:15750039	SUPPORT		The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components.	This study mentions DNAI1 mutations as frequent genetic defects causing primary ciliary dyskinesia.	"{""explanation"": ""This study mentions DNAI1 mutations as frequent genetic defects causing primary ciliary dyskinesia."", ""reference"": ""PMID:15750039"", ""snippet"": ""The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components."", ""supports"": ""SUPPORT""}"
6486	6344	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	genetic	0	evidence	3	PMID:11231901	SUPPORT		We identified compound heterozygous DNAI1 gene defects in three independent patients and in two of their siblings who presented with PCD and situs solitus.	The study links compound heterozygous DNAI1 gene defects with primary ciliary dyskinesia.	"{""explanation"": ""The study links compound heterozygous DNAI1 gene defects with primary ciliary dyskinesia."", ""reference"": ""PMID:11231901"", ""snippet"": ""We identified compound heterozygous DNAI1 gene defects in three independent patients and in two of their siblings who presented with PCD and situs solitus."", ""supports"": ""SUPPORT""}"
6487	6345	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	genetic	1	evidence	0	PMID:31118369	SUPPORT		A genetic examination detected compound heterozygous mutations of DNAH5 that encode ODA components.	The study reports a case of primary ciliary dyskinesia (PCD) with DNAH5 mutations, confirming the association between PCD and pathogenic variants in DNAH5.	"{""explanation"": ""The study reports a case of primary ciliary dyskinesia (PCD) with DNAH5 mutations, confirming the association between PCD and pathogenic variants in DNAH5."", ""reference"": ""PMID:31118369"", ""snippet"": ""A genetic examination detected compound heterozygous mutations of DNAH5 that encode ODA components."", ""supports"": ""SUPPORT""}"
6488	6345	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	genetic	1	evidence	1	PMID:36727596	SUPPORT		Most PCD-causing variants result in abnormal outer dynein arms (ODAs), which provide the generative force for respiratory ciliary beating and proper mucociliary clearance.	The study indicates that pathogenic variants causing PCD often result in abnormal ODAs, which are associated with DNAH5.	"{""explanation"": ""The study indicates that pathogenic variants causing PCD often result in abnormal ODAs, which are associated with DNAH5."", ""reference"": ""PMID:36727596"", ""snippet"": ""Most PCD-causing variants result in abnormal outer dynein arms (ODAs), which provide the generative force for respiratory ciliary beating and proper mucociliary clearance."", ""supports"": ""SUPPORT""}"
6565	6409	273	Primary Progressive Aphasia	Primary_Progressive_Aphasia.yaml	genetic	0	evidence	0	PMID:19300609	SUPPORT		Pathogenic mutations in genes coding for the proteins tau and progranulin have been isolated.	The abstract cites pathogenic mutations in the tau gene (MAPT).	"{""explanation"": ""The abstract cites pathogenic mutations in the tau gene (MAPT)."", ""reference"": ""PMID:19300609"", ""snippet"": ""Pathogenic mutations in genes coding for the proteins tau and progranulin have been isolated."", ""supports"": ""SUPPORT""}"
6566	6410	273	Primary Progressive Aphasia	Primary_Progressive_Aphasia.yaml	genetic	1	evidence	0	PMID:19300609	SUPPORT		Pathogenic mutations in genes coding for the proteins tau and progranulin have been isolated.	The abstract cites pathogenic mutations in the progranulin gene (GRN).	"{""explanation"": ""The abstract cites pathogenic mutations in the progranulin gene (GRN)."", ""reference"": ""PMID:19300609"", ""snippet"": ""Pathogenic mutations in genes coding for the proteins tau and progranulin have been isolated."", ""supports"": ""SUPPORT""}"
6665	6481	276	Proteus syndrome	Proteus_syndrome.yaml	genetic	0	evidence	0	DOI:10.1038/srep17162	SUPPORT		A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome.	This identifies the causative somatic AKT1 variant.	"{""explanation"": ""This identifies the causative somatic AKT1 variant."", ""reference"": ""DOI:10.1038/srep17162"", ""snippet"": ""A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."", ""supports"": ""SUPPORT""}"
6666	6481	276	Proteus syndrome	Proteus_syndrome.yaml	genetic	0	evidence	1	DOI:10.1093/hmg/ddz116	SUPPORT		Proteus syndrome is a mosaic, progressive overgrowth disorder caused by a somatic activating variant c.49G > A p.(E17K) in AKT1.	This independently confirms the AKT1 p.E17K mosaic variant as the cause.	"{""explanation"": ""This independently confirms the AKT1 p.E17K mosaic variant as the cause."", ""reference"": ""DOI:10.1093/hmg/ddz116"", ""snippet"": ""Proteus syndrome is a mosaic, progressive overgrowth disorder caused by a somatic activating variant c.49G > A p.(E17K) in AKT1."", ""supports"": ""SUPPORT""}"
6716	6524	278	Psoriasis	Psoriasis.yaml	genetic	1	evidence	0	PMID:38686385	SUPPORT		Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease.	IL12B encodes the p40 subunit shared by IL-12 and IL-23. Given IL-23's hierarchically dominant role in psoriasis, genetic variants in IL12B that affect IL-23 levels represent important risk factors.	"{""explanation"": ""IL12B encodes the p40 subunit shared by IL-12 and IL-23. Given IL-23's hierarchically dominant role in psoriasis, genetic variants in IL12B that affect IL-23 levels represent important risk factors."", ""reference"": ""PMID:38686385"", ""snippet"": ""Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease."", ""supports"": ""SUPPORT""}"
6717	6525	278	Psoriasis	Psoriasis.yaml	genetic	2	evidence	0	PMID:38686385	SUPPORT		We review IL-23 biology, IL-23 signaling in IMIDs, and the effect of IL-23 inhibition in treating these diseases.	IL23R encodes the IL-23 receptor, and genetic variants affecting IL-23 signaling are risk factors for psoriasis given the central role of this pathway.	"{""explanation"": ""IL23R encodes the IL-23 receptor, and genetic variants affecting IL-23 signaling are risk factors for psoriasis given the central role of this pathway."", ""reference"": ""PMID:38686385"", ""snippet"": ""We review IL-23 biology, IL-23 signaling in IMIDs, and the effect of IL-23 inhibition in treating these diseases."", ""supports"": ""SUPPORT""}"
6739	6599	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	genetic	0	evidence	0	PMID:39502057	SUPPORT		The common gene mutations in PTC include BRAF V600E,RET/PTC rearrangement,and RAS mutations.	Supports RET/PTC rearrangements as common mutations in papillary thyroid carcinoma.	"{""explanation"": ""Supports RET/PTC rearrangements as common mutations in papillary thyroid carcinoma."", ""reference"": ""PMID:39502057"", ""snippet"": ""The common gene mutations in PTC include BRAF V600E,RET/PTC rearrangement,and RAS mutations."", ""supports"": ""SUPPORT""}"
6741	6616	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	genetic	0	evidence	0	PMID:35220468	SUPPORT		Approximately 1-2% of non-small cell lung cancer (NSCLC) patients harbor RET (rearranged during transfection) fusions.	Abstract reports the frequency of RET fusions in NSCLC.	"{""explanation"": ""Abstract reports the frequency of RET fusions in NSCLC."", ""reference"": ""PMID:35220468"", ""snippet"": ""Approximately 1-2% of non-small cell lung cancer (NSCLC) patients harbor RET (rearranged during transfection) fusions."", ""supports"": ""SUPPORT""}"
6744	6636	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	genetic	0	evidence	0	PMID:32327173	SUPPORT		ROS1-rearranged non-small cell lung cancer (NSCLC) makes up approximately 1% to 2% of all NSCLC,	Abstract reports ROS1-rearranged NSCLC accounts for about 1-2% of cases.	"{""explanation"": ""Abstract reports ROS1-rearranged NSCLC accounts for about 1-2% of cases."", ""reference"": ""PMID:32327173"", ""snippet"": ""ROS1-rearranged non-small cell lung cancer (NSCLC) makes up approximately 1% to 2% of all NSCLC,"", ""supports"": ""SUPPORT""}"
6841	6739	289	Rett Syndrome	Rett_Syndrome.yaml	genetic	0	evidence	0	PMID:10508514	SUPPORT		we have identified mutations in the gene (MECP2) encoding X-linked methyl-CpG-binding protein 2 (MeCP2) as the cause of some cases of RTT	Original discovery paper identified MECP2 mutations as the cause of Rett syndrome.	"{""explanation"": ""Original discovery paper identified MECP2 mutations as the cause of Rett syndrome."", ""reference"": ""PMID:10508514"", ""snippet"": ""we have identified mutations in the gene (MECP2) encoding X-linked methyl-CpG-binding protein 2 (MeCP2) as the cause of some cases of RTT"", ""supports"": ""SUPPORT""}"
6877	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	0	PMID:24447879	SUPPORT		HLA-DRB1*04 was found to have increased frequency in the RA group compared to controls (P < 0.001, OR = 3.14)...HLA-DRB1*04:05 was associated with RA (P = 0.005, OR = 3.41)	The study shows an increased frequency of HLA-DRB1*04 and HLA-DRB1*04:05 in the RA group, indicating an association with increased risk.	"{""explanation"": ""The study shows an increased frequency of HLA-DRB1*04 and HLA-DRB1*04:05 in the RA group, indicating an association with increased risk."", ""reference"": ""PMID:24447879"", ""snippet"": ""HLA-DRB1*04 was found to have increased frequency in the RA group compared to controls (P < 0.001, OR = 3.14)...HLA-DRB1*04:05 was associated with RA (P = 0.005, OR = 3.41)"", ""supports"": ""SUPPORT""}"
6878	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	1	PMID:32638005	SUPPORT		This review identifies the most significant genetic variants associated with RA susceptibility to date, with particular focus on the contribution of the HLA class II genes across different ethnic groups.	The review discusses the significant role of HLA-DRB1 in RA susceptibility.	"{""explanation"": ""The review discusses the significant role of HLA-DRB1 in RA susceptibility."", ""reference"": ""PMID:32638005"", ""snippet"": ""This review identifies the most significant genetic variants associated with RA susceptibility to date, with particular focus on the contribution of the HLA class II genes across different ethnic groups."", ""supports"": ""SUPPORT""}"
6879	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	2	PMID:16542468	SUPPORT		HLA-DR alleles such as HLA-DR4 and HLA-DR1 are associated with the risk to develop RA.	HLA-DR4, a subtype of HLA-DRB1, is associated with an increased risk of developing RA.	"{""explanation"": ""HLA-DR4, a subtype of HLA-DRB1, is associated with an increased risk of developing RA."", ""reference"": ""PMID:16542468"", ""snippet"": ""HLA-DR alleles such as HLA-DR4 and HLA-DR1 are associated with the risk to develop RA."", ""supports"": ""SUPPORT""}"
6880	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	3	PMID:32370106	SUPPORT		Association studies of the HLA-DRB1 gene clearly indicate its importance in RA morbidity.	The review presents the current understanding of HLA-DRB1's role in increasing the risk of RA.	"{""explanation"": ""The review presents the current understanding of HLA-DRB1's role in increasing the risk of RA."", ""reference"": ""PMID:32370106"", ""snippet"": ""Association studies of the HLA-DRB1 gene clearly indicate its importance in RA morbidity."", ""supports"": ""SUPPORT""}"
6881	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	4	PMID:24336335	SUPPORT		Certain HLA-DRB1 alleles and single-nucleotide polymorphisms (SNPs) are associated with rheumatoid arthritis (RA).	The study reinforces the association of HLA-DRB1 alleles with RA.	"{""explanation"": ""The study reinforces the association of HLA-DRB1 alleles with RA."", ""reference"": ""PMID:24336335"", ""snippet"": ""Certain HLA-DRB1 alleles and single-nucleotide polymorphisms (SNPs) are associated with rheumatoid arthritis (RA)."", ""supports"": ""SUPPORT""}"
6882	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	5	PMID:3067866	SUPPORT		Part of this genetic predisposition is accounted for by genes within the MHC where there is a well-documented association with HLA-DR4.	The study mentions the association of HLA-DR4, a subtype of HLA-DRB1, with RA.	"{""explanation"": ""The study mentions the association of HLA-DR4, a subtype of HLA-DRB1, with RA."", ""reference"": ""PMID:3067866"", ""snippet"": ""Part of this genetic predisposition is accounted for by genes within the MHC where there is a well-documented association with HLA-DR4."", ""supports"": ""SUPPORT""}"
6883	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	6	PMID:29037901	SUPPORT		HLA-DRB1*01 and HLA-DRB1*04 may be involved in the genetic predisposition of Rheumatoid Factor (RF) positive forms of JIA.	The meta-analysis highlights the role of HLA-DRB1 alleles in RA-related conditions, such as juvenile idiopathic arthritis.	"{""explanation"": ""The meta-analysis highlights the role of HLA-DRB1 alleles in RA-related conditions, such as juvenile idiopathic arthritis."", ""reference"": ""PMID:29037901"", ""snippet"": ""HLA-DRB1*01 and HLA-DRB1*04 may be involved in the genetic predisposition of Rheumatoid Factor (RF) positive forms of JIA."", ""supports"": ""SUPPORT""}"
6884	6763	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	0	evidence	7	PMID:36155967	SUPPORT		We evaluated whether RA-ILD is associated with these genetic variants and HLA-DRB1 shared epitope (SE) alleles in a large RA cohort stratified by race and smoking history.	The study discusses the association of HLA-DRB1 SE alleles with RA-ILD.	"{""explanation"": ""The study discusses the association of HLA-DRB1 SE alleles with RA-ILD."", ""reference"": ""PMID:36155967"", ""snippet"": ""We evaluated whether RA-ILD is associated with these genetic variants and HLA-DRB1 shared epitope (SE) alleles in a large RA cohort stratified by race and smoking history."", ""supports"": ""SUPPORT""}"
6885	6764	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	1	evidence	0	PMID:30957405	SUPPORT		The overall effect of PTPN22-1123 on RA risk in all genetic random models showed significant positive associations.	The study found significant positive associations between PTPN22 genetic variations and increased risk of rheumatoid arthritis.	"{""explanation"": ""The study found significant positive associations between PTPN22 genetic variations and increased risk of rheumatoid arthritis."", ""reference"": ""PMID:30957405"", ""snippet"": ""The overall effect of PTPN22-1123 on RA risk in all genetic random models showed significant positive associations."", ""supports"": ""SUPPORT""}"
6886	6764	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	1	evidence	1	PMID:15790351	SUPPORT		A functional variant (R620W) of the intracellular protein tyrosine phosphatase N22 (PTPN22) has now been conclusively shown to confer approximately two-fold risk for seropositive RA as well as several other autoimmune disorders.	The variant R620W of PTPN22 is associated with a significantly increased risk of rheumatoid arthritis.	"{""explanation"": ""The variant R620W of PTPN22 is associated with a significantly increased risk of rheumatoid arthritis."", ""reference"": ""PMID:15790351"", ""snippet"": ""A functional variant (R620W) of the intracellular protein tyrosine phosphatase N22 (PTPN22) has now been conclusively shown to confer approximately two-fold risk for seropositive RA as well as several other autoimmune disorders."", ""supports"": ""SUPPORT""}"
6887	6764	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	1	evidence	2	PMID:15838240	SUPPORT		The second risk factor for rheumatoid arthritis, the PTPN22 polymorphism, has been identified.	The PTPN22 polymorphism has been identified as a genetic risk factor for rheumatoid arthritis.	"{""explanation"": ""The PTPN22 polymorphism has been identified as a genetic risk factor for rheumatoid arthritis."", ""reference"": ""PMID:15838240"", ""snippet"": ""The second risk factor for rheumatoid arthritis, the PTPN22 polymorphism, has been identified."", ""supports"": ""SUPPORT""}"
6888	6765	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	2	evidence	0	PMID:30864557	SUPPORT		Herein, we found a significant positive association between minor T allele as well as different genotypes with the risk of RA.	The study found a significant positive association between the STAT4 gene rs7574865 SNP and the risk of rheumatoid arthritis (RA).	"{""explanation"": ""The study found a significant positive association between the STAT4 gene rs7574865 SNP and the risk of rheumatoid arthritis (RA)."", ""reference"": ""PMID:30864557"", ""snippet"": ""Herein, we found a significant positive association between minor T allele as well as different genotypes with the risk of RA."", ""supports"": ""SUPPORT""}"
6889	6765	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	2	evidence	1	PMID:20453440	SUPPORT		We and other investigators also found that IRF5, STAT4 and BLK are associated not only with SLE, but also rheumatoid arthritis and systemic sclerosis.	The literature supports an association between the STAT4 gene and increased risk of rheumatoid arthritis.	"{""explanation"": ""The literature supports an association between the STAT4 gene and increased risk of rheumatoid arthritis."", ""reference"": ""PMID:20453440"", ""snippet"": ""We and other investigators also found that IRF5, STAT4 and BLK are associated not only with SLE, but also rheumatoid arthritis and systemic sclerosis."", ""supports"": ""SUPPORT""}"
6890	6766	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	3	evidence	0	PMID:34339393	SUPPORT		This meta-analysis confirmed that rs3087243 and rs231775 polymorphism were associated with the risk of RA in both overall population and ethnic-specific analysis, but there was no association between rs5742909 polymorphism and RA risk	The meta-analysis provides evidence that CTLA-4 gene polymorphisms are associated with an increased risk of rheumatoid arthritis.	"{""explanation"": ""The meta-analysis provides evidence that CTLA-4 gene polymorphisms are associated with an increased risk of rheumatoid arthritis."", ""reference"": ""PMID:34339393"", ""snippet"": ""This meta-analysis confirmed that rs3087243 and rs231775 polymorphism were associated with the risk of RA in both overall population and ethnic-specific analysis, but there was no association between rs5742909 polymorphism and RA risk"", ""supports"": ""SUPPORT""}"
6891	6766	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	3	evidence	1	PMID:35758965	SUPPORT		There was a significantly higher median (inter-quartile range) expression of CTLA-4 and CCL2 in RA patients in comparison to controls (P < 0.05)	The study found significantly higher expression of CTLA-4 in RA patients, supporting the association of CTLA-4 with increased RA risk.	"{""explanation"": ""The study found significantly higher expression of CTLA-4 in RA patients, supporting the association of CTLA-4 with increased RA risk."", ""reference"": ""PMID:35758965"", ""snippet"": ""There was a significantly higher median (inter-quartile range) expression of CTLA-4 and CCL2 in RA patients in comparison to controls (P < 0.05)"", ""supports"": ""SUPPORT""}"
6892	6766	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	3	evidence	2	PMID:11196709	SUPPORT		For most autoimmune disorders... the gene encoding cytotoxic T lymphocyte-associated antigen 4 (CTLA4) has been suggested as a candidate gene for conferring susceptibility to autoimmunity.	The article discusses CTLA4 as a candidate gene for susceptibility to autoimmune diseases, including rheumatoid arthritis.	"{""explanation"": ""The article discusses CTLA4 as a candidate gene for susceptibility to autoimmune diseases, including rheumatoid arthritis."", ""reference"": ""PMID:11196709"", ""snippet"": ""For most autoimmune disorders... the gene encoding cytotoxic T lymphocyte-associated antigen 4 (CTLA4) has been suggested as a candidate gene for conferring susceptibility to autoimmunity."", ""supports"": ""SUPPORT""}"
6893	6767	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	genetic	4	evidence	0	PMID:17893996	SUPPORT		peptidylarginine deiminase (gene name abbreviated to PADI, protein name abbreviated to PAD) type 4 is the one of the non-HLA genetic factors involved in RA via citrullination	This review identifies PADI4 as a key non-HLA genetic susceptibility factor for RA, demonstrating the link between citrullination of proteins and generation of autoantigens targeted by anti-citrullinated protein antibodies.	"{""explanation"": ""This review identifies PADI4 as a key non-HLA genetic susceptibility factor for RA, demonstrating the link between citrullination of proteins and generation of autoantigens targeted by anti-citrullinated protein antibodies."", ""reference"": ""PMID:17893996"", ""snippet"": ""peptidylarginine deiminase (gene name abbreviated to PADI, protein name abbreviated to PAD) type 4 is the one of the non-HLA genetic factors involved in RA via citrullination"", ""supports"": ""SUPPORT""}"
6988	6810	291	Roifman-syndrome	Roifman-syndrome.yaml	genetic	0	evidence	0	PMID:26522830	SUPPORT		Roifman Syndrome is a rare congenital disorder... Targeted sequencing confirms allele segregation in six cases from four unrelated families.	This study confirms that Roifman Syndrome is associated with compound heterozygous mutations in the RNU4ATAC gene, which is inherited in an autosomal recessive manner.	"{""explanation"": ""This study confirms that Roifman Syndrome is associated with compound heterozygous mutations in the RNU4ATAC gene, which is inherited in an autosomal recessive manner."", ""reference"": ""PMID:26522830"", ""snippet"": ""Roifman Syndrome is a rare congenital disorder... Targeted sequencing confirms allele segregation in six cases from four unrelated families."", ""supports"": ""SUPPORT""}"
6989	6810	291	Roifman-syndrome	Roifman-syndrome.yaml	genetic	0	evidence	1	PMID:35450878	SUPPORT		Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.	This literature explicitly mentions that Roifman syndrome is inherited in an autosomal recessive manner.	"{""explanation"": ""This literature explicitly mentions that Roifman syndrome is inherited in an autosomal recessive manner."", ""reference"": ""PMID:35450878"", ""snippet"": ""Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."", ""supports"": ""SUPPORT""}"
6990	6810	291	Roifman-syndrome	Roifman-syndrome.yaml	genetic	0	evidence	2	PMID:37225827	SUPPORT		All patients had biallelic RNU4ATAC variants.	This study confirms that Roifman syndrome patients have biallelic (autosomal recessive) variants in the RNU4ATAC gene.	"{""explanation"": ""This study confirms that Roifman syndrome patients have biallelic (autosomal recessive) variants in the RNU4ATAC gene."", ""reference"": ""PMID:37225827"", ""snippet"": ""All patients had biallelic RNU4ATAC variants."", ""supports"": ""SUPPORT""}"
7016	6827	292	SADDAN	SADDAN.yaml	genetic	0	evidence	0	PMID:24352917	SUPPORT		The disorder is the result of a single missense mutation at codon 650 (p.Lys650Met) in the fibroblast growth factor receptor 3 gene (FGFR3).	The abstract identifies p.Lys650Met in FGFR3 as the causal mutation.	"{""explanation"": ""The abstract identifies p.Lys650Met in FGFR3 as the causal mutation."", ""reference"": ""PMID:24352917"", ""snippet"": ""The disorder is the result of a single missense mutation at codon 650 (p.Lys650Met) in the fibroblast growth factor receptor 3 gene (FGFR3)."", ""supports"": ""SUPPORT""}"
7039	6848	293	Salla Disease	Salla_Disease.yaml	genetic	0	evidence	0	PMID:37727271	SUPPORT	IN_VITRO	Free sialic acid storage disorders (FSASDs) result from pathogenic variations in the SLC17A5 gene, which encodes the lysosomal transmembrane protein sialin.	Studies of patient-derived cells demonstrate SLC17A5 biallelic mutations as causative for FSASD including Salla disease.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Studies of patient-derived cells demonstrate SLC17A5 biallelic mutations as causative for FSASD including Salla disease."", ""reference"": ""PMID:37727271"", ""snippet"": ""Free sialic acid storage disorders (FSASDs) result from pathogenic variations in the SLC17A5 gene, which encodes the lysosomal transmembrane protein sialin."", ""supports"": ""SUPPORT""}"
7040	6848	293	Salla Disease	Salla_Disease.yaml	genetic	0	evidence	1	PMID:34667062	SUPPORT	HUMAN_CLINICAL	SLC17A5 gene sequencing was initiated with no sequence variants identified; however, the assay failed to amplify exons 8 and 9, prompting an exon-level copy-number analysis that revealed a novel homozygous deletion of exons 8 and 9, inherited from heterozygous carrier parents.	Case report documents a novel homozygous deletion of SLC17A5 exons 8-9 causing infantile-onset FSASD with prenatal hydrops, demonstrating the spectrum of SLC17A5 pathogenic variants extends beyond point mutations to exonic deletions.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report documents a novel homozygous deletion of SLC17A5 exons 8-9 causing infantile-onset FSASD with prenatal hydrops, demonstrating the spectrum of SLC17A5 pathogenic variants extends beyond point mutations to exonic deletions."", ""reference"": ""PMID:34667062"", ""snippet"": ""SLC17A5 gene sequencing was initiated with no sequence variants identified; however, the assay failed to amplify exons 8 and 9, prompting an exon-level copy-number analysis that revealed a novel homozygous deletion of exons 8 and 9, inherited from heterozygous carrier parents."", ""supports"": ""SUPPORT""}"
7106	6923	297	Schizophrenia	Schizophrenia.yaml	genetic	7	evidence	0	PMID:30286368	SUPPORT		DISC1 gene has been shown as a risk factor for schizophrenia in some reports.	The meta-analysis confirms associations between specific SNPs in the DISC1 gene and schizophrenia risk.	"{""explanation"": ""The meta-analysis confirms associations between specific SNPs in the DISC1 gene and schizophrenia risk."", ""reference"": ""PMID:30286368"", ""snippet"": ""DISC1 gene has been shown as a risk factor for schizophrenia in some reports."", ""supports"": ""SUPPORT""}"
7107	6923	297	Schizophrenia	Schizophrenia.yaml	genetic	7	evidence	1	PMID:24056909	NO_EVIDENCE		Questions about DISC1 as a genetic risk factor for schizophrenia.	This reference raises questions about the role of DISC1 as a risk factor, implying a lack of consensus.	"{""explanation"": ""This reference raises questions about the role of DISC1 as a risk factor, implying a lack of consensus."", ""reference"": ""PMID:24056909"", ""snippet"": ""Questions about DISC1 as a genetic risk factor for schizophrenia."", ""supports"": ""NO_EVIDENCE""}"
7108	6923	297	Schizophrenia	Schizophrenia.yaml	genetic	7	evidence	2	PMID:30285728	SUPPORT		The human DISC1 gene is located on chromosome 1 and is highly associated with schizophrenia and other mental disorders.	This study associates the DISC1 gene with schizophrenia among other mental disorders, supporting its role as a risk factor.	"{""explanation"": ""This study associates the DISC1 gene with schizophrenia among other mental disorders, supporting its role as a risk factor."", ""reference"": ""PMID:30285728"", ""snippet"": ""The human DISC1 gene is located on chromosome 1 and is highly associated with schizophrenia and other mental disorders."", ""supports"": ""SUPPORT""}"
7109	6923	297	Schizophrenia	Schizophrenia.yaml	genetic	7	evidence	3	PMID:20302823	SUPPORT		Modeling the disease in genetically tractable animals is thus a challenging but increasingly important task. In this review, I discuss the potential problems and perspectives associated with modeling schizophrenia in fruit flies, and briefly review the recent studies analyzing the molecular and cellular functions of Disrupted-In-Schizophrenia-1 (DISC1) in transgenic flies.	This review highlights the relevance of studying DISC1 functions in the context of schizophrenia.	"{""explanation"": ""This review highlights the relevance of studying DISC1 functions in the context of schizophrenia."", ""reference"": ""PMID:20302823"", ""snippet"": ""Modeling the disease in genetically tractable animals is thus a challenging but increasingly important task. In this review, I discuss the potential problems and perspectives associated with modeling schizophrenia in fruit flies, and briefly review the recent studies analyzing the molecular and cellular functions of Disrupted-In-Schizophrenia-1 (DISC1) in transgenic flies."", ""supports"": ""SUPPORT""}"
7110	6924	297	Schizophrenia	Schizophrenia.yaml	genetic	8	evidence	0	PMID:23573605	SUPPORT		COMT is an enzyme that is distributed widely throughout the brain, but seems to be uniquely relevant to how dopamine affects information-processing in the prefrontal cortex. There is a common variation in the genetic sequence of the COMT gene, which causes a dramatic change in its enzyme activity. In people with schizophrenia, in their healthy siblings, and also in normal controls, the COMT genotype predicts 4% of the variation in human executive cognition and working memory. We have thus identified a genetic mechanism in the human species that affects the efficiency and efficacy of information-processing in the prefrontal cortex. It is, also, a weak genetic risk factor for schizophrenia: in family studies, it increases the risk of schizophrenia by 50-80%.	The COMT gene is identified as a weak genetic risk factor for schizophrenia, increasing the risk by 50-80% in family studies.	"{""explanation"": ""The COMT gene is identified as a weak genetic risk factor for schizophrenia, increasing the risk by 50-80% in family studies."", ""reference"": ""PMID:23573605"", ""snippet"": ""COMT is an enzyme that is distributed widely throughout the brain, but seems to be uniquely relevant to how dopamine affects information-processing in the prefrontal cortex. There is a common variation in the genetic sequence of the COMT gene, which causes a dramatic change in its enzyme activity. In people with schizophrenia, in their healthy siblings, and also in normal controls, the COMT genotype predicts 4% of the variation in human executive cognition and working memory. We have thus identified a genetic mechanism in the human species that affects the efficiency and efficacy of information-processing in the prefrontal cortex. It is, also, a weak genetic risk factor for schizophrenia: in family studies, it increases the risk of schizophrenia by 50-80%."", ""supports"": ""SUPPORT""}"
7111	6925	297	Schizophrenia	Schizophrenia.yaml	genetic	9	evidence	0	PMID:16520822	PARTIAL		Our meta-analysis provides support for the association of NRG1 with schizophrenia, but indicates that firmly establishing the role of NRG1 gene in schizophrenia by genetic association requires much larger sample sizes than have hitherto been reported.	The meta-analysis found some evidence supporting the association of NRG1 with schizophrenia, but also highlighted the need for larger sample sizes to firmly establish this role.	"{""explanation"": ""The meta-analysis found some evidence supporting the association of NRG1 with schizophrenia, but also highlighted the need for larger sample sizes to firmly establish this role."", ""reference"": ""PMID:16520822"", ""snippet"": ""Our meta-analysis provides support for the association of NRG1 with schizophrenia, but indicates that firmly establishing the role of NRG1 gene in schizophrenia by genetic association requires much larger sample sizes than have hitherto been reported."", ""supports"": ""PARTIAL""}"
7112	6925	297	Schizophrenia	Schizophrenia.yaml	genetic	9	evidence	1	PMID:15162166	SUPPORT		Recently, the gene that encodes neuregulin-1 (NRG1) has been identified as a potential susceptibility gene for schizophrenia, and defects in the expression of erbB3, one of the NRG1 receptors, have been shown to occur in the prefrontal cortex of schizophrenic patients...	This reference identifies NRG1 as a potential susceptibility gene for schizophrenia, indicating a genetic association.	"{""explanation"": ""This reference identifies NRG1 as a potential susceptibility gene for schizophrenia, indicating a genetic association."", ""reference"": ""PMID:15162166"", ""snippet"": ""Recently, the gene that encodes neuregulin-1 (NRG1) has been identified as a potential susceptibility gene for schizophrenia, and defects in the expression of erbB3, one of the NRG1 receptors, have been shown to occur in the prefrontal cortex of schizophrenic patients..."", ""supports"": ""SUPPORT""}"
7113	6925	297	Schizophrenia	Schizophrenia.yaml	genetic	9	evidence	2	PMID:20600464	SUPPORT		We mainly focus on genes including:...NRG1 (Neuregulin 1)... Taken together there is converging evidence for the contribution of genes potentially related to alterations in intracellular Ca-homeostasis to the risk of schizophrenia.	This review points to NRG1 as a gene potentially related to the risk of schizophrenia.	"{""explanation"": ""This review points to NRG1 as a gene potentially related to the risk of schizophrenia."", ""reference"": ""PMID:20600464"", ""snippet"": ""We mainly focus on genes including:...NRG1 (Neuregulin 1)... Taken together there is converging evidence for the contribution of genes potentially related to alterations in intracellular Ca-homeostasis to the risk of schizophrenia."", ""supports"": ""SUPPORT""}"
7114	6925	297	Schizophrenia	Schizophrenia.yaml	genetic	9	evidence	3	PMID:24968777	SUPPORT		...It considers models for understanding the role(s) of risk genes, with a particular focus on DTNBP1 and NRG1...	This paper focuses on NRG1 as one of the risk genes associated with schizophrenia.	"{""explanation"": ""This paper focuses on NRG1 as one of the risk genes associated with schizophrenia."", ""reference"": ""PMID:24968777"", ""snippet"": ""...It considers models for understanding the role(s) of risk genes, with a particular focus on DTNBP1 and NRG1..."", ""supports"": ""SUPPORT""}"
7115	6926	297	Schizophrenia	Schizophrenia.yaml	genetic	10	evidence	0	PMID:19862852	SUPPORT		This study shows that DTNBP1 is a risk gene for schizophrenia in EAs. Variation at DTNBP1 may modify risk for schizophrenia in this population.	This reference provides evidence that DTNBP1 is associated with an increased risk of schizophrenia, particularly in European-Americans.	"{""explanation"": ""This reference provides evidence that DTNBP1 is associated with an increased risk of schizophrenia, particularly in European-Americans."", ""reference"": ""PMID:19862852"", ""snippet"": ""This study shows that DTNBP1 is a risk gene for schizophrenia in EAs. Variation at DTNBP1 may modify risk for schizophrenia in this population."", ""supports"": ""SUPPORT""}"
7116	6926	297	Schizophrenia	Schizophrenia.yaml	genetic	10	evidence	1	PMID:18474210	SUPPORT		To date, DTNBP1 has provided the greatest evidence of illness modification, as associations with negative and cognitive symptoms and worse outcome have been published in independent samples.	This reference elaborates on the association of DTNBP1 with specific clinical features of schizophrenia, further supporting its role as a risk factor.	"{""explanation"": ""This reference elaborates on the association of DTNBP1 with specific clinical features of schizophrenia, further supporting its role as a risk factor."", ""reference"": ""PMID:18474210"", ""snippet"": ""To date, DTNBP1 has provided the greatest evidence of illness modification, as associations with negative and cognitive symptoms and worse outcome have been published in independent samples."", ""supports"": ""SUPPORT""}"
7117	6926	297	Schizophrenia	Schizophrenia.yaml	genetic	10	evidence	2	PMID:24968777	SUPPORT		It considers models for understanding the role(s) of risk genes, with a particular focus on DTNBP1 and NRG1, their interactions with environmental factors, and with each other (epistasis).	This reference discusses the role of DTNBP1 as a risk gene for schizophrenia within the context of genetic and environmental interactions.	"{""explanation"": ""This reference discusses the role of DTNBP1 as a risk gene for schizophrenia within the context of genetic and environmental interactions."", ""reference"": ""PMID:24968777"", ""snippet"": ""It considers models for understanding the role(s) of risk genes, with a particular focus on DTNBP1 and NRG1, their interactions with environmental factors, and with each other (epistasis)."", ""supports"": ""SUPPORT""}"
7213	6961	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	genetic	0	evidence	0	PMID:34210367	SUPPORT	HUMAN_CLINICAL	A molecular genetic diagnosis was made in 7 of 18 cases (39% of those tested). Ninety-six per cent of the cohort had some type of extracardiac finding, with 43% having asthma and 20% having a gastrointestinal pathology.	Texas Children's Hospital cohort of 89 patients showing 39% diagnostic yield from genetic testing and high prevalence of extracardiac findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Texas Children's Hospital cohort of 89 patients showing 39% diagnostic yield from genetic testing and high prevalence of extracardiac findings."", ""reference"": ""PMID:34210367"", ""snippet"": ""A molecular genetic diagnosis was made in 7 of 18 cases (39% of those tested). Ninety-six per cent of the cohort had some type of extracardiac finding, with 43% having asthma and 20% having a gastrointestinal pathology."", ""supports"": ""SUPPORT""}"
7308	7028	303	Sengers syndrome	Sengers_syndrome.yaml	genetic	0	evidence	0	DOI:10.3389/fped.2021.639687	SUPPORT		Sengers syndrome (OMIM #212350) is a rare autosomal recessive disorder due to mutations in acylglycerol kinase (AGK) gene.	This statement identifies AGK mutations as the cause of Sengers syndrome with autosomal recessive inheritance.	"{""explanation"": ""This statement identifies AGK mutations as the cause of Sengers syndrome with autosomal recessive inheritance."", ""reference"": ""DOI:10.3389/fped.2021.639687"", ""snippet"": ""Sengers syndrome (OMIM #212350) is a rare autosomal recessive disorder due to mutations in acylglycerol kinase (AGK) gene."", ""supports"": ""SUPPORT""}"
7309	7028	303	Sengers syndrome	Sengers_syndrome.yaml	genetic	0	evidence	1	PMID:34164355	SUPPORT		After genetic analysis, a novel homozygous (c.1131+2T>C) variant of AGK gene was identified in the proband.	This case report provides direct genetic evidence of a pathogenic AGK variant in Sengers syndrome.	"{""explanation"": ""This case report provides direct genetic evidence of a pathogenic AGK variant in Sengers syndrome."", ""reference"": ""PMID:34164355"", ""snippet"": ""After genetic analysis, a novel homozygous (c.1131+2T>C) variant of AGK gene was identified in the proband."", ""supports"": ""SUPPORT""}"
7352	7061	304	Shigellosis	Shigellosis.yaml	genetic	0	evidence	0	PMID:40915309	SUPPORT		prevention of infection with vaccination and sanitation strategies remains a crucial step in reducing worldwide morbidity and mortality	Understanding NLRC4 genetic variation in susceptible populations informs vaccine design targeting T3SS components	"{""explanation"": ""Understanding NLRC4 genetic variation in susceptible populations informs vaccine design targeting T3SS components"", ""reference"": ""PMID:40915309"", ""snippet"": ""prevention of infection with vaccination and sanitation strategies remains a crucial step in reducing worldwide morbidity and mortality"", ""supports"": ""SUPPORT""}"
7353	7062	304	Shigellosis	Shigellosis.yaml	genetic	1	evidence	0	PMID:40915309	SUPPORT		Rising antibiotic resistance rates increasingly reduce the ability to adequately treat severe disease	NLRP3 genetic variation may contribute to inter-individual differences in disease severity and treatment response	"{""explanation"": ""NLRP3 genetic variation may contribute to inter-individual differences in disease severity and treatment response"", ""reference"": ""PMID:40915309"", ""snippet"": ""Rising antibiotic resistance rates increasingly reduce the ability to adequately treat severe disease"", ""supports"": ""SUPPORT""}"
7354	7063	304	Shigellosis	Shigellosis.yaml	genetic	2	evidence	0	PMID:29493962	SUPPORT		Shigella produces 3 enterotoxins that cause watery or bloody diarrhea and infection-associated symptoms, eg, tenesmus, malaise, and fever	CASP1-mediated pyroptosis in response to Shigella T3SS components drives the inflammatory manifestations of disease	"{""explanation"": ""CASP1-mediated pyroptosis in response to Shigella T3SS components drives the inflammatory manifestations of disease"", ""reference"": ""PMID:29493962"", ""snippet"": ""Shigella produces 3 enterotoxins that cause watery or bloody diarrhea and infection-associated symptoms, eg, tenesmus, malaise, and fever"", ""supports"": ""SUPPORT""}"
7355	7064	304	Shigellosis	Shigellosis.yaml	genetic	3	evidence	0	PMID:37952487	SUPPORT		destruction and inflammation of the colonic epithelium accompanied by acute diarrhea, fever, and abdominal pain	GSDMD-mediated pore formation drives epithelial damage and loss of barrier integrity	"{""explanation"": ""GSDMD-mediated pore formation drives epithelial damage and loss of barrier integrity"", ""reference"": ""PMID:37952487"", ""snippet"": ""destruction and inflammation of the colonic epithelium accompanied by acute diarrhea, fever, and abdominal pain"", ""supports"": ""SUPPORT""}"
7356	7065	304	Shigellosis	Shigellosis.yaml	genetic	4	evidence	0	PMID:29493962	SUPPORT		Shigella produces 3 enterotoxins that cause watery or bloody diarrhea and infection-associated symptoms	CASP4/5-mediated non-canonical inflammasome activation in response to bacterial LPS contributes to mucosal damage	"{""explanation"": ""CASP4/5-mediated non-canonical inflammasome activation in response to bacterial LPS contributes to mucosal damage"", ""reference"": ""PMID:29493962"", ""snippet"": ""Shigella produces 3 enterotoxins that cause watery or bloody diarrhea and infection-associated symptoms"", ""supports"": ""SUPPORT""}"
7357	7066	304	Shigellosis	Shigellosis.yaml	genetic	5	evidence	0	PMID:37952487	SUPPORT		The human-specific nature of shigellosis and the absence of a dependable animal model have posed significant obstacles in understanding Shigella pathogenesis	TLR1/TLR2 polymorphisms likely contribute to the observed variation in disease severity across populations with different genetic backgrounds	"{""explanation"": ""TLR1/TLR2 polymorphisms likely contribute to the observed variation in disease severity across populations with different genetic backgrounds"", ""reference"": ""PMID:37952487"", ""snippet"": ""The human-specific nature of shigellosis and the absence of a dependable animal model have posed significant obstacles in understanding Shigella pathogenesis"", ""supports"": ""SUPPORT""}"
7358	7067	304	Shigellosis	Shigellosis.yaml	genetic	6	evidence	0	PMID:32940644	SUPPORT		lack of the Lewis histo-blood group antigen was associated with increased susceptibility to shigellosis	Genetic control of glycan biosynthesis influences epithelial cell susceptibility to Shigella invasion	"{""explanation"": ""Genetic control of glycan biosynthesis influences epithelial cell susceptibility to Shigella invasion"", ""reference"": ""PMID:32940644"", ""snippet"": ""lack of the Lewis histo-blood group antigen was associated with increased susceptibility to shigellosis"", ""supports"": ""SUPPORT""}"
7382	7092	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	genetic	0	evidence	0	PMID:18667698	SUPPORT		Sickle cell disease (SCD) is a debilitating monogenic blood disorder with a highly variable phenotype characterized by severe pain crises, acute clinical events, and early mortality.	Confirms SCD is a monogenic blood disorder caused by HBB mutations.	"{""explanation"": ""Confirms SCD is a monogenic blood disorder caused by HBB mutations."", ""reference"": ""PMID:18667698"", ""snippet"": ""Sickle cell disease (SCD) is a debilitating monogenic blood disorder with a highly variable phenotype characterized by severe pain crises, acute clinical events, and early mortality."", ""supports"": ""SUPPORT""}"
7383	7093	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	genetic	1	evidence	0	PMID:18667698	SUPPORT		Common single nucleotide polymorphisms (SNPs) at the BCL11A and HBS1L-MYB loci have been implicated previously in HbF level variation	BCL11A polymorphisms regulate fetal hemoglobin levels and modify sickle cell disease severity.	"{""explanation"": ""BCL11A polymorphisms regulate fetal hemoglobin levels and modify sickle cell disease severity."", ""reference"": ""PMID:18667698"", ""snippet"": ""Common single nucleotide polymorphisms (SNPs) at the BCL11A and HBS1L-MYB loci have been implicated previously in HbF level variation"", ""supports"": ""SUPPORT""}"
7384	7094	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	genetic	2	evidence	0	PMID:18667698	SUPPORT		Together, common SNPs at the BCL11A, HBS1L-MYB, and beta-globin (HBB) loci account for >20% of the variation in HbF levels in SCD patients.	HBS1L-MYB locus polymorphisms are major modifiers of HbF levels in sickle cell disease.	"{""explanation"": ""HBS1L-MYB locus polymorphisms are major modifiers of HbF levels in sickle cell disease."", ""reference"": ""PMID:18667698"", ""snippet"": ""Together, common SNPs at the BCL11A, HBS1L-MYB, and beta-globin (HBB) loci account for >20% of the variation in HbF levels in SCD patients."", ""supports"": ""SUPPORT""}"
7448	7209	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	genetic	0	evidence	0	PMID:18572081	SUPPORT		It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation.	Lancet review confirms SMN1 gene disruption is the causative mechanism of SMA.	"{""explanation"": ""Lancet review confirms SMN1 gene disruption is the causative mechanism of SMA."", ""reference"": ""PMID:18572081"", ""snippet"": ""It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation."", ""supports"": ""SUPPORT""}"
7461	7227	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	genetic	0	evidence	0	PMID:7550321	SUPPORT	HUMAN_CLINICAL	We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1.	Established that heterozygous COL2A1 mutations are causative in SEMD Strudwick through biochemical characterization in multiple unrelated patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Established that heterozygous COL2A1 mutations are causative in SEMD Strudwick through biochemical characterization in multiple unrelated patients."", ""reference"": ""PMID:7550321"", ""snippet"": ""We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1."", ""supports"": ""SUPPORT""}"
7462	7227	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	genetic	0	evidence	1	PMID:12925722	SUPPORT	HUMAN_CLINICAL	All previously reported autosomal dominant mutations causing SEMD have substituted an obligate glycine within the triple helix, in particular at codons 292, 304 and 709 in the three reported Strudwick-type patients.	Documents specific glycine substitution mutations at codons 292, 304, and 709 that cause Strudwick-type SEMD.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents specific glycine substitution mutations at codons 292, 304, and 709 that cause Strudwick-type SEMD."", ""reference"": ""PMID:12925722"", ""snippet"": ""All previously reported autosomal dominant mutations causing SEMD have substituted an obligate glycine within the triple helix, in particular at codons 292, 304 and 709 in the three reported Strudwick-type patients."", ""supports"": ""SUPPORT""}"
7471	7244	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	genetic	0	evidence	0	PMID:1971141	SUPPORT	HUMAN_CLINICAL	Previous evidence suggesting defects of type II collagen associated with the SEDC phenotype led us to genotype the family for various COL2A1 gene-associated RFLPs. A total of 17 affected and unaffected members of this family were studied. The family was informative for a recently discovered HinfI RFLP. No recombinants between the marker and the phenotype were found in eight informative meioses. A maximum LOD score of 3.01 was obtained at a recombination fraction of .00. Our results indicate that the SEDC phenotype in this family is caused by mutations in or very close to the COL2A1 locus.	This landmark linkage study established that SEDC is caused by mutations in or near the COL2A1 gene, with a highly significant LOD score of 3.01.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This landmark linkage study established that SEDC is caused by mutations in or near the COL2A1 gene, with a highly significant LOD score of 3.01."", ""reference"": ""PMID:1971141"", ""snippet"": ""Previous evidence suggesting defects of type II collagen associated with the SEDC phenotype led us to genotype the family for various COL2A1 gene-associated RFLPs. A total of 17 affected and unaffected members of this family were studied. The family was informative for a recently discovered HinfI RFLP. No recombinants between the marker and the phenotype were found in eight informative meioses. A maximum LOD score of 3.01 was obtained at a recombination fraction of .00. Our results indicate that the SEDC phenotype in this family is caused by mutations in or very close to the COL2A1 locus."", ""supports"": ""SUPPORT""}"
7472	7244	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	genetic	0	evidence	1	PMID:7550321	SUPPORT	HUMAN_CLINICAL	A clinical spectrum of chondrodysplasia phenotypes, ranging from mild to perinatal lethal, is due to defects in the gene for type II collagen, COL2A1. This spectrum includes Stickler syndrome, Kniest dysplasia, spondyloepiphyseal dysplasia congenita (SEDC), achondrogenesis type II, and hypochondrogenesis.	This study confirms SEDC is part of the clinical spectrum of COL2A1-related chondrodysplasias and demonstrates that COL2A1 mutations produce a range of phenotypes including SEDC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study confirms SEDC is part of the clinical spectrum of COL2A1-related chondrodysplasias and demonstrates that COL2A1 mutations produce a range of phenotypes including SEDC."", ""reference"": ""PMID:7550321"", ""snippet"": ""A clinical spectrum of chondrodysplasia phenotypes, ranging from mild to perinatal lethal, is due to defects in the gene for type II collagen, COL2A1. This spectrum includes Stickler syndrome, Kniest dysplasia, spondyloepiphyseal dysplasia congenita (SEDC), achondrogenesis type II, and hypochondrogenesis."", ""supports"": ""SUPPORT""}"
7497	7282	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	genetic	0	evidence	0	PMID:35084720	SUPPORT		In spite of the unique clinical phenotype that each of these disorders has, there is significant overlapping symptomatology characterized by autoimmune neuronal excitability	The shared autoimmune basis across GAD-spectrum disorders implies common genetic susceptibility factors including HLA associations.	"{""explanation"": ""The shared autoimmune basis across GAD-spectrum disorders implies common genetic susceptibility factors including HLA associations."", ""reference"": ""PMID:35084720"", ""snippet"": ""In spite of the unique clinical phenotype that each of these disorders has, there is significant overlapping symptomatology characterized by autoimmune neuronal excitability"", ""supports"": ""SUPPORT""}"
7524	7302	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	genetic	0	evidence	0	PMID:15208645	SUPPORT		The t(X;18)(p11.2;q11.2) is the cytogenetic hallmark of synovial sarcoma and is present in more than 90% of the cases.	Abstract notes t(X;18) as the cytogenetic hallmark of synovial sarcoma.	"{""explanation"": ""Abstract notes t(X;18) as the cytogenetic hallmark of synovial sarcoma."", ""reference"": ""PMID:15208645"", ""snippet"": ""The t(X;18)(p11.2;q11.2) is the cytogenetic hallmark of synovial sarcoma and is present in more than 90% of the cases."", ""supports"": ""SUPPORT""}"
7553	7326	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	0	evidence	0	PMID:37801591	SUPPORT		HLA-DR2 patients had an earlier onset of disease as well as a higher prevalence of oral ulcer, avascular necrosis of bone, and renal involvement (lupus nephritis)	The study indicates that HLA-DR2 is associated with an increased susceptibility to SLE in the Taiwanese population.	"{""explanation"": ""The study indicates that HLA-DR2 is associated with an increased susceptibility to SLE in the Taiwanese population."", ""reference"": ""PMID:37801591"", ""snippet"": ""HLA-DR2 patients had an earlier onset of disease as well as a higher prevalence of oral ulcer, avascular necrosis of bone, and renal involvement (lupus nephritis)"", ""supports"": ""SUPPORT""}"
7554	7327	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	1	evidence	0	PMID:17910142	PARTIAL		A positive HLA-DR3 anti-Ro/La antibody association was found in the patients with SLE (9/21, 43% vs 5/55, 9%; odds ratio (OR) = 7.5; CP = 0.01).	The study finds a significant association between HLA-DR3 and the presence of anti-Ro/La antibodies in SLE patients, though it does not establish that HLA-DR3 alone is a genetic risk factor for SLE.	"{""explanation"": ""The study finds a significant association between HLA-DR3 and the presence of anti-Ro/La antibodies in SLE patients, though it does not establish that HLA-DR3 alone is a genetic risk factor for SLE."", ""reference"": ""PMID:17910142"", ""snippet"": ""A positive HLA-DR3 anti-Ro/La antibody association was found in the patients with SLE (9/21, 43% vs 5/55, 9%; odds ratio (OR) = 7.5; CP = 0.01)."", ""supports"": ""PARTIAL""}"
7555	7327	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	1	evidence	1	PMID:6103441	NO_EVIDENCE		It was also noted that the distribution of DR antigens in the hydralazine-SLE patients was significantly different from that in the group with idiopathic SLE.	This study highlights differences in HLA-DR distribution between drug-induced SLE and idiopathic SLE, but it does not specifically address the genetic contribution of HLA-DR3 to idiopathic SLE.	"{""explanation"": ""This study highlights differences in HLA-DR distribution between drug-induced SLE and idiopathic SLE, but it does not specifically address the genetic contribution of HLA-DR3 to idiopathic SLE."", ""reference"": ""PMID:6103441"", ""snippet"": ""It was also noted that the distribution of DR antigens in the hydralazine-SLE patients was significantly different from that in the group with idiopathic SLE."", ""supports"": ""NO_EVIDENCE""}"
7556	7328	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	2	evidence	0	PMID:31232672	SUPPORT		We found that the PTPN22 polymorphisms rs1310182 A allele (p = 0.01, OR = 1.92 95% CI = 1.16-3.18), and rs1310182 AA genotype with (p < 0.001) and rs12760457 TT (p = 0.046) were associated with PSLE.	The study indicates that certain polymorphisms in the PTPN22 gene are associated with pediatric systemic lupus erythematosus (PSLE), supporting the genetic association between PTPN22 and SLE.	"{""explanation"": ""The study indicates that certain polymorphisms in the PTPN22 gene are associated with pediatric systemic lupus erythematosus (PSLE), supporting the genetic association between PTPN22 and SLE."", ""reference"": ""PMID:31232672"", ""snippet"": ""We found that the PTPN22 polymorphisms rs1310182 A allele (p = 0.01, OR = 1.92 95% CI = 1.16-3.18), and rs1310182 AA genotype with (p < 0.001) and rs12760457 TT (p = 0.046) were associated with PSLE."", ""supports"": ""SUPPORT""}"
7557	7329	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	3	evidence	0	PMID:23912645	SUPPORT		Our results showed a significant association between rs7574865 T allele (odds ratio (OR) = 1.50, 95 % CI = 1.18-1.92, P = 0.002) and susceptibility to SLE.	The study found a significant association between the STAT4 gene (specifically rs7574865) and susceptibility to SLE.	"{""explanation"": ""The study found a significant association between the STAT4 gene (specifically rs7574865) and susceptibility to SLE."", ""reference"": ""PMID:23912645"", ""snippet"": ""Our results showed a significant association between rs7574865 T allele (odds ratio (OR) = 1.50, 95 % CI = 1.18-1.92, P = 0.002) and susceptibility to SLE."", ""supports"": ""SUPPORT""}"
7558	7329	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	3	evidence	1	PMID:31082500	SUPPORT		Analysis of existing transcriptomes and GWAS data identified eight up-regulated candidate genes with more than four relationships among the different pathways associated with SNPs to pinpoint the relevant loci linked to SLE... STAT4...	This study identified STAT4 as one of the candidate genes associated with SLE through transcriptomic data analysis and pathway analysis of GWAS data.	"{""explanation"": ""This study identified STAT4 as one of the candidate genes associated with SLE through transcriptomic data analysis and pathway analysis of GWAS data."", ""reference"": ""PMID:31082500"", ""snippet"": ""Analysis of existing transcriptomes and GWAS data identified eight up-regulated candidate genes with more than four relationships among the different pathways associated with SNPs to pinpoint the relevant loci linked to SLE... STAT4..."", ""supports"": ""SUPPORT""}"
7559	7329	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	3	evidence	2	PMID:34525002	SUPPORT		The main objective of this study was to evaluate an association between HLA, STAT4, IRF5, and BLK polymorphisms and the presence of JA in Brazilian individuals with SLE. METHODS: Patients were selected from a cohort of individuals with SLE followed at 2 rheumatology reference centers in Salvador, Bahia, Brazil.	The study aimed to evaluate the association between STAT4 polymorphisms and the presence of Jaccoud Arthropathy in individuals with SLE, implying an association between STAT4 and SLE.	"{""explanation"": ""The study aimed to evaluate the association between STAT4 polymorphisms and the presence of Jaccoud Arthropathy in individuals with SLE, implying an association between STAT4 and SLE."", ""reference"": ""PMID:34525002"", ""snippet"": ""The main objective of this study was to evaluate an association between HLA, STAT4, IRF5, and BLK polymorphisms and the presence of JA in Brazilian individuals with SLE. METHODS: Patients were selected from a cohort of individuals with SLE followed at 2 rheumatology reference centers in Salvador, Bahia, Brazil."", ""supports"": ""SUPPORT""}"
7560	7330	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	4	evidence	0	PMID:20962850	SUPPORT		Our results replicate previously reported associations to alleles of interferon regulatory factor 5 (IRF5)... This study confirms the existence of multiple genetic risk factors for SLE...	The study clearly identifies IRF5 as one of the genetic risk factors associated with SLE.	"{""explanation"": ""The study clearly identifies IRF5 as one of the genetic risk factors associated with SLE."", ""reference"": ""PMID:20962850"", ""snippet"": ""Our results replicate previously reported associations to alleles of interferon regulatory factor 5 (IRF5)... This study confirms the existence of multiple genetic risk factors for SLE..."", ""supports"": ""SUPPORT""}"
7561	7330	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	4	evidence	1	PMID:26233721	SUPPORT		This meta-analysis demonstrated the IRF5 rs2070197 polymorphism conferred susceptibility to SLE in all subjects... The IRF5 rs2070197 polymorphism was identified as risk factors for SLE...	The meta-analysis confirms the association of IRF5 polymorphism with SLE in multiple populations.	"{""explanation"": ""The meta-analysis confirms the association of IRF5 polymorphism with SLE in multiple populations."", ""reference"": ""PMID:26233721"", ""snippet"": ""This meta-analysis demonstrated the IRF5 rs2070197 polymorphism conferred susceptibility to SLE in all subjects... The IRF5 rs2070197 polymorphism was identified as risk factors for SLE..."", ""supports"": ""SUPPORT""}"
7562	7330	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	4	evidence	2	PMID:23251221	SUPPORT		Interferon regulatory factor 5 (IRF5) is a transcription factor which... genetic variants of IRF5 have been strongly linked to SLE pathogenesis.	The paper discusses the role of IRF5 in SLE pathogenesis and confirms its genetic association with the disease.	"{""explanation"": ""The paper discusses the role of IRF5 in SLE pathogenesis and confirms its genetic association with the disease."", ""reference"": ""PMID:23251221"", ""snippet"": ""Interferon regulatory factor 5 (IRF5) is a transcription factor which... genetic variants of IRF5 have been strongly linked to SLE pathogenesis."", ""supports"": ""SUPPORT""}"
7563	7330	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	4	evidence	3	PMID:20453440	SUPPORT		Recent large-scale studies in the Caucasian populations identified many new susceptibility genes to systemic lupus erythematosus (SLE)... In IRF5, the risk haplotype in Caucasians was not present in Japanese... All of these genes were associated with SLE...	The study confirms that IRF5 is associated with SLE in both Caucasian and Japanese populations.	"{""explanation"": ""The study confirms that IRF5 is associated with SLE in both Caucasian and Japanese populations."", ""reference"": ""PMID:20453440"", ""snippet"": ""Recent large-scale studies in the Caucasian populations identified many new susceptibility genes to systemic lupus erythematosus (SLE)... In IRF5, the risk haplotype in Caucasians was not present in Japanese... All of these genes were associated with SLE..."", ""supports"": ""SUPPORT""}"
7564	7330	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	genetic	4	evidence	4	PMID:36245280	SUPPORT		IRF5 plays a crucial role in the development of lupus... Genome-wide association studies have identified several systemic lupus erythematosus (SLE) risk single-nucleotide polymorphisms (SNPs) enriched in the IRF5 locus.	The study identifies IRF5 as playing a key role in SLE development with confirmed risk SNPs.	"{""explanation"": ""The study identifies IRF5 as playing a key role in SLE development with confirmed risk SNPs."", ""reference"": ""PMID:36245280"", ""snippet"": ""IRF5 plays a crucial role in the development of lupus... Genome-wide association studies have identified several systemic lupus erythematosus (SLE) risk single-nucleotide polymorphisms (SNPs) enriched in the IRF5 locus."", ""supports"": ""SUPPORT""}"
7657	7389	320	TARP syndrome	TARP_syndrome.yaml	genetic	0	evidence	0	PMID:36944446	SUPPORT		a previously unreported splicing mutation c.2295+1G>A in the RBM10 gene	Lane et al. 2023 documents RBM10 splice-site mutations as causative for TARP syndrome.	"{""explanation"": ""Lane et al. 2023 documents RBM10 splice-site mutations as causative for TARP syndrome."", ""reference"": ""PMID:36944446"", ""snippet"": ""a previously unreported splicing mutation c.2295+1G>A in the RBM10 gene"", ""supports"": ""SUPPORT""}"
7802	7544	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	genetic	0	evidence	0	PMID:31045815	SUPPORT		TP53 gene is mutated in approximately 80% of triple-negative breast cancer (TNBC).	Abstract reports TP53 mutation frequency in TNBC, supporting this genetic association.	"{""explanation"": ""Abstract reports TP53 mutation frequency in TNBC, supporting this genetic association."", ""reference"": ""PMID:31045815"", ""snippet"": ""TP53 gene is mutated in approximately 80% of triple-negative breast cancer (TNBC)."", ""supports"": ""SUPPORT""}"
7960	7643	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	0	evidence	0	PMID:22184118	SUPPORT		HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D).	This study identifies HLA-DQ2 as a strongly predisposing haplotype for type 1 diabetes susceptibility.	"{""explanation"": ""This study identifies HLA-DQ2 as a strongly predisposing haplotype for type 1 diabetes susceptibility."", ""reference"": ""PMID:22184118"", ""snippet"": ""HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D)."", ""supports"": ""SUPPORT""}"
7961	7644	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	1	evidence	0	PMID:22184118	SUPPORT		HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D).	This statement specifically mentions HLA-DQ8 as a strong predisposing haplotype for type 1 diabetes, supporting the association with susceptibility.	"{""explanation"": ""This statement specifically mentions HLA-DQ8 as a strong predisposing haplotype for type 1 diabetes, supporting the association with susceptibility."", ""reference"": ""PMID:22184118"", ""snippet"": ""HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D)."", ""supports"": ""SUPPORT""}"
7962	7644	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	1	evidence	1	PMID:26492519	SUPPORT		The DR3-DQ2/DR4-DQ8 genotype conferred the highest detected risk for T1D.	This study identifies the DR4-DQ8 genotype as highly associated with a risk for developing type 1 diabetes, thus supporting the genetic susceptibility.	"{""explanation"": ""This study identifies the DR4-DQ8 genotype as highly associated with a risk for developing type 1 diabetes, thus supporting the genetic susceptibility."", ""reference"": ""PMID:26492519"", ""snippet"": ""The DR3-DQ2/DR4-DQ8 genotype conferred the highest detected risk for T1D."", ""supports"": ""SUPPORT""}"
7963	7644	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	1	evidence	2	PMID:34946827	SUPPORT		The combination of HLA-DQA1*03:01 and DQB1*03:02 alleles (summarized as 'HLA-DQ8') is reported to be among the two most prevalent HLA class II haplotypes in Caucasian type 1 diabetes patients.	This reference confirms that HLA-DQ8 is one of the most prevalent haplotypes among type 1 diabetes patients in the studied population, supporting its association with susceptibility.	"{""explanation"": ""This reference confirms that HLA-DQ8 is one of the most prevalent haplotypes among type 1 diabetes patients in the studied population, supporting its association with susceptibility."", ""reference"": ""PMID:34946827"", ""snippet"": ""The combination of HLA-DQA1*03:01 and DQB1*03:02 alleles (summarized as 'HLA-DQ8') is reported to be among the two most prevalent HLA class II haplotypes in Caucasian type 1 diabetes patients."", ""supports"": ""SUPPORT""}"
7964	7645	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	2	evidence	0	PMID:15529622	SUPPORT		Our results indicate an exceptionally strong association of the class I INS-VNTR alleles with T1DM for the Romanian population.	The study presents evidence of a strong association between INS-VNTR alleles of the insulin gene and susceptibility to type 1 diabetes in the Romanian population.	"{""explanation"": ""The study presents evidence of a strong association between INS-VNTR alleles of the insulin gene and susceptibility to type 1 diabetes in the Romanian population."", ""reference"": ""PMID:15529622"", ""snippet"": ""Our results indicate an exceptionally strong association of the class I INS-VNTR alleles with T1DM for the Romanian population."", ""supports"": ""SUPPORT""}"
7965	7645	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	2	evidence	1	PMID:8934932	SUPPORT		Genetic susceptibility predominantly results from specific alleles in the HLA complex and insulin gene region.	This paper states that genetic susceptibility to insulin-dependent diabetes mellitus predominantly results from specific alleles, including those in the insulin gene region.	"{""explanation"": ""This paper states that genetic susceptibility to insulin-dependent diabetes mellitus predominantly results from specific alleles, including those in the insulin gene region."", ""reference"": ""PMID:8934932"", ""snippet"": ""Genetic susceptibility predominantly results from specific alleles in the HLA complex and insulin gene region."", ""supports"": ""SUPPORT""}"
7966	7645	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	2	evidence	2	PMID:11845220	SUPPORT		However, only within the past decade has it been possible to systematically attempt to identify the genes that increase susceptibility to this disorder using linkage and association analysis of genetic markers distributed across the genome.	This study discusses the identification of susceptibility genes for type 1 diabetes, including the insulin gene.	"{""explanation"": ""This study discusses the identification of susceptibility genes for type 1 diabetes, including the insulin gene."", ""reference"": ""PMID:11845220"", ""snippet"": ""However, only within the past decade has it been possible to systematically attempt to identify the genes that increase susceptibility to this disorder using linkage and association analysis of genetic markers distributed across the genome."", ""supports"": ""SUPPORT""}"
7967	7645	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	2	evidence	3	PMID:11921414	SUPPORT		Because insulin has such a central role in the pathogenesis of both forms of diabetes, the insulin gene (INS) has always been considered a candidate susceptibility gene.	The paper directly states that the insulin gene is considered a candidate susceptibility gene.	"{""explanation"": ""The paper directly states that the insulin gene is considered a candidate susceptibility gene."", ""reference"": ""PMID:11921414"", ""snippet"": ""Because insulin has such a central role in the pathogenesis of both forms of diabetes, the insulin gene (INS) has always been considered a candidate susceptibility gene."", ""supports"": ""SUPPORT""}"
7968	7645	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	2	evidence	4	PMID:11347740	SUPPORT		The disease-associated INS genotype (Hph I) was identified in 87.5% of the concordant twins but only in 59.5% (P = 0.005) of the discordant twins.	The study demonstrates the presence of a disease-associated INS genotype in a high percentage of concordant twins for type 1 diabetes.	"{""explanation"": ""The study demonstrates the presence of a disease-associated INS genotype in a high percentage of concordant twins for type 1 diabetes."", ""reference"": ""PMID:11347740"", ""snippet"": ""The disease-associated INS genotype (Hph I) was identified in 87.5% of the concordant twins but only in 59.5% (P = 0.005) of the discordant twins."", ""supports"": ""SUPPORT""}"
7969	7645	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	2	evidence	5	PMID:33483996	SUPPORT		Over half of the genetic risk has been attributed to the human leukocyte antigen (HLA) class II gene region and to the insulin (INS) gene locus.	This article attributes a significant portion of the genetic risk for type 1 diabetes to the insulin (INS) gene locus.	"{""explanation"": ""This article attributes a significant portion of the genetic risk for type 1 diabetes to the insulin (INS) gene locus."", ""reference"": ""PMID:33483996"", ""snippet"": ""Over half of the genetic risk has been attributed to the human leukocyte antigen (HLA) class II gene region and to the insulin (INS) gene locus."", ""supports"": ""SUPPORT""}"
7970	7646	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	3	evidence	0	PMID:15734872	SUPPORT		The homozygous genotype for the T allele encoding the 620W residue is associated with an increased risk for developing type 1 diabetes	This study demonstrates that the PTPN22 R620W polymorphism confers significant genetic susceptibility to type 1 diabetes in Caucasian populations.	"{""explanation"": ""This study demonstrates that the PTPN22 R620W polymorphism confers significant genetic susceptibility to type 1 diabetes in Caucasian populations."", ""reference"": ""PMID:15734872"", ""snippet"": ""The homozygous genotype for the T allele encoding the 620W residue is associated with an increased risk for developing type 1 diabetes"", ""supports"": ""SUPPORT""}"
7971	7647	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	4	evidence	0	PMID:22461703	SUPPORT		CD4(+)CD25(+) regulatory T cells (Tregs) from individuals with a range of human autoimmune diseases, including type 1 diabetes, are deficient in their ability to control autologous proinflammatory responses	This study demonstrates that IL2RA variants associated with type 1 diabetes lead to diminished IL-2 responsiveness and impaired regulatory T cell function.	"{""explanation"": ""This study demonstrates that IL2RA variants associated with type 1 diabetes lead to diminished IL-2 responsiveness and impaired regulatory T cell function."", ""reference"": ""PMID:22461703"", ""snippet"": ""CD4(+)CD25(+) regulatory T cells (Tregs) from individuals with a range of human autoimmune diseases, including type 1 diabetes, are deficient in their ability to control autologous proinflammatory responses"", ""supports"": ""SUPPORT""}"
7972	7648	333	Type I Diabetes	Type_I_Diabetes.yaml	genetic	5	evidence	0	PMID:9353155	SUPPORT		the presence of a G-containing CTLA-4 genotype confers a moderate but significant RR for IDDM that is independent of age and genetic or immune disease markers	This study demonstrates that CTLA4 gene polymorphisms confer susceptibility to type 1 diabetes independent of other genetic and immune markers.	"{""explanation"": ""This study demonstrates that CTLA4 gene polymorphisms confer susceptibility to type 1 diabetes independent of other genetic and immune markers."", ""reference"": ""PMID:9353155"", ""snippet"": ""the presence of a G-containing CTLA-4 genotype confers a moderate but significant RR for IDDM that is independent of age and genetic or immune disease markers"", ""supports"": ""SUPPORT""}"
8152	7772	338	Vitiligo	Vitiligo.yaml	genetic	0	evidence	0	PMID:17637824	SUPPORT	HUMAN_CLINICAL	This study confirms genetic association of generalized vitiligo with variation in NALP1, which contains at least two independent risk signals.	The study identified and confirmed a genetic association between generalized vitiligo and variations in the NALP1 gene. This supports the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study identified and confirmed a genetic association between generalized vitiligo and variations in the NALP1 gene. This supports the statement."", ""reference"": ""PMID:17637824"", ""snippet"": ""This study confirms genetic association of generalized vitiligo with variation in NALP1, which contains at least two independent risk signals."", ""supports"": ""SUPPORT""}"
8153	7773	338	Vitiligo	Vitiligo.yaml	genetic	1	evidence	0	PMID:20410501	SUPPORT	HUMAN_CLINICAL	We also detected associations between generalized vitiligo and SNPs in two additional immune-related loci, RERE (P=7.07x10(-15)) and GZMB (P=3.44x10(-8)), and in a locus containing TYR (P=1.60x10(-18)), encoding tyrosinase.	The study identified a significant association between generalized vitiligo and a genetic locus containing the TYR gene.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study identified a significant association between generalized vitiligo and a genetic locus containing the TYR gene."", ""reference"": ""PMID:20410501"", ""snippet"": ""We also detected associations between generalized vitiligo and SNPs in two additional immune-related loci, RERE (P=7.07x10(-15)) and GZMB (P=3.44x10(-8)), and in a locus containing TYR (P=1.60x10(-18)), encoding tyrosinase."", ""supports"": ""SUPPORT""}"
8154	7773	338	Vitiligo	Vitiligo.yaml	genetic	1	evidence	1	PMID:32838589	SUPPORT	HUMAN_CLINICAL	The tyrosinase levels were significantly elevated in patients. The TT genotype was the most prevalent one in the patients... MiRNA 196a-2 C/T (11614913) gene polymorphism and the elevated serum tyrosinase levels might be related to the pathogenesis of vitiligo and may affect its therapeutic response.	Elevated serum tyrosinase levels in vitiligo patients suggest a genetic association involving the TYR gene with vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Elevated serum tyrosinase levels in vitiligo patients suggest a genetic association involving the TYR gene with vitiligo."", ""reference"": ""PMID:32838589"", ""snippet"": ""The tyrosinase levels were significantly elevated in patients. The TT genotype was the most prevalent one in the patients... MiRNA 196a-2 C/T (11614913) gene polymorphism and the elevated serum tyrosinase levels might be related to the pathogenesis of vitiligo and may affect its therapeutic response."", ""supports"": ""SUPPORT""}"
8155	7774	338	Vitiligo	Vitiligo.yaml	genetic	2	evidence	0	PMID:21515266	SUPPORT	HUMAN_CLINICAL	The PTPN22 locus is one of the strongest risk factors outside of the major histocompatability complex that associates with autoimmune diseases...vitiligo	The literature specifically mentions that PTPN22 is associated with vitiligo as part of its association with several autoimmune diseases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature specifically mentions that PTPN22 is associated with vitiligo as part of its association with several autoimmune diseases."", ""reference"": ""PMID:21515266"", ""snippet"": ""The PTPN22 locus is one of the strongest risk factors outside of the major histocompatability complex that associates with autoimmune diseases...vitiligo"", ""supports"": ""SUPPORT""}"
8156	7774	338	Vitiligo	Vitiligo.yaml	genetic	2	evidence	1	PMID:28164884	PARTIAL	HUMAN_CLINICAL	Several studies have demonstrated the association of protein tyrosine phosphatase, non-receptor type 22 +1858C-->T polymorphism with vitiligo... limited ethnic-based studies... In conclusion, protein tyrosine phosphatase, non-receptor type 22 +1858 T allele predisposes European individuals to vitiligo.	This source confirms the association but notes that the genetic association is specific to the European population and not found in the Asian population, suggesting partial support.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This source confirms the association but notes that the genetic association is specific to the European population and not found in the Asian population, suggesting partial support."", ""reference"": ""PMID:28164884"", ""snippet"": ""Several studies have demonstrated the association of protein tyrosine phosphatase, non-receptor type 22 +1858C-->T polymorphism with vitiligo... limited ethnic-based studies... In conclusion, protein tyrosine phosphatase, non-receptor type 22 +1858 T allele predisposes European individuals to vitiligo."", ""supports"": ""PARTIAL""}"
8157	7775	338	Vitiligo	Vitiligo.yaml	genetic	3	evidence	0	PMID:20197744	SUPPORT	HUMAN_CLINICAL	Genome-wide association studies (GWAS) have unveiled single nucleotide polymorphisms (SNPs) or genetic variants in MC1R, TPCN2, ASIP, KITLG, NCKX5, TYR, IRF4, OCA2, and TYRP1 pigmentation genes.	This reference provides evidence of an association between the MC1R gene and vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference provides evidence of an association between the MC1R gene and vitiligo."", ""reference"": ""PMID:20197744"", ""snippet"": ""Genome-wide association studies (GWAS) have unveiled single nucleotide polymorphisms (SNPs) or genetic variants in MC1R, TPCN2, ASIP, KITLG, NCKX5, TYR, IRF4, OCA2, and TYRP1 pigmentation genes."", ""supports"": ""SUPPORT""}"
8158	7775	338	Vitiligo	Vitiligo.yaml	genetic	3	evidence	1	PMID:33757175	SUPPORT	HUMAN_CLINICAL	MC1R was found as a key gene in vitiligo and involved in the melanogenesis.	This reference identifies MC1R as a key gene involved in vitiligo, providing further support for its genetic association.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference identifies MC1R as a key gene involved in vitiligo, providing further support for its genetic association."", ""reference"": ""PMID:33757175"", ""snippet"": ""MC1R was found as a key gene in vitiligo and involved in the melanogenesis."", ""supports"": ""SUPPORT""}"
8159	7776	338	Vitiligo	Vitiligo.yaml	genetic	4	evidence	0	PMID:17243956	SUPPORT	HUMAN_CLINICAL	Meta-analysis showed a significantly increased frequency of HLA-A2 in vitiligo among cases [OR = 2.07, 95% confidence interval (CI) 1.67-2.58].	The meta-analysis strongly suggests an association between HLA-A2, a specific allele of HLA-A, and vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The meta-analysis strongly suggests an association between HLA-A2, a specific allele of HLA-A, and vitiligo."", ""reference"": ""PMID:17243956"", ""snippet"": ""Meta-analysis showed a significantly increased frequency of HLA-A2 in vitiligo among cases [OR = 2.07, 95% confidence interval (CI) 1.67-2.58]."", ""supports"": ""SUPPORT""}"
8160	7777	338	Vitiligo	Vitiligo.yaml	genetic	5	evidence	0	PMID:34686989	SUPPORT	HUMAN_CLINICAL	In this study, we have evaluated the association and role of HLA-DRB4*01:01, -DRB1*07:01, and -DQB1*03:03:2 genes in different clinical subtypes of Vitiligo in the Iranian population.	The study discusses the association of different HLA-DRB1 allelic genes, including HLA-DRB1, with vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study discusses the association of different HLA-DRB1 allelic genes, including HLA-DRB1, with vitiligo."", ""reference"": ""PMID:34686989"", ""snippet"": ""In this study, we have evaluated the association and role of HLA-DRB4*01:01, -DRB1*07:01, and -DQB1*03:03:2 genes in different clinical subtypes of Vitiligo in the Iranian population."", ""supports"": ""SUPPORT""}"
8161	7777	338	Vitiligo	Vitiligo.yaml	genetic	5	evidence	1	PMID:20526339	SUPPORT	HUMAN_CLINICAL	Further analyses suggested that the strong association at rs11966200 might reflect the reported association of the HLA-A*3001, HLA-B*1302, HLA-C*0602 and HLA-DRB1*0701 alleles...	The findings of the genome-wide association study indicate an association of HLA-DRB1 alleles with vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The findings of the genome-wide association study indicate an association of HLA-DRB1 alleles with vitiligo."", ""reference"": ""PMID:20526339"", ""snippet"": ""Further analyses suggested that the strong association at rs11966200 might reflect the reported association of the HLA-A*3001, HLA-B*1302, HLA-C*0602 and HLA-DRB1*0701 alleles..."", ""supports"": ""SUPPORT""}"
8162	7777	338	Vitiligo	Vitiligo.yaml	genetic	5	evidence	2	PMID:6600753	SUPPORT	HUMAN_CLINICAL	Association of HLA-DR4 with vitiligo.	Although this specifically mentions HLA-DR4, it generally supports the connection between HLA class II genes and vitiligo, which includes HLA-DRB1.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Although this specifically mentions HLA-DR4, it generally supports the connection between HLA class II genes and vitiligo, which includes HLA-DRB1."", ""reference"": ""PMID:6600753"", ""snippet"": ""Association of HLA-DR4 with vitiligo."", ""supports"": ""SUPPORT""}"
8163	7778	338	Vitiligo	Vitiligo.yaml	genetic	6	evidence	0	PMID:22561518	SUPPORT	HUMAN_CLINICAL	IFIH1 (P = 4.91 × 10(-15))	Large-scale GWAS meta-analysis identified IFIH1 as a vitiligo susceptibility locus at genome-wide significance, encoding an immunoregulatory protein involved in innate immune sensing.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large-scale GWAS meta-analysis identified IFIH1 as a vitiligo susceptibility locus at genome-wide significance, encoding an immunoregulatory protein involved in innate immune sensing."", ""reference"": ""PMID:22561518"", ""snippet"": ""IFIH1 (P = 4.91 × 10(-15))"", ""supports"": ""SUPPORT""}"
8164	7779	338	Vitiligo	Vitiligo.yaml	genetic	7	evidence	0	PMID:22561518	SUPPORT	HUMAN_CLINICAL	BACH2 (P = 2.53 × 10(-8))	GWAS meta-analysis identified BACH2 as a vitiligo susceptibility locus at genome-wide significance. BACH2 encodes an immunoregulatory transcription factor involved in immune cell development.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GWAS meta-analysis identified BACH2 as a vitiligo susceptibility locus at genome-wide significance. BACH2 encodes an immunoregulatory transcription factor involved in immune cell development."", ""reference"": ""PMID:22561518"", ""snippet"": ""BACH2 (P = 2.53 × 10(-8))"", ""supports"": ""SUPPORT""}"
8165	7780	338	Vitiligo	Vitiligo.yaml	genetic	8	evidence	0	PMID:27723757	SUPPORT	HUMAN_CLINICAL	identified 23 new significantly associated loci and 7 suggestive loci. Most encode immune and apoptotic regulators, with some also associated with other autoimmune diseases, as well as several melanocyte regulators.	GWAS meta-analysis identified IRF4 as one of the 23 new vitiligo susceptibility loci at genome-wide significance (P = 8.86 × 10-16). IRF4 is a key transcription factor for both immune cells and melanocytes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GWAS meta-analysis identified IRF4 as one of the 23 new vitiligo susceptibility loci at genome-wide significance (P = 8.86 × 10-16). IRF4 is a key transcription factor for both immune cells and melanocytes."", ""reference"": ""PMID:27723757"", ""snippet"": ""identified 23 new significantly associated loci and 7 suggestive loci. Most encode immune and apoptotic regulators, with some also associated with other autoimmune diseases, as well as several melanocyte regulators."", ""supports"": ""SUPPORT""}"
8166	7781	338	Vitiligo	Vitiligo.yaml	genetic	9	evidence	0	PMID:33181260	SUPPORT	HUMAN_CLINICAL	FOXP3 mRNA and protein levels were significantly decreased (p < 0.001) in GV Tregs compared to controls	This study found that FOXP3 expression is significantly reduced in regulatory T cells of vitiligo patients, and identified FOXP3 promoter polymorphisms associated with disease susceptibility.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study found that FOXP3 expression is significantly reduced in regulatory T cells of vitiligo patients, and identified FOXP3 promoter polymorphisms associated with disease susceptibility."", ""reference"": ""PMID:33181260"", ""snippet"": ""FOXP3 mRNA and protein levels were significantly decreased (p < 0.001) in GV Tregs compared to controls"", ""supports"": ""SUPPORT""}"
8283	7878	342	Wilson Disease	Wilsons_Disease.yaml	genetic	0	evidence	0	PMID:37741465	SUPPORT		Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease, an autosomal recessive disorder	Establishes ATP7B mutations as the causative genetic defect in Wilson's disease.	"{""explanation"": ""Establishes ATP7B mutations as the causative genetic defect in Wilson's disease."", ""reference"": ""PMID:37741465"", ""snippet"": ""Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease, an autosomal recessive disorder"", ""supports"": ""SUPPORT""}"
8351	7928	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	genetic	0	evidence	0	PMID:32914558	SUPPORT		Less than half of the patients can be identified by conventional cytogenetics and molecular cytogenetic testing should be offered for diagnosis. Karyotyping of the parents should always be offered in a child with WHS.	This provides important diagnostic guidance regarding the need for molecular cytogenetic testing and parental karyotyping.	"{""explanation"": ""This provides important diagnostic guidance regarding the need for molecular cytogenetic testing and parental karyotyping."", ""reference"": ""PMID:32914558"", ""snippet"": ""Less than half of the patients can be identified by conventional cytogenetics and molecular cytogenetic testing should be offered for diagnosis. Karyotyping of the parents should always be offered in a child with WHS."", ""supports"": ""SUPPORT""}"
8393	7955	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	genetic	0	evidence	0	PMID:37215500	SUPPORT		two compound heterozygous mutations, including a likely pathogenic TELO2 variant, c.2245A > T (p.K749X) from her mother and an uncertain variant, c.2299C > T (p.R767C) from her father	Documents novel compound heterozygous TELO2 variants causing YHFS.	"{""explanation"": ""Documents novel compound heterozygous TELO2 variants causing YHFS."", ""reference"": ""PMID:37215500"", ""snippet"": ""two compound heterozygous mutations, including a likely pathogenic TELO2 variant, c.2245A > T (p.K749X) from her mother and an uncertain variant, c.2299C > T (p.R767C) from her father"", ""supports"": ""SUPPORT""}"
